ࡱ>   u v w x y z { | } ~   0sTbjbj  CL/dd)))))4)))hC* '6 );A.'ihhhhjTkm?nlWYYYYYY$`d})njjnn}))hhqqqnb)h)hWqnWqq0O"~h@/0) 9C0<Aff~~(f)Snnqnnnnn}}Ønnnnnnnfnnnnnnnnnd m(:  Handbook on Oral Disease (with emphasis on Diagnosis and Treatment) Samar Zaal Burgan, BDS, MSc, PhD Professor of Oral Medicine Faculty of Dentistry, University of Jordan Amman, Jordan This work was accomplished during a sabbatical year 2010-2011 granted by the University of Jordan Contents Preface Commonly-used abbreviations Oral ulcerative lesions Traumatic ulcer Eosinophilic ulcer Riga-Fede disease Psychiatric ulcer Iron deficiency anaemia Plummer-Vinson syndrome Vitamin B12 deficiency Folic acid deficiency Cyclic neutropenia Acute necrotic stomatitis or mucositis Fixed drug eruption Recurrent aphthous stomatitis Behcets disease Lupus erythematosus Erythema multiforme Lichen planus Pemphigus vulagris Mucous membrane pemphigoid Linear IgA disease Bullous pemphigoid Desquamative gingivitis Dermatitis herpetiformis Epidermolysis bullosa Angina bullosa haemorrhagica Oral infections Primary herpes simplex Recurrent herpes simplex Herpetic whitlow Chickenpox Herpes zoster Herpes zoster oticus Hand, foot and mouth disease Herpangina Focal epithelial hyperplasia Infectious mononucleosis Necrotising ulcerative gingivitis Tuberculosis Syphilis Actinomycosis Acute pseudomebraneous candidiasis Erythematous candidiasis Acquired immunodeficiency syndrome Systemic diseases with oral manifestations Scleroderma Amyloidosis Sarcoidosis Cystic fibrosis Wegeners granulomatosis Graft versus host disease Rheumatoid arthritis Food allergy Adverse drug reactions Crohn disease Ulcerative colitis Coeliac disease Tongue disorders Geographic tongue Fissured tongue Lingual thyroid Angioedema Oral hairy leukoplakia Ankyloglossia Coated tongue Black hairy tongue Burning mouth syndrome Granular cell tumor Macroglossia Lingual varicosities Oral white and red lesions Fordyces granules Leukoedema White sponge naevus Linea alba buccalis Lip and cheek biting Leukoplakia Erythroplakia Nicotine stomatitis Oral submucous fibrosis Lip disorders Lip pit Median lip fissure Cleft lip and palate Double lip Cheilitis glanduaris Actinic cheilitis Exfoliative cheilitis Contact cheilitis Granulomatous cheilitis Angular cheilitis Lip-lickers dermatitis Plasma cell cheilitis Cutaneous leishmaniasis Keratoacanthoma Labial melanotic macule Lentigo maligna Abbreviations ACEangiotensin-converting enzymeELISAenzyme linked immunosorbent assayMW mouth wash ACTHadrenocorticotropic hormoneENTear, nose, and throatNoctebefore going to sleepAHAamerican heart associationESRerythrocyte sedimentation rateNSAIDs non-steroidal anti-inflammatory drugsAIDSacquired immunodeficiency syndromeFBPfull blood pictureNUGnecrotizing ulcerative gingivitisALPalkaline phosphataseFBSfasting blood sugarOPGorthopantomogramALT alanine transaminaseG6PD glucose 6-phosphate dehydrogenasePASperiodic acid-schiffANAantinuclear antibody GGTgamma glutamyl transpeptidasePCPpneumocystis carinii pneumoniaAST aspartate transaminaseGIgastrointestinalPETpositron emission tomographyAZAazathioprineGITgastrointestinal tractPRNper needBMD HYPERLINK "http://www.nlm.nih.gov/medlineplus/ency/article/003808.htm" bone mineral densityHbhaemoglobinPTprothrombin timeBotoxbotulinum toxin aHBA1cglycated haemoglobinPTTpartial thromboplastin timeBPblood pressureHCT (PCV)haematocrite (packed cell volume)RBCred blood cell CcomplementHDLhigh-density lipoproteinRCCred cell count (total)CACancerHIVhuman immunodeficiency virusREMrapid eye movementCABGcoronary artery-bypass graftingHPVhuman papillomavirusRFrheumatoid factorCBCcomplete blood countHSV herpes simplex virus SLS HYPERLINK "http://en.wikipedia.org/wiki/Sodium_dodecyl_sulfate" \o "Sodium dodecyl sulfate" sodium lauryl sulfateCDcluster of differentiationIgimmunoglobulin SPFsun protection factorCKcreatine kinaseImintramuscularT3triiodothyronineCRPc-reactive proteinIvintravenousT4thyroxineCSFcerebrospinal fluidKSkaposis sarcomaTIBCtotal iron binding capacityCTcomputed tomographyLDHlactate dehydrogenaseTMJtemporomandibular jointCTXchemotherapyLDLlow-density lipoproteinTSHthyroid stimulating hormoneDVT deep vein thrombosis LFTliver function testtspteaspoonDWCCdifferential white cell countMCHmean corpuscular haemoglobinU&Eurea and electrolytesEBVepstein-barr virusMCHCmean corpuscular haemoglobin concentrationWBCwhite blood cell ECGelectrocardiogramMCVmean cell volumeWCCwhite cell count (total)egfor exampleMRImagnetic resonance imagingWHOworld health organisation 1 Oral ulcerative lesions Traumatic ulcer Traumatic injury involving the oral cavity is one of the commonest causes of surface ulcerations, and it is frequently overlooked. If a patient presents with ulcers for the first time or of recent onset, and is quite healthy, then traumatic ulcer should be suspected first. In most cases, the source of the injury is identified and the patients usual complaint is pain or a painful ulceration. Traumatic ulcers are usually sensitive to hot, spicy or salty foods, and they heal within a few days after removal of the irritant. Aetiology Physical, chemical, electrical or thermal insults. Fractured, carious, malposed or malformed teeth, as well as premature eruption of teeth. Poorly maintained and  HYPERLINK "http://emedicine.medscape.com/article/1075994-overview" ill-fitting dental prosthetic appliances. Accidentally biting oneself while talking, sleeping or secondary to mastication. Diagnosis Usually a single ulcer is seen, with an obvious cause. There may be a small degree of ipsilateral cervical lymph node enlargement. Chronic irritation may cause hyperplasia or hyperkeratosis of the adjacent mucosa. Treatment Removal of the irritant or cause. Consumption of soft bland diet. Use of antiseptic and analgesic mouth washes. Application of topical corticosteroid oral gel. If the ulceration is accompanied with secondary infection, lymphadenitis and fever, then oral antibiotic therapy is recommended. Biopsy is needed if there is any suspicion of malignancy, or if the ulcer does not heal within 2 weeks of removal of the cause. Eosinophilic ulcer Eosinophilic ulcer of the oral mucosa is an uncommon benign ulcer that develops suddenly. It affects middle-aged to elderly adults. There is a slight female predominance reported. The lateral and dorsal surfaces of the tongue are most commonly affected, accounting for 60% of reported cases, followed by the lower lip. It appears as a solitary, painful nonhealing ulcer, with size ranges from a few mm to several cm. It should be differentiated from neoplastic ulcer. If eosinophilic ulcer is formed and chronic irritation persists, a reactive hyperplasia of the surrounding epithelium occurs, which appears as a raised white border. This keratosis is not present in a neoplastic ulcer which appears as a crater-like defect with raised rolled borders and indurated base. Aetiology The cause of eosinophilic ulcer is unknown. It may be due to chronic irritation or trauma. About one-third of patients have a history of a crush injury due to biting. Diagnosis The lesion is self-limiting. It has a characteristic appearance under the microscope. If left untreated, most heal spontaneously within 1 month, and this may be accelerated by excisional biopsy. Treatment The source of chronic irritation must be eliminated when an eosinophilic ulcer is due to obvious trauma. NSAIDs and topical anaesthetic oral rinses (eg lidocaine or dyclonine) may be used to provide temporary relief and comfort when the patient eats. Topical corticosteroid (eg triamcinolone oral gel or dexamethasone elixir) is often effective. As a rule, if the lesion does not resolve or if it continues to appear after 2 weeks of treatment, excisional biopsy is warranted. After biopsy, rapid healing of the ulcer is often typical, and no further treatment is necessary. Riga-Fede disease Riga-Fede disease is a form of eosinophilic ulcer that develops in infants, and typically is seen in children aged 1 week to 1 year. It usually occurs on the anterior ventral surface of the tongue. Aetiology It develops as a result of chronic mucosal trauma from adjacent anterior primary teeth, and it usually occurs in association with breastfeeding. Diagnosis The distinctive, self-limiting ulceration heals spontaneously upon removal of the trauma. Treatment Although extraction of the anterior primary teeth is not recommended, this may resolve the ulceration. If the teeth are stable, they should be retained and breastfeeding should be discontinued, or a protective shield should be constructed to prevent any further trauma. These measures are usually sufficient to resolve the condition. Psychiatric ulcer Rarely, oral ulceration may be self-induced (stomatitis artefacta) in the same way that some patients deliberately cause skin lesions in dermatitis artefacta. It is sometimes difficult to diagnose, and it is uncommon in children. It varies and depends on mode of production. Aetiology Lesions are produced or perpetuated by the patients own action. External causes include fingernails, sharp instruments, and chemicals. Diagnosis A vague history with frequent recurrence of ulcerations in the same area, which is accessible to the patient, delayed healing, non-specific histological features, and healing without scarring usually leads to diagnosis. Treatment Patients with repeated self-induced ulcerations may be considered for referral to a psychiatrist or psychologist. Iron deficiency anaemia It is the most common haematological deficiency, and can result in oral ulceration. Patients usually present complaining of a red sore tip of tongue, especially when eating hot or spicy food, which is an early sign of iron deficiency. Clinical examination may not reveal any obvious abnormality; although in long standing cases, loss of the fungiform and filiform papillae produce a smooth surface and a patchy atrophy with thinning of the mucosa. As the deficiency advances, the epithelium becomes eroded, leaving shallow ulcers resembling aphthae. Occasionally, in severe cases, large chronic ulcers are seen surrounded by areas of hyperkeratosis, which may resemble carcinoma. Angular cheilitis is common in iron deficiency, and pallor is unreliable, but may occur with low haemoglobin. Aetiology Poor absorption of iron by the body. Inadequate daily intake of iron. Blood loss due to heavy menstruation or internal bleeding.  HYPERLINK "http://www.mamashealth.com/pregnancy/" Pregnancy. Growth spurts. Diagnosis CBC and serum ferritin level should be routinely performed. In iron deficiency anaemia the blood picture is of hypochromic microcytic. Glossitis due to iron deficiency can occur even before the condition has progressed to anaemia, as measured by the haemoglobin level (sideropenic or latent anaemia). Treatment Analgesic mouth washes for oral ulcers. Ferrous sulphate or gluconate iron supplement for 3-6 months. Taking  HYPERLINK "http://www.mamashealth.com/oranges.asp" vitamin-C aides iron absorption. Referral to a haematologist is indicated. Plummer-Vinson syndrome Plummer-Vinson syndrome (PVS), also called Paterson-Brown-Kelly syndrome or sideropenic dysphagia, presents as a triad of  HYPERLINK "http://en.wikipedia.org/wiki/Dysphagia" \o "Dysphagia" dysphagia (due to  HYPERLINK "http://en.wikipedia.org/wiki/Esophageal_webs" \o "Esophageal webs" esophageal webs),  HYPERLINK "http://en.wikipedia.org/wiki/Glossitis" \o "Glossitis" glossitis, and  HYPERLINK "http://en.wikipedia.org/wiki/Iron_deficiency_anemia" \o "Iron deficiency anemia" iron deficiency anaemia. Plummer-Vinson syndrome sufferers often complain of burning sensation of the tongue and oral mucosa; and atrophy of lingual papillae produces a smooth, shiny red tongue dorsum. Women are at higher risk than men, particularly in middle age. In these patients, esophageal  HYPERLINK "http://en.wikipedia.org/wiki/Squamous_cell_carcinoma" \o "Squamous cell carcinoma" squamous cell carcinoma risk is increased. Therefore, it is considered a  HYPERLINK "http://en.wikipedia.org/wiki/Premalignant" \o "Premalignant" premalignant condition. Aetiology The cause is unknown.  HYPERLINK "http://en.wikipedia.org/wiki/Genetics" \o "Genetics" Genetic factors and  HYPERLINK "http://en.wikipedia.org/wiki/Nutrition" \o "Nutrition" nutritional deficiencies may play a role. Diagnosis Serial contrasted gastrointestinal  HYPERLINK "http://en.wikipedia.org/wiki/Radiography" \o "Radiography" radiography or upper gastrointestinal  HYPERLINK "http://en.wikipedia.org/wiki/Endoscopy" \o "Endoscopy" endoscopy may reveal the web in the esophagus. Biopsy taken of suspicious lesions may show epithelial atypia or  HYPERLINK "http://en.wikipedia.org/wiki/Dysplasia" \o "Dysplasia" dysplasia.  HYPERLINK "http://en.wikipedia.org/wiki/Blood_tests" \o "Blood tests" Blood tests show a hypochromic  HYPERLINK "http://en.wikipedia.org/wiki/Microcytic_anemia" \o "Microcytic anemia" microcytic anaemia that is consistent with iron deficiency anaemia. Treatment Primarily aimed at correcting the iron deficiency anaemia. Patients with PVS should receive  HYPERLINK "http://en.wikipedia.org/wiki/Iron" \o "Iron" iron supplementation in their  HYPERLINK "http://en.wikipedia.org/wiki/Diet_(nutrition)" \o "Diet (nutrition)" diet, which may improve dysphagia and pain. If no improvement, then the web can be dilated during  HYPERLINK "http://en.wikipedia.org/wiki/Upper_endoscopy" \o "Upper endoscopy" upper endoscopy to allow normal swallowing and passage of food. Vitamin B12 deficiency Clinical presentation is similar to that with iron deficiency anaemia; and the initial sign is a tender red tip, which spreads over the entire dorsum. This active inflammatory reaction produces the red raw beefy tongue, which later regresses as the filiform, fungiform and circumvallate papillae atrophy. Finally, the entire tongue is smooth and atrophic, prone to traumatic ulceration and surface erosions. The ventral surface may also become reddened and sore with small ulcers similar to aphthae. Generalised mucosal atrophy may take months or years to develop. Angular cheilitis is rare in vitamin B12 deficiency. Aetiology It may be idiopathic, secondary to gastric surgery, autoimmune, or may be due to diseases of the terminal ileum. Diagnosis Routine blood screening for CBC, serum vitamin B12 level, and antiparietal cell antibodies (APCA) (autoantibodies against the intrinsic factor in pernicious anaemia) will lead to a diagnosis. Vitamin B12 deficiency results in a megaloblastic macrocytic anaemia. A Schilling test may also be helpful if pernicious anaemia is suspected. Schilling test Radiolabelled vitamin B12 (small dose) given orally. Unlabelled vitamin B12 (large dose), given intramuscular 2 hours later. Collect urine over 24 hours. Normal: excrete more than 15% of radiolabelled B12 in 24 hours. B12 deficiency: excrete less than 15% of radiolabelled B12 in 24 hours. Repeat with added oral intrinsic factor. Pernicious anaemia: excretion of B12 increases to normal. Ileal disease: excretion of B12 remains low. Treatment Vitamin B12 can be given as intramuscular injections of cyanocobalamin; the dose and duration of treatment depend on aetiology. Oral replacement is now an accepted route, as it has become increasingly appreciated that sufficient quantities of B12 are absorbed when large doses are given (1-2 mg daily). This absorption does not rely on the presence of intrinsic factor or an intact ileum. However, with the advent of sublingual pill and intranasal spray administration, tablet usage is becoming outdated. The tongue changes are reversed rapidly following therapy. Folic acid deficiency In folic acid deficiency, oral mucosal atrophy is uncommon, but angular cheilitis always occurs. In infants and children, folate deficiency can slow growth rate. It should be remembered that large and prolonged doses of folic acid can lower the blood concentration of vitamin B12. Folic acid should never be given alone in treatment of pernicious anaemia or other B12 macrocytic anaemia because of the risk of precipitating subacute combined degeneration of the spinal cord. Aetiology Malabsorption syndrome such as coeliac disease is the commonest cause of folic acid deficiency, which usually presents in adolescence or early adulthood. It may also be associated with inadequate dietary intake, pregnancy, cytotoxic drugs, or due to drugs with long-term treatment such as anticonvulsants (eg carbamazepine or phenytoin). Diagnosis It can be made from the history. CBC, low serum folate and red cell folate level. Advanced folate deficiency results in a megaloblastic macrocytic anaemia. Treatment Folic acid tablets reverse the symptoms including those caused by malabsorption syndromes, in addition to gluten free diet in case of coeliac disease. Cyclic neutropenia It is a rare blood disorder characterised by recurrent periods of extremely low blood levels of neutrophils which results in frequent infections. The low levels usually occur every 21 days, and last for about 7 days. Levels of other blood components may also be affected. This condition occurs in both children and adults, and often presents in several members of the same family. Symptoms include fever, neutropenic ulcers, necrotising ulcerative gingivitis, and oral infections on regular intervals. Children with cyclic neutropenia usually improve after puberty. Aetiology Cyclic neutropenia is the result of autosomal dominantly inherited mutations in the neutrophil elastase gene ( HYPERLINK "http://en.wikipedia.org/wiki/ELA2" \o "ELA2" ELA2). Diagnosis Measure WCC and DWCC as a compensatory rise in numbers of other leucocyte types lead to normal total count. Acute and convalescent serum to exclude viral infections. Bone marrow biopsy. Treatment Treatment includes granulocyte colony stimulating factor (G-CSF) which stimulates the production of WBC. Chlorhexidine mouth wash and anaesthetic oral rinse or gel can give relief from pain and infection of oral ulcers. Acute necrotic stomatitis or mucositis The absence of granulocytes in peripheral blood may present as oral ulcerations, which initially are shallow and associated with irregular inflammatory red patches of mucosa. Eventually the ulcerations may progress to extensive necrotic painful lesions. Thus, during or after chemotherapy, a cancer patient may present with severe mucositis, and the condition may clear up in few days, unless recovery is slowed by malnutrition. If symptoms persist, viral or fungal infection should be examined. In addition, radiation treatment of the head and neck can destroy the salivary glands resulting in oral dryness and mucositis. Aetiology Bone marrow disease. Chemotherapy drugs. Radiation therapy. Diagnosis It can be made from history and CBC. Treatment Treatment is mostly supportive until the cells regenerate themselves. Maintain optimal oral hygiene measures. Use soft-bristle toothbrush (those used for children are the softest) and a bland tooth paste with fluoride. Floss gently with unwaxed dental floss (if platelets count adequate). Ill-fitting dental appliances or sharp teeth should be corrected by a dentist. Avoid spicy, coarse, or rough textured food, very hot or cold beverages and foods, citric juices or foods containing citric acid (tomatoes, oranges, lemon, etc.), tea, coffee, tobacco, alcohol, alcoholic mouth washes, and carbonated drinks as they tend to dry the mouth. Follow a soft diet and maintain hydration. Use equal parts of: corticosteroid oral rinse, nystatin suspension, acyclovir suspension (alcohol-free), and lidocaine oral solution. Mix ingredients thoroughly, swish and gargle for 2 minutes and spit out immediately, repeat hour before each meal and at bed time until resolution. A solution of salt and baking soda (sodium bicarbonate) (1 tsp of each dissolved in 8 ounces of warm water) can also be used as oral rinse every 2 hours. For oral dryness, biotine oral rinse and tooth paste, and biotene oral balance gel are used often to moisten the mouth while sores are healing and this also helps control oral bacteria. NSAIDs are often required to ease pain. Provide zinc supplementation for loss of taste. A humidifier in the sleeping area will alleviate or reduce nighttime oral dryness. Monthly recalls during the first year is recommended. Fixed drug eruption Fixed drug eruption is an uncommon occurrence which characteristically recurs in the same site or sites each time a particular drug is taken. With each new exposure however, the number of involved sites may increase. Usually just one drug is involved; although independent lesions from more than one drug have been described. They are sometimes solitary patches at first, but with repeated attacks new lesions may appear, and existing ones may increase in size. Lesions may occur around the mouth or the eyes. The genitals or inside the mouth may be involved in association with skin lesions or on their own. Oral lesions are characterised by a single or several erythematous, eczematous, or bullous plaques. Pruritus is rare, but burning and discomfort are possible. Aetiology It is a type of allergic reaction to a medicine. Commonly implicated drugs are fluconazole, ciprofloxacin, tetracyclines, doxycycline, clarithromycin, penicillins, metronidazole, sulphonamides, NSAIDs, aspirin, anticonvulsants,  HYPERLINK "http://www.patient.co.uk/DisplayConcepts.asp?WordId=BENZODIAZEPINES&MaxResults=50" benzodiazepines,  HYPERLINK "http://www.patient.co.uk/DisplayConcepts.asp?WordId=CETIRIZINE&MaxResults=50" cetirizine, loratadine, and oral contraceptives. Diagnosis From history as the lesion usually develops within 30 minutes to 8 hours of taking a certain drug, and recurs at the same site each time the drug is reintroduced. Treatment Prompt identification and withdrawal of the offending agent may help limit the toxic effects associated with the drug. The decision to discontinue a potentially vital drug often presents a dilemma. If the condition resolves as expected, make notes to the effect that the patient has an adverse reaction to that drug. Provided that they are not thought to be part of the problem,  HYPERLINK "http://www.patient.co.uk/DisplayConcepts.asp?WordId=ANTIHISTAMINES&MaxResults=50" antihistamines may give some symptomatic relief. Recurrent aphthous stomatitis Recurrent aphthous stomatitis (RAS), also known as canker sore, is a condition characterised by recurrent discrete areas of ulceration which are almost always painful. It is one of the most common oral conditions. At least 10% of the population has it, and women are more often affected than men. The onset of RAS usually is during childhood, with a tendency for ulcers to diminish in frequency and severity with age. In about 80% of patients with RAS, the condition develops before 30 years of age. The onset in later years suggests a possibility of definable predisposing factors leading to RAS, or that the ulceration is not a simple RAS, but rather a part of a more complex disorder such as Behcets disease. A prodrome of localised burning or pain for 24-48 hours can precede the ulcers. The lesions are painful, well-defined, shallow, round or oval, with a shallow necrotic center covered with a yellow grayish pseudomembrane and surrounded by raised margins and erythematous haloes. There are 3 main clinical types: minor, major, and herpetiform ulcers. Minor aphthae, also called Mikuliczs aphthae or mild aphthous ulcers, account for 75-85% of all cases of RAS. It can involve every nonkeratinised mucosa of the oral cavity, usually the labial and buccal mucosae, floor of the mouth, and the ventral or lateral surface of the tongue. Ulcers are smaller than 8-10 mm and tend to heal within 10-14 days without scarring. Major aphthae, also referred to as periadenitis mucosa necrotica recurrens or Suttons disease, tend to involve mucosa overlying minor salivary glands. Approximately 10-15% of RAS cases are major aphthae, usually appearing after puberty. The prodromal symptoms are more intense than those of minor aphthae, and the ulcers usually are deeper and larger and last significantly longer than do minor aphthae. They have a raised irregular border and frequently exceed 1 cm in diameter, are painful and tend to appear on the lips, soft palate and throat. They can last for weeks or months and often leave a scar after healing. Fever, dysphagia, and malaise sometimes can occur early in the disease process. Herpetiform ulcers are rare and constitute only 5-10% of all RAS cases. Multiple, small, rounded and painful ulcers (5-100 in number) resembling ulcers of herpes simplex are seen anywhere on the oral mucosa. They tend to fuse and produce much larger ulcers lasting 10-14 days, and they heal without scarring. These ulcers tend to appear in women and generally have a later age onset than other types of RAS. Most patients have mild ulcers with recurrences only 2-4 times each year (simple aphthosis). Some may have almost continuous disease activity with new lesions developing as older lesions heal (complex aphthosis). Although 3 clinical variants of RAS are now recognised, it is still unclear if they are variants of one disease or represent different disorders which manifest as recurrent oral ulceration. In most cases, remission occurs spontaneously several years later. Aetiology Although many theories on the cause of RAS have been proposed, no single causative factor has been identified. About 3040% of patients with RAS report a family history. Precipitating factors include stress, trauma, allergies, endocrine alterations, and dietary components such as acidic foods and juices, and foods that contain gluten. Patients with frequent recurrences should be screened for diseases such as anaemia, vitamin deficiency, coeliac disease, diabetes mellitus, and immunosuppression. Higher prevalence has been found in upper socioeconomic groups. Diagnosis It is made on the basis of history and clinical criteria since there are no specific laboratory tests available. Family history is important and full medical history should be taken to rule out other ulcerative disorders and conditions such as Crohn disease, neutropenia, HIV infection, and Behcets disease. CBC, serum ferritin, serum vitamin B12 level, serum red cell folate level, and serum zinc level to exclude deficiencies. IgA anti-gliadin antibody (AGA), IgA anti-endomysial antibody (EmA), and anti-tissue transglutaminase antibody (ATA) are indicated tests to rule out coeliac disease. Treatment Since the aetiology of RAS remains unknown, there is no definitive treatment. Relief of pain and reduction of ulcer duration are the main goals of therapy. The treatment approach should be determined by the patients medical history, disease severity, frequency of flare-ups, and the patients ability to tolerate the medication. In all patients with RAS, it is important to identify and correct predisposing factors before introducing more specific therapy. Suggestions to reduce the  HYPERLINK "http://en.wikipedia.org/wiki/Pain" \o "Pain" pain caused by an oral ulcer include atraumatic toothbrushing (eg with a small-headed, soft toothbrush), avoid eating spicy, hard or sharp food such as toast or potato crisps, rinsing with  HYPERLINK "http://en.wikipedia.org/wiki/Saline_water" \o "Saline water" salt warm water, and proper  HYPERLINK "http://en.wikipedia.org/wiki/Oral_hygiene" \o "Oral hygiene" oral hygiene measures. Treatment should be initiated as soon as the ulcers appear. Topical corticosteroid therapy should be the first line of treatment. It can reduce the severity and duration of RAS, but it does not significantly influence the frequency of the episodes. For mild ulcers of the anterior mouth, use chlorhexidine mouth wash (alcohol free) and a short course of topical steroid oral gel until resolution. For multiple and severe RAS use equal parts of: high-potency topical steroid oral rinse, nystatin suspension, and analgesic mouth wash. Mix ingredients thoroughly, swish and gargle for 2 minutes and spit out immediately. Repeat after each meal and at bed time until resolution, then reduce by one dose every other day until 2 times daily as a maintenance dose, or stop. Prolonged use of potent topical steroids may result in mucosal atrophy, and may increase the potential for systemic absorption. Intralesional injections of corticosteroid such as triamcinolone hexacetonide may be used to enhance or boost the local response. In patients with recalcitrant RAS, a short course of systemic steroid therapy may be required. This course of treatment is best left to the specialist. Topical tetracyclines plus nicotinamide or doxycycline alone administered as oral rinse, may provide relief and reduce ulcer duration especially in herpetiform type. Using toothpaste free of SLS has been found to help reduce the amount, size and recurrence of oral ulcers in up to 80% of patients.  HYPERLINK "http://en.wikipedia.org/wiki/Vitamin_B12" \o "Vitamin B12" Vitamin B12 pills (1 mg dissolved under the tongue each evening) has been found to be effective in treating RAS, regardless of whether there is a vitamin deficiency present.  HYPERLINK "http://en.wikipedia.org/wiki/Zinc_deficiency" \o "Zinc deficiency" Zinc deficiency has been reported in people with RAS, and zinc supplementation has positive results, although some research has found no therapeutic effect. Behcets disease Behcets disease or syndrome is a form of  HYPERLINK "http://en.wikipedia.org/wiki/Vasculitis" \o "Vasculitis" vasculitis that can lead to ulceration and other lesions. It affects more males than females (10:1) of 20-40 years of age. It can be interpreted as a chronic disturbance in the bodys  HYPERLINK "http://en.wikipedia.org/wiki/Immune_system" \o "Immune system" immune system. This system, which normally protects the body against  HYPERLINK "http://en.wikipedia.org/wiki/Infection" \o "Infection" infections through controlled  HYPERLINK "http://en.wikipedia.org/wiki/Inflammation" \o "Inflammation" inflammation, becomes overactive and produces unpredictable outbreaks of exaggerated inflammation. This extra inflammation affects  HYPERLINK "http://en.wikipedia.org/wiki/Blood_vessel" \o "Blood vessel" blood vessels, usually the small ones. Aetiology The ultimate cause of Behcet's disease remains unknown. Current evidence suggests that interplay of genetic and environmental factors may be responsible. Diagnosis There is no specific pathological test for Behcet disease. It is diagnosed clinically by specific patterns of symptoms and repeated outbreaks. Other causes for these symptoms have to be ruled out before making the diagnosis, and biopsy is rarely indicated. According to the internationl study group (ISG) for Behcet's disease, to be diagnosed with this condition, a person must have oral  HYPERLINK "http://en.wikipedia.org/wiki/Aphthous" \o "Aphthous" aphthous ulcers of any shape, size or number at least 3 times in one year, along with 2 or more out of the next 4  HYPERLINK "http://en.wikipedia.org/wiki/Hallmark" \o "Hallmark" hallmark symptoms: -Genital ulcers (including  HYPERLINK "http://en.wikipedia.org/wiki/Anus" \o "Anus" anal ulcers and spots in the genital region, and swollen  HYPERLINK "http://en.wikipedia.org/wiki/Testicle" \o "Testicle" testicles or  HYPERLINK "http://en.wikipedia.org/wiki/Epididymitis" \o "Epididymitis" epididymitis in men) - HYPERLINK "http://en.wikipedia.org/wiki/Skin" \o "Skin" Skin  HYPERLINK "http://en.wikipedia.org/wiki/Lesion" \o "Lesion" lesions (papulo-pustules,  HYPERLINK "http://en.wikipedia.org/wiki/Folliculitis" \o "Folliculitis" folliculitis,  HYPERLINK "http://en.wikipedia.org/wiki/Erythema_nodosum" \o "Erythema nodosum" erythema nodosum,  HYPERLINK "http://en.wikipedia.org/wiki/Acne" \o "Acne" acne in post-adolescents not on corticosteroids) -Eye inflammation ( HYPERLINK "http://en.wikipedia.org/wiki/Iritis" \o "Iritis" iritis,  HYPERLINK "http://en.wikipedia.org/wiki/Uveitis" \o "Uveitis" uveitis, retinal vasculitis, and cells in the vitreous) - HYPERLINK "http://en.wikipedia.org/wiki/Pathergy_reaction" \o "Pathergy reaction" Pathergy reaction (papule more than 2mm in diameter, 1-2 days or more after needle- prick) Treatment Local therapy Topical tetracycline or doxycycline oral rinse remains the drug of choice for aphthous ulcers of Behcets disease. Topical corticosteroids are effective for oral or genital ulcerations if they are applied during the prodromal stage of ulceration. The usage of hyaluronic acid oral solution reduces pain and inflammation of oral ulcers. Systemic therapy No single drug has proven effective, and oral corticosteroid therapy is the mainstay of treatment for all the various clinical manifestations. Uveitis and central nervous system involvement is treated with systemic corticosteroids, azathioprine or cyclosporine. Oral tacrolimus is an immunosuppressive agent similar to cyclosporine and is effective in treating refractory uveitis. Mucocutaneous lesions and arthritis have been treated with NSAIDs, zinc gluconate, levamisole, colchicine, dapsone, sulfapyridine, or thalidomide (use is strictly limited because of its teratogenicity). Other therapeutic approaches have included interferon (IFN) alfa or gamma, acyclovir, or dexamethasone-cyclophosphamide pulse therapy (discontinuous intravenous infusion of very high doses of corticosteroids over a short time to achieve a faster response and stronger efficacy and to decrease the need for long-term use of systemic corticosteroids). With the possible role of tumor necrosis factor-alpha (TNF-A) in the pathogenesis of Behcet disease, infliximab, a chimeric monoclonal IgG antibody that inhibits TNF-A, and etanercept, a TNF receptor blocker, have steroid sparing effects and have decreased the frequency of attacks in patients with Behcets disease. Lupus erythematosus Systemic lupus erythematosus (SLE) is a chronic  HYPERLINK "http://en.wikipedia.org/wiki/Autoimmunity" \o "Autoimmunity" autoimmune  HYPERLINK "http://en.wikipedia.org/wiki/Connective_tissue_disease" \o "Connective tissue disease" connective tissue disease that can affect any part of the body, most often the  HYPERLINK "http://en.wikipedia.org/wiki/Heart" \o "Heart" heart,  HYPERLINK "http://en.wikipedia.org/wiki/Joint" \o "Joint" joints,  HYPERLINK "http://en.wikipedia.org/wiki/Skin" \o "Skin" skin,  HYPERLINK "http://en.wikipedia.org/wiki/Lung" \o "Lung" lungs,  HYPERLINK "http://en.wikipedia.org/wiki/Blood_vessel" \o "Blood vessel" blood vessels,  HYPERLINK "http://en.wikipedia.org/wiki/Liver" \o "Liver" liver,  HYPERLINK "http://en.wikipedia.org/wiki/Kidney" \o "Kidney" kidneys, and  HYPERLINK "http://en.wikipedia.org/wiki/Nervous_system" \l "Vertebrates" \o "Nervous system" nervous system. The course of the disease is unpredictable, with periods of relapse or flares alternating with  HYPERLINK "http://en.wikipedia.org/wiki/Remission_(medicine)" \o "Remission (medicine)" remissions. The disease occurs 9 times more often in women than in men, especially between the ages of 15-50 years, and is more common in those of non-European descent. It is characterised by a butterfly-like redness across the bridge of the nose and cheeks (malar butterfly rash). Other symptoms may include skin rash, arthritis, fatigue, weight loss,  HYPERLINK "http://www.healthscout.com/ency/68/429/main.html" hair loss, nephritis, and other serious problems. Skin bullae and ulcers are rare, although ulcers do commonly occur on the palate, buccal mucosa, gingiva, and inside the nose. Painless oral ulcers may appear as persistent atrophic or erosive area surrounded by a radiating white striae. A form of lupus that can be isolated to the skin, without internal disease, is called  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=8067" discoid lupus erythematosus (DLE) which is a chronic skin condition of sores with inflammation and scarring favouring the face, ears, scalp, and at times on other body areas. Up to 10% of persons with DLE eventually develop the systemic form of lupus. The outlook for patients with lupus today is much better than years ago because of greater awareness and more accurate tests leading to earlier diagnosis and treatment as well as more effective and safer medications. Aetiology It is an autoimmune disease in which the  HYPERLINK "http://en.wikipedia.org/wiki/Immune_system" \o "Immune system" immune system attacks the bodys cells and tissues, resulting in  HYPERLINK "http://en.wikipedia.org/wiki/Inflammation" \o "Inflammation" inflammation and tissue damage. Possible triggers include heredity, infections, drugs, and sunlight. Hormonal changes may play a role which could explain why it is much more common in women. Diagnosis By taking incisional biopsy from the edge of oral ulcer that shows perivascular inflammatory infiltrate. Blood tests include CBC, U&E, liver enzymes,  HYPERLINK "http://en.wikipedia.org/wiki/Renal_function" \o "Renal function" renal function (disturbed if the kidney is involved), and  HYPERLINK "http://en.wikipedia.org/wiki/Complement_system" \o "Complement system" complement system levels (low levels suggest consumption by the immune system). ANA and anti-double stranded DNA (dsDNA) antibody testing are recommended. Treatment There is no cure for SLE and the treatment is directed toward decreasing inflammation and the level of autoimmune activity. Patients with SLE can help prevent flares of disease by avoiding sun exposure, and by not abruptly discontinuing medications. Occupational exposure to  HYPERLINK "http://en.wikipedia.org/wiki/Silica" \o "Silica" silica,  HYPERLINK "http://en.wikipedia.org/wiki/Pesticide" \o "Pesticide" pesticides, and  HYPERLINK "http://en.wikipedia.org/wiki/Mercury_(element)" \o "Mercury (element)" mercury can worsen the disease. Mild or remittent disease can sometimes be safely left untreated.  HYPERLINK "http://en.wikipedia.org/wiki/Cyclophosphamide" \o "Cyclophosphamide" Cyclophosphamide,  HYPERLINK "http://en.wikipedia.org/wiki/Corticosteroid" \o "Corticosteroid" corticosteroids and  HYPERLINK "http://en.wikipedia.org/wiki/Immunosuppression" \o "Immunosuppression" immunosuppressants ( HYPERLINK "http://en.wikipedia.org/wiki/Methotrexate" \o "Methotrexate" methotrexate or azathioprine) are prescribed when vital organs are involved. NSAIDs and  HYPERLINK "http://en.wikipedia.org/wiki/Malaria" \o "Malaria" antimalarials (hydroxychloroquine) may be used. With treatment, most people with lupus can lead active lives. Erythema multiforme Erythema multiforme (EM) is a common, self-limited mucocutaneous disorder with peak incidence at the age of 20-30 years. Males are slightly more affected than females. It is of acute onset that is characterised by typical target skin lesions, with oral or ocular involvement in some cases, and a marked tendency to recur. The attacks occur once or twice a year and the condition usually resolves after 6 or 7 episodes. The condition varies from a mild self-limited rash (EM minor) to a severe life-threatening form (EM major). The mild form is far more common than the severe form and it usually presents with mildly itchy, pink-red blotches, symmetrically arranged, and starting on the extremities. It often takes on the classical target lesion appearance within a 72 hours period, with a pink-red ring around a pale center. Oral lesions include cracked, bleeding, crusted lips and diffuse, widely spread ulceration mostly pronounced in the anterior parts of the mouth. Attacks may last 2-4 weeks, but it may recur. Recurrences are more common in the spring and can probably be triggered by sunlight. The frequency of recurrence usually decreases with time. Erythema multiforme major may be related to  HYPERLINK "http://en.wikipedia.org/wiki/Stevens-Johnson_syndrome" \o "Stevens-Johnson syndrome" Stevens-Johnson syndrome (SJS) and  HYPERLINK "http://emedicine.medscape.com/article/229698-overview" toxic epidermal necrolysis (TEN) (SJS and TEN probably represent differing severities of the same disease process). The severe form usually begins as febrile erosive stomatitis, severe conjunctivitis, and disseminated cutaneous eruption. Lesions typically begin on the face and trunk. They are flat, atypical lesions, described as irregular purpuric macules with occasional blistering. Most patients also have extensive mucosal involvement. This is a more serious illness and is potentially life threatening. Aetiology It is of unknown aetiology. EM minor usually follows an antecedent herpes simplex or mycoplasma infection. More than 50% of EM major is attributed to medications. Chronic EM has been linked to ingestion of benzoic acid which occurs naturally in some fruits, or to sodium benzoate which is a common food preservative. Diagnosis It is based mainly on the appearance of the skin lesion, especially if there is a history of risk factors or related diseases. It can be confirmed by biopsy and microscopic examination of the tissue. Treatment Mild form Topical steroid oral rinse and gel to treat oral ulcerations. Topical anaesthetics to ease oral pain that interferes with eating and drinking. Paracetamol to reduce fever and discomfort. Antihistamines to control itching. Patients with frequent recurrences may benefit from an antiviral drug, such as oral acyclovir, given at the first sign of an outbreak. Severe form It is difficult to treat. Stop suspected medications with doctor's approval. Oral antibiotics to control infections. Systemic corticosteroids to control inflammation. Hospitalisation and treatment in an intensive care or burn care unit for severe cases of SJS and TEN. High dose intravenous immunoglobulin may be used to stop the disease process. HYPERLINK "http://en.wikipedia.org/wiki/Ophthalmologist" \o "Ophthalmologist"Ophthalmologist should be consulted immediately as this form frequently causes the formation of scar tissue inside the eyelids leading to impaired vision. Lichen planus Lichen planus (LP) is a relatively common, chronic inflammatory disease that affects HYPERLINK "http://en.wikipedia.org/wiki/Oral_mucosa" \o "Oral mucosa"oral mucosa, with or without the involvement of the HYPERLINK "http://en.wikipedia.org/wiki/Skin" \o "Skin"skin and other HYPERLINK "http://en.wikipedia.org/wiki/Mucous_membrane" \o "Mucous membrane"mucous membranes. It affects women more than men and occurs most often in middle-aged adults. Children are rarely affected. Skin lesions, when present consist of itchy, pinkish, flat top papules which affect flexor surfaces of the arms, trunk and legs, and heal with pigmentation. The face is rarely involved. Oral mucosal lesions typically present as bilateral white lesions in the buccal and lingual mucosa. The reticular type is the most common presentation and manifests as asymptomatic white lacy streaks on the mucosa known as HYPERLINK "http://en.wikipedia.org/wiki/Wickham%27s_striae" \o "Wickham's striae"Wickham's striae. The lacy streaks may also be seen on other parts of the mouth, including the gingiva, palate and lips. The less common but painful erosive LP presents with erythematous areas that are ulcerated and uncomfortable, the erosions may occur in multiple areas of the mouth, or in one area, such as the gingiva, where they resemble desquamative gingivitis. Wickham's striae may also be seen near these ulcerated areas. The erosive form may undergo malignant transformation. Lichen planus may also affect mucous membranes of genital tract, rectum, epiglottis, and GIT. The clinical presentation of oral LP lesions may also resemble HYPERLINK "http://en.wikipedia.org/wiki/Lichenoid_drug_reaction" \o "Lichenoid drug reaction"lichenoid eruptions which are identical both clinically and histologically. However, lichenoid lesions may be single in comparison to the usual bilateral appearance of oral LP lesions, with proximity to amalgam dental restoration. Many of the lichenoid lesions resolve after the restorations are replaced. Aetiology The cause of LP is not well-known. It is not HYPERLINK "http://en.wikipedia.org/wiki/Contagious" \o "Contagious"contagious and does not involve any known HYPERLINK "http://en.wikipedia.org/wiki/Pathogen" \o "Pathogen"pathogen. It is postulated to have a genetic predisposition that is initiated by a variety of factors, including emotional stress and hypersensitivity to drugs or foods. Occasionally, it may be related to factors such as materials used in dental work, hepatitis C infection, or graft versus host disease. Diagnosis Histopathological examination of a specimen taken from the white lesion shows a dense band-like of T-lymhocytic infiltrate subepithelium. Biopsy is also necessary to exclude dysplasia particularly in the erosive type. Blood test is essential to exclude anaemia and chronic liver disease in the erosive type. Treatment Currently there is no cure for LP. The patient should avoid smoking, hot liquids, spicy foods, and prosthetic appliances. Identification of any dietary component, dental product or medication should be undertaken to ensure against a hypersensitivity reaction. Reticular LP is asymptomatic and no treatment is needed. In the erosive type, topical corticosteroids and analgesic mouth washes are useful in controlling symptoms. Short-term course of oral steroids may be used in difficult cases. In view of the slight risk, oral carcinoma in erosive LP should be regularly reviewed. LP may go into a dormant state after treatment; however, it can flare up years after it is considered cured. Pemphigus vulagris Pemphigus vulgaris (PV) is a life-threatening autoimmune vesiculobullous disease that affects the skin and mucous membranes. Although PV may occur at any age, it is most common among people between the ages of 50-70 years, predominantly in women. Children and adolescents are rarely affected. The mouth is the only site of involvement in 50% of all cases of pemphigus, and is the initial site of presentation in almost 75% of cases. While there are several types of pemphigus (vulgaris, foliaceus, vegetans, and paraneoplastic), 80% of patients have PV. Patients with PV produce IgG autoantibodies to desmoglein 3 which forms the glue that attaches adjacent epithelial cells via attachment points called HYPERLINK "http://en.wikipedia.org/wiki/Desmosomes" \o "Desmosomes"desmosomes. When autoantibodies attack desmoglein, the cells become separated from each other and the epithelium becomes unglued, a phenomenon called acantholysis. This progressive acantholysis results in the classic suprabassilar bullae. The oral lesion is a fragile bullae arising on otherwise normal mucosa, almost always is ruptured by the time of diagnosis. The ruptured bullae continue to extend peripherally leaving irregular, ragged mucosal ulcers. The lesion starts most commonly on the buccal mucosa, often areas of trauma along the occlusal line, the palate and gingiva are other common sites of involvement. Occasional patients have erosive lesions restricted completely to the gingiva (desquamative gingivitis). Skin lesions are similar, except that the more heavily keratinised epidermis allows blisters to remain intact much longer. The overall mortality is less than 6%, either from electrolyte loss (loss of body fluid from a large number of blisters), wound infection or treatment complications. Note that HYPERLINK "http://en.wikipedia.org/wiki/Haley-Haley_disease" \o "Haley-Haley disease"Haley-Haley disease, also called familial benign pemphigus, is a rare relatively benign disease that is inherited in an autosomal dominant pattern, not an autoimmune disease. It is characterised by recurrent acantholytic vesicular eruptions on the skin. Oral involvement has also been reported. Despite acantholysis, the immunological findings are negative, and this with the family history helps differentiate it from PV. It is therefore not considered part of the pemphigus group of diseases. Aetiology PV is an autoimmune disease with IgG autoantibodies to desmoglein 3 that are found within the epithelium called desmosomes. It may coexist with other autoimmune disorders like myasthenia gravis and thymoma, or with neoplasm such as lymphoma. It may be triggered by medications, although most cases are idiopathic. Diagnosis The diagnosis can be made from the appearance and distribution of oral lesions. Positive  HYPERLINK "http://en.wikipedia.org/wiki/Nikolsky_sign" \o "Nikolsky sign" Nikolskys sign (application of pressure to an apparently normal mucosa will result in formation of a new lesion). Smear of the early bullous lesion will show Tzank cells (floating acantholytic cells). The pathologist looks for an intraepithelial HYPERLINK "http://en.wikipedia.org/wiki/Vesicle_(dermatology)" \o "Vesicle (dermatology)"vesicle caused by HYPERLINK "http://en.wikipedia.org/wiki/Acantholysis" \o "Acantholysis"acantholysis; thus, the superficial portion of the epithelium sloughs off, leaving the bottom layer of cells on the floor of the blister. This bottom layer of cells is said to have a tombstone appearance. Definitive diagnosis requires the demonstration of anti-desmoglein 3 antibodies by HYPERLINK "http://en.wikipedia.org/wiki/Immunofluorescence" \o "Immunofluorescence"direct immunofluorescence on a perilesional biopsy. These antibodies appear as HYPERLINK "http://en.wikipedia.org/wiki/IgG" \o "IgG"IgG deposits along the HYPERLINK "http://en.wikipedia.org/wiki/Desmosomes" \o "Desmosomes"desmosomes between epithelial cells, particularly of the prickle cell layer, a pattern reminiscent of chicken wire. Anti-desmoglein 3 antibodies can also be detected in a blood sample using the HYPERLINK "http://en.wikipedia.org/wiki/ELISA" \o "ELISA"ELISA technique. Treatment High doses of systemic corticosterisids (prednisolone) is initially required, combined later with the so called steroid-sparing immunosuppressant azathioprine which is among those being used to reduce complications of high dose steroids. Once the outbreaks are under control, the dosage is often reduced to lessen side effects. If PV is restricted to the mouth, then lower doses of prednisolone can be used to control the disease. The dose may also be lowered further by combining topical with systemic corticosteroids. Recently,  HYPERLINK "http://en.wikipedia.org/wiki/Rituximab" \o "Rituximab" Rituximab, an anti- HYPERLINK "http://en.wikipedia.org/wiki/CD20" \o "CD20" CD20 antibody, was found to improve otherwise untreatable severe cases of PV. Mucous membrane pemphigoid Mucous membrane pemphigoid (MMP) is a rare chronic autoimmune vesiculobullous disease characterised by blistering lesions that predominately affect the various mucous membranes of the body. The mucous membranes of the mouth and  HYPERLINK "http://www.webmd.com/eye-health/picture-of-the-eyes" eyes are most often affected. The mucous membranes of the nose, throat, genitalia, and anus may also be affected. It has been referred to as benign MMP. However, currently such designation is thought to be inappropriate because of the potential for serious complications in some cases. Scarring of the mucous membranes is common, hence the designation cicatricial pemphigoid. However, this term does not include affected individuals who do not develop scarring. Therefore, it has been determined that MMP is the best designation for this group of disorders. Most patients with MMP are elderly, with a mean age of 62-66 years. It appears to be twice as common in women as men. The HYPERLINK "http://en.wikipedia.org/wiki/Autoimmune" \o "Autoimmune"autoimmune reaction occurs at the level of the hemidesmosome in the HYPERLINK "http://en.wikipedia.org/wiki/Basement_membrane" \o "Basement membrane"basement membrane and when the condition is active, the basement membrane is dissolved by the antibodies produced, and areas of mucosa lift away at the base, causing hard blisters which scar if they burst. In other words, this is a desquamating/blistering disease in which the HYPERLINK "http://en.wikipedia.org/wiki/Epithelium" \o "Epithelium"epithelium is detached from the underlying connective tissue, that subsequently manifest as HYPERLINK "http://en.wikipedia.org/wiki/Bullae" \o "Bullae"bullae or blisters which may be blood filled. Mouth involvement presents as recurrent painful erosions that most commonly involve the gingivae, followed by the palate and the buccal mucosa. The lesion of the gingivae is called desquamative gingivitis. Involvement of the oropharynx may present with hoarseness or dysphagia. When the cornea of the eye is affected, repeated scarring may result in blindness. Aetiology It is an autoimmune disease with IgG autoantibodies against antigens that are found at the base of the epithelium within the hemidesmosomes. It may be triggered by medications. Diagnosis It depends on taking a careful clinical history and performing a thorough clinical examination. The gingiva can be the only site of involvement, and this frequently results in delayed diagnosis as the patient is put through repeated sessions of periodontal therapy and/or prescribed various antimicrobials. Positive  HYPERLINK "http://en.wikipedia.org/wiki/Nikolsky_sign" \o "Nikolsky sign" Nikolskys sign (slight rubbing of an apparently normal mucosa results in formation of a new lesion). Biopsy is essential and should be taken from the edge of the ulcerative lesion for immunofluorescent analysis that shows linear deposition of IgG and C3 along the basement membrane zone. A low titre of circulating autoantibodies against bullous pemphigoid 1 (BP1) antigen is depicted, although 50% of cases have BP2 antigen. It should be differentiated from HYPERLINK "http://medical-dictionary.thefreedictionary.com/Pemphigus"pemphigus vulgaris, erosive oral lichen planus, and linear IgA disease, among other rare autoimmune diseases. Treatment Patients with mild localised disease may benefit from topical steroids, either oral rinse or gel-based for oral lesions or ointment-based for skin lesions. Patients with more extensive disease and progressive scarring require systemic therapy with prednisolone and immunosuppressants. High dose intravenous immunoglobulin has been used successfully in the treatment of MMP in patients who were refractory to other therapies. Ophthalmic referral is essential once the diagnosis is confirmed, because nearly 25% of patients with oral lesions will have ocular lesions. Linear IgA disease Linear IgA disease (LAD) or dermatosis is a rare chronic autoimmune vesiculobullous disease characterised by the presence of linear IgA deposits along the basement membrane zone. This disease can develop at any age, but it seems to be more frequent at the age of 40-50 years. Some authors differentiate between 2 clinical subtypes of LAD, the adults subtype, and the paediatric subtype which affects mainly children under the age of 5 years. Linear IgA disease most often affects the limbs, face or genital regions but may occur anywhere. The clinical presentation is similar to other blistering diseases, such as HYPERLINK "http://emedicine.medscape.com/article/1062391-overview"bullous pemphigoid. Small vesicles are usually grouped together on plaques of erythema, and bullae rarely occur. Oral manifestations in LAD have been reported as minor clinical presentations. However, oral painful ulceration may predominate, and may be the only clinical manifestations for years before the onset of skin lesions. Occasionally, LAD can manifest in the mouth as a desquamative gingivitis. Linear IgA disease should be included in the differential diagnosis of bullous dermatoses with oral lesions. It has no association with gluten-sensitive enteropathy. Aetiology It is an autoimmune disease with IgA autoantibodies against antigens that are found at the base of the epithelium within the hemidesmosomes. It may be idiopathic, drug-induced, or following infection. Diagnosis Biopsy is essential and should be taken from the edge of the ulcerative lesion for immunofluorescent analysis that shows linear deposition of IgA along the basement membrane zone. Treatment Withdrawal of the offending drug. Most cases have been reported to respond to dapsone or sulfapyridine. A response may be seen in 48-72 hours. Severe cases of linear IgA dermatosis respond to a short course of oral corticosteroids. Bullous pemphigoid Bullous pemphigoid (BP) is a chronic autoimmune vesiculobullous skin disease that rarely involves mucous membranes. It usually occurs in people 70 years of age and older, very rarely seen in children. Bullous pemphigoid is the most common of the autoimmune bullous dermatoses, representing 70% of these diseases. Clinically the earliest HYPERLINK "http://en.wikipedia.org/wiki/Lesion" \o "Lesion"lesions may appear HYPERLINK "http://en.wikipedia.org/wiki/Urticaria" \o "Urticaria"urticarial (like hives), eventually tense bullae erupt symmetrically, most commonly at the inner thighs and upper arms; but the trunk and extremities are frequently involved. Oral lesions are smaller, form more slowly and are less painful than those seen in pemphigus vulgaris. The oral lesions in BP are clinically and histologically indistinguishable from those of mucous membrane pemphigoid. The prognosis of survival of BP patients is poor, either due to severe clinical manifestations or due to the side effects of systemic immunosuppressive treatment. Lichen planus pemphigoides (LPP) is thought to be a rare variant of BP. It is characterised by bullous lesions arising on lichen planus papules and on clinically uninvolved skin. It is reported that LPP is induced by numerous medications. Aetiology It is an autoimmune disease with IgG autoantibodies against bullous pemphigoid antigens (BP1 and BP2) that are found at the base of the epithelium within the hemidesmosomes. Diagnosis Biopsy is essential and should be taken from the edge of the ulcerative lesion for immunofluorescent analysis that shows linear IgG deposition along the basement membrane zone. Nikolskys sign is absent. Treatment Topical treatment with corticosteroids is an established alternative to systemic steroids; however, prolonged application is accompanied by side effects such as skin atrophy. In difficult to manage or widespread cases of BP, oral corticosteroid (HYPERLINK "http://en.wikipedia.org/wiki/Prednisone" \o "Prednisone"prednisolone) and a powerful steroid-sparing HYPERLINK "http://en.wikipedia.org/wiki/Immunosuppressant" \o "Immunosuppressant"immunosuppressant medication such as HYPERLINK "http://en.wikipedia.org/wiki/Methotrexate" \o "Methotrexate"methotrexate or HYPERLINK "http://en.wikipedia.org/wiki/Azathioprine" \o "Azathioprine"azathioprine may be appropriate. Oral tacrolimus, an  HYPERLINK "http://en.wikipedia.org/wiki/Immunosuppression" \o "Immunosuppression" immunosuppressive  HYPERLINK "http://en.wikipedia.org/wiki/Medication" \o "Medication" drug, has been reported to be effective in several inflammatory skin disorders including BP. Desquamative gingivitis The term desquamative gingivitis (DG) is used as a clinical description of the gingiva which may manifest as a result of various underlying conditions. Desquamative gingivitis is more common in middle-aged to elderly females. It is painful and affects the buccal/labial gingiva predominantly, frequently spares the marginal gingiva but can involve the whole thickness of the attached gingiva. Its clinical appearance is not significantly altered by traditional oral hygiene measures or conventional periodontal therapy alone. Desquamative gingivitis is characterised by an erythematous erosive or desquamative state of the free and attached gingiva. There is loss of stippling and the gingiva may desquamate easily with minimal trauma. It can be mistaken for plaque induced gingivitis and this can lead to delayed diagnosis and inappropriate treatment of serious dermatological disease. Plasma cell gingivitis (PCG) is a rare condition that presents as DG. It is generally believed to represent a hypersensitivity reaction to exogenous substances such as toothpastes, chewing gum, flavoured mints, mouth washes or cinnamon flavouring products. However, in other cases no agent can be identified. Chronic ulcerative stomatitis (CUS) is a rare disease characterised by unique immunostaining properties. It seems to almost exclusively affect white women in late middle age with an average age at onset of 60 years. It mimics erosive oral lichen planus both clinically and histologically, and DG can be its presenting feature as well. Aetiology The majority of cases are now known to be due to erosive oral lichen planus, pemphigus vulgaris, pemphigoid or linear IgA disease. Other causes include allergic reactions (PCG), and CUS. Diagnosis A definitive diagnosis depends on taking an incisional biopsy from a perilesional site (with intact epithelium), and sending a fresh specimen for immunostaining to exclude pemphigus vulgaris (chicken wire appearance of epithelium), pemphigoid (linear IgG deposit along the basal cell layer), linear IgA disease (linear IgA deposit along the basal cell layer), and CUS (a speckled pattern of IgG deposit in the basal one-third of the epithelium). In addition, a fixed specimen is required to exclude erosive oral lichen planus (band-like lymphocytic infiltrate subepithelium) and PCG (a dense plasmacytic infiltrate in the lamina propria). Circulating ANA are detectable in case of CUS, whereas anti-desmoglein 3 antibodies can be detected in a blood sample in case of pemphigus vulgaris. Identification of the possible inciting agent to exclude PCG by taking a careful clinical history (patch testing is usually negative). Removal of the offending agent results in resolution of symptoms. If a blistering condition is diagnosed, referral to a dermatologist is advised. Treatment Oral hygiene measures. Potent topical steroid gel may bring resolution in some cases. Custom trays (occlusive therapy) may be used to localise topical steroid medications on the gingival tissues. Corticosteroid gel should be used with systemic steroid (prednisolone) in case of pemphigus vulgaris. CUS does not respond to steroid therapy, but a long-lasting favourable therapy appears to be achieved with systemic hydroxychloroquine. PCG may respond to 2% fusidic acid gel. Dermatitis herpetiformis Dermatitis herpetiformis (DH) is an uncommon chronic autoimmune and subepidermal papulovesicular eruption, mainly involving the skin and is associated with gluten-sensitive enteropathy. A connection between DH and HYPERLINK "http://en.wikipedia.org/wiki/Gluten_sensitivity" \o "Gluten sensitivity"gluten intolerance (HYPERLINK "http://en.wikipedia.org/wiki/Coeliac_disease" \o "Coeliac disease"coeliac disease) was recognised in 1967, although the exact causal mechanism is not known. The age of onset is usually about 15-40 years, but DH can also affect children and the elderly. Patients with DH are more likely than others to have HYPERLINK "http://en.wikipedia.org/wiki/Thyroid_disease" \o "Thyroid disease"thyroid problems and HYPERLINK "http://en.wikipedia.org/wiki/Intestinal" \o "Intestinal"intestinal HYPERLINK "http://en.wikipedia.org/wiki/Lymphoma" \o "Lymphoma"lymphoma. Despite its name, DH is not related to or caused by HYPERLINK "http://en.wikipedia.org/wiki/Herpesvirus" \o "Herpesvirus"herpes virus. The name means that it is a skin inflammation having an appearance similar to HYPERLINK "http://en.wikipedia.org/wiki/Herpes" \o "Herpes"herpes. Dermatitis herpetiformis is characterised by intensely HYPERLINK "http://en.wikipedia.org/wiki/Itch" \o "Itch"itchy, chronic HYPERLINK "http://en.wikipedia.org/wiki/Vesicle_(dermatology)" \o "Vesicle (dermatology)"papulovesicular eruptions, usually distributed symmetrically on extensor surfaces, especially the elbows, knees, buttocks, back of neck, scalp, and back. The blisters vary in size from very small up to 1 cm across. The condition is extremely itchy, and the desire to scratch can be overwhelming. Intense itching or burning sensations are sometimes felt before the blisters appear in a particular area. Oral lesions occur in up to 70% of those with skin lesions and affect mainly the palate, buccal mucosa or gingivae as an erythematous, purpuric, vesicular or ulcerated. Untreated, the severity of DH can vary significantly over time, probably in response to the amount of HYPERLINK "http://en.wikipedia.org/wiki/Gluten" \o "Gluten"gluten ingested. Sometimes it is difficult to differentiate DH from other bullous lesions of the oral mucosa. Aetiology Gluten sensitivity may be involved with IgA autoantibodies against gliaden and especially endomysium may be responsible. Diagnosis Simple blood test for IgA antibodies (anti-gliaden and anti-endomysial) and anti-tissue transglutaminase antibodies. These antibodies are present in the majority of patients as has been found with coeliac disease. HYPERLINK "http://en.wikipedia.org/wiki/Biopsy" \l "Skin_Biopsy" \o "Biopsy"Biopsy is essential and should be taken from the edge of the lesion for direct immunofluorescent analysis that shows granular IgA deposits along the tips of HYPERLINK "http://en.wikipedia.org/wiki/Dermal_papillae" \o "Dermal papillae" papillae of both involved skin and mucosa. This distinguishes it from HYPERLINK "http://en.wikipedia.org/wiki/Adult_linear_IgA_disease" \o "Adult linear IgA disease"linear IgA bullous dermatosis. Histologically, the typical of DH consists of microabscesses at the tips of connective tissue papillae. These tests should be done before the patient starts on a gluten-free diet, otherwise they might produce HYPERLINK "http://en.wikipedia.org/wiki/False_negative" \o "False negative"false negatives. If the patient has already started a gluten-free diet, it might be necessary for him to come off it for some weeks before the tests can be done reliably. Treatment DH responds well to  HYPERLINK "http://en.wikipedia.org/wiki/Medication" \o "Medication" medication and changes in  HYPERLINK "http://en.wikipedia.org/wiki/Diet_(nutrition)" \o "Diet (nutrition)" diet. Dapsone is an effective treatment, and itching is significantly reduced within 2-3 days. It is an  HYPERLINK "http://en.wikipedia.org/wiki/Antibacterial" \o "Antibacterial" antibacterial drug and its role in the treatment of DH, which is not caused by  HYPERLINK "http://en.wikipedia.org/wiki/Bacteria" \o "Bacteria" bacteria, is poorly understood. Dapsone can cause adverse effects on the blood, and regular blood monitoring is required. Strict HYPERLINK "http://en.wikipedia.org/wiki/Gluten-free_diet" \o "Gluten-free diet"gluten-free diet must also be followed, and this will usually be a lifelong requirement. This will reduce any associated intestinal damage, and the risk of other complications. After some time on a gluten-free diet, the dosage of dapsone can usually be reduced or even stopped, although this can take up to anything from 1-3 years. Epidermolysis bullosa Epidermolysis bullosa (EB) is a rare inherited bullous disorder characterised by the presence of extremely fragile HYPERLINK "http://en.wikipedia.org/wiki/Skin" \o "Skin"skin and recurrent HYPERLINK "http://en.wikipedia.org/wiki/Blister" \o "Blister"blister formation, resulting from minor mechanical friction or trauma. It mostly affects children. In people born with EB, the 2 skin layers lack the anchors that hold them together, and any action that creates friction between the layers (like rubbing or pressure) will create blisters and painful sores. Sufferers of EB have compared the sores to third-degree burns. Niklosky sign is positive and hands, feet, knees, elbows, buttocks, and occipital area are common sites. The skin will blister after even mild trauma leading to scarring and severe mutilation. Blisters may also occur on internal organs such as the esophagus, stomach, and respiratory tract, without any apparent friction. Bullae and ulcers can arise in the mouth as a result of sucking, eating, toothbrushing, and dental treatment. Caries and periodontal disease are common as a result of inability to maintain good oral hygiene. This disorder results in extra-articular limitations of the movement of the jaws. Patients with EB usually need frequent hospitalisation. There are 3 major types of EB based on different sites of blister formation within the skin structure and these can be classified as EB simplex, dystrophic, and lethalis. Depending on the type of EB, the condition can vary from minor blistering of the skin to a lethal form involving other organs. The condition generally starts at birth or soon after. The simplex type usually commences in the first year of life. The oral mucosa can be affected, but not severely. Healing takes place without scar formation and general development of the patient is otherwise normal. The condition is usually permanent, although some patients improve in the second decade. The dystrophic type is characterised by scar formation that follows healing but physical and mental growth remain unaffected. Scarring can restrict mobility and impair daily activities. The oral mucosa and other mucous membranes including the larynx, pharynx, and esophagus may be involved. Carcinoma developing in scar tissue is not uncommon. Associated findings include dystrophic changes in the nails, hair and teeth. Severe anaemia and amyloidosis usually gives this type an unfavourable prognosis. In EB lethalis, there is a high incidence of abortion and stillbirths, but if the infant is born alive extensive bullae usually develop rapidly and there is little tendency to heal. The oral mucosa is nearly always affected and usually occurs in early infancy. Prognosis of EB depends on how severe the illness is. Epidermolysis bullosa should be distinguished from EB  HYPERLINK "http://dermnetnz.org/immune/epidermolysis-bullosa-acquisita.html" acquisita, which is an autoimmune blistering disease that is not inherited and often doesn't develop until adult life. Aetiology Epidermolysis bullosa is a rare genetic disorder. Diagnosis Evaluate infection using bacterial cultures from poorly healing wounds or wounds that appear infected. Evaluate anaemia using CBC with iron studies in patients with severe EB. Obtain 2 biopsy specimens, one for transmission electron microscopy (TEM) and the other using immunofluorescence microscopy for subtyping EB. If there are swallowing or feeding difficulties,  HYPERLINK "http://health.nytimes.com/health/guides/test/egd-esophagogastroduodenoscopy/overview.html" upper endoscopy or an  HYPERLINK "http://health.nytimes.com/health/guides/test/upper-gi-and-small-bowel-series/overview.html" upper GI series may be needed. Because most forms of EB are inherited, the results of genetic testing, usually done with a blood sample sent to a lab for analysis, can confirm the diagnosis. Treatment Good dental hygiene is very important, including regular dental visits. Working with a physical therapist can help keep the full range of motion in the joints and minimise contractures. Measures should be taken to avoid skin trauma and avoid hot environments. Prevent skin infections by applying antibiotic ointments to wound-like areas.  HYPERLINK "http://www.umm.edu/ency/article/002982.htm" Skin grafting for denuded or ulcerated areas of the skin may be necessary. When there are blisters in the mouth or esophagus, eating soft foods can help prevent making the sores worse. Antifungal therapy is used if there is  HYPERLINK "http://www.umm.edu/ency/article/000643.htm" candida infection. If there are swallowing difficulties, use of oral steroids for short periods of time may be prescribed. Long-term use of steroids is generally not recommended. Other surgical procedures for complications of EB might be recommended such as dilation of the esophagus if there is a stricture (narrowing), repair of hand deformities, and removal of any squamous cell carcinoma lesions that develop. EB acquisita may be treated with oral steroids and immunosuppressants. Current clinical research has included a bone marrow transplant, strongly suggesting that a cure may have been found. Angina bullosa haemorrhagica Angina bullosa haemorrhagica (ABH) is the term used to describe sudden appearance of one or more blood blisters within the mouth. The subepithelial oral blisters are not attributable to a systemic disorder or haemostatic defect. The disease occurs usually in the middle-aged or elderly patients and there is no familial history. Some patients with ABH describe a stinging pain or burning sensation immediately before the appearance of the blood blister. The blister lasts only few minutes and then spontaneously ruptures, leaving a shallow ulcer that heals without scarring, discomfort or pain. The blisters reach an average size of 1-3 cm in diameter. The soft palate is the most commonly affected site, followed by the buccal mucosa and tongue. The condition is not serious except in rare cases where a large bulla that does not rupture spontaneously may cause airway obstruction. The lesions may be confused with other more serious disorders such as mucous membrane pemphigoid, epidermolysis bullosa, linear IgA disease, and dermatitis herpetiformis. However, the isolated nature, rapid healing, and rare recurrence of ABH blisters generally are sufficient findings to rule out the previously mentioned conditions. The lesions may be indistinguishable from blood blisters related to thrombocytopenia. However, blood tests and the absence of areas of ecchymosis, epistaxis, or gingival bleeding are helpful signs to rule it out. Aetiology More than 50% of ABH cases are related to minor trauma of hot foods, restorative dentistry or periodontal therapy. Other potential causes are dental injections of anaesthetics and steroid inhalers. Diagnosis The diagnosis of ABH essentially is clinical. Coagulation tests and platelet count may be indicated to rule out a blood dyscrasia. Treatment No treatment is required because blood blisters spontaneously rupture and heal. Analgesic or chlorhexidine mouth wash may be used. Any large intact blood blister should be incised to prevent further enlargement that could cause airway obstruction. 2 Oral infections Primary herpes simplex Primary herpes simplex or herpetic gingivostomatitis is a combination of HYPERLINK "http://en.wikipedia.org/wiki/Gingivitis" \o "Gingivitis"gingivitis and HYPERLINK "http://en.wikipedia.org/wiki/Stomatitis" \o "Stomatitis"stomatitis caused by herpes simplex virus (HSV) type 1. Herpes viruses are contagious and the contact may occur directly or through contact with infected razors, towels, dishes, and other shared articles. It generally affects children under the age of 3 and young adults. Up to 80% of herpes simplex infections are asymptomatic. Symptomatic infections can be characterised by significant morbidity and recurrence. In immunocompromised patients, infections can cause life-threatening complications. The first symptoms usually appear within 510 days after contact with an infected person. There are prodromal symptoms (fever, malaise, irritability, headache, vomiting, and HYPERLINK "http://en.wikipedia.org/wiki/Lymphadenopathy" \o "Lymphadenopathy"lymphadenopathy) 1-2 days prior to oral lesions. Then small, yellowish vesicles form, which rupture quickly, resulting in shallow, round, discrete ulcers with erythematous halo. It affects both the free and attached gingiva. A generalised marginal gingivitis may precede oral ulcers. HYPERLINK "http://en.wikipedia.org/wiki/Primary_infection" \o "Primary infection"Primary infection in HYPERLINK "http://en.wikipedia.org/wiki/Adolescent" \o "Adolescent"adolescents frequently manifests as severe HYPERLINK "http://en.wikipedia.org/wiki/Pharyngitis" \o "Pharyngitis"pharyngitis, with HYPERLINK "http://en.wikipedia.org/wiki/Lesion" \o "Lesion"lesions developing on the buccal mucosa and gingiva. In healthy individuals the lesions heal spontaneously within 2 weeks. Once infected, the virus remains in the body for life. The prevalence of HSV infection worldwide has increased over the last several decades, making it a major public health concern. Prompt recognition of herpes simplex infection and early initiation of therapy are of utmost importance in the management of the disease. Aetiology A transmissible infection with HSV, usually type I and less commonly type II. Diagnosis The primary herpes simplex is readily identified by clinical examination. The older immunodot HSV IgM typing test is an enzyme immunoassay (EIA) detecting HSV or glycoprotein G (gG) type specific IgM antibodies. Unlike HSV IgG typing, IgM does not provide optimal HSV typing results, but may offer information about a particular patient's antibody response. The new immunodot HSV typing test is an enzyme immunoassay (EIA) detecting HSV or glycoprotein G (gG) type specific IgG antibodies. The test detects the presence or absence of past infection, and specifically determines whether past infection is due to HSV type 1, type 2 or both. Treatment Soft diet and adequate fluid intake, analgesics and antipyretics (paracetamol), and chlorhexidine mouth wash. In severe cases it may be necessary to use topical anaesthetics. Topical steroids should be avoided because they tend to permit spread of the viral infection on mucous membranes. Systemic HYPERLINK "http://en.wikipedia.org/wiki/Acyclovir" \o "Acyclovir"acyclovir is recommended to treat oral herpes only in immunocompromised patients. Patients should be cautioned to avoid touching the herpetic lesions and then touching the eyes, genitals or other areas because of the possibility of self-inoculation. Recurrent herpes simplex After the initial or primary infection, herpes simplex virus (HSV) becomes latent in the nerve tissue of the face. In some people, the virus reactivates and produces recurrent cold sores or fever blisters that are usually in the same area, but are not serious. It mostly affects the mucocutaneous junction, and is confined to a localised area of skin or mucous membranes that affects more the upper and lower lips. The recurrent infection is thus often called herpes labialis. Symptoms typically begin with tingling (itching) and reddening of the skin around the infected site. Within 24 hours fluid-filled HYPERLINK "http://en.wikipedia.org/wiki/Blister" \o "Blister"blisters form, which ruptures within a further 48 hours to leave an erosive area of epithelium which subsequently crusts over and heals. The lesion usually disappears spontaneously in 1-2 weeks. Infection may be severe and dangerous if it occurs in or near the eye, or if it occurs in immunocompromised individuals. Rarely, reinfection occurs inside the mouth (intraoral herpes simplex stomatitis), usually affecting the hard palate and gingiva, possibly accompanied by herpes labialis, as a small crop of painful ulcers which heals within 1-2 weeks. Aetiology Reactivation of the latent HSV that resides in the sensory ganglion of the trigeminal nerve. Precipitating factors include fever, stress, sunlight, trauma, hormonal alterations, and immunosuppression. Diagnosis It is made by history and clinical examination. Treatment Application of sunscreen (SPF 15 or higher) to lips 1 hour before sun exposure and every hour thereafter. Constant or intermittent application of ice to the area for 90 minutes during the prodromal phase may result in abortion of the lesion. Acyclovir cream works best when applied early to the affected area at the first sign of pain or tingling. Zinc oxide cream may be palliative. Oral acyclovir, given prophylactically and therapeutically, may be considered when frequent recurrent herpetic episodes interfere with daily function and nutrition, and for recurrent intraoral herpes. Herpetic whitlow A herpetic whitlow is a painful infection that typically affects the fingers or thumbs. Occasionally infection occurs on the toes or on the nail cuticle. It can be caused by infection with herpes simplex virus (HSV) type 1 or 2. Herpes simplex virus-1 whitlow is most commonly contracted by dental or medical workers exposed to oral secretions. It is also often observed in HYPERLINK "http://en.wikipedia.org/wiki/Thumb-sucking" \o "Thumb-sucking"thumb-sucking children with primary HSV-1 oral infection (HYPERLINK "http://en.wikipedia.org/wiki/Autoinoculation" \o "Autoinoculation"autoinoculation), and in adults aged 20-30 years following contact with HSV-2 infected genitals. Symptoms of herpetic whitlow include swelling, reddening, and tenderness of the skin of infected fingers. This may be accompanied by fever and swollen lymph nodes. Small, clear vesicles initially form individually, then merge and become cloudy. Associated pain often seems large, relative to the physical symptoms. The herpes whitlow lesion usually heals in 2-3 weeks. Aetiology Herpetic HYPERLINK "http://en.wikipedia.org/wiki/Whitlow" \o "Whitlow"whitlow can be caused by infection with HSV-1 or HSV-2. Diagnosis It is made by history and clinical examination. Treatment To prevent this infection, gloves should be used routinely when examining or treating patients. Although it is a self-limited illness, HYPERLINK "http://en.wikipedia.org/wiki/Antiviral_drug" \o "Antiviral drug"antiviral treatments applied to the infected skin, particularly HYPERLINK "http://en.wikipedia.org/wiki/Acyclovir" \o "Acyclovir"acyclovir cream, have been shown to be effective in decreasing the duration of symptoms. HYPERLINK "http://en.wikipedia.org/wiki/Incision_and_drainage" \o "Incision and drainage"Lancing or surgically HYPERLINK "http://en.wikipedia.org/wiki/Debride" \o "Debride"debriding the HYPERLINK "http://en.wikipedia.org/wiki/Lesion" \o "Lesion"lesion may make it worse by causing a HYPERLINK "http://en.wikipedia.org/wiki/Superinfection" \o "Superinfection"superinfection or HYPERLINK "http://en.wikipedia.org/wiki/Encephalitis" \o "Encephalitis"encephalitis. Chickenpox Chickenpox, also known as varicella, is a primary infection caused by  HYPERLINK "http://en.wikipedia.org/wiki/Varicella_zoster_virus" varicella zoster virus (VZV). It spreads from person to person by direct contact or by air from an infected person's coughing or sneezing. Touching the fluid HYPERLINK "http://en.wikipedia.org/wiki/Blister" \o "Blister"blister can also spread the disease. It takes from 1-3 weeks after contact with an infected person for someone to develop chickenpox. It is most common between the ages of 2-8. A person with chickenpox is infectious from 1-5 days before the skin rash appears. The contagious period continues until all blisters crust over forming scabs which may take 5-10 days. It also presents clinically as oral ulceration mainly of the oropharynx. The condition resolves by itself within a couple of weeks. It is most common in the winter and spring and usually affects lots of children at the same time, around once every 3 years as an HYPERLINK "http://www.nhsdirect.nhs.uk/glossary/" \l "Epidemic" \o "Click for definition"epidemic. Children should not be sent back to school until all skin lesions have crusted over to avoid spreading the disease to others. Following primary infection there is usually lifelong protective immunity from further episodes of chickenpox. Aetiology Chickenpox is a highly  HYPERLINK "http://en.wikipedia.org/wiki/Infectious_disease" \o "Infectious disease" contagious illness caused by primary  HYPERLINK "http://en.wikipedia.org/wiki/Infection" infection with VZV. Diagnosis The diagnosis of varicella is primarily clinical with typical early  HYPERLINK "http://en.wikipedia.org/wiki/Prodrome" \o "Prodrome" prodromal symptoms, followed by the characteristic skin  HYPERLINK "http://en.wikipedia.org/wiki/Rash" rash. Confirmation of the diagnosis can be sought through either examination of the fluid within the vesicles of the rash, or by testing blood for evidence of an acute immunologic response. Treatment It consists of easing the symptoms as there is no actual  HYPERLINK "http://en.wikipedia.org/wiki/Cure" cure of the condition. Topical antiseptic and analgesic mouth wash (eg benzydamine hydrochloride) is recommended to alleviate pain and prevent secondary infection of oral ulcers. Topical application of  HYPERLINK "http://en.wikipedia.org/wiki/Calamine_lotion" \o "Calamine lotion" calamine lotion containing  HYPERLINK "http://en.wikipedia.org/wiki/Zinc_oxide" zinc oxide to skin rash is one of the most commonly used interventions to ease itching. Painkillers such as paracetamol or ibuprofen are also recommended as they are effective in relieving itching and other symptoms such as fever or pains. Antihistamines may be used in cases when the symptoms cause the inability to  HYPERLINK "http://en.wikipedia.org/wiki/Sleep" sleep, as they are efficient for easing the itching and they are acting as a  HYPERLINK "http://en.wikipedia.org/wiki/Sedative" sedative. Chickenpox in otherwise healthy adults tends to be more severe and  HYPERLINK "http://en.wikipedia.org/wiki/Therapy" \o "Therapy" treatment with oral  HYPERLINK "http://en.wikipedia.org/wiki/Acyclovir" \o "Acyclovir" acyclovir is generally advised, as long as it is initiated at the earliest sign or symptom. Herpes zoster Herpes zoster, also known as shingles or zona, is a HYPERLINK "http://en.wikipedia.org/wiki/Viral_disease" \o "Viral disease"viral disease caused by HYPERLINK "http://en.wikipedia.org/wiki/Varicella_zoster_virus" \o "Varicella zoster virus"varicella zoster virus (VZV). Once an episode of chickenpox has resolved, the virus is not eliminated from the body but becomes HYPERLINK "http://en.wikipedia.org/wiki/Viral_latency" \o "Viral latency"latent in dorsal root HYPERLINK "http://en.wikipedia.org/wiki/Ganglion" \o "Ganglion"ganglia without causing any HYPERLINK "http://en.wikipedia.org/wiki/Symptoms" \o "Symptoms"symptoms as it is kept under control by the HYPERLINK "http://www.nhsdirect.nhs.uk/glossary/" \l "Immune system" \o "Click for definition"immune system. The disease results from the virus reactivating in a single sensory ganglion. The virus breaks out of nerve cell bodies and travels down nerve HYPERLINK "http://en.wikipedia.org/wiki/Axon" \o "Axon"axons to cause viral infection of the skin in the region of the nerve, causing a painful rash. Exactly how the virus remains latent in the body, and subsequently reactivates is not understood. Most zoster affects the thoracic region, but in 30% of the cases the trigeminal nerve, with its 3 branches: ophthalmic, maxillary and mandibular, is affected. Most common and not welcomed branch to be involved is the ophthalmic. The earliest symptoms are nonspecific and include HYPERLINK "http://en.wikipedia.org/wiki/Headache" \o "Headache"headache, HYPERLINK "http://en.wikipedia.org/wiki/Fever" \o "Fever"fever, and HYPERLINK "http://en.wikipedia.org/wiki/Malaise" \o "Malaise"malaise, followed by sensations of burning pain, itching, HYPERLINK "http://en.wikipedia.org/wiki/Hyperesthesia" \o "Hyperesthesia"hyperesthesia (oversensitivity), or HYPERLINK "http://en.wikipedia.org/wiki/Paresthesia" \o "Paresthesia"paresthesia (pins and needles). The pain may be extreme in the affected dermatome, with sensations that are often described as stinging, tingling, aching, numbing or throbbing, and can be interspersed with quick stabs of agonising pain. In most cases, after 1-2 days (but sometimes as long as 3 weeks) the initial phase is followed by the appearance of the characteristic skin rash normally resulting in a stripe or belt-like pattern that is limited to one side of the body and does not cross the midline. The painful vesicles eventually crust over within 7-10 days, and usually the crusts fall off and the skin heals. Until the rash has developed crusts, a person is extremely contagious. Intra oral lesions may appear if maxillary or mandibular branches are involved. Patients older than 60 years of age are particularly prone to residual nerve pain for months or years, a condition called HYPERLINK "http://en.wikipedia.org/wiki/Postherpetic_neuralgia" \o "Postherpetic neuralgia"postherpetic neuralgia, which is often difficult to manage. Other serious effects include partial HYPERLINK "http://en.wikipedia.org/wiki/Bell%27s_palsy" \o "Bell's palsy"facial paralysis (usually temporary), ear damage or HYPERLINK "http://en.wikipedia.org/wiki/Encephalitis" \o "Encephalitis"encephalitis. There is a slightly increased risk of developing HYPERLINK "http://en.wikipedia.org/wiki/Cancer" \o "Cancer"cancer after a herpes zoster infection. Repeated attacks of herpes zoster are rare, and it is extremely rare for patients to suffer more than 3 recurrences. Aetiology Reactivation of latent herpes varicella virus from an original varicella infection introduced through chickenpox. Herpes zoster is more likely to occur in people whose immune system is impaired due to aging, HYPERLINK "http://en.wikipedia.org/wiki/Immunosuppressive_therapy" \o "Immunosuppressive therapy"immunosuppressive therapy, HYPERLINK "http://en.wikipedia.org/wiki/Psychological_stress" \o "Psychological stress"psychological stress or other factors. Diagnosis VZV-specific HYPERLINK "http://en.wikipedia.org/wiki/IgM" \o "IgM"IgM HYPERLINK "http://en.wikipedia.org/wiki/Antibody" \o "Antibody"antibody in blood is a popular test. This only appears during chickenpox or herpes zoster and not while the virus is dormant. There may be a need to exclude malignancy and immune defect (including HIV). Treatment Topical application of  HYPERLINK "http://en.wikipedia.org/wiki/Calamine_lotion" \o "Calamine lotion" calamine lotion containing  HYPERLINK "http://en.wikipedia.org/wiki/Zinc_oxide" zinc oxide to skin rash or blisters is commonly used to ease itching. Topical HYPERLINK "http://en.wikipedia.org/wiki/Lidocaine" \o "Lidocaine"lidocaine and nerve blocks may also reduce pain. Severe pain may require an opioid medication, such as HYPERLINK "http://en.wikipedia.org/wiki/Morphine" \o "Morphine"morphine. Oral acyclovir, valacyclovir or famciclovir inhibits VZV replication and reduces the severity and duration of herpes zoster with minimal side effects, preferably initiated within 72 hours of the appearance of the rash, but it doesnt reliably prevent postherpetic neuralgia. In the absence of specific contraindications, consideration should be given to prescribing short-term, high-dose corticosteroid prophylaxis for postherpetic neuralgia, in conjunction with oral acyclovir. Treatment for HYPERLINK "http://en.wikipedia.org/wiki/Ophthalmic_zoster" \o "Ophthalmic zoster"herpes zoster ophthalmicus is similar to standard treatment for herpes zoster at other sites. Live HYPERLINK "http://en.wikipedia.org/wiki/Vaccine" \o "Vaccine"vaccine for VZV exists, marketed as HYPERLINK "http://en.wikipedia.org/wiki/Zostavax" \o "Zostavax"Zostavax. It prevents half the cases of herpes zoster and reduces the number of cases of postherpetic neuralgia by two-thirds. Herpes zoster oticus Herpes zoster oticus, also known as HYPERLINK "http://en.wikipedia.org/wiki/Ramsay_Hunt_syndrome_type_II" \o "Ramsay Hunt syndrome type II"Ramsay Hunt syndrome type II (RHS II), involves the HYPERLINK "http://en.wikipedia.org/wiki/Ear" \o "Ear"ear and it is essentially HYPERLINK "http://en.wikipedia.org/wiki/Shingles" \o "Shingles"shingles of the geniculate ganglion. Briefly, the herpes zoster virus, which causes HYPERLINK "http://en.wikipedia.org/wiki/Chicken_pox" \o "Chicken pox"chickenpox, lies dormant in various nerve cells in the body, where it is kept in check by the patient's immune system. Given the opportunity, for example during an illness that suppresses the immune system, the virus is reactivated and travels to the end of the nerve cell, where it causes the symptoms. Since the HYPERLINK "http://en.wikipedia.org/wiki/Vestibulocochlear_nerve" \o "Vestibulocochlear nerve"vestibulocochlear nerve is in proximity to the geniculate ganglion, it may also be affected. Symptoms include HYPERLINK "http://en.wikipedia.org/wiki/Acute_facial_nerve_paralysis" \o "Acute facial nerve paralysis"acute facial nerve paralysis, pain in the ear, taste loss in the front two-thirds of the tongue, dry mouth and eyes, and eruption of HYPERLINK "http://en.wikipedia.org/wiki/Erythematous" \o "Erythematous"erythematous vesicular HYPERLINK "http://en.wikipedia.org/wiki/Rash" \o "Rash"rash in the ear canal, the tongue or HYPERLINK "http://en.wikipedia.org/wiki/Hard_palate" \o "Hard palate"hard palate. Patients may also suffer from HYPERLINK "http://en.wikipedia.org/wiki/Tinnitus" \o "Tinnitus"tinnitus, hearing loss, and HYPERLINK "http://en.wikipedia.org/wiki/Vertigo_(medical)" \o "Vertigo (medical)"vertigo. Treatment The largest study on the treatment of RHS II has shown that complete recovery can be achieved in 75% of patients if treatment with HYPERLINK "http://en.wikipedia.org/wiki/Prednisone" \o "Prednisone"prednisolone and HYPERLINK "http://en.wikipedia.org/wiki/Acyclovir" \o "Acyclovir"acyclovir is started within the first 3 days of onset of symptoms. Chances of complete recovery decrease as treatment is delayed. Hand, foot and mouth disease Hand, foot and mouth disease (HFMD) is a childhood illness which affects mostly children aged 10 years and under. It is moderately contagious and is spread through direct contact with the mucus, saliva or faeces of an infected person. It typically occurs in small epidemics in nursery schools or kindergartens, usually during the summer and autumn months. The usual incubation period is 3-7 days. Hand, foot and mouth disease is not to be confused with HYPERLINK "http://en.wikipedia.org/wiki/Foot-and-mouth_disease" \o "Foot-and-mouth disease"foot and mouth disease, which is a disease affecting sheep, cattle, and swine, and which is unrelated to HFMD. Clinically the disease manifests as painful vesicles on soles of feet and palms of hand that are surrounded by inflammatory halos. Oral ulcers which usually affect the tongue or buccal mucosa are painful, shallow, surrounded with erythema and accompanied with mild fever, sore throat, loss of appetite, malaise and anorexia. In most cases, infection is HYPERLINK "http://en.wikipedia.org/wiki/Asymptomatic" \o "Asymptomatic"asymptomatic or causes only mild symptoms. Aetiology It is often produced by an intestinal virus called Coxsackie A16. Diagnosis It is based on a combination of clinical history and characteristic physical findings. Laboratory confirmation is rarely necessary unless severe complications develop. Treatment Many doctors do not issue medicine for this illness unless the infection is severe. Therapy is directed towards symptomatic relief of fever and  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=480" sore throat. Antipyretics (eg paracetamol or ibuprofen) and topical anaesthetics can be used to lessen fever and pain. Herpangina Herpangina, also called mouth  HYPERLINK "http://en.wikipedia.org/wiki/Blister" \o "Blister" blisters, is the name of a painful mouth  HYPERLINK "http://en.wikipedia.org/wiki/Infection" \o "Infection" infection that is most common in children and is very contagious. Though herpangina can be asymptomatic, symptoms are usually high HYPERLINK "http://en.wikipedia.org/wiki/Fever" \o "Fever"fever and HYPERLINK "http://en.wikipedia.org/wiki/Sore_throat" \o "Sore throat"sore throat. A small number of ulcers (usually 2-6) form in the back area of the HYPERLINK "http://en.wikipedia.org/wiki/Mouth" \o "Mouth"mouth, particularly the HYPERLINK "http://en.wikipedia.org/wiki/Soft_palate" \o "Soft palate"soft palate or HYPERLINK "http://en.wikipedia.org/wiki/Tonsil" \o "Tonsil"tonsillar pillars. The lesions heal in 7-10 days. Aetiology Several common Coxsackie A viruses can cause herpangina, although it can also be caused by Coxsackie virus B, or HYPERLINK "http://en.wikipedia.org/wiki/Echovirus" \o "Echovirus"echoviruses. Diagnosis A HYPERLINK "http://en.wikipedia.org/wiki/Medical_diagnosis" \o "Medical diagnosis"diagnosis can be made from clinical signs and symptoms. Treatment Treatment is generally supporative as the disease is self-limiting and usually runs its course in less than a week. Management includes hydration, antipyretics (eg paracetamol or ibuprofen), and topical anaesthetics. Focal epithelial hyperplasia Focal epithelial hyperplasia, also known as Heck's disease, is one of the most contagious oral papillary lesions. The level of contagion is exemplified by the fact that in some isolated populations up to 40% of children have been affected. Today it is known to exist in numerous populations and ethnic groups. Where the infection is endemic among children, adults seem to have minimal evidence of residual oral lesions and so the lesions are presumed to eventually disappear on their own. Sites of greatest involvement include the labial, buccal and lingual mucosa, but gingival and tonsillar lesions have also been reported. Clinically, lesions are frequently papillary in nature, but are relatively smooth-surfaced and flat-topped. The lack of pronounced surface projections easily differentiates it from squamous papilloma, verruca vulgaris, and condyloma. Lesions are usually the colour of normal mucosa, small, discrete and well-demarcated, but they frequently cluster so closely together that the entire mucosa takes on a cobblestone or fissured appearance. Spontaneous regression has been reported after months or years, and the disease is rather rare in adults. No case has been reported to transform into carcinoma. It should be remembered that focal epithelial hyperplasia may be an oral manifestation of AIDS. Aetiology It is produced by one of the subtypes of the human papilloma virus (HPV-13), and possibly HPV-32. Diagnosis Conservative excisional biopsy may be required to establish the proper diagnosis. Treatment Additional treatment is unnecessary, except perhaps for aesthetic reasons relating to visible labial lesions. When desired, lesions can be removed by conservative surgery or laser destruction. Successful use of topical 5%  HYPERLINK "http://dermnetnz.org/treatments/imiquimod.html" imiquimod cream, an immune response modifier, has been reported. Follow up is recommended in all cases. Infectious mononucleosis Infectious mononucleosis, also known as mono, kissing disease, or glandular  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=361" fever is a very common illness. The designation mononucleosis refers to an increase in one type of WBC (lymphocytes) in the bloodstream relative to the other blood components as a result of the Epstein Barr virus (EBV) infection. The EBV that causes mono is found throughout the world with a peak incidence at ages 15-17. Generally, the illness is less severe in young children and may mimic the symptoms of other common childhood illnesses, which may explain why it is less commonly diagnosed or recognised in this younger age group. By the time most people reach adulthood, an antibody against EBV can be detected in their blood. The anginose type shows ulcers in the mouth with spongy gums which bleed easily and petechial haemorrhages at the junction of hard and soft palate. Cervical lymphadenopathy is present and oedema of face and eyelids may be present with fever, fatigue, and  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=480" sore throat. A feeling of  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=26114" tiredness may persist for months following the  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=2133" acute phase of the illness. Patients can continue to have virus particles present in their saliva for as long as 18 months after the initial infection. When symptoms persist for more than 6 months, the condition is frequently called chronic EBV infection. However, laboratory tests generally cannot confirm continued active EBV infection in people with chronic infection. Aetiology It is caused by the EBV. Mono is spread by person-to-person contact and saliva is the primary method of transmitting mono. Diagnosis More useful in a diagnostic sense are the signs and symptoms themselves. The presence of  HYPERLINK "http://en.wikipedia.org/wiki/Splenomegaly" \o "Splenomegaly" splenomegaly, posterior cervical adenopathy,  HYPERLINK "http://en.wikipedia.org/wiki/Axillary" \o "Axillary" axillary adenopathy, and  HYPERLINK "http://en.wikipedia.org/wiki/Inguinal" \o "Inguinal" inguinal adenopathy are the most useful to suspect a diagnosis of mono. Presence of 50% lymphocytes, with at least 10% atypical lymphocytes (large, irregular  HYPERLINK "http://en.wikipedia.org/wiki/Cell_nucleus" \o "Cell nucleus" nuclei) that resembled monocytes when they were first discovered, thus the name mononucleosis was coined. A positive heterophile antibody test (Paul-Bunnel or monospot test). Unfortunately, the heterophile antibodies may not become detectable until the second or third weeks of the illness. More sensitive tests have been developed such as the IgG and IgM tests. IgG, when positive, reflects a past infection, whereas IgM reflects a current infection. Therefore, they are useful for diagnosing mono in people with highly suggestive symptoms and a negative heterophile antibody test. Elevated hepatic  HYPERLINK "http://en.wikipedia.org/wiki/Transaminase" \o "Transaminase" transaminase level is highly suggestive of infectious mononucleosis, occurring in up to 50% of patients. Treatment It is generally a  HYPERLINK "http://en.wikipedia.org/wiki/Self-limiting_(biology)" \o "Self-limiting (biology)" self-limiting disease and only supportive treatment is used. Rest is recommended during the acute phase of the infection, but activity should be resumed once acute symptoms have resolved.  HYPERLINK "http://en.wikipedia.org/wiki/Non-steroidal_anti-inflammatory_drug" \o "Non-steroidal anti-inflammatory drug" NSAIDs like  HYPERLINK "http://en.wikipedia.org/wiki/Ibuprofen" \o "Ibuprofen" ibuprofen may be used to reduce fever and pain. Gargling with salt water or using anaesthetic throat lozenges to soothe  HYPERLINK "http://www.webmd.com/cold-and-flu/tc/sore-throat-topic-overview" sore throat. There is little evidence to support the use of  HYPERLINK "http://en.wikipedia.org/wiki/Aciclovir" \o "Aciclovir" acyclovir, although it may reduce initial viral shedding. However, the antiviral drug  HYPERLINK "http://en.wikipedia.org/wiki/Valacyclovir" \o "Valacyclovir" valacyclovir has recently been shown to lower or eliminate the presence of the EBV in subjects afflicted with acute mono, leading to a significant decrease in the severity of symptoms. Occasionally streptococcus throat occurs in conjunction with mono and is best treated with penicillin or  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=748" erythromycin. The antibiotics  HYPERLINK "http://en.wikipedia.org/wiki/Ampicillin" \o "Ampicillin" ampicillin and later the related  HYPERLINK "http://en.wikipedia.org/wiki/Amoxicillin" \o "Amoxicillin" amoxicillin should be avoided if there is a possibility of mono because their use precipitates a non-allergic rash close to 99% of the time. It is recommended that patients with mono avoid participation in any contact sports or heavy lifting for at least 4 weeks after the onset of symptoms to prevent trauma to the  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=109152" enlarged spleen. Necrotising ulcerative gingivitis Necrotising ulcerative gingivitis (NUG) or Vincents stomatitis is a subclassification of necrotising periodontal disease. It presents as an  HYPERLINK "http://en.wikipedia.org/wiki/Acute" \o "Acute" acute infection of the  HYPERLINK "http://en.wikipedia.org/wiki/Gingiva" \o "Gingiva" gingiva without involvement of other tissues of the  HYPERLINK "http://en.wikipedia.org/wiki/Periodontium" \o "Periodontium" periodontium. If the infection has progressed deeper into the  HYPERLINK "http://en.wikipedia.org/wiki/Periodontium" \o "Periodontium" periodontal tissues, it is subclassified as necrotising ulcerative periodontitis (NUP). Men are affected more than women, and the condition is now found more commonly in the younger generation with peak incidence at 20-25 years. Clinical features of necrotising periodontal disease may include  HYPERLINK "http://en.wikipedia.org/wiki/Necrosis" \o "Necrosis" necrosis and  HYPERLINK "http://en.wikipedia.org/wiki/Ulceration" \o "Ulceration" ulceration of the  HYPERLINK "http://en.wikipedia.org/wiki/Interdental_papilla" \o "Interdental papilla" interdental papillae (punched-out papillae), painful and bright red  HYPERLINK "http://en.wikipedia.org/wiki/Gingiva" \l "Marginal_gingiva" \o "Gingiva" marginal gingiva that bleed upon gentle manipulation, pseudomembranous formation, and  HYPERLINK "http://en.wikipedia.org/wiki/Halitosis" \o "Halitosis" halitosis. Aetiology It is associated with anaerobes such as Prevotella intermedia and  HYPERLINK "http://en.wikipedia.org/wiki/Fusobacterium" \o "Fusobacterium" Fusobacterium as well as  HYPERLINK "http://en.wikipedia.org/wiki/Spirochetes" \o "Spirochetes" spirochetes. It may be due to interacting factors such as poor oral hygiene, poor nutrition, smoking, stress, lifestyle, and other infections. It sometimes complicates a preexisting periodontitis. Immunosuppressive and antimetabolite therapy may also be associated. Diagnosis It can be confirmed by a smear and gram stain, and the response to treatment. Treatment Metronidazole or penicillin-V for 5 days. Chlorhexidine mouth wash, vitamin C, and oral analgesics may also be prescribed. The patient should be asked to stop smoking until acute symptoms subside. When inflammation subsides, all supragingival and subgingival deposits should be removed and oral hygiene instructions should be given. A periodontal surgery (gingivoplasty) to restore the contour and to prevent chronic recurrent infections may be required. Any defects in general health such as nutritional deficiency, incipient diabetes mellitus, or anaemia should be corrected. Tuberculosis Tuberculosis or tubercle bacillus (TB) is a chronic infectious granulomatous disease that can affect any part of the body, including the mouth. Even though the diseases prevalence declined decades ago, the number of cases started to increase since 1985. The plausible reasons for this increase may be the lack of public health efforts to control TB after its elimination, the epidemic of HIV infection, an increase in poverty, and the development of multidrug-resistant species of the bacteria. Although oral manifestations of TB are rare, clinicians should be aware of their possible occurrence in their patients. Such awareness can help diagnose TB at an early stage, thereby preventing complications and potential contaminations. Tuberculous oral lesions may be either primary or secondary. Primary lesions are uncommon, seen in younger patients and present as single painless ulcer with regional lymph node enlargement. The secondary lesions are common, often associated with pulmonary disease, and usually present as single, persistent, irregular painful ulcer, which most frequently affects the dorsum tongue and is covered by inflammatory exudates. It affects patients of any age group but relatively more common in middle aged and elderly patients. Clinical examination reveals cough, haemoptysis, fever, weight loss, and malaise. The pathogenesis of oral TB usually is self-inoculation with infected sputum, resulting from the constant coughing up of bacteria that seed themselves in the oral tissue along their line of discharge through the mouth. The low incidence of mucosal involvement may be due to constant flow of saliva, mucosal resistance, and that TB tends to single out one organ or tissue for attack. Although rare, TB must be considered in the differential diagnosis of chronic ulcers in the oral region, and its association with HIV must not be overlooked. Aetiology It is usually acquired by inhaling droplets contaminated by a bacterium called Mycobacterium tuberculosis (MTB). Diagnosis Cultures of the biopsy specimen and the sputum smear reveal acid fast bacilli. Histopathologic examination of the biopsy specimen is probably the most satisfactory. Chest x-ray to identify the primary lesion. Treatment Treating TB with antibiotics takes for at least 6-9 months (eg isoniazid, rifampin, ethambutol, or pyrazinamide). The exact drugs and length of treatment depend on age of patient, overall health, possible drug resistance, type of TB (latent or active), and its location in the body. Syphilis Syphilis is a sexually transmitted disease that may progress through 3 distinct stages. Sometimes not all 3 may be evident. The primary phase is highly contagious and the tongue is second only to the lip as the site for the chancre which is painless, hard and punched out. The associated cervical glands are hard and non-tender. The chancre develops 3-4 weeks after infection and heals spontaneously after 1 week. Though the sore goes away, the disease does not. It progresses into the secondary phase which may develop 4-10 weeks after the chancre and may last up to 2 years. This phase has many symptoms, which is why syphilis is called the great pretender. It may look like a number of other illnesses. The mucous patches may be found on the sides and tip of the tongue as oval, raised shallow lesions that later coalesce to form snail track ulcers (named due to their silvery appearance). This phase of syphilis can go away without treatment, but the disease then enters the third phase. In the third phase symptoms may develop soon after the occurrence of secondary syphilis, or syphilis may lie hidden for up to 15 years if not treated in the early stages. Tertiary syphilis is less contagious than secondary, but for the individual carrying this disease it can be fatal, particularly if the heart or central nervous system is affected. This stage is characterised by the formation of  HYPERLINK "http://en.wikipedia.org/wiki/Gumma_(pathology)" \o "Gumma (pathology)" gummas which are soft, tumor-like balls of inflammation known as  HYPERLINK "http://en.wikipedia.org/wiki/Granuloma" \o "Granuloma" granulomas. The granulomas are chronic and represent an inability of the immune system to completely clear the organism. They are seen as deep punched out ulcers on the hard palate or dorsal surface of tongue. In addition, tertiary syphilis produces syphilitic glossitis which presents as a leukoplakia of the dorsal lingual mucosa with nonspecific papillary atrophy. This condition predisposes to carcinoma of the tongue, perhaps as a result of endarteritis obliterans producing relative mucosal ischaemia and an increased susceptibility to environmental carcinogens. Great care should be taken by the clinician during examination, especially during the secondary stage because of the risk of infection. Aetiology Syphilis is a sexually transmitted infection caused by the spirochete bacteria Treponema palladium. It can be transmitted to the faetus via the placenta in a pregnant woman after 16 weeks of pregnancy. Diagnosis It is confirmed by a history of painless enlarged regional lymph nodes that last 2 months, fever, skin rashes, and painless laryngitis. It should be differentiated from tuberculosis. Diagnosis of early cases involves looking for the bacterium in scrapings from the chancre using a special instrument called a dark-field microscope. Diagnosis of advanced cases is by taking a blood sample for fluorescent treponemal antibody absorption test (FTA-ABS) and treponema pallidum particle agglutination assay (TPPA). If the results are positive then the patient must be referred to a specialist (venereologist). Treatment Without treatment syphilis can cause irreversible damage to the brain, nerves, and body tissues. The drug of choice is parenteral penicillin-G for all stages of syphilis. Actinomycosis Actinomycosis is a rare chronic bacterial infection that commonly affects the face and neck and produces abscesses and open-draining sinuses. A favourable condition is required for the growth of the microorganism such as periodontal pockets, fracture sites, and mainly post extraction. A male to female ratio of approximately 3:1 has been observed and the incidence is higher in persons aged 30-60 years. It is rare in children. Symptoms occur when the bacteria enter the facial tissues after trauma, oral surgery, dental abscess or radiation therapy causing local tissue damage of oral mucosa, all of which predispose the person to develop actinomycosis. Clinical symptoms of actinomycosis may include nonspecific complaints such as weight loss, pain, and fever. Actinomycosis affects the mandible more and the soft tissues may be involved in 60% of cases. Once in the tissue, it forms a painful abscess, producing a hard, red to reddish-purple lump. Eventually, the abscess breaks through the skin surface to produce multiple draining sinuses. Actinomycosis abscesses grow larger as the disease progresses, often over a period of months. Aetiology It is usually caused by  HYPERLINK "http://www.nlm.nih.gov/medlineplus/ency/article/002230.htm" anaerobicanaerobic bacteria called Actinomyces israelii, which is a common and non-pathogenic organism found in the nose and throat. Diagnosis Smear and culture of the tissue or fluid shows Actinomyces species. Examination of drained fluid under a microscope shows sulfur granules which are yellowish granules made of clumped organisms. A positive Kveim test confirms the diagnosis. Treatment Penicillin-G for 2-6 weeks followed by oral penicillin or amoxicillin for 6-12 months is the typical therapy. High penicillin concentrations are necessary to penetrate areas of fibrosis and suppuration and possibly the granules themselves. If the person is allergic to penicillin then doxycycline is used. Surgical drainage of the abscesses or radical excision of the sinus tracts may be necessary. Acute pseudomebraneous candidiasis Acute pseudomebraneous candidiasis, also known as moniliasis or thrush, is more common in people who smoke and can arise in patients after recent use of antibiotics, corticosteroids, immunosuppressive drugs, cytotoxic chemotherapy or irradiation. It is also common in those with xerostomia, immunodeficiencies such as leukaemia or AIDS, malnutrition, diabetes mellitus, and in neonates who have little immunity to candida species. The tongue, palate, and buccal mucosa are most frequently affected and angular cheilitis is often found. The soft, creamy white patches of thrush can be wiped off the mucosa, leaving erythema. The surrounding mucosa is not inflamed. Occasional distal spread occurs and tissues as lungs, liver and kidney may be involved. This may be due to underlying genetic defect, endocrine deficiency states, and malignancy. Aetiology Candida albicans is the most common cause of candidiasis. Diagnosis It is confirmed by a smear (gram or PAS stain) and culture swab (Saboureds medium). Treatment Avoid smoking, improve oral hygiene, and treat predisposing causes. Topical antifungal therapy such as nystatin suspension or lozenges. Systemic antifungal therapy such as fluconazole is recommended for resistant cases. Miconazole oral gel should be used for angular cheilitis if present. Erythematous candidiasis There are 2 types of erythematous candidiasis, acute and chronic. Acute erythematous candidiasis, also known as acute atrophic candidiasis or antibiotic sore mouth is common in patients taking broad spectrum antibiotics. These patients typically manifest with erythema of the affected area of oral mucosa with atrophy of dorsal lingual papillae. Red, flat persistent lesions are also seen on the palate and buccal mucosa. The major problem faced by these patients is excessive burning sensation in the affected area. Chronic erythematous candidiasis, also known as chronic atrophic candidiasis or denture stomatitis is commonly seen in patients wearing ill fitting dentures for prolonged duration, as well as in those wearing dentures through the night. These patients usually present with erythema limited to the area beneath an upper denture. Despite its name, this condition is rarely sore, though angular cheilitis or stomatitis may be associated. Patients are usually otherwise healthy. Median rhomboid glossitis (central papillary atrophy) is a red depapillated rhomboidal area in the centre of the tongue dorsum, now believed to be associated with erythematous candidiasis. Aetiology It is an infection caused by Candida albicans. Predisposing factors include poor oral and denture hygiene, xerostomia, long standing diabetes mellitus, carbohydrate-rich diets, iron or vitamin B12 deficiency, steroid therapy, HIV infection, and in people who smoke. Diagnosis It is confirmed by a smear (gram or PAS stain) collected by gentle scraping of the affected area with a wet wooden tongue depressor, and culture swab (Saboureds medium). Treatment Treat the predisposing causes. Topical antifungal therapy such as nystatin suspension or lozenges. Remove prosthesis before use of topical agents. Eradicate infection by soaking dentures overnight in 1% sodium hypochlorite (mannitol) solution or if metallic in a solution of 10% cetrimide (cetavlon), then apply a thin coating of miconazole oral gel on the acrylic portion of the appliance before reinserting into the mouth. This will prevent re-infection by the appliance. Oral miconazole gel should be used for angular cheilitis if present. Refractory cases of oral candidiasis may be caused by C. Glabrata, C. Tropicalis, or C. Krusei, all of which are azole-resistant (eg fluconazole). Acquired immunodeficiency syndrome Acquired immunodeficiency syndrome (AIDS) was first recognised in 1981 in young men and its cause, human immunodeficiency virus (HIV), was identified in the early 1980s. Today, 75% of new infections are transmitted heterosexually. After infection the HIV establishes itself in the lymphocytes where it undergoes a variable incubation period before full blown AIDS. This incubation period may be from 6 months to 2 years up to 18 years. Only one-third of patients will develop AIDS in 7 years while two-thirds will develop certain manifestations of pre-AIDS. People infected with HIV may have no symptoms for several years, but they can still transmit the infection to others during this symptom-free period. If the infection is not detected and treated, the immune system gradually weakens and AIDS develops. Acute HIV infection progresses over time (usually a few weeks to months) to  HYPERLINK "http://www.nlm.nih.gov/medlineplus/ency/article/000682.htm" asymptomatic HIV infectionasymptomatic HIV infection and then to early symptomatic HIV infection that includes chills, fevers, sweats (particularly at night), swollen lymph nodes, weakness, and weight loss. Later, it progresses to AIDS even if they do not have opportunistic infections. Full blown AIDS is characterised by immunodeficiency causing opportunistic infections such as Pneumocystis carinii pneumonia (PCP), Kaposis sarcoma (KS), Burkett-type lymphoma, unresolved candidal infection, GIT infections, severe glomerulonephritis and renal damage. Oral problems are often the first significant clinical manifestations of infection with HIV. The likelihood of AIDS presenting to the general dental practitioner become more common as the prevalence of the syndrome increases. Therefore, it is important that the dentist be aware of the condition and the recognition of its early signs and symptoms. This will avoid the possibility of the dentist getting the infection or cross the infection to the patients and allows the referral of the patients to the appropriate centre. The commonest oral manifestations are florid candidiasis, KS, recurrent herpetic infections, and to a lesser extent hairy leukoplakia, necrotising ulcerative gingivitis, squamous cell carcinoma, and malignant melanomas. Almost all people infected with HIV, if not treated, will develop AIDS. There is a small group of patients who develop AIDS very slowly, or never at all. These patients are called nonprogressors, and many seem to have a genetic difference that prevents the virus from damaging their immune system. Although treatments for AIDS and HIV can slow the course of the disease, there is currently no known cure or  HYPERLINK "http://en.wikipedia.org/wiki/HIV_vaccine" \o "HIV vaccine" vaccine. Aetiology It is a disease of the human  HYPERLINK "http://en.wikipedia.org/wiki/Immune_system" \o "Immune system" immune system caused by a retrovirus known as HIV. HIV is  HYPERLINK "http://en.wikipedia.org/wiki/Transmission_(medicine)" \o "Transmission (medicine)" transmitted through direct contact of a  HYPERLINK "http://en.wikipedia.org/wiki/Mucous_membrane" \o "Mucous membrane" mucous membrane or the bloodstream with a  HYPERLINK "http://en.wikipedia.org/wiki/Bodily_fluid" \o "Bodily fluid" bodily fluid containing HIVsuch as  HYPERLINK "http://en.wikipedia.org/wiki/Blood" \o "Blood" blood,  HYPERLINK "http://en.wikipedia.org/wiki/Semen" \o "Semen" semen,  HYPERLINK "http://en.wikipedia.org/wiki/Vaginal_fluid" \o "Vaginal fluid" vaginal fluid,  HYPERLINK "http://en.wikipedia.org/wiki/Preseminal_fluid" \o "Preseminal fluid" preseminal fluid, and  HYPERLINK "http://en.wikipedia.org/wiki/Breast_milk" \o "Breast milk" breast milk. Diagnosis Smear and culture swab of candida from buccal mucosa or tongue. Viral culture swab from dorsal lingual mucosa. Biopsy of tongue in hairy leukoplakia shows characteristic features. CBC, LFT, hepatitis B surface antigen (HBsAg), number of T4 and T4:T8 ratio (reduced). Serology for detection of serum antibodies directed against the virus. Barium swallow, bronchoscopy and smear of esophagus, biopsy of lung tissue and bone marrow, and chest x-ray. Treatment Right now there is no cure for AIDS. The highly active antiretroviral therapy (HAART), that suppresses the replication of the HIV virus in the body, reduces both  HYPERLINK "http://en.wikipedia.org/wiki/Mortality_rate" \o "Mortality rate" mortality and morbidity. Opportunistic infections are treated when they happen. Due to the difficulty in treating HIV infection, prevention is a key aim in controlling the  HYPERLINK "http://en.wikipedia.org/wiki/AIDS_pandemic" \o "AIDS pandemic" AIDS pandemic. 3 Systemic diseases with oral manifestations Scleroderma Scleroderma is a  HYPERLINK "http://en.wikipedia.org/wiki/Chronic_disease" \o "Chronic disease" chronic  HYPERLINK "http://en.wikipedia.org/wiki/Autoimmune_disease" \o "Autoimmune disease" autoimmune disease characterised by  HYPERLINK "http://en.wikipedia.org/wiki/Fibrosis" \o "Fibrosis" fibrosis, vascular alterations, and autoantibodies. Activation of the immune system causes injury to tissues. This injury is similar to  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=43240" scar tissue formation. The disease is more frequent in females than males. There are autoimmune diseases that can be associated with scleroderma such as Sjogrens syndrome, systemic lupus erythmatosus, mysthenia gravis, and acquired haemolytic anaemia. There are 3 major forms of scleroderma; diffuse, limited (previously called CREST syndrome in reference to calcinosis,  HYPERLINK "http://en.wikipedia.org/wiki/Raynaud%27s_phenomenon" \o "Raynaud's phenomenon" Raynaud's phenomenon, esophageal dysfunction,  HYPERLINK "http://en.wikipedia.org/wiki/Sclerodactyly" \o "Sclerodactyly" sclerodactyly, and telangiectasias), and morphea/linear. Diffuse and limited sclerodermas are both a systemic disease, whereas the morphea/linear form is localised to the skin. Diffuse scleroderma is severe, has a rapid onset and progression, with widespread skin hardening and will generally cause much internal organ damage. It can be fatal, as a result of  HYPERLINK "http://en.wikipedia.org/wiki/Heart" \o "Heart" heart,  HYPERLINK "http://en.wikipedia.org/wiki/Kidney" \o "Kidney" kidney,  HYPERLINK "http://en.wikipedia.org/wiki/Lung" \o "Lung" lung or  HYPERLINK "http://en.wikipedia.org/wiki/Intestinal" \o "Intestinal" intestinal damage. However, the limited type is much milder and has a slow onset and progression; skin hardening is usually confined to the hands and face; internal organ involvement is less severe, and a much better prognosis is expected. In typical cases of limited scleroderma, Raynaud's phenomenon may precede scleroderma by several years. Most patients with systemic sclerosis have waxy, tight, smooth facial skin (Mona Lisa face) and skin tightening can cause the  HYPERLINK "http://www.sclero.org/medical/symptoms/dental/a-to-z.html" \l "microstomia" mouth to become smaller (microstomia) with difficulty in opening the mouth wide. It can cause numerous oral and dental problems when it affects the mouth and face. The oral mucosa will probably reveal atrophic epithelium and the tongue and soft palate are often partially immobilised giving rise to difficulty in eating, talking and swallowing. In the early stages, macroglossia is usual, but as fibrosis occurs the tongue becomes small, hard and immobilised (chicken tongue). The systemic disease is often accompanied by  HYPERLINK "http://www.sclero.org/medical/symptoms/sjogrens/a-to-z.html" Sjogren's syndrome and the resulting  HYPERLINK "http://www.sclero.org/medical/symptoms/dental/a-to-z.html" \l "xerostomia" dry mouth leads to increased  HYPERLINK "http://www.sclero.org/medical/symptoms/dental/a-to-z.html" \l "dentalcaries" cavities,  HYPERLINK "http://www.sclero.org/medical/symptoms/dental/a-to-z.html" \l "periodontal" gum disease, and candida infections. It can also loosen teeth by causing the ligament around the teeth to expand due to collagen deposition. When the ligament expands, the teeth are less supported by bone structure. Function is further inhibited by progressive involvement of the facial skin, muscles of mastication, and the TMJ. The localised type of the disease, known as  HYPERLINK "http://en.wikipedia.org/wiki/Morphea" \o "Morphea" morphea/linear, while disabling, tends not to be fatal and involves isolated patches of hardened skin, with no internal organ involvement. Individuals with morphea or limited scleroderma have a relatively positive outlook. Those with diffuse systemic scleroderma have a negative prognosis, and although more females are affected, the disease kills more men. Following diagnosis, two-thirds of patients live at least 11 years. The higher the patient's age at diagnosis, the more likely they are to die from the disease. Aetiology It is an autoimmune disease. It could be inherited, but the environment seems to also play a role. Diagnosis It is essentially a clinical one. Blood analysis is non-contributory in localised scleroderma. The  HYPERLINK "http://en.wikipedia.org/wiki/Anti-topoisomerase_antibodies" \o "Anti-topoisomerase antibodies" anti-topoisomerase antibody is most often seen in patients with the diffuse form of scleroderma, whereas  HYPERLINK "http://en.wikipedia.org/wiki/Anti-centromere_antibodies" \o "Anti-centromere antibodies" anti-centromere antibody is found almost exclusively in the limited form. Nearly all patients with scleroderma have ANA. Other tests are used to evaluate the presence or extent of any internal disease. These may include GIT tests,  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=336" chest x-ray, lung function testing and  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=315" CT scanning,  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=1944" ECG,  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=42331" echocardiogram (Echo), and sometimes heart catheterisation to evaluate the pressure in the arteries of the heart and lungs. Treatment There is no cure for scleroderma, and treatment aims at ameliorating the symptoms.  HYPERLINK "http://en.wikipedia.org/wiki/Raynaud%27s_phenomenon" \o "Raynaud's phenomenon" Raynaud's phenomenon may be treated with agents to increase blood flow to the fingers. Fibrosis of the skin has been treated with drugs that soften the skin and reduce inflammation. Some patients may benefit from exposure to heat. Because scleroderma is an autoimmune disease, one of the major pillars of treatment involves the use of immunosuppressive agents such as  HYPERLINK "http://en.wikipedia.org/wiki/Methotrexate" \o "Methotrexate" methotrexate,  HYPERLINK "http://en.wikipedia.org/wiki/Azathioprine" \o "Azathioprine" azathioprine,  HYPERLINK "http://en.wikipedia.org/wiki/Cyclophosphamide" \o "Cyclophosphamide" cyclophosphamide, and  HYPERLINK "http://en.wikipedia.org/wiki/Mycophenolate" \o "Mycophenolate" mycophenolate. Amyloidosis Amyloidosis is the abnormal deposition of amyloid protein in various body tissues, leading to organ or tissue damage. Most often, amyloid protein comes from cells in the bone marrow. Deposition of amyloid in a localised area or a single tissue of the body is called localised amyloidosis, causing relatively few symptoms. Often with aging, amyloid can be locally produced and deposited to cause tissue injury. Amyloidosis that affects tissues throughout the body is referred to as systemic amyloidosis, and can cause serious changes in virtually any organ of the body. It has been classified into 3 major types that are very different from each other. These are distinguished by a 2 letter code that begins with an A (for amyloid). The second letter of the code stands for the protein that accumulates in the tissues in that particular type of amyloidosis. The types of systemic amyloidosis are currently categorised as primary (AL), secondary (AA), and hereditary (ATTR). Primary amyloidosis or AL is of unknown cause and occurs when a specialised cell in the bone marrow (plasma cell) spontaneously overproduces a particular protein portion of an antibody called the light chain. Primary amyloidosis can occur with a bone marrow  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=13931" cancer of plasma cells called multiple myeloma. It is not associated with any other diseases, but is a disease entity of its own. Secondary amyloidosis or AA is more common than AL and occurs secondarily as a result of another illness, such as chronic infections (eg tuberculosis, osteomyelitis) or inflammatory diseases (eg rheumatoid arthritis, ankylosing spondylitis). Hereditary amyloidosis or ATTR is a rare form of amyloidosis, inherited as an autosomal dominant. The amyloid deposits are composed of the protein transthyretin, or TTR, which is made in the liver. Therefore, the offspring of a person with the condition has a 50% chance of inheriting it. Symptoms of amyloidosis result from abnormal functioning of the particular organs involved. The heart, kidneys, liver, bowels, skin, nerves, joints, and lungs can be affected. As a result, symptoms are vague and can include  HYPERLINK "http://www.medicinenet.com/script/main/forum.asp?articlekey=26109" fatigue,  HYPERLINK "http://www.medicinenet.com/script/main/forum.asp?articlekey=34434" shortness of breath,  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=18262" weight loss and  HYPERLINK "http://www.medicinenet.com/script/main/forum.asp?articlekey=32101" loss of appetite, numbness, tingling, and weakness. Amyloidosis affecting the kidney leads to nephrotic syndrome which is characterised by severe loss of protein in the urine and swelling of the extremities. The most frequent cause of death in systemic amyloidosis is kidney failure. The most common oral manifestation of amyloidosis is macroglossia, which occurs in 20% of patients. The enlarged tongue demonstrates lateral ridging due to teeth indentation. Although pain is not usually present, enlargement, firmness, and loss of mobility are common. Submandibular swelling occurs subsequent to tongue enlargement and can lead to respiratory obstruction. Interference with taste has also been reported in some patients, and hyposalivation may result from amyloid deposition in the salivary glands. Aetiology It is caused by extracellular deposition of insoluble protein called amyloid. Diagnosis It is made by detecting the characteristic amyloid protein in a biopsy specimen of involved tissue (such as mouth, rectum, kidney, heart or liver). A needle aspiration biopsy of fat, just under the skin of the belly (fat pad aspiration), offers a simple and less invasive method to diagnose systemic amyloidosis. The detection of amyloid deposits in a patient warrants further evaluation for possible multiple myeloma which yields a poor prognosis for the patient. Treatment Currently, amyloidosis has no cure and treatment seeks to limit further production of the amyloid protein. Combination aggressive treatment in AL using melphalan chemotherapy medication, in conjunction with bone marrow stem cells transplantation, has been promising. More aggressive treatment options may be employed in AA to directly target the underlying disease responsible for amyloidosis. ATTR can now be cured with liver transplantation. Sarcoidosis Sarcoidosis is a disease in which noncaseating epithelioid granulomas form nodules that may affect any organ system. It usually occurs between the ages of 20-40 years. Women are slightly more likely to develop the disease than men. Normally the  HYPERLINK "http://en.wikipedia.org/wiki/Natural_history_of_disease" \o "Natural history of disease" onset is gradual and it may be  HYPERLINK "http://en.wikipedia.org/wiki/Asymptomatic" \o "Asymptomatic" asymptomatic or  HYPERLINK "http://en.wikipedia.org/wiki/Chronic" \o "Chronic" chronic.  HYPERLINK "http://en.wikipedia.org/wiki/Granuloma" \o "Granuloma" Granulomas most often appear in the  HYPERLINK "http://en.wikipedia.org/wiki/Lung" \o "Lung" lungs or the  HYPERLINK "http://en.wikipedia.org/wiki/Lymph_nodes" \o "Lymph nodes" lymph nodes, but virtually any organ can be affected. Common symptoms are vague, such as  HYPERLINK "http://en.wikipedia.org/wiki/Fatigue_(physical)" \o "Fatigue (physical)" fatigue, fever, swollen lymph nodes,  HYPERLINK "http://en.wikipedia.org/wiki/Weight_loss" \o "Weight loss" weight loss, aches and pains,  HYPERLINK "http://en.wikipedia.org/wiki/Arthritis" \o "Arthritis" arthritis,  HYPERLINK "http://en.wikipedia.org/wiki/Xerophthalmia" \o "Xerophthalmia" dry eyes, blurred vision, severe redness of the eyes and sensitivity to light. Almost everyone who has sarcoidosis eventually experiences lung problems, which may include persistent dry cough,  HYPERLINK "http://en.wikipedia.org/wiki/Dyspnea" \o "Dyspnea" shortness of breath ( HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=3145" dyspnea), wheezing, and chest pain. About 5-10% of patients develop serious disability, and lung scarring or infection may lead to respiratory failure and death. Up to 25% of the individuals who have sarcoidosis develop skin problems, which vary and range from  HYPERLINK "http://en.wikipedia.org/wiki/Rash" \o "Rash" rashes and nodules to  HYPERLINK "http://en.wikipedia.org/wiki/Erythema_nodosum" \o "Erythema nodosum" erythema nodosum or  HYPERLINK "http://en.wikipedia.org/wiki/Lupus_pernio" \o "Lupus pernio" lupus pernio. Oral involvement in sarcoidosis is rare and usually manifests after systemic symptoms develop. The symptoms may include lip swelling and multiple nodular painless ulcerations of the gingiva, buccal/labial mucosa, and palate. Although less common, salivary gland involvement is a possibility, leading to tumor-like swellings. Sarcoidosis can be difficult to diagnose, partly because the disease produces few signs and symptoms in its early stages; and when symptoms do occur, they vary and can mimic those of other disorders. Aetiology The cause of the disease is still unknown. Diagnosis This is commonly a diagnosis of exclusion of other granulomatous diseases such as Wegener granulomatosis, Crohn disease, syphilis or tuberculosis. Blood test may show a high level of calcium, and liver and kidney function tests should be carried out to determine the extent of the disease. Chest x-ray, CT scan, and pulmonary function tests are needed. Microscopic examination of specimens of lung tissue obtained with a  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=2538" bronchoscope, or of other tissues can provide the ultimate diagnosis. Kveim reaction is a diagnostic test for sarcoidosis, involving intradermal injection of antigen derived from a lymph node known to be sarcoid. If a lump appears on the skin at the test site in 4-8 weeks, the reaction is said to be positive and that the patient has sarcoidosis. Treatment Between 30-70% of patients do not require therapy because the disease commonly improves or clears up spontaneously.  HYPERLINK "http://en.wikipedia.org/wiki/Corticosteroid" \o "Corticosteroid" Corticosteroids ( HYPERLINK "http://en.wikipedia.org/wiki/Prednisone" \o "Prednisone" prednisolone) have been the standard treatment for many years and their use is generally limited to severe, progressive or organ-threatening disease. Multiple organ and progressive pulmonary involvement indicate a poor prognosis. Cystic fibrosis Cystic fibrosis (CF) is an inherited common multisystemic disease which affects the entire body causing progressive disability and often early death. The name CF refers to the characteristic  HYPERLINK "http://en.wikipedia.org/wiki/Scar" \o "Scar" scarring ( HYPERLINK "http://en.wikipedia.org/wiki/Fibrosis" \o "Fibrosis" fibrosis) and cyst formation. Cystic fibrosis affects the cells that produce sweat, mucus, and digestive juices. Normally, these secretions are thin and slippery, but in CF a defective gene causes the secretions to become thick and sticky. Instead of acting as a lubricant, the secretions plug up tubes, ducts and passageways, especially in the lungs and pancreas. Cystic fibrosis is the most common fatal disorder among  HYPERLINK "http://en.wikipedia.org/wiki/Caucasian_race" \o "Caucasian race" caucasians of European descent and one in 25  HYPERLINK "http://en.wikipedia.org/wiki/Genetic_carrier" \o "Genetic carrier" carry one gene for CF. In the past, most people with CF died in their teens. Improved screening and treatment allow many people with CF to live into their 50s or even longer. The symptoms and severity of CF vary widely. Some people have serious problems from birth. Others have a milder version of the disease that doesn't show up until they are teens or young adults. One of the first signs of CF is an excessive salt in the sweat. Most of the other signs and symptoms affect the respiratory or the digestive system.  HYPERLINK "http://en.wikipedia.org/wiki/Shortness_of_breath" \o "Shortness of breath" Difficulty in breathing is the most serious symptom and results from frequent  HYPERLINK "http://en.wikipedia.org/wiki/Pneumonia" \o "Pneumonia" lung infections, which is the cause of death in CF patients. Other symptoms include  HYPERLINK "http://en.wikipedia.org/wiki/Sinusitis" \o "Sinusitis" sinus infections,  HYPERLINK "http://en.wikipedia.org/wiki/Failure_to_thrive" \o "Failure to thrive" poor growth,  HYPERLINK "http://en.wikipedia.org/wiki/Diarrhea" \o "Diarrhea" diarrhea, and  HYPERLINK "http://en.wikipedia.org/wiki/Infertility" \o "Infertility" infertility. Lip swelling, gingivitis, and dryness are the more frequent oral findings. Aetiology Children who inherit a faulty  HYPERLINK "http://en.wikipedia.org/wiki/Cystic_fibrosis_transmembrane_conductance_regulator" \o "Cystic fibrosis transmembrane conductance regulator" cystic fibrosis transmembrane conductance regulator (CFTR) gene from each parent will have CF. Those who inherit a faulty gene from one parent and a normal CFTR gene from the other parent will be CF carriers. CF carriers usually have no symptoms and live normal lives; however, they can pass the faulty CFTR gene onto their children. Diagnosis Newborn screening for CF can be achieved by using genetic testing and blood test. DNA samples from blood or saliva can be checked for specific mutations on the gene responsible for CF, and blood tests help measure the health of liver and pancreas. In early childhood, sweat test that measures the amount of salt in sweat, is the most useful test for diagnosing CF. Chest x-ray, CT scan or MRI are recommended to examine the lungs and internal organs. In case of lung infection, sputum test is needed to identify the pathogen and choose the antibiotic. Treatment There is no cure for CF. Medications such as antibiotics, mucus thinning drugs, and bronchodilators are used to treat and prevent lung infections. Ultimately  HYPERLINK "http://en.wikipedia.org/wiki/Lung_transplantation" \o "Lung transplantation" lung transplantation is often necessary as CF worsens. Wegeners granulomatosis Wegener's granulomatosis (WG) is an uncommon necrotising vasculitis of small arteries and veins. It classically involves inflammation of the arteries that supply blood to the tissues of the lungs, the nasal passages (sinuses), and the kidneys. When both lungs and kidneys are affected, the condition is referred to as generalised WG. When only the lungs are involved, the condition is referred to as limited WG. It usually affects young or middle-aged adults. Symptoms of WG include  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=120806" fatigue, weight loss and  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=361" fever, shortness of breath, bloody sputum, joint pains, and  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=476" sinusitis. Nasal ulcerations, and even bloody nasal discharge, can occur. Other areas of the body that can also become inflamed include eyes, nerves (neuropathy), middle ear (otitis media), and skin, resulting in skin nodules or ulcers. Oral involvement in WG is common, and autopsy studies of patients with the disease show this site is affected in nearly all cases. Oral lesions include ulcerations and gingival enlargement. Initially, bright red to purple friable diffuse papules originate on the labial interdental papillae. The gingivae take on a characteristic swollen, reddened, and granular appearance. The characteristic gingival appearance is a pathognomonic finding termed strawberry gingivitis, although it is less common than other findings. Involvement may eventually include the lingual and palatal mucosa. Tooth and alveolar bone loss are common. Oral manifestations may correlate with disease progression, thereby providing prognostic value. Aetiology The cause of WG is unknown. Diagnosis Early diagnosis of the disease is essential. Blood tests include ESR, CRP, and urine tests to detect protein and RBC. A more specific blood test used to diagnose and monitor WG is the antineutrophil cytoplasmic antibodies (ANCAs), which is elevated when the disease is active. Biopsy findings of the gingival papillomatous lesion confirm the diagnosis.  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=336" X-ray tests of the chest and sinuses are recommended to detect abnormalities of WG. Open lung or kidney biopsies are also commonly used in making a diagnosis. Treatment Treatment is usually with oral corticosteroids and cyclophosphamide. Prompt treatment is important to prevent further damage to the lungs and kidneys. Graft versus host disease Graft versus host disease (GVHD) is a common  HYPERLINK "http://en.wikipedia.org/wiki/Complication_(medicine)" \o "Complication (medicine)" complication that occurs in the bone marrow involving a donor and a recipient. Since only identical twins have identical tissue types, a donor's bone marrow is normally a close, but not perfect match to the recipient's tissues. Histocompatibility antigen test Bone marrow transplantation is frequently used to treat  HYPERLINK "http://en.wikipedia.org/wiki/Cancer" \o "Cancer" cancer, mainly  HYPERLINK "http://en.wikipedia.org/wiki/Leukemia" \o "Leukemia" leukaemias. Clinically, GVHD is divided into  HYPERLINK "http://en.wikipedia.org/wiki/Acute_(medical)" \o "Acute (medical)" acute and  HYPERLINK "http://en.wikipedia.org/wiki/Chronic_(medicine)" \o "Chronic (medicine)" chronic forms. The acute form of the disease is normally observed within the first 3 months after transplant, and is a major challenge to transplants owing to associated morbidity and mortality. The chronic form of GVHD usually starts more than 3 months after transplant, and can last a lifetime. Rates of GVHD vary from between 30-40% among related donors and recipients to 60-80% between unrelated donors and recipients. The greater the mismatch between the donor and recipient, the greater the risk of GVHD. After a transplant, the recipient usually takes drugs that suppress the immune system; this helps reduce the chances or severity of GVHD. Symptoms in both acute and chronic GVHD range from mild to severe. The acute form is characterised by selective damage to the  HYPERLINK "http://en.wikipedia.org/wiki/Liver" \o "Liver" liver,  HYPERLINK "http://en.wikipedia.org/wiki/Skin" \o "Skin" skin and  HYPERLINK "http://en.wikipedia.org/wiki/Mucosa" \o "Mucosa" mucosa, and the GIT. Chronic GVHD also attacks the above organs, but over its long-term course it can also cause damage to the  HYPERLINK "http://en.wikipedia.org/wiki/Connective_tissue" \o "Connective tissue" connective tissue and  HYPERLINK "http://en.wikipedia.org/wiki/Exocrine_glands" \o "Exocrine glands" exocrine glands. In both acute and chronic GVHD, the patient is very vulnerable to infections. The oral manifestations of acute GVHD have been described as painful ulcerations together with cheilitis, striae, white plaque-like patches, xerostomia and erythema. Minor erythema of the oral mucosa suggests chronic GVHD, whereas a normal oral cavity denotes absence of the disease. Additional contributing causes of oral complications are thought to arise from the side effects of chemotherapy and radiation therapy. Aetiology Graft versus host disease is a complication that can occur after a  HYPERLINK "http://www.nlm.nih.gov/medlineplus/ency/article/003009.htm" bone marrow transplant in which the newly transplanted material attacks the transplant recipient's body. Diagnosis It is by oral biopsy if white lesion (lichenoid reaction), minor salivary gland biopsy if xerostomia (Sjogrens syndrome), and  HYPERLINK "http://www.nlm.nih.gov/medlineplus/ency/article/003840.htm" skin biopsySkin biopsy if scleroderma-like lesions. Chest x-ray and  HYPERLINK "http://www.nlm.nih.gov/medlineplus/ency/article/003338.htm" GI endoscopyGastrointestinal endoscopy with or without a  HYPERLINK "http://www.nlm.nih.gov/medlineplus/ency/article/003416.htm" biopsybiopsy.  HYPERLINK "http://www.nlm.nih.gov/medlineplus/ency/article/003436.htm" Liver function testsLiver function tests (ALP, AST, and bilirubin levels will be increased), and  HYPERLINK "http://www.nlm.nih.gov/medlineplus/ency/article/003895.htm" liver biopsyLiver biopsy if the patient only has liver symptoms. Treatment The goal is to suppress the immune response without damaging the new cells. High dose corticosteroids are the most effective treatment for acute GVHD. Treatment of chronic GVHD includes corticosteroids with or without cyclosporine. Antibodies to T-cells and other medicines are given to patients who do not respond to steroids. Rheumatoid arthritis Rheumatoid arthritis (RA) is a common, autoimmune systemic disease that causes chronic inflammation of the joints. The disease is 3 times more common in women than in men. It can begin at any age, but it most often starts between 40-60 years. While RA is a chronic illness, meaning it can last for years, patients may experience long periods without symptoms. However, RA is typically a progressive illness that has the potential to cause joint destruction and functional disability; and is often accompanied by Sjogrens syndrome. When the disease is active, symptoms can include fatigue, loss of energy, lack of appetite, low grade fever, muscle and joint aches, and stiffness. The joint inflammation of RA causes swelling, pain, stiffness, and redness. Moreover, studies have shown that the progressive damage to the joints does not necessarily correlate with the degree of pain, stiffness, or swelling present in the joints. The TMJ is affected in more than 17% of adults and children with RA, but it is usually among the last joints involved. Pain, swelling, and limited movement are the most common findings. In children, destruction of the condyle results in mandibular growth disturbance and facial deformity, followed by ankylosis. In early stages, x-rays of the TMJ are usually negative but later show bone destruction, which may result in an anterior open-bite deformity. In most patients with RA, the condition will necessitate few or no changes in routine dental care. However, considerations include the patients ability to maintain adequate oral hygiene, xerostomia and its related complications, the patients susceptibility to infections, impaired haemostasis, and untoward drug actions and interactions. Oral ulcerations and lichenoid reaction may appear as a consequence of the use of NSAIDs or other anti-rheumatics. Aetiology It is an autoimmune diseas. In some families, multiple members can be affected, suggesting a genetic basis for the disorder. Diagnosis Blood tests for CBC, CRP, and RF (found in 80% of patients). Anticitrulline antibody (anti-CCP) and ANA is present in most patients with RA. Imaging techniques to visualise the structural integrity of the jaw joint, such as x-ray, CT scan, MRI or arthroscopy. Arthrocentesis, the removal and analysis of fluid in the joint using a syringe, can be helpful to determine if an infection is present. Treatment Applying moist heat packs to the painful jaw joint, eating a soft diet, and using night guard is often helpful. NSAIDs may be given, and jaw function should be restricted. Injection of steroids directly into the painful joint may provide pain relief. This can only be done a limited number of times, as repeated use can harm the joint. Arthrocentesis can be helpful in relieving joint swelling and pain. Antibiotic prophylaxis may be needed before dental treatment if patient is taking oral corticosteroid due to immunosuppression. The enzyme geranylgeranyltransferase-I (GGTase-I) inhibitor has the potential to treat RA, as it protects against inflammation and joint destruction. Food allergy Food allergy is an exaggerated  HYPERLINK "http://en.wikipedia.org/wiki/Immune_system" \o "Immune system" immune response to a food protein, which is distinct from other adverse responses to food, such as  HYPERLINK "http://en.wikipedia.org/wiki/Food_intolerance" \o "Food intolerance" food intolerances to milk and dairy products, wheat and other gluten-containing grains. Only 6-8% of children and 3% of adults have clinically proven true allergic reactions to food. A food allergy frequently starts in childhood, but it can begin at any age. Fortunately, many children will outgrow their allergy to milk, egg, wheat, peanuts, tree nuts, soy, shellfish, and fruits (particularly tomatoes and strawberries) by the time they are 5 years old if they avoid the offending foods when they are young, but adults usually do not lose theirs. The most common foods that cause allergic reactions in adults are fish, shellfish, peanuts, and tree nuts. Symptoms usually begin immediately, within 2 hours after eating. Although usually mild and not severe, these reactions can cause devastating illness, and in rare instances can be fatal. A food allergy can initially be experienced as an  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=15781" itching in the mouth and difficulty swallowing and breathing. Then, during digestion of the food in the stomach and intestines, symptoms such as  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=41943" nausea, vomiting,  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=1900" diarrhea, and  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=1908" abdominal pain can start. When they reach the skin, allergens can induce  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=511" hives or  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=64425" eczema, and when they reach the airways, they can cause  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=284" asthma. As the allergens travel through the blood vessels, they can cause light headedness, weakness, and  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=12953" anaphylaxis, which is a sudden drop in blood pressure. Allergies to foods may be manifested in the oral cavity as a perioral rash, itchy lips, tongue, and throat, and sometimes swollen lips. Less than 1% of patients with RAS may be attributed to food allergy or intolerance. An oral allergy syndrome (OAS) is a type of food allergy that is caused by cross-reactivity between proteins in fresh fruits and vegetables and pollens, and about 70% of people with allergy to pollen have OAS as well. These foods contain substances similar to certain pollens. The proteins in fresh fruits and vegetables are easily broken down with cooking or processing. Therefore, OAS typically does not occur with cooked or baked fruits and vegetables, or processed fruits. However, unlike other food allergies, touching fresh fruits and vegetables that cause allergies leads to tingling, itching, and swelling of the throat, mouth, lips, and tongue. However, these symptoms do not last very long and do not progress to anything more serious. It can occur anytime of the year but is most prevalent during the pollen season, and the syndrome will abate within 23 years if the patient moves to an area free of the triggering pollen. Aetiology Food allergy occurs when the body's immune system mistakenly identifies a protein in the food as harmful. This leads to the body making a type of allergy-producing substance called IgE antibodies to a particular food. Diagnosis The dietary diary provides more details than the oral history. Elimination diet by eliminating the suspected food from the diet. Skin prick test in which a dilute extract of the suspected food is placed on the skin of the forearm or back. Prick-prick testing with fresh foods (skin-testing needle is inserted into the fresh food, and then used to prick the persons skin) is more reliable than testing with commercial extracts which will commonly give a false negative since the proteins resulting are broken down during processing. Blood tests include radioallergosorbent test (RAST) and  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=9105" ELISA that measures the amount of food-specific IgE antibodies to inhalants and/or foods in the blood of patients. Treatment It consists of either  HYPERLINK "http://en.wikipedia.org/wiki/Immunotherapy" \o "Immunotherapy" immunotherapy (desensitisation), or avoidance in which the allergic person avoids all forms of contact with the food to which he is allergic. Areas of research include a humanised monoclonal anti-IgE antibody (omalizumab) and specific oral tolerance induction (SOTI) (oral exposure to increasing doses of the specific food allergen), which have shown some promise for treatment of certain food allergies. Persons with a history of severe anaphylactic reaction may carry a self-injectable dose of  HYPERLINK "http://en.wikipedia.org/wiki/Epinephrine" \o "Epinephrine" epinephrine (adrenaline) such as an EpiPen. Other treatments include  HYPERLINK "http://en.wikipedia.org/wiki/Antihistamines" \o "Antihistamines" antihistamines and  HYPERLINK "http://en.wikipedia.org/wiki/Steroids" \o "Steroids" steroids. Adverse drug reactions Mucocutaneous eruptions are often central to untoward drug reactions. An ever-expanding list of medications is linked to pathologic reactions in the oral and perioral region. These adverse drug reactions have a broad spectrum of clinical manifestations that can mimic those of other disease states, including both local and systemic conditions. Fortunately, several patterns of disease have been identified, and these can assist the clinician in determining a possible cause-and-effect relationship with a particular medication or group of medications. The clinical patterns of adverse drug reactions of the oral cavity include xerostomia (antidepressants, antipsychotics, antihypertensives, antihistamines, anticholinergics), swelling (penicillins, aspirin, sulfa drugs, ACE inhibitors), nonspecific ulcerations and mucositis (NSAIDs, antineoplastics, barbiturates, dapsone, sulfonamides, tetracyclines, penicillamine, phenytoin, and the potassium channel activator nicorandil, which has recently been recognised as a new cause of persistent oral ulceration with a predilection for the tongue), lupus erythematosus (carbamazepine, penicillamine, streptomycin, minocycline), erythema multiforme major (NSAIDs, penicillins, sulfonamides, hydroxychloroquine, tetracyclines, HYPERLINK "http://en.wikipedia.org/wiki/Phenytoin" \o "Phenytoin"phenytoin, HYPERLINK "http://en.wikipedia.org/wiki/Barbiturates" \o "Barbiturates"barbiturates, HYPERLINK "http://en.wikipedia.org/wiki/Allopurinol" \o "Allopurinol"allopurinol), lichen planus (NSAIDs, amphotericin B, beta-blockers, carbamazepine, dapsone, ketoconazole, lorazepam, tetracycline, botox), pemphigus vulgaris (ampicillin, cephalexin, ibuprofen, voltaren, penicillamine, rifampin, captopril, phenobarbital), mucous membrane pemphigoid (penicillamine, ibuprofen, penicillins, sulfonamides), lichen planus pemphigoides (cinnarizine, captopril, ramipril, simvastatin, PUVA, antituberculous medication), pigmentation (ACTH, phenolphthalein, hydroxychloroquine, estrogen, ketoconazole, minocycline, tranquilisers, zidovudine), and gingival enlargement (calcium channel blockers, bleomycin, cyclosporine, phenytoin). Aetiology An estimated 2-4% of hospital admissions are related to adverse drug reactions. Diagnosis A detailed drug history can reveal the responsible medication. Treatment Withdrawal of the drug or dose reduction will resolve the lesion. Crohn disease Crohn disease, also known as regional enteritis, is an idiopathic chronic inflammatory disease of the intestines that may affect any part of the GIT from  HYPERLINK "http://en.wikipedia.org/wiki/Mouth" \o "Mouth" mouth to  HYPERLINK "http://en.wikipedia.org/wiki/Anus" \o "Anus" anus, causing a wide variety of  HYPERLINK "http://en.wikipedia.org/wiki/Symptom" \o "Symptom" symptoms. Most Crohn disease cases involve the small bowel, particularly the terminal ileum. Studies throughout the world have shown a small excess risk of Crohn disease among women. The first peak occurs between the ages of 15-30 years, and the second peak occurs between the ages of 60-80. However, most cases begin before age 30 years. Symptoms of Crohn disease include intermittent attacks of diarrhea, constipation, abdominal pain, and fever. Patients may develop malabsorption and subsequent malnutrition. Fissures or fistulas may occur in persons with chronic disease. With oral involvement, the likelihood of extraintestinal manifestations is greater, and these may manifest systemically as skin rashes, arthritis, eye inflammation, tiredness, and lack of concentration. Oral involvement in Crohn disease occurs in 8-9% of patients and may precede intestinal involvement. Oral symptoms include diffuse labial, gingival, or mucosal swelling, cobblestoning of the buccal mucosa and gingiva, aphthous-like ulcers, mucosal tags, and angular cheilitis. Lip swelling is the most common manifestation of Crohn disease and is often a cosmetic complaint. The pattern of swelling, inflammation, ulcers, and fissures is similar to that of the lesions occurring in the intestinal tract. Oral granulomas may occur without the characteristic alimentary involvement and is called orofacial granulomatoses. However, the term orofacial granulomatoses encompasses a variety of other disorders, including sarcoidosis, Melkersson-Rosenthal syndrome, and rarely tuberculosis. Whether patients with orofacial granulomatoses will subsequently develop intestinal manifestations of Crohn disease is uncertain, but histologic similarities between the oral lesions and the intestinal lesions are obvious. Oral findings as described above warrant a full systemic evaluation for intestinal Crohn disease, including referral for colonoscopy and biopsy with histopathologic correlation. Negative findings on GIT evaluations should be repeated in patients with oral symptoms. The severity of oral lesions may coincide with the severity of the systemic disease, and it may be used as a marker for intestinal impairment. Patients diagnosed younger have worse prognosis than those diagnosed later in life and a reduced life expectancy compared with the general population. Mortality appears to be the highest in the first 4-5 years after diagnosis, and over time, 10% of patients will be disabled by their disease. The most common disease that mimics the symptoms of Crohn disease is ulcerative colitis, as both are inflammatory bowel diseases that can affect the  HYPERLINK "http://en.wikipedia.org/wiki/Colon_(anatomy)" \o "Colon (anatomy)" colon with similar symptoms. It is important to differentiate these diseases, since the course of the diseases and treatments may be different. Aetiology The exact cause of Crohn disease remains unknown. It is thought to be an  HYPERLINK "http://en.wikipedia.org/wiki/Autoimmune_disease" \o "Autoimmune disease" autoimmune disease in which the body's  HYPERLINK "http://en.wikipedia.org/wiki/Immune_system" \o "Immune system" immune system attacks the GIT causing  HYPERLINK "http://en.wikipedia.org/wiki/Inflammation" \o "Inflammation" inflammation. Environmental, microbial, immunologic, dietary, vascular, smoking, oral contraceptive, NSAIDs, and psychosocial factors have been implicated in its pathogenesis. There has been evidence of a  HYPERLINK "http://en.wikipedia.org/wiki/Genetics" \o "Genetics" genetic link to Crohn disease, putting individuals with siblings afflicted with the disease at higher risk. Diagnosis CBC may reveal  HYPERLINK "http://en.wikipedia.org/wiki/Anemia" \o "Anemia" anaemia, which may be caused either by blood loss or by  HYPERLINK "http://en.wikipedia.org/wiki/Cyanocobalamin" \o "Cyanocobalamin" vitamin B12 deficiency, in addition to CRP. Anti- HYPERLINK "http://en.wikipedia.org/wiki/Saccharomyces_cerevisiae" \o "Saccharomyces cerevisiae" Sa+ccharomyces cerevisiae antibodies (ASCA) and  HYPERLINK "http://en.wikipedia.org/wiki/Anti-neutrophil_cytoplasmic_antibody" \o "Anti-neutrophil cytoplasmic antibody" anti-neutrophil cytoplasmic antibodies (ANCA) are among the two most useful markers to differentiate Crohn disease (ASCA) from ulcerative colitis (ANCA). Biopsy of the affected oral mucosa may show noncaseating granulomas. The  HYPERLINK "http://en.wikipedia.org/wiki/Capsule_endoscopy" \o "Capsule endoscopy" capsule endoscopy and a  HYPERLINK "http://en.wikipedia.org/wiki/Barium_follow-through" \o "Barium follow-through" barium follow-through x-ray are useful when the disease involves only the small intestine.  HYPERLINK "http://en.wikipedia.org/wiki/Colonoscopy" \o "Colonoscopy" Colonoscopy is the best test for diagnosis as it allows direct visualisation of the colon and the  HYPERLINK "http://en.wikipedia.org/wiki/Terminal_ileum" \o "Terminal ileum" terminal ileum. Treatment Antibiotics are used to treat any infection. Prolonged use of corticosteroids has significant  HYPERLINK "http://en.wikipedia.org/wiki/Adverse_effect_(medicine)" \o "Adverse effect (medicine)" side effects; as a result they are generally not used for long-term treatment. Alternatives include aminosalicylates alone, though only a minority is able to maintain the treatment, and many require immunosuppressive drugs. When symptoms are in remission, treatment enters maintenance with a goal of avoiding the recurrence of symptoms. Remissions tend to occur with the restriction of certain proteins, especially dairy produce. Most patients (80%) develop complications that require surgery, and the disease frequently recurs after surgery. Ulcerative colitis Ulcerative colitis (UC) is a chronic  HYPERLINK "http://en.wikipedia.org/wiki/Inflammatory_bowel_disease" \o "Inflammatory bowel disease" inflammatory bowel disease of the large intestine or  HYPERLINK "http://en.wikipedia.org/wiki/Colon_(anatomy)" \o "Colon (anatomy)" colon. Like Crohn disease, UC can be debilitating and sometimes can lead to life-threatening complications. It occurs in less than 0.1% of the population. Ucerative colitis can occur at any age, but the peak incidence is between the ages of 15-25 years with a second peak in incidence occurring in the 6th decade of life. The disease affects females more than males. It is more prevalent in northern countries of the world. Ulcerative colitis usually affects only the innermost lining of the colon and rectum, unlike Crohn disease, which occurs in patches anywhere in the digestive tract, and often spreads deep into the layers of affected tissues. The main symptom of active disease is usually constant  HYPERLINK "http://en.wikipedia.org/wiki/Diarrhea" \o "Diarrhea" diarrhea mixed with blood, in addition to abdominal pain and fever. Ulcerative colitis may also cause problems outside the colon such as arthritis, inflammation of the eye, liver disease, and osteoporosis. Lesions in the colon consist of areas of haemorrhage and ulcerations along with abscesses. Similar lesions may manifest in the oral cavity as aphthous ulcers or superficial haemorrhagic ulcers that coincide with exacerbations of the colonic disease. Ulcerative colitis is an intermittent disease, with periods of exacerbated symptoms, and periods that are relatively symptom free. Although the symptoms of UC can sometimes diminish on their own, the disease usually requires treatment to go into  HYPERLINK "http://en.wikipedia.org/wiki/Remission_(medicine)" \o "Remission (medicine)" remission. There is a significantly increased risk of  HYPERLINK "http://en.wikipedia.org/wiki/Colorectal_cancer" \o "Colorectal cancer" colorectal cancer in patients with UC after 10 years of involvement. Aetiology It is of unknown cause, but there is a presumed  HYPERLINK "http://en.wikipedia.org/wiki/Genetics" \o "Genetics" genetic component to susceptibility. Although it is treated as though it is an  HYPERLINK "http://en.wikipedia.org/wiki/Autoimmunity" \o "Autoimmunity" autoimmune disease, there is no consensus that it is such. The disease may be triggered in a susceptible person by environmental factors, and dietary modification may reduce the discomfort of a person with the disease. Recent studies have reported the development of inflammatory bowel disease with isotretinoin use, which is a powerful medication sometimes used to treat acne that doesn't respond to other treatments. Additionally, NSAIDs can make existing UC worse and may make the initial diagnosis more difficult. Diagnosis Blood tests should include CBC to check for anaemia, and CRP with an elevated level indicating inflammatory process,  HYPERLINK "http://en.wikipedia.org/wiki/Electrolyte" \o "Electrolyte" electrolyte studies and  HYPERLINK "http://en.wikipedia.org/wiki/Renal_function" \o "Renal function" renal function tests as chronic  HYPERLINK "http://en.wikipedia.org/wiki/Diarrhea" \o "Diarrhea" diarrhea may be associated with  HYPERLINK "http://en.wikipedia.org/wiki/Hypokalemia" \o "Hypokalemia" hypokalemia,  HYPERLINK "http://en.wikipedia.org/wiki/Hypomagnesemia" \o "Hypomagnesemia" hypomagnesemia, and pre-renal failure.  HYPERLINK "http://en.wikipedia.org/wiki/Liver_function_tests" \o "Liver function tests" LFT are performed to screen for bile duct involvement. Endoscopy is the best test for diagnosis of UC, and a biopsy is taken from the lining of the colon to view with a microscope. Full colonoscopy is attempted only if diagnosis is unclear; otherwise, a flexible sigmoidoscopy is sufficient to support the diagnosis. Barium enema is usually only performed if a colonoscopy cannot be done, and CT scans may also be used to diagnose UC or its complications. Stool culture to rule out parasites and infectious causes. Treatment Chlorhexidine and analgesic mouth washes for oral ulcers. Anti-inflammatory drugs are often the first step in the treatment of inflammatory bowel disease. Sulfasalazine can be effective, but has a number of side effects. Therefore, mesalamine, balsalazide, and olsalazine medications tend to have fewer side effects than sulfasalazine. Corticosteroids are only used in moderate to severe cases that do not respond to other treatments and for short term use only. Immunosuppressants (eg azathioprine, mercaptopurine, cyclosporine, and infliximab) can also be used to suppress the disease. Medications such as antibiotics, antidiarrheal, pain relievers, and iron supplements may be prescribed. Surgery is indicated for patients with severe colitis or  HYPERLINK "http://en.wikipedia.org/wiki/Toxic_megacolon" \o "Toxic megacolon" toxic megacolon, but it usually means removing the entire colon and rectum. Coeliac disease Coeliac disease, also known as gluten enteropathy or gluten intolerance, is an  HYPERLINK "http://en.wikipedia.org/wiki/Autoimmunity" \o "Autoimmunity" autoimmune disorder of the  HYPERLINK "http://en.wikipedia.org/wiki/Small_intestine" \o "Small intestine" small intestine that occurs in  HYPERLINK "http://en.wikipedia.org/wiki/Genetic_predisposition" \o "Genetic predisposition" genetically predisposed people of all ages. Upon exposure to gliadin, the immunological reaction causes  HYPERLINK "http://en.wikipedia.org/wiki/Inflammation" \o "Inflammation" inflammation that destroys the lining of the small intestine (called villous atrophy). This decreases the  HYPERLINK "http://en.wikipedia.org/wiki/Malabsorption" \o "Malabsorption" absorption of nutrients, because the  HYPERLINK "http://en.wikipedia.org/wiki/Intestinal_villus" \o "Intestinal villus" intestinal villi are responsible for absorptions, and can lead to vitamin and mineral deficiencies. Symptoms include chronic  HYPERLINK "http://en.wikipedia.org/wiki/Diarrhea" \o "Diarrhea" diarrhea, abdominal pain, bloating, pale, loose and greasy stool ( HYPERLINK "http://en.wikipedia.org/wiki/Steatorrhoea" \o "Steatorrhoea" steatorrhoea), and weight loss or failure to gain weight (in young children). But these may be absent, and symptoms in other  HYPERLINK "http://en.wikipedia.org/wiki/Organ_(anatomy)" \o "Organ (anatomy)" organ systems, rather than the bowel itself, have been described. It is also possible to have coeliac disease without any symptoms whatsoever. Many adults with subtle disease only have fatigue or  HYPERLINK "http://en.wikipedia.org/wiki/Anaemia" \o "Anaemia" anaemia. The main oral manifestations in coeliac disease are oral ulcerations, mucosal erythema, and lingual depapillation. It is reported that some 25% of patients with coeliac disease may give a history of oral ulceration. However, the converse is not true, and in recent studies of the prevalence of coeliac disease in patients presenting with RAS, a figure of 2-4% was found on the basis of small intestinal biopsy. The oral ulcers of those patients with coeliac disease often respond extremely well to correction of underlying haematological deficiencies, particularly folate and iron. It seems that the oral ulceration is often due to the associated deficiencies rather than a direct response of the oral mucosa to the allergen. Some individuals with coeliac disease and GI symptoms are mistakenly diagnosed to have  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=396" irritable bowel syndrome. An estimated 10% of individuals with coeliac disease also have  HYPERLINK "http://www.medicinenet.com/script/main/art.asp?articlekey=64425" dermatitis herpetiformis. Aetiology It is an autoimmune disease caused by a reaction to  HYPERLINK "http://en.wikipedia.org/wiki/Gliadin" \o "Gliadin" gliadin ( HYPERLINK "http://en.wikipedia.org/wiki/Gluten" \o "Gluten" gluten protein) found in  HYPERLINK "http://en.wikipedia.org/wiki/Wheat" \o "Wheat" wheat, rye, barley, and to a lesser extent in oats. Diagnosis CBC, iron studies,  HYPERLINK "http://en.wikipedia.org/wiki/Folic_acid" \o "Folic acid" folic acid,  HYPERLINK "http://en.wikipedia.org/wiki/Vitamin_B12" \o "Vitamin B12" vitamin B12, and calcium level (low calcium level often due to decreased  HYPERLINK "http://en.wikipedia.org/wiki/Vitamin_D" \o "Vitamin D" vitamin D level).  HYPERLINK "http://en.wikipedia.org/wiki/Thyroid_function_test" \o "Thyroid function test" Thyroid function test (TSH, T3, and T4) to identify  HYPERLINK "http://en.wikipedia.org/wiki/Hypothyroidism" \o "Hypothyroidism" hypothyroidism which is more common in people with coeliac disease. IgA anti-gliadin antibody (AGA), IgA anti-endomysial antibody (EmA), and anti-tissue transglutaminase antibody (ATA). A total serum IgA level is checked in parallel, as coeliac patients with IgA deficiency may be unable to produce the antibodies on which these tests depend. Endoscopy and small intestinal biopsy is considered the most accurate test for coeliac disease.  HYPERLINK "http://en.wikipedia.org/wiki/Osteopenia" \o "Osteopenia" Osteopenia and  HYPERLINK "http://en.wikipedia.org/wiki/Osteoporosis" \o "Osteoporosis" osteoporosis are often present in adults with coeliac disease, and bone densitometry or bone mineral density (BMD) scan may be performed to measure bone density and the need for medication. A trial of a gluten-free diet also can confirm a diagnosis. Treatment Coeliac disease has no cure. The only known effective treatment is a lifelong  HYPERLINK "http://en.wikipedia.org/wiki/Gluten-free_diet" \o "Gluten-free diet" gluten-free diet. Vitamin and mineral supplements are needed to help correct the deficiencies. 4 Tongue disorders Geographic tongue Geographic tongue, also known as benign migratory glossitis or erythema migrans, is an inflammatory condition of the  HYPERLINK "http://en.wikipedia.org/wiki/Tongue" \o "Tongue" tongue affecting approximately 2% of the population. It can affect all ages, but it is more predominant in adults than in children. The classic manifestation of geographic tongue is an area of erythema, with atrophy of the filiform papillae surrounded by white hyperkeratotic border. The patient often reports spontaneous resolution of the lesion in one area, with the return of normal tongue architecture, only to have another lesion appear in a different location of the tongue. The small patches may disappear and reappear in a short period of time (hours or days), and change in shape or size. If lesions occur at other mucosal sites, including the floor of the mouth and buccal mucosa, the condition is termed erythema migrans. Geographic tongue is usually chronic, and most often patients are asymptomatic, however, it may cause a burning or stinging sensation, especially after contact with certain foods such as tomato, eggplant, walnuts, sharp cheeses, spicy foods, sour foods, chocolate, candy, and HYPERLINK "http://en.wikipedia.org/wiki/Citrus" \o "Citrus"citrus. Chemicals, such as mouth washes and teeth whiteners, can also aggravate the condition. Coexistence of  HYPERLINK "http://en.wikipedia.org/wiki/Fissured_tongue" \o "Fissured tongue" fissured tongue is often noticed, and it has also been reported with increased frequency in patients with HYPERLINK "http://emedicine.medscape.com/article/762805-overview"psoriasis. Aetiology The aetiology and pathogenesis are still poorly understood, though the disease tends to run in families. Causes vary, but may include vitamin B deficiencies, allergies, and hormonal changes. It is said to occur more often in women, especially during high hormonal times such as during ovulation or HYPERLINK "http://en.wikipedia.org/wiki/Pregnancy" \o "Pregnancy"pregnancy, and while taking birth control. It may also be linked to stress or diets high in sugar or processed foods. Diagnosis It is based on symptoms and clinical examination of the tongue. Exclusion of diabetes mellitus, anaemia, and oral fungal infections are recommended. Treatment There is no known cure for geographic tongue. Avoid foods that exacerbate the condition. Phenolic essential oil mouth washes and peroxidase toothpaste may help some patients. Some individuals report relief from chewing mint leaves, sucking on a mint candy or gum during a flare up. Steroid gel applied topically may clear the patches. Oral HYPERLINK "http://en.wikipedia.org/wiki/Vitamin_B" \o "Vitamin B"vitamin B complex or sublingual vitamin B12 causes the condition to go away temporarily in some patients. Zinc supplements have resulted in a dramatic reduction in the incidence of the condition in those who have sensitivity to certain fruits such as strawberries or pineapple. Burning may also be reduced by taking antihistamines. Reassurance, as patients are occasionally concerned about the diagnosis of HYPERLINK "http://emedicine.medscape.com/article/1075729-overview"oral cancer. Fissured tongue Fissured tongue, also known as scrotal tongue or placated tongue, is a  HYPERLINK "http://en.wikipedia.org/wiki/Benign" \o "Benign" benign condition characterised by deep grooves or  HYPERLINK "http://en.wikipedia.org/wiki/Fissure" \o "Fissure" fissures along the dorsal and lateral aspects of the tongue. Some reports have shown a slight male predilection for fissured tongue. Although fissured tongue may be diagnosed initially during childhood, it is diagnosed more frequently in adulthood. The prominence of the condition appears to increase with increasing age. The condition is initially noted on routine intraoral examination as an incidental finding. The depth of the fissures varies, but has been noted to be up to 6 mm in depth. When particularly prominent, the fissures may be interconnected, separating the tongue dorsum into what may appear to be several lobules. The lesions associated with fissured tongue are usually asymptomatic unless debris is entrapped within the fissure or when it occurs in association with geographic tongue which is a common finding. Fissured tongue is seen in Melkersson-Rosenthal syndrome (a triad of lip or facial swelling, facial nerve paralysis, and fissured tongue), HYPERLINK "http://emedicine.medscape.com/article/943216-overview"Down syndrome, and in association with chronic dry mouth. Aetiology Although a definitive aetiology is unknown, a polygenic mode of inheritance is suspected because the condition is seen clustering in families who are affected. Diagnosis A biopsy is rarely performed on a fissured tongue because of its characteristic diagnostic clinical appearance. Treatment Fissured tongue is a benign condition that does not require any specific treatment. Patients should be encouraged to brush the top surface of their tongue to remove any debris that may cause irritation or infection when lodged between the grooves. Analgesic mouth washes without alcohol may help. Lingual thyroid Lingual thyroid or ectopic lingual thyroid is an uncommon abnormality of migration of the thyroid gland. It is often found in the region of the foramen caecum at the base of the tongue in patients whose gland fails to descend. The lingual thyroid is 4 times more common in females than in males. It presents as an asymptomatic nodular mass, usually less than 1 cm in size but sometimes reaching more than 4 cm in size. Larger lesions can interfere with swallowing and breathing, but most patients are unaware of the mass at the time of diagnosis, which is usually in the teenage or young adult years. Up to 70% of patients with lingual thyroid lack thyroid tissue in the neck or have hypothyroidism. Therefore, it is important to know that 3 of every 4 patients with infantile hypothyroidism (cretinism) have ectopic thyroid tissue. Rarely, parathyroid glands are associated with the ectopic thyroid tissue and their inadvertent removal has developed tetany in these patients. Other sites of ectopic thyroid deposition include the cervical lymph nodes, submandibular glands and the trachea. Rare examples of thyroid carcinoma arising in the mass have been reported, almost always in males. Aetiology In the first trimester of embryonic development, the thyroid gland originates in the back of the tongue at the junction of the oral tongue (anterior 2/3) and the tongue base (posterior 1/3) and migrates to the front of the neck. When migration fails and the gland remains in the base of the tongue, it is called lingual thyroid. Diagnosis Iodine radioisotope scan is useful in the diagnosis of suspected lingual thyroid. Biopsy should be considered with caution because of the potential for haemorrhage, infection or release of large amounts of hormone into the vascular system (thyroid storm). Treatment Most cases require no treatment. Surgical excision or radioiodine therapies are effective treatments only if iodine radioisotope scan has determined that there is adequate thyroid tissue in the neck. In those patients lacking thyroid tissue in the neck, the lingual thyroid can be excised and autotransplanted to the muscles of the neck. Angioedema Angioedema or Quincke's oedema is a relatively common allergic disorder that refers to oedema of the subcutaneous or submucosal tissues due to increased vascular permeability.  HYPERLINK "http://emedicine.medscape.com/article/762917-overview" Urticaria (hives) and angioedema are similar in pathogenesis, however, angioedema manifests deeper in mucosal tissue. In general, angioedema can be categorised as with urticaria or without urticaria. Angioedema associated with urticaria is a hypersensitivity to an offending agent. Ten percent of angioedema cases occur without urticaria and is considered to be kinin-mediated rather than a hypersensitivity reaction. Angioedema without urticaria can be classified as hereditary angioedema (HAE) and acquired angioedema (AAE), and both are associated with insufficient or dysfunctional C1 esterase inhibitor. Women tend to have more occurrences of angioedema than men. Persons who are predisposed to angioedema have an increase in frequency of attacks after adolescence, with the peak incidence occurring in the third decade of life. It characteristically presents with acute onset of self-limiting, well-demarcated, painless, non-pitting, smooth swelling of distensible tissues (eg lips, periorbital area, earlobes, tongue, and oropharynx) over the period of minutes to several hours and lasts for 24-48 hours. In severe cases,  HYPERLINK "http://en.wikipedia.org/wiki/Stridor" \o "Stridor" stridor of the airway occurs with gasping or wheezy inspiratory breath sounds and decreasing  HYPERLINK "http://en.wikipedia.org/wiki/Oxygen" \o "Oxygen" oxygen levels. Patients with HAE can also have recurrent episodes of  HYPERLINK "http://en.wikipedia.org/wiki/Abdominal_pain" \o "Abdominal pain" abdominal pain, nausea or vomiting. Aetiology HAE has an autosomal dominant pattern and it may be noticed after dental treatment or local trauma to the mouth. AAE is often associated with autoimmune conditions and B-cell  HYPERLINK "http://www.patient.co.uk/DisplayConcepts.asp?WordId=LYMPHOPROLIFERATIVE%20DISORDERS&MaxResults=50" lymphoproliferative disorders. Angioedema in general may be triggered by stress, drugs (eg ACE inhibitors, aspirin, NSAIDs), food allergy (broccoli, cheese), chemicals, and infections, but most cases are idiopathic. Diagnosis It is usually based on clinical findings and family history. ` CBC, U&E, renal or kidney  HYPERLINK "http://en.wikipedia.org/wiki/Renal_function" \o "Renal function" function, LFT, thyroid function (TSH, T4, T3), and serum immunoglobulins are typically performed. Complement profile can be useful, particularly where HAE is suspected. Depletion of complement factors 2 and 4 (C2&C4) may indicate deficiency of  HYPERLINK "http://en.wikipedia.org/wiki/C1-inhibitor" \o "C1-inhibitor" C1-esterase inhibitor. Skin testing and/or  HYPERLINK "http://www.patient.co.uk/DisplayConcepts.asp?WordId=RADIO%20ALLERGOSORBENT%20TESTS&MaxResults=50" radioallergosorbent test (RAST) and ELISA on blood to confirm sensitivity to possible allergens. Stool tests for ova, cysts, and parasites when there is chronic urticaria may be associated with the angioedema.  HYPERLINK "http://en.wikipedia.org/wiki/Tryptase" \o "Tryptase" Mast cell tryptase level may be elevated if the attack is due to an acute allergic (anaphylactic) reaction. HAE and AAE do not respond in an acute attack to  HYPERLINK "http://en.wikipedia.org/wiki/Antihistamines" \o "Antihistamines" antihistamines, corticosteroids or epinephrine, a characteristic that distinguishes it from the acute allergic reactions. Treatment Patients with mild limited symptoms can be reassured that symptoms are self-limiting and typically disappear within hours to days on steroids and antihistamines. C1-esterase inhibitor concentrate is used in acute HAE. Otherwise,  HYPERLINK "http://en.wikipedia.org/wiki/Fresh_frozen_plasma" \o "Fresh frozen plasma" fresh frozen plasma (FFP) can be used as an alternative. Treatment of any underlying lymphoproliferative disease can eliminate the cause of AAE, and antifibrinolytics such as  HYPERLINK "http://en.wikipedia.org/wiki/Tranexamic_acid" \o "Tranexamic acid" tranexamic acid may be effective. Antihistamines, adrenaline, and steroids are used in acute allergic angioedema. Severe cases may require desensitisation to the putative allergen as mortality can occur. It may be useful to carry an epinephrine or adrenaline auto-Injector (EpiPen) for use when there is airway involvement Surgical intervention may be necessary in case of severe laryngeal oedema, when intubation is difficult to perform and tracheotomy is needed. Oral hairy leukoplakia Oral hairy leukoplakia (OHL) is seen in severe defects of  HYPERLINK "http://en.wikipedia.org/wiki/Immunity_(medical)" \o "Immunity (medical)" immunity, particularly in  HYPERLINK "http://en.wikipedia.org/wiki/HIV" \o "HIV" HIV infection. It is not associated with any  HYPERLINK "http://en.wikipedia.org/wiki/Malignant" \o "Malignant" malignant potential but is a predictor of poor prognosis, and in HIV infection is an AIDS-defining condition. It appears as unilateral or bilateral white corrugated or hairy lesions typically seen on the lateral margins of the tongue. This infection may spread across the entire dorsal surface, onto the ventral surface of the tongue, and occasionally may be found on the buccal mucosa. It is asymptomatic, but occasionally may cause alteration in taste, discomfort or other symptoms. These patches cannot easily be scraped off and most cases are colonised by candidiasis. Aetiology The cause of this condition is an  HYPERLINK "http://en.wikipedia.org/wiki/Opportunistic_infection" \o "Opportunistic infection" opportunistic infection by the EBV. Once infected, the virus remains in the body for life. Diagnosis In most cases, the diagnosis is established on a clinical basis. Definitive diagnosis requires both an appropriate histopathological appearance and the demonstration of EBV DNA, RNA, or protein within the epithelial cells of the lesion. Biopsy and histologic examination are indicated only if the lesions are ulcerated or unusual in appearance, to distinguish it from cancer or other causes. Treatment OHL does not require specific treatment in every case. Indications for treatment include symptoms attributable to the lesion or a patient's desire to eliminate the lesion for cosmetic reasons. Topical therapy with tretinoin (Retin-A) 0.025-0.05% or podophyllin resin 25% solutions has been reported to resolve OHL; however, once the medication is stopped, the lesion returns. Systemic antiviral therapy usually achieves resolution of the lesion within 1-2 weeks of therapy. Oral therapy with acyclovir requires high doses (800 mg 5 times per day) to achieve therapeutic levels. Valacyclovir (1000 mg 3 times per day) and famciclovir (500 mg 3 times per day) are newer antiviral drugs with higher oral bioavailability than acyclovir, and can be dosed less often. Antiviral drugs inhibit productive EBV replication but do not eliminate the latent state of infection. OHL often recurs several weeks after the cessation of antiviral therapy. Ankyloglossia Ankyloglossia, commonly known as tongue tie, varies in degree of severity from mild cases to complete ankyloglossia whereby the HYPERLINK "http://en.wikipedia.org/wiki/Tongue" \o "Tongue"tongue is tethered to the floor of the HYPERLINK "http://en.wikipedia.org/wiki/Mouth" \o "Mouth"mouth. Although present from birth, patients present in adulthood as it is asymptomatic. The tip of the tongue normally grows until 4 years of age and initial restrictions of movement may improve as the child gets older. Ankyloglossia can affect HYPERLINK "http://en.wikipedia.org/wiki/Feeding" \o "Feeding"feeding, HYPERLINK "http://en.wikipedia.org/wiki/Speech_communication" \o "Speech communication"speech, and HYPERLINK "http://en.wikipedia.org/wiki/Oral_hygiene" \o "Oral hygiene"oral hygieneHYPERLINK "http://en.wikipedia.org/wiki/Ankyloglossia" \l "cite_note-Travis-2" as well as have HYPERLINK "http://en.wikipedia.org/w/index.php?title=Mechanical/social_effects&action=edit&redlink=1" \o "Mechanical/social effects (page does not exist)"mechanical and social effects. It can also prevent the tongue from contacting the HYPERLINK "http://en.wikipedia.org/wiki/Anterior" \o "Anterior"anterior HYPERLINK "http://en.wikipedia.org/wiki/Palate" \o "Palate"palate. This can result in an HYPERLINK "http://en.wikipedia.org/wiki/Open_bite" \o "Open bite"open bite deformity and HYPERLINK "http://en.wikipedia.org/wiki/Mandibular_prognathism" \o "Mandibular prognathism"mandibular prognathism. Aetiology It is a HYPERLINK "http://en.wikipedia.org/wiki/Congenital" \o "Congenital"congenital HYPERLINK "http://en.wikipedia.org/w/index.php?title=Oral_anomaly&action=edit&redlink=1" \o "Oral anomaly (page does not exist)"anomaly in which the lingual frenulum, which is a membrane connecting the underside of the tongue to the floor of the mouth, is either too short or anteriorly placed, limiting the mobility of the tongue. HYPERLINK "http://en.wikipedia.org/wiki/Diagnosis" \o "Diagnosis"Diagnosis It may be difficult as it is not always apparent by looking at the underside of the tongue. For infants, passively elevating the tongue tip with a HYPERLINK "http://en.wikipedia.org/wiki/Tongue_depressor" \o "Tongue depressor"tongue depressor may reveal the problem. For older children, making the tongue move to its maximum range will demonstrate a v-shaped notch at the tip. Treatment Frenectomy (frenulectomy or frenotomy) is the removal of the  HYPERLINK "http://en.wikipedia.org/wiki/Frenulum" frenulum by laser and should not be performed before 4 years of age. An alternative to surgery is to take a wait-and-see approach as the frenulum often continues to recede during the process of a childs growth between 6 months and 6 years of age. Coated tongue Coated tongue or furred tongue is when the entire healthy tongue mucosa may appear coated in a whitish or yellowish layer without being associated with underlying pathology or candidal colonisation. Normal eating habits help to prevent the build-up of desquamated keratin on the dorsal surface of the tongue. The thickness of coating might increase due to many factors and stain with food stuffs, dyes, and smoking, a common cause of anxiety among patients. Aetiology Predisposing factors are poor oral hygiene, febrile illnesses, dehydration, and soft diet. Diagnosis It is based on clinical examination. It can be scraped off leaving normal lingual mucosa. Treatment Reassurance. Improvement of oral hygiene. Brushing the tongue with a soft toothbrush or by using a tongue scraper. Rinse with peroxidase or sodium bicarbonate mouth washes. Treat the underlying illnesses. Black hairy tongue Black hairy tongue, also known as hairy tongue, is a benign common oral condition that gives the tongue a dark, furry appearance. It typically results when papillae grow longer and do not shed like normal. The hairy areas are usually on the posterior of the tongue and never involve the undersurface. Debris, bacteria or other organisms can collect on the papillae and result in black, yellow, or brown discolouration. Hairy tongue has been reported with greater frequency in males. Patients with hairy tongue often may develop a secondary infection of  HYPERLINK "http://en.wikipedia.org/wiki/Candida_albicans" \o "Candida albicans" Candida albicans. The condition is rarely symptomatic, although overgrowth of Candida albicans may result in glossopyrosis (burning tongue). Patients frequently complain of a tickling sensation in the soft palate and the oral pharynx during swallowing. In more severe cases, patients may actually complain of a gagging sensation. Retention of debris between the elongated papillae may result in halitosis, and some patients may complain of altered taste or metallic taste. Aetiology Precipitating factors for hairy tongue include poor oral hygiene, heavy smoking, regular use of mouth washes, the use of broad-spectrum antibiotics and medications that contain bismuth, and therapeutic radiation of the head and neck. Diagnosis Culture swab of the tongue's dorsal surface may be taken if a superimposed oral candidiasis or other specific infection is suspected. Cytologic smears stained with gram or PAS may reveal candidal organisms. Treatment Improvement of oral hygiene and eliminate factors that potentially contribute to the condition. Simply brushing the tongue with a soft children's toothbrush or using a commercially available tongue scraper is sufficient to remove elongated filiform papillae and retard the growth of additional ones. Topical antifungal therapy (nystatin suspension) can be used to treat oral candidiasis. If antibiotic use led to the condition then it may resolve naturally after the antibiotic course is completed. Burning mouth syndrome Burning mouth syndrome (BMS) is a chronic painful, frustrating condition, often described as a scalding or hot sensation in the tongue, lips, gums, inside of cheeks, palate, or throughout the mouth. The prevalence of BMS in the general population varies from 0.7-15%, with the tongue being the most common site. Although BMS can affect anyone, it occurs most commonly in middle-aged or older women. The term syndrome is generally employed when no medical or odontological cause can be identified. Moderate to severe burning in the mouth is the main symptom of BMS and can persist for months or years. For many people, the burning sensation begins in late morning, builds to a peak by evening, and often subsides at night. Some feel constant daily pain, while others feel the pain comes and goes throughout the day, with some entirely pain-free days. Other symptoms of BMS include tingling or numbness on the tip of the tongue or in the mouth, bitter or metallic changes in taste, and dry or sore mouth. In some cases, however, symptoms may suddenly go away or become less frequent. Complications that BMS may be associated with are mainly related to chronic pain and include irritability, anxiety, depression, difficulty sleeping, difficulty eating, and decreased socialising. Aetiology The cause of BMS in the absence of obvious mucosal disease can be classified as either primary or secondary: Primary BMS is of unknown cause and may be related to damaged nerves (neuropathy) of the taste and sensory nerves. Secondary BMS is caused by either local factors that may include dry mouth, oral candidiasis, poorly-fitting dentures or allergies to denture materials, oral parafunctional habits, and excessive mouth irritation due to overbrushing of tongue, overuse of mouthwashes, or having too many acidic drinks; or due to systemic factors such as nutritional deficiencies, acid reflux, endocrine disorders such as diabetes and hypothyroidism, hormonal changes, ACE inhibitors, cancer phobia or excessive health worries, and anxiety or depression. In some patients, BMS may have more than one cause. But for many, the exact cause of symptoms cannot be found. Diagnosis It is made on the medical history, a thorough oral examination, and a general medical examination to identify the source of BMS. Oral swab culture and smear to check for oral candidiasis Allergy testing for denture materials, certain foods, or other substances that may be causing the symptoms. CBC, serum ferritin, folate, vitamin B1, B2, B6, B12, and zinc levels, FBS level, thyroid function, gastric reflux tests, salivary flow rate measurements, immune functioning, and psychological assessment are aimed at eliminating possible underlying factors. Temporarily stopping medications if possible to see if the pain goes away. Treatment Primary BMS When no underlying cause can be found, treatment aims to control pain from nerve damage, and may include one or a combination of the following: A lozenge-type form of the anticonvulsant medication clonazepam (benzodiazepine) 0.25 mg at bedtime. Chlordiazepoxide (benzodiazepine) 5 mg at bedtime in certain cases. Tricyclic antidepressants (amitriptyline) 10 mg at bedtime may give some relief. Capsaicin, an oral rinse with 1 tsp of 1:2 dilutions of hot pepper and water is a pain reliever and desensitising agent, may be useful in some patients. The best response is obtained with the combination of the antioxidant alpha lipoic acid (ALA) (200 mg caps 3 times per day) and the anticonvulsant gabapentin (start with 100 mg caps at bedtime and increase to 100 mg 3 times per day) for at least 2 months. This can have long-term benefits in the majority of patients suffering from BMS. Secondary BMS Treat local and underlying causes if identified. Possible treatments may include: Avoid hot and spicy foods, citrus fruits and juices, mouth washes that contain alcohol, and avoid alcohol and tobacco products. Chew sugarless gum, suck on ice chips, brush teeth/dentures with sodium bicarbonate and water, and adjusting or replacing irritating dentures. Treat dry mouth or oral candidiasis, and relieve anxiety and depression. Switching medicine, where possible, if a drug is causing burning mouth. Recommending supplements for nutritional deficiencies. Treat existing disorders such as Sjogrens syndrome, diabetes, or thyroid problem. Granular cell tumor Granular cell tumor (GCT), also known as granular cell myoblastoma or Abrikossoff's tumor, is an uncommon lesion that can affect all parts of the body, but head and neck areas are affected 50% of the time. Of the head and neck cases, 70% of lesions are located intraoral, more common in the  HYPERLINK "http://en.wikipedia.org/wiki/Tongue" \o "Tongue" tongue. The dorsal and lateral borders of the tongue are the sites of predilection, followed by the buccal mucosa. Granular cell tumor is also found in the internal organs, particularly in the upper aerodigestive tract. The tumor most frequently occurs between 30-60 years of age and is more common in women. The usual presentation is of asymptomatic, slow growing solitary nodule, with a normal or whitish colour and rarely larger than 2 cm. This type of tumor has been found to be both HYPERLINK "http://en.wikipedia.org/wiki/Benign" \o "Benign"benign and HYPERLINK "http://en.wikipedia.org/wiki/Malignant" \o "Malignant"malignant, although malignancy is rare and comprises only 2% of all GCT. Benign GCT has a recurrence rate of 2-8% when resection margins are deemed clear of tumor infiltration. When the resection margins are positive for tumor infiltration, the recurrence rate is increased to 20%. Recurrence of GCT has been reported several years after removal. Aetiology The formation of GCT is a neoplastic process, and the HYPERLINK "http://en.wikipedia.org/wiki/Lesions" \o "Lesions"lesion formed is of neural derivation. Diagnosis A definitive diagnosis requires biopsy. Treatment Conservative excisional biopsy is indicated because the lesion is rarely larger than 2 cm in diameter. The depth of biopsy approximates the diameter of the lesion, and the margins do not need to be extensive but a few millimeters are adequate. Macroglossia Macroglossia is an abnormal enlargement of the tongue. The 2 broadest categories under the heading of macroglossia are pseudomacroglossia and true enlargement. Pseudomacroglossia includes habitual posturing of the tongue, enlarged tonsils or adenoids displacing tongue, low palate and decreased oral cavity volume displacing tongue, deficiency in the maxillary or mandibular arches displacing tongue, retrognathism, and hypotonia of the tongue. True macroglossia may be either congenital (existing at birth) such as  HYPERLINK "http://emedicine.medscape.com/article/1080571-overview" haemangioma,  HYPERLINK "http://emedicine.medscape.com/article/1086806-overview" lymphangioma, Down syndrome, rare genetic syndromes, congenital  HYPERLINK "http://emedicine.medscape.com/article/122393-overview" hypothyroidism, primary  HYPERLINK "http://emedicine.medscape.com/article/335414-overview" amyloidosis, and idiopathic muscle hypertrophy; or acquired such as  HYPERLINK "http://emedicine.medscape.com/article/116366-overview" acromegaly,  HYPERLINK "http://emedicine.medscape.com/article/301914-overview" sarcoidosis, diabetes,  HYPERLINK "http://emedicine.medscape.com/article/229461-overview" syphilis, trauma, and malignancy. Symptoms and physical findings associated with macroglossia may include noisy high-pitched breathing (stridor), snoring, or feeding difficulties. In severe cases, the tongue may protrude from the mouth causing cosmetic and functional difficulties including airway obstruction, which is usually worsened by lying supine,  HYPERLINK "http://www.britannica.com/EBchecked/topic/559061/speech-disorder" \o "speech impediment" speech impediment, and difficulty in eating, swallowing, or sleeping. Aetiology It may be pseudomacroglossia or true enlargement (congenital and acquired). Diagnosis Evaluation of the enlarged tongue is based on both clinical examination and functional assessments of the tongue. Treatment Medical therapy for macroglossia is only useful when the aetiology of the disease is clearly defined. When the aetiology is unclear or the histology reveals simple hypertrophy, the primary treatment is surgery. Neoplasms of the tongue often require surgical intervention. Lingual varicosities Lingual varicosities, also known as sublingual varices, are abnormally dilated and tortuous veins seen along the ventral surface of the tongue. They are rare in children but have been shown to increase with age. The incidence of sublingual varices in persons over the age of 60 years is approximately 68%. Varicosities in the younger age groups might indicate premature aging. It has not been associated with systemic hypertension or other cardiopulmonary diseases. However, people with varicosities of the legs are more likely to develop sublingual varices. Aetiology It is of unknown cause. A relationship between chronic vitamin-C deficiency and lingual varicosities has been suggested. Diagnosis Clinical examination of the ventral tongue shows dilated tortuous veins, seen as purple to red lesions that blanch on pressure. Treatment No treatment is required and the patient needs to be reassured that they are not abnormal. 5 Oral white and red lesions Fordyces granules Fordyce's granules or ectopic sebaceous glands are sebaceous glands without hair follicles. They are a normal anatomic variation that presents as small, painless, pale, raised, white or yellowish white spots 1-3mm in diameter. The most common sites of predilection are the buccal mucosa and vermilion border of the upper lip. It is occasionally seen on the retromolar pad area and the anterior tonsillar pillars. The granules tend to become prominent during puberty and increase in number with age. Some patients will have hundreds of granules while most have only 1 or 2. They are common in men and women of all ages and 80% of the population are affected. Aetiology They are ectopic sebaceous glands presumed to be a developmental anomaly. Diagnosis They are clinically diagnosed and no biopsy is needed. Treatment Eventually fordyces granules go away without any treatment. Treatment is only required for cosmetic removal of lip lesions. Tretinoin gel or cream is a very popular fordyces spots treatment. This product can be even more effective when used in combination with an alpha hydroxyacid agent. Trichloroacetic acid (TCA) chemical peel causes significant improvement in the appearance of the spots. Vaporising laser treatments such as CO2 laser or electro desiccation can reduce the appearance of the spots. Treatment through pulse dye laser gives relief but is usually expensive. Surgical diathermy and cryotherapy can also sometimes be used to remove the condition. Leukoedema Leukoedema is a normal anatomic variation characterised by a filmy, opalescent to whitish gray tinge of the  HYPERLINK "http://en.wikipedia.org/wiki/Buccal_mucosa" \o "Buccal mucosa" buccal mucosa. It is almost always bilateral and the surface tissue may exhibit a corrugated, folded configuration. Leukoedema may begin as early as 3-5 years of age, but is not usually noticeable until adolescence. It is more prevalent in people who have dark skin and can be more intense in smokers. Patients who exhibit leukoedema are usually unaware of its presence since it is asymptomatic. Aetiology Leukoedema is a common developmental alteration of the buccal mucosa which appears to be a simple variation of normal anatomy. Diagnosis When the cheeks are stretched outward the leukoedema typically disappears. This aids to differentiate it from other similar conditions which could be premalignant, such as  HYPERLINK "http://en.wikipedia.org/wiki/Leukoplakia" \o "Leukoplakia" leukoplakia.  HYPERLINK "http://en.wikipedia.org/wiki/Histology" \o "Histology" Histologically, the white clinical appearance is caused by intracellular oedema and a thickened epithelium. Treatment No treatment is necessary since this is considered a variant of normal. It has no malignant potential and does not change significantly with age. Should the affected individual stop smoking, the lesion will likely become less pronounced. White sponge naevus White sponge naevus (WSN), also known as Cannon's disease, is an inherited condition in which several family members may manifest the disorder. White sponge naevus almost always presents during childhood and there is no gender predilection. It is a relatively rare, asymptomatic, bilateral lesion that presents in the  HYPERLINK "http://en.wikipedia.org/wiki/Mouth" \o "Mouth" mouth, most frequently as a thick bilateral  HYPERLINK "http://en.wikipedia.org/wiki/White" \o "White" white plaque with a spongy texture, usually on the  HYPERLINK "http://en.wikipedia.org/wiki/Buccal_mucosa" \o "Buccal mucosa" buccal mucosa, but sometimes on the  HYPERLINK "http://en.wikipedia.org/wiki/Labial" \o "Labial" labial mucosa,  HYPERLINK "http://en.wikipedia.org/wiki/Alveolar_ridge" \o "Alveolar ridge" alveolar ridge, or floor of the mouth. The gingival margin and  HYPERLINK "http://en.wikipedia.org/wiki/Dorsum" \o "Dorsum" dorsum of the tongue are almost never affected. Severely affected patients exhibit corrugated vertical folds which may cover most of the buccal mucosa. Lesions are usually well demarcated from the surrounding normal mucosa, as opposed to the poor demarcation of leukoedema. Although this condition is perfectly  HYPERLINK "http://en.wikipedia.org/wiki/Benign" \o "Benign" benign, it is often mistaken for  HYPERLINK "http://en.wikipedia.org/wiki/Leukoplakia" \o "Leukoplakia" leukoplakia. Aetiology It is a developmental anomaly inherited as an autosomal dominant trait. Diagnosis The distinctive clinical appearance and a positive family history lead to a definitive diagnosis. Incisional biopsy may be needed to differentiate it from leukoplakia. Treatment No treatment is required and reassurance is all that is needed. The rare form which extends onto the lip vermilion can be surgically removed for aesthetic reasons. Linea alba buccalis Linea alba buccalis is a common finding on the buccal mucosa that presents as asymptomatic, bilateral, linear white line beginning at the corners of the mouth and extending posteriorly at the level of the occlusal plane of teeth. Aetiology It is a frictional keratosis most likely due to sucking trauma from the occlusal surfaces of teeth. Diagnosis It is usually present bilaterally. It is restricted to dentulous areas. Treatment No treatment is required. Lip and cheek biting Mild chronic biting of lip or cheek is relatively common and usually occurs as an unconscious habit. It most often begins in late childhood or early teens and is twice as prevalent in females compared with males. It generally refers to a more superficial lesion produced by frequently repeated rubbing, sucking, or chewing movements that abrade the surface of a wide area without producing discrete ulceration. The lesion is characterised by diffuse irregular small furrows with ragged borders. It is asymptomatic but in severe cases, tenderness, swelling, and a burning sensation may be presenting symptoms. Aetiology It is considered to be a self-inflected injury caused by stress and anxiety. Researchers are investigating a possible genetic component. Diagnosis Such lesions feel rough to the examiners fingers and appear as poorly outlined, macerated and reddened areas, usually with whitish patches of partly detached surface epithelium. Treatment The patient should be encouraged to stop the habit. Locally applied therapy such as chlorhexidine or hexitidine mouth washes may help to eradicate the hyperkeratotic flakes and inflammation. In severe cases a splint or dental guard is recommended and referral for psychological evaluation may be appropriate. Leukoplakia Leukoplakia is a clinical term used to describe patches of keratosis and is the best-known potentially malignant oral disorder. It is defined by the WHO as a white patch or plaque that cannot be rubbed off and cannot be characterised clinically or pathologically as any other disease. It is visible as adherent white patches on the mucous membranes of the oral cavity, including the  HYPERLINK "http://en.wikipedia.org/wiki/Tongue" \o "Tongue" tongue, mandibular alveolar ridge, and buccal mucosa in about 50% of patients. The palate, maxillary alveolar ridge, and lower lip are somewhat less frequently involved, and the floor of the mouth and the retromolar regions are comparatively infrequently involved. The typical white patch of leukoplakia develops slowly, over weeks to months. Leukoplakic lesions are found in approximately 3% of the world's population. Like  HYPERLINK "http://en.wikipedia.org/wiki/Erythroplakia" \o "Erythroplakia" erythroplakia, leukoplakia is usually found in adults between 40-70 years of age, with a 2:1 male predominance. The overall prevalence of malignant change in leukoplakia is 3-33% over 10years period. The clinical appearance of leukoplakia may vary from nonpalpable, faintly translucent white areas to thick, fissured, papillomatous, and indurated lesions. Homogenous leukoplakia is present clinically as uniformly white patch of a slightly raised mucosa affecting the buccal mucosa, mucobuccal fold, and oral floor. The most dangerous example is the sublingual keratosis which affects the oral floor and the ventral surface of tongue as bilateral, well defined white homogenous lesion with irregular borders. Proliferative verrucous leukoplakia appears as diffuse warty or papillary white appearance, most often arises on the mandibular ridge and vestibular region, over time it will spread laterally, becoming extensive. It has a predilection for elderly females. Many progress to verrucous carcinoma or speckled leukoplakia that appears as a white patch with multiple red foci. Candidal leukoplakia is a hyperkeratotic lesion which is superficially infected by fungus, most commonly candida albicans. It is well established that the presence of this organism increases the risk of malignant transformation. Smokeless tobacco leukoplakia arises due to tobacco chewing and presents as a white lesion of the mucobuccal fold. Lesions are rough and may have undulating or wrinkled surface, usually well-circumscribed with thickening of one of the epithelial layers. Progression to invasive carcinoma is rare. A major problem with leukoplakia is that the histological status of the lesion whether benign or malignant cannot be distinguished by clinical appearance alone as even carcinoma can present as a white lesion. Therefore, it is now recommended that this term is used only as a clinical description of a lesion and should never be used once histological information is available. Aetiology Leukoplakia is primarily caused by the use of tobacco, either smoked or chewed. Other possible etiological agents implicated are chronic irritants such as sharp edges of teeth, HPV,  HYPERLINK "http://en.wikipedia.org/wiki/Candida_albicans" \o "Candida albicans" candida albicans, and possibly alcohol consumption.  HYPERLINK "http://en.wikipedia.org/wiki/Bloodroot" \o "Bloodroot" Bloodroot, otherwise known as sanguinaria, is also believed to be associated with leukoplakia. Diagnosis Serum levels of patients with leukoplakia may be low in vitamin A, B12, C, and folic acid. All leukoplakia should be treated as potentially malignant and should be biopsied to obtain a definitive diagnosis. Staining with toluidine blue may help highlight the most appropriate area for biopsy, cellular atypia, dysplasia, carcinoma in situ, or superficial invasive squamous cell carcinoma may be encountered. An oral brush biopsy (removing cells from the leukoplakic patches with a small, spinning brush that allows a pathologist to detect abnormal cells) may be helpful, but incisional biopsy is needed if carcinoma is strongly suspected. A screening device to detect early oral cancer called a VELscope is non-invasive and uses a bright blue light to visualise mucosa abnormalities that may require biopsy Treatment Obvious predisposing factors must be reduced or eliminated. Regression of leukoplakia has been observed in over 50% of patients who stopped smoking for a year. Taking  HYPERLINK "http://en.wikipedia.org/wiki/Beta-carotene" \o "Beta-carotene" beta-carotene (vitamin A) orally seems to induce remission in patients with oral leukoplakia. Vigorous oral antifungal therapy is an important part of management of candidal leukoplakia. Lesions of oral leukoplakia should be surgically excised if  HYPERLINK "http://en.wikipedia.org/wiki/Pre-cancerous" \o "Pre-cancerous" precancerous changes or cancer is detected. Cryotherapy and laser ablation have been used, although these methods do not allow for tissue preservation or microscopic examination. Patients should then be followed up regularly at intervals of 3-6months as excised lesions sometimes recur. Erythroplakia Erythroplakia, also known as erythroplasia, is a rare, asymptomatic, isolated flat red  HYPERLINK "http://en.wikipedia.org/wiki/Lesion" \o "Lesion" lesion in the  HYPERLINK "http://en.wikipedia.org/wiki/Mouth" \o "Mouth" mouth that cannot be attributed to any other  HYPERLINK "http://en.wikipedia.org/wiki/Pathology" \o "Pathology" pathology. It is mostly found in elderly men around the ages of 65-74 years. The most common areas in the mouth where erythroplakia is found are the floor of mouth, the  HYPERLINK "http://en.wikipedia.org/wiki/Tongue" \o "Tongue" tongue, and the  HYPERLINK "http://en.wikipedia.org/wiki/Soft_palate" \o "Soft palate" soft palate. It appears as a red plaque with well-demarcated borders, and the texture is characterised as soft and velvety. An adjacent area of  HYPERLINK "http://en.wikipedia.org/wiki/Leukoplakia" \o "Leukoplakia" leukoplakia may be found along with the erythroplakia. Erythroplakia is one of the most important oral lesions because 75-90% exhibit severe epithelial dysplasia, carcinoma-in-situ, or invasive squamous cell carcinoma. The incidence of malignant change is 17times higher in erythroplakia than in leukoplakia. Aetiology It has an unknown cause. It is commonly associated with  HYPERLINK "http://en.wikipedia.org/wiki/Tobacco_smoking" \o "Tobacco smoking" smoking and alcohol consumption. Diagnosis Diagnosis It involves  HYPERLINK "http://en.wikipedia.org/wiki/Biopsy" \o "Biopsy" biopsy of the lesion for histological examination. Treatment Complete excision of the lesion is sometimes advised depending on the histopathology found in the biopsy. Recurrence of erythroplakia is common and thus long-term follow up is needed. Nicotine stomatitis Nicotine stomatitis (NS), also known as smoker's palate, is an  HYPERLINK "http://en.wikipedia.org/wiki/Oral_pathology" \o "Oral pathology" oral pathological condition that appears in the  HYPERLINK "http://en.wikipedia.org/wiki/Hard_palate" \o "Hard palate" hard palate as a white  HYPERLINK "http://en.wikipedia.org/wiki/Lesion" \o "Lesion" lesion. More commonly found in men over 45 years of age. It is an asymptomatic or mildly irritating condition that affects the oral mucosa of the hard palate posterior to the rugae and the adjacent soft palate. Nicotine stomatitis first becomes visible as a reddened area and slowly progresses to a white, thickened, and fissured appearance. The palate has numerous minor salivary glands which become swollen and the orifices become prominent, giving the tissue a speckled white and red appearance. Patients typically report that they are either unaware of the lesion or have had it for many years without changes. Although NS is caused by smoking tobacco products, it is generally not associated with dysplastic or malignant changes. The exception to this is in individuals who reverse smoke which is a severe form of palatal keratosis caused from smoking a  HYPERLINK "http://en.wikipedia.org/wiki/Cigarette" \o "Cigarette" cigarette with the lit end inside the mouth. Reverse smoking is common in some parts of the Caribbean and Southeast Asia. The concentrated heat and chemicals increase the potential for malignant change. Aetiology The lesion is observed in pipe and reverse cigarette smokers, and less often in cigarette and cigar smokers. The mechanism of action is heat and chemical irritation from a tobacco product that acts as a local irritant. Dentures often protect the palate from these irritants in patients who wear them. Diagnosis If unable to make the diagnosis by clinical appearance, or if the lesion does not resolve after cessation of smoking, perform a 5 mm  HYPERLINK "http://emedicine.medscape.com/article/700-overview" punch biopsy to confirm diagnosis. Biopsy is also indicated in patients with a symptomatic lesion, even if it appears consistent with a benign smokers palate, or if the patient reports that he or she is a reverse smoker. The  HYPERLINK "http://en.wikipedia.org/wiki/Teeth" \o "Teeth" teeth may be stained brown or black from tobacco smoke. Treatment The only definitive treatment for NS is smoking cessation. The lesion should completely resolve on its own after 12 weeks upon termination of smoking. Oral submucous fibrosis Oral submucous fibrosis (OSF) is a chronic debilitating disease of the oral cavity characterised by inflammation and progressive fibrosis of the submucosal tissues. In this condition, the patient usually complains of burning sensation in the mouth, particularly while taking hot and spicy foods. This is often followed by the formation of multiple ulcerations or inflammatory reactions in the oral mucosa. In the initial phase of the disease, palpation of the mucosa causes a wet leathery feeling. In the advanced stage the oral mucosa loses its resiliency and becomes blanched and stiff. Usually it is believed that the disease initiates from the posterior part of the oral cavity and it gradually spreads to the anterior locations. It results in marked rigidity and an eventual inability to open the mouth. The buccal mucosa is the most commonly involved site, but any part of the oral mucosa can be involved, even the pharynx. The incidence of the disease is higher in people from certain parts of the world including Southeast Asia and India. It is observed that females are more frequently affected with this disease than males. Oral submucous fibrosis has a high rate of morbidity because it causes a progressive inability to open the mouth, resulting in difficulty eating and consequent nutritional deficiencies. It also has a significant mortality rate because it can transform into malignancy, particularly squamous cell carcinoma. Aetiology It is particularly associated with areca nut chewing, the main component of betel quid, which is similar to tobacco chewing in westernised societies. Other factors include excessive consumption of red chillies, genetic and immunologic processes, and prolonged deficiency to iron and vitamins in the diet. Diagnosis If the disease is detected at a very early stage, cessation of the habit is sufficient to reverse the condition. However, most patients present with moderate to severe disease which is irreversible. Oral biopsy provides the most definitive diagnosis and is crucial because of the association of OSF with oral cancer. Treatment It depends on the degree of clinical involvement. It is symptomatic and predominantly aimed at improving mouth movements. Avoid chewing areca nut, tobacco, alcohol, and spicy foods consumption. Vitamin A, B-complex, C, and iron supplements may be recommended. The benefit of the powerful antioxidant lycopene (16 mg per day) has been documented with significant improvement. In patients with moderate OSF, weekly submucosal intralesional injections or topical application of steroids may help prevent further damage. The combination of steroids and hyaluronidase shows better long-term results than either agent used alone. In patients with advanced OSF, pentoxifylline (400 mg 3 times daily) improves blood flow through peripheral blood vessels and leads to significant improvement in the lesion. Intralesional injection of  HYPERLINK "http://en.wikipedia.org/wiki/Autologous" \o "Autologous" autologous bone marrow stem cells is a safe and effective treatment modality. Surgical treatment is indicated in patients with severe trismus and/or biopsy results revealing dysplastic or neoplastic changes. 6 Lip disorders Lip pit Lip pit, also known as lip sinus, is one of the more frequently occurring congenital malformations of the lower lip. It affects males and females equally. Clinically, it appears as uni- or bilateral lesion of lips, paramedial or at the commissures, as a blind epithelial lined depression with a diameter range from1-4 mm. Aetiology It is an uncommon developmental anomaly. Diagnosis The diagnosis is based on the clinical findings. Treatment The lesion can be surgically removed for cosmetic reasons. Median lip fissure Median lip fissure is a relatively uncommon chronic inflammatory disorder of the midline of the lips. It presents as a deep, persistent vertical fissure at the middle of the lip, which becomes symptomatic when infected by candida albicans and bacteria. Spontaneous bleeding, discomfort, and pain are common. Aetiology It is a hereditary predisposition for weakness in the first branchial arch fusion. Diagnosis The diagnosis is based on the clinical findings. Treatment Topical high-potency corticosteroid with miconazole oral gel may be helpful. Plastic reconstruction in severe cases is the best treatment. Cleft lip and palate Cleft lip and cleft palate, which can also occur together as cleft lip and palate, are the most common craniofacial abnormalities caused by the interaction between genetic and environmental factors. They occur in 1 per 700 births, and males are equally affected as females. A  HYPERLINK "http://en.wikipedia.org/wiki/Cleft" \o "Cleft" cleft is a fissure or a gap. Cleft lipcan occur as a unilateral (incomplete or complete cleft) or bilateral complete anomaly, and the line of cleft always starts on the lateral part of the upper lip and continues through the philtrum to the alveolus between the lateral incisor and the canine tooth. Several subtypes ofcleft palatecan be diagnosed, based on severity. It varies from incomplete cleft palate (usually as a cleft soft palate), to a unilateral or bilateral complete cleft lip and palate (a cleft lip, hard palate, soft palate, and uvula). Cleft lips and palates can occur on their own or are sometimes part of a wider series of birth defects. A cleft lip or combined cleft lip and palate are more common in males, but a cleft palate on its own is more common in females. Aetiology It is a congenital anomaly caused by abnormal facial development during the 6th-10th week of pregnancy. It has a familial tendency, and when one parent is affected the risk to a child is about 10%. Diagnosis It is made at the time of birth by physical examination. Recent advances in  HYPERLINK "http://en.wikipedia.org/wiki/Prenatal_diagnosis" \o "Prenatal diagnosis" prenatal diagnosis have allowed  HYPERLINK "http://en.wikipedia.org/wiki/Obstetrician" \o "Obstetrician" obstetricians to diagnose facial clefts  HYPERLINK "http://en.wikipedia.org/wiki/In_utero" \o "In utero" in utero. Treatment Taking a daily supplement of folic acid in the month before conception and in the first 2 months of pregnancy can help prevent cleft lip and palate. The most common treatment protocol presently used in most cleft treatment centers includes: Newborn - general counseling of parents, feeding instructions, palatal obturator if necessary, and advice on a protocol for the prevention of a cleft recurrence in the family. Age 3 months - repair ofcleft lipand placement of ventilation tubes. Age 6 months - presurgical orthodontics if necessary and speech evaluation. Age 9 months - speech therapy begins. Age 9-12 months - repair of cleft palate and placement of ventilation tubes if not done at the time of cleft lip repair. Age 1-7 years - orthodontic treatment. Age 7-8 years - alveolar bone graft. Older than 8 years - orthodontic treatment continues. Other surgical procedures can be performed in patients with severe clefts as necessary. Double lip Double lip usually affects the upper lip bilaterally, although it can also occur unilaterally in both the upper and lower lips. The condition consists of an accessory fold of redundant mucous membrane inside the vermilion border of the involved lip, either with or without other anomalies. It is equally prevalent in both genders, and also shows no racial predilection. Aetiology It is a rare developmental anomaly. Diagnosis Typical appearance of lip is seen when the lip is tensed during smiling. Treatment It usually requires correction only for aesthetic reasons. The initial surgery is usually performed by the time a baby is 3 months old. Cheilitis glanduaris Cheilitis glanduaris is an uncommon suppurative chronic inflammatory disorder of the minor salivary glands, characteristically affecting the lower lip. It is characterised by progressive enlargement and eversion of the lower labial mucosa that results in obliteration of the mucosal-vermilion interface. Characteristically, the orifices of the salivary glands are dilated, and pressure on the lip may produce mucous or mucopustular fluid from the ductal openings. It appears to favour adult males between 40-70 years old. However, cases have been reported in women and in children. Cheilitis glandularis can be considered a potential predisposing factor for the development of  HYPERLINK "http://emedicine.medscape.com/article/1101535-overview" squamous cell carcinoma. Aetiology It is idiopathic, but risk factors may include chronic lip biting, habitual lip licking, or actinic damage. Diagnosis CBC and ACE levels to rule out systemic granulomatous diseases that predispose to lip enlargement such as sarcoidosis or Crohn disease. In cases with suppuration, bacterial culture and sensitivity, testing is indicated for selection of appropriate antibiotic therapy. Incisional biopsy specimen is indicated to aid in establishing a definitive diagnosis. Treatment If lip biopsy demonstrates chronic inflammation without evidence of epithelial atypia or dysplasia and no suggestion of deep infection, treatment using combined oral minocycline plus tacrolimus ointment may be successful. Suppurative cases require management with appropriate antimicrobial treatment as determined by culture and sensitivity testing. Concomitant intralesional or oral corticosteroid therapy may potentiate the effectiveness of antimicrobial therapy in cases with nodularity; however, the potential systemic adverse effects of long-term corticosteroid therapy, plus its tendency to promote local fibrosis and scarring, limit its potential use. Topical 5-fluorouracil is useful for treatment of dysplastic cases to curtail its progression, and it can be prescribed as an alternative to vermilionectomy, or as a prophylactic measure following vermilionectomy (a lip shave procedure that excise the vermilion border of the lip and replaces it with a portion of the intraoral labial mucosa). Carcinoma of the vermilion is treated with surgical wedge resection with adequate margins or vermilionectomy. Submental lymph nodes should be palpated to rule out regional metastasis. Actinic cheilitis Actinic cheilitis or solar cheilosis is a chronic degenerative disorder of the lower lip. It occurs primarily in males over 50 years of age, and its frequency increases with advancing age. In actinic cheilitis, there is a thickening whitish discolouration of the lip with loss of the usually sharp border between the vermillion border and normal skin. The lip may become scaly and  HYPERLINK "http://en.wikipedia.org/wiki/Induration" \o "Induration" indurated as actinic cheilitis progresses. Painless ulceration may develop in one or more sites, especially in areas of mild trauma. The lesion is potentially malignant, with an estimated 10% risk of cancer development. It primarily affects persons with light complexions, especially those with a tendency to sunburn easily. Aetiology It is caused by long-term exposure to sunlight. Additional factors may also play a role, including lip irritation,  HYPERLINK "http://en.wikipedia.org/wiki/Tobacco" \o "Tobacco" tobacco use, poor  HYPERLINK "http://en.wikipedia.org/wiki/Oral_hygiene" \o "Oral hygiene" oral hygiene, and ill-fitting  HYPERLINK "http://en.wikipedia.org/wiki/Dentures" \o "Dentures" dentures. Diagnosis Incisional biopsy is recommended to differentiate it from leukoplakia, early squamous cell carcinoma, or cheilitis due to radiation. Treatment Protection of lips from sunlight is by using lip balm with sunscreens in order to prevent further degeneration. Both  HYPERLINK "http://en.wikipedia.org/wiki/Cryosurgery" \o "Cryosurgery" cryosurgery and  HYPERLINK "http://en.wikipedia.org/wiki/Electrosurgery" \o "Electrosurgery" electrosurgery are effective choices for small areas of actinic cheilitis. Topical  HYPERLINK "http://en.wikipedia.org/wiki/5-fluorouracil" \o "5-fluorouracil" 5-fluorouracil, 5%  HYPERLINK "http://en.wikipedia.org/wiki/Imiquimod" \o "Imiquimod" imiquimod cream, or  HYPERLINK "http://en.wikipedia.org/wiki/Chemical_peel" \o "Chemical peel" chemical peels are curative treatments for diffuse actinic cheilitis that attempt to destroy or remove the damaged  HYPERLINK "http://en.wikipedia.org/wiki/Epithelium" \o "Epithelium" epithelium. More extensive or recurring areas of actinic cheilitis may be treated with either vermilionectomy or a  HYPERLINK "http://en.wikipedia.org/wiki/Carbon_dioxide_laser" \o "Carbon dioxide laser" carbon dioxide laser. Exfoliative cheilitis Exfoliative cheilitis is a chronic superficial inflammatory disorder of the lips, in which upper, lower, or both lips may be involved. Clinically, it is characterised by persistent scaling, crusting, and erythema of the vermilion border of the lips. This pattern is repetitive, resulting in yellowish, hyperkeratotic thickening, crusting, and fissuring. Dryness of the lips is also an important feature and varying degrees of discomfort can be present. The lesions are more common in young women. They usually persist with variable severity for months or years, and may cause cosmetic problems. Aetiology It is unknown, and is thought to be related to chronic lip sucking, picking, or unconscious licking of the lips (self-inflicted injury). It may be associated with candidal infection in some cases. Diagnosis The diagnosis is based on the clinical findings. Treatment Topical moistening agents, and corticosteroid or tacrolimus ointment may be helpful. The use of 10% calendula officinalis (pot marigold) ointment, several times daily, which is a phytotherapic plant extract, is a better alternative with good results. Contact cheilitis Contact cheilitis is an acute inflammatory disorder of the lips provoked by topical contact with various chemical agents. Clinically it is characterised by mild oedema and erythema, followed by irritation and thick scaling. It is usually confined to the vermilion border of both lips. Aetiology The most common causes that have been incriminated are lip sticks, tooth pastes, mouth washes, or foods. Diagnosis The diagnosis is based on clinical criteria and a skin patch test to confirm the causative substance. Treatment It is by discontinuing all contact with the offending chemicals. Use of topical steroids. Granulomatous cheilitis Granulomatous cheilitis is a rare chronic swelling of the lips due to granulomatous inflammation that affects adolescents, more females. The earliest manifestation of granulomatous cheilitis is sudden diffuse soft swelling of the lip or face, involving (in decreasing order of frequency) the upper lip, the lower lip, and one or both cheeks. The forehead, eyelids, or one side of the scalp is less commonly involved. The first episode of oedema typically subsides completely in hours or days. After recurrent attacks, swelling may persist and slowly increase in degree, eventually becoming permanent. Recurrences can range from days to years. Attacks sometimes are accompanied by fever and mild constitutional symptoms such as headache and visual disturbance. Once chronicity is established, the enlarged lip appears cracked and fissured with reddish brown discolouration and scaling. The fissured lip becomes painful and eventually acquires the consistency of firm rubber. Miescher cheilitis is the term used when the granulomatous changes are confined to the lips. It is generally regarded as a monosymptomatic form of the rare disorder called Melkersson-Rosenthal syndrome, although the possibility remains that these may be 2 separate diseases. Melkersson-Rosenthal syndrome is the term used when cheilitis occurs with facial nerve palsy and fissured tongue, and less often intraoral and facial oedema. The term orofacial granulomatosis is the specific histology finding of granulomas in mucosal or skin biopsies taken from the mouth or face in the absence of a recognised systemic condition known to cause granulomas. It therefore includes Melkersson-Rosenthal syndrome and Miescher cheilitis, but excludes  HYPERLINK "http://dermnetnz.org/systemic/crohns-skin.html" Crohn disease,  HYPERLINK "http://dermnetnz.org/dermal-infiltrative/sarcoidosis.html" sarcoidosis and Wegener granulomatosis. However, the term is often used loosely to mean any diagnosis of granulomas in the orofacial region, including oral Crohn disease. Aetiology The cause of granulomatous cheilitis is unknown. It may represent an abnormal immune response in someone with predisposing genetic factors. Food allergies, reactions to dental materials, infections, and medicaments such as cinnamon aldehyde and benzoates are sometimes implicated. Diagnosis As there are many possible causes of lip swelling, tests are often required to prove the diagnosis and to exclude other systemic diseases. Blood tests such as serum and red cell folate, serum ferritin, and vitamin B12 level; and serum ACE to help exclude  HYPERLINK "http://emedicine.medscape.com/article/1123970-overview" sarcoidosis. Biopsy of the swollen lip or orofacial tissues is indicated but often only shows lymphoedema and nonspecific inflammation during the early stages, and may only later show the presence of noncaseating granulomas in less than 50% of cases. GIT endoscopy and biopsy may be used to help exclude Crohn disease. Chest x-ray and positron emission tomography (PET) scanning may be performed to help exclude  HYPERLINK "http://emedicine.medscape.com/article/301914-overview" sarcoidosis. Patch tests may be used to help exclude reactions to metals, food additives, or other oral antigens. Treatment Response to treatment is very slow, and partial or complete improvement can be observed in most but not all patients, although this can take years. Improvement may be achieved by implementation of a cinnamon and benzoate-free diet.  HYPERLINK "http://dermnetnz.org/treatments/topical-steroids.html" Topical steroids or  HYPERLINK "http://dermnetnz.org/treatments/tacrolimus.html" tacrolimus ointment has been used for mild swelling. Multiple intralesional triamcinolone injections for moderate swelling.  HYPERLINK "http://dermnetnz.org/treatments/systemic-steroids.html" Systemic steroid in addition to immunosuppressive drugs ( HYPERLINK "http://dermnetnz.org/treatments/clofazimine.html" clofazamine,  HYPERLINK "http://dermnetnz.org/treatments/azathioprine.html" azathioprine) is often required for severe swelling. Cheiloplasty or lip reduction may be required for severe permanent swelling, followed by periodic intralesional triamcinolone injections and oral tetracycline, offer the best results and avoid recurrence. Angular cheilitis Angular cheilitis, also known as angular stomatitis or cheilosis, is a common inflammatory lesion at the labial commissure or corner of the mouth, and often occurs bilaterally. The condition manifests as deep cracks or splits. In severe cases, the splits can bleed when the mouth is opened and shallow  HYPERLINK "http://en.wikipedia.org/wiki/Ulcer_(dermatology)" \o "Ulcer (dermatology)" ulcers or a crust may form. Classically, the lesions do not extend beyond the mucocutaneous border. A burning sensation and a feeling of dryness may occur. Remissions and exacerbations are common. Aetiology It occurs frequently in the elderly population who experience a loss of vertical dimension due to loss of teeth, thus allowing for overclosure of the mouth. It can also be due to mechanical trauma, hypersalivation, xerostomia, nutritional deficiencies, coeliac disease, zinc deficiency, medications, or could be an early manifestation of immune deficiency (diabetes and HIV). Less severe cases occur when it is quite cold (such as in the winter time) and is widely known as having  HYPERLINK "http://en.wikipedia.org/wiki/Chapped_lips" \o "Chapped lips" chapped lips. The infective agents responsible are candida albicans and staphylococcus aureus. Diagnosis It is based on the clinical findings. Treatment Treatment of angular cheilitis varies depending on the cause. Miconazole oral gel in mild cases, or hydrocortisone and miconazole cream in severe cases until resolution of the lesion is effective. Lip-lickers dermatitis Lip-lickers dermatitis is an irritant contact dermatitis that most commonly occurs in children due to chronic lip licking. When lips are exposed to the cold, particularly cold, dry winds, they become dry and irritated. When this happens, there is a natural, sometimes unconscious, tendency for a person to lick their lips to relieve the dryness. Unfortunately, exposing already burning, chapped lips to saliva only worsens the condition, leading to a vicious cycle of lip licking, dryness, redness, and chapping. This problem can extend onto the skin around the mouth causing redness and skin irritation. Aetiology It is due to dry lips, stress, and anxiety. Diagnosis It is based on the clinical findings. Treatment It is important to break the lip-licking habit and reduce stress level if present. Petroleum jelly (Vaseline) should be applied to the lips and around the edges of the mouth very frequently. In severe cases, topical steroids or tacrolimus ointment are needed. Plasma cell cheilitis Plasma cell cheilitis is a rare benign inflammatory disorder of the lip that affects the elderly more than 60 years of age. Clinically, it presents as a circumscribed, flat to slightly raised, erythematous patches, usually on the lower lip. Aetiology The cause is unknown. Diagnosis Histopathological examination of a biopsy specimen shows a characteristic dense band-like infiltrate of plasma cells in the upper dermis of the lip and other mucosa close to body orifices. Treatment Intralesional triamcinolone injections lead to dramatic improvements. Cutaneous leishmaniasis Cutaneous leishmaniasis is a parasitic skin infection that is endemic in the tropical and subtropical areas and around the Mediterranean. Clinically, it appears initially as a small papule that grows slowly and progressively to a red or brownish-red, large nodule with a smooth and glistening surface. It finally ulcerates and becomes secondarily infected with organisms such as staphylococcus aureus. Aetiology It is caused by leishmania tropica. Diagnosis It is based on the characteristic appearance of the lesion. Diagnosis can be made by the polymerase chain reaction ( HYPERLINK "http://en.wikipedia.org/wiki/Polymerase_chain_reaction" \o "Polymerase chain reaction" PCR) technique. Treatment It is treated with long courses of  HYPERLINK "http://en.wikipedia.org/wiki/Pentavalent_antimonial" \o "Pentavalent antimonial" pentavalent antimonials injections in a high dose (20mg/kg). Keratoacanthoma Keratoacanthoma (KA) is a relatively common low grade malignancy that originates from hair follicles and closely resembles  HYPERLINK "http://en.wikipedia.org/wiki/Squamous_cell_carcinoma" \o "Squamous cell carcinoma" squamous cell carcinoma (SCC). In fact, strong arguments support classifying KA as a variant of invasive SCC. It is a disease of the elderly with a mean age of 64 years. It is characterised by rapidly growing, painless, dome shaped red papule that expands to 1-2cm and develop a central crater that is frequently filled with crust, and persists for a period of 1-2 months, followed by spontaneous resolution over 4-6 months in most cases. Keratoacanthoma reportedly progresses, although rarely, to invasive or metastatic carcinoma. Aetiology It is of uncertain aetiology but sunlight probably plays a role. Diagnosis It is best made with history and clinical examination. Excisional biopsy of the lesion is often required to confirm the diagnosis. Treatment Aggressive surgical treatment often is advocated. Labial melanotic macule Labial melanotic macule is a common, small brown macule, most near the midline on the vermilion border of the lower lip and usually less than 7 mm in diameter. Occasionally the lesion can be found on the upper lip. It has a well defined border and a uniform colour. It is most commonly seen in young adult females but it also occurs in males. Once developed the lesion usually remains unchanged in size and colour. It can occasionally have an irregular edge, and there may be a history of colour change which can cause confusion with other pigmented lesions including  HYPERLINK "http://dermnetnz.org/lesions/melanoma.html" melanoma. Aetiology It is thought to be provoked by sun exposure; however, similar lesions can arise in sites that are never sun exposed. Diagnosis In recent years, the use of dermoscopy (a hand-held instrument that magnifies the skin lesion 10 times) has proven to enable dermatologist distinguish benign from malignant lesions. Suspicious lesions, including lesions showing progressive change, should be excised and examined histopathologically. Treatment No treatment is required for typical lesions except for cosmetic considerations. Cryotherapy or laser surgery is used to remove the lesion in patients who request treatment.  HYPERLINK "http://dermnetnz.org/procedures/excision.html" Excisional removal can also be performed but will leave a scar. Lentigo maligna Lentigo maligna, also known as Hutchinson's melanotic freckle, is a  HYPERLINK "http://en.wikipedia.org/wiki/Melanoma" \o "Melanoma" melanoma  HYPERLINK "http://en.wikipedia.org/wiki/In_situ" \o "In situ" in situ that consists of  HYPERLINK "http://en.wikipedia.org/wiki/Malignant" \o "Malignant" malignant cells but does not show invasive growth. It manifests as a slowly expanding black or brown plaque with irregular border, and can remain in a non-invasive form for years. The transition to true melanoma is marked by the appearance of a bumpy surface (a marker of vertical growth and invasion), at which point it is called  HYPERLINK "http://en.wikipedia.org/wiki/Lentigo_maligna_melanoma" \o "Lentigo maligna melanoma" lentigo maligna melanoma. It is normally found in the elderly with peak incidence in the 9th decade, on skin areas with high levels of sun exposure like the face and forearms. Incidence of evolution to lentigo maligna melanoma is very low, about 2.2-5% in elderly patients. Aetiology It is due to ultraviolet radiation exposure. Diagnosis It is difficult to distinguish these lesions with the naked eye alone, and even with some difficulty using  HYPERLINK "http://en.wikipedia.org/wiki/Dermatoscopy" \o "Dermatoscopy" dermoscopy. The preferred method of diagnosis is by using a punch biopsy of 1.5mm or larger. Treatment When cellular atypia is noted, the entire lesion should be excised, followed by treatment of the area with 5%  HYPERLINK "http://en.wikipedia.org/wiki/Imiquimod" \o "Imiquimod" imiquimod cream, which is an immune enhancing agent. Table 1. Topical oral preparations used in oral medicine Generic name/brand name Corticosteroids* DoseUsesIndicationsTriamicnolone acetonide 0.1% Adcortyl in Orabase (kenalog) Fluocinonide 0.05% ** (Lidex, Vanos) Fluocinolone acetonide 0.1%** (Synalar, Capex)oral gel oral gel oral gelApply to dry lesion with wet finger or cotton wool bud 1x4/day after meals and at bed time until resolution More potent than triamcinolone, 1x4/day after meals and at bed time until resolution-For ulcers on lower lip or RAS of anterior mouth, not suitable for ulcers of the oropharynx -Desquamative gingivitis -As for triamcinolone Hydrocortisone sodium succinate (Corlan)2.5 mg pellets1x4/day during ulcer attack, then 1x2/day between attacks. Usually taken for at least 2/12 (suck slowly after meals)- RAS of posterior mouth -Mild erosive OLPBetamethasone valerate 0.1% (Bextasol, Valisone)100g/puff spray2 puffs (200g) sprayed onto sore mucosa 1x3/day after meals (max 8 puffs/day)-RAS of anterior mouth -Oropharyngeal ulcers -Localised erosive OLPBeclomethasone dipropionate (Becotide, Beclovent, Vanceril)50g/puff spray2 puffs (100g) sprayed onto sore mucosa 1x3/day after meals (max 8 puffs/day)-As for betamethasone spray (may be less effective)Betamethasone sodium phosphate** (Betnesol) Clobetasol propionate 0.05%** (Cormax, Temovate)0.5 mg tab solutionUsed as oral rinse 1x4/day and up to 6 times daily (Betnesol 1 tab dissolved in 10 ml of warm water), swish for 3 minutes each time, and spit out-Severe RAS of posterior mouth -Severe oral ulcerations, including erosive OLP (long-term use may cause adrenal suppression )Dexamethasone elixir** (Decardon, DexPak)0.5 mg/5ml used as oral rinse1x5/day for 3 min and spit out after meals and at bed time until resolution, then reduce by one dose every other day until 1x2/day as a maintenance dose , or stop-Extensive or severe oral ulcerations -For long-term use, it can be mixed with equal parts of Tantum verde mw and Nystatin suspension Triamcinolone hexacetonide injection (Kenacort 10 / 40mg, Aristospan 5/20mg)20 mg/ml vial1 ml intralesional mixed with 1/3 vial local anaesthesia, before injection anaesthetise area with gel, repeat every week until resolution-Useful in chronic localised ulcerative oral lesion (should exclude CA before) -For inflammatory swollen lipsOther alternatives to steroidsdose UsesIndicationsHyaluronic acid sachets 0.2% (Syno-Vital) Gingegel, Aftamedoral solution gel, spray 1x3/day after meals, it is a safer alternative to topical steroids 1x3/day after meals-Oral ulcers of Behcets disease -Oral mucositis in CA patients - Severe RASTetracycline plus nicotinamide (vitamin B3) Or Doxycycline ( HYPERLINK "http://www.drugs.com/cdi/doryx-delayed-release-capsules.html" Doryx,  HYPERLINK "http://www.drugs.com/cdi/adoxa.html" Adoxa, Monodox)500 mg caps 500 mg tab oral rinse 100 mg caps oral rinse1x4/day after meals for 1/52, (break open caps and tab, and dissolve contents in 10 ml of warm water, rinse for 3 min and spit out As above-Herpetiform RAS -Oral ulcers of Behcets disease - Gingival OLP (avoid tetracyclines in children younger than 12 years) Carbenoxolone sodium sachets 1% (Bioplex)2g bioral granulesDissolve 2g in 30-50 ml water, and rinse for 3 min 1x4/day then spit out-RAS unresponsive to topical steroids or tetracyclineChlorhexidine gluconate (PerioKin) (PerioKin)  oral gel oral spray1x3/day after meals (apply on gums with a soft brush or a cotton bud). Dont eat or drink half an hour after its use. Do not rinse.-Dental plaque -Peri-implant -Oral antisepticeg 4/12 (i.e. 4 months), 5/52 (i.e. 5 weeks), 2/7 (i.e. 2 days) *Check for systemic effects in case of long-term use (longer than 2 weeks) of topical steroid oral spray, rinse or elixir every 3/12 (CBC, U&E, LFT, serum cortisol level, urinalysis, BP and weight) **Topical corticosteroids with high-potency Table 2. Topical skin preparations used in oral medicine Generic name/brand nameDoseUsesIndicationsFusidic acid 2% (Fucidin) 5 g gel1x3/day to lips for 1/52-Staphylococcal infected lip lesions (eg central fissure of lip) -Non-candidal angular cheilitisFusidic acid 2% Sodium fusidate 2% (Fucidin)5 g cream 5 g ointment1x3/day to skin for 1/52-Bacterial skin infectionsBetamethasone valerate 0.1% plus fusidic acid 2% (Fucicort)15 g cream Apply sparingly 1x3/day to skin-Inflammatory skin lesionsHydrocortisone 1% plus miconazole 2% (Daktacort)5 g cream or ointment1x2 or 1x3/day to skin -Bacterial and fungal infections - Severe angular cheilitisClobetasol propionate (Dermovate, Temovate)60 g cream or ointment1x2/day for 4/52 (must not exceed 50 mg/week)-Various skin disorders -Skin lichen planusImiquimod 5% (Aldara)creamTwice weekly for 6/52 (an immune response modifier)-Actinic cheilitis -Focal epithelial hyperplasia -Lentigo malignaHYPERLINK "http://dermnetnz.org/treatments/tacrolimus.html"Tacrolimus 0.1% (Protopic)ointment 0.1% >16yr 0.03% < 16yr1x2/day for 6/52 Short-term use only Topical immunomodulator Use with caution Gradually stopped-Granulomatous cheilitis -Lip-licking dermatitis -Exfoliative cheilitis - Cheilitis glanduaris eg 4/12 (i.e. 4 months), 5/52 (i.e. 5 weeks), 2/7 (i.e. 2 days) Table 3. Systemic drugs used in oral medicine Generic name/brand nameDoseUsesIndicationsMILD CASES Corticosteroids* (Prednisolone) 1 5 10 mg tabsReducing dose: 20 mg 1x2/day after breakfast and lunch for 5 days, reducing by 5mg every 2 days (20/15, 20/10, 20/5, 20, 15, 10, 5), then reducing by 1 mg/day until stop. Best taken dissolved in some water but can be swallowed Maintenance dose: 5-10 mg daily or on alternate days - RAS unresponsive to topical treatment -Severe erosive OLP -Oral ulcers of EM -Oral pemphigus vulgaris -Oral pemphigoid -Oral pemphigus vulgaris -Oral pemphigoid -Oral ulcers of Behcets diseaseSEVERE CASES Corticosteroids (Prednisolone) Admit to hospital 100 mg tab1x2 mg/day until control, then reduces to 40 mg daily, and add AZA 50 mg 1x2/day for 3 weeks. Reduce prednisolone to 40 mg on alternate days. When stable reduce to a maintenance dose above, then add AZA 50 mg daily-Systemic pemphigus vulgaris with oral ulcers (patients usually need to be maintained on low dose of prednisolone for life) -To be monitored by a specialist Azathiorpirne (AZA) (Imuran, Asasan, Immunoprin)50 100 mg tab50-100 mg/day in combination with 10-20 mg of prednisolone on alternate days -Steroid sparing agent and immunosuppressant used as long term treatment in pemphigus vulgaris, severe pemphigoid, or Behcets disease Carbenoxolone Sodium (Bioplex, Bioral)20 mg tab1 or 2/day after meals-Severe RAS unresponsive to topical steroids or tetracyclineColchicine (Colcrys) 0.5 0.6 mg tab0.5-0.6 mg 1x2 or 1x3/day depending on the disease for which it is used-Behcets disease -Sarcoidosis Diaminodiphenyl sulfone (Dapsone)25 100 mg tab1x2/day up to maximum 200 mg (if no response add prednisolone 40mg/alternate days)-Dermatitis herpetiformis -Pemphigoid unresponsive to oral steroidsSulphasalazine (Azulfidine, Salazopyrin) 500 mg tab1-4 g/day depending on the disease for which it is used -Oral Crohn -Ulcerative colitis -Rheumatoid arthritis Supplements doseUsesIndicationsFerrous sulphate (iron) (Feosol, Ferosul, Fer-iron, Hemobion) 200 mg tab 1x3/day for 3/12, 2 hrs after meals, if patient cant tolerate ferrous sulphate, then ferrous gluconate 325 mg 1x3/day or ferrous fumarate 325 mg 1x2/day-Iron deficiencyFolic acid (Folvite) 150-400 mcg tab Once daily taken as directed -Folic acid deficiency -Folic acid deficiency due to coeliac disease Vitamin B12 injection (cyanocobalamin ) Mecobalamin (copal)1000 mcg/ml vial im 500 mg tabOn alternate days for 2/52, then once every 2-3/12 1x2/day-Vitamin B12 deficiency -Pernicious anemia -Vitamin B12 deficiencyZinc gluconate 10 mg/ (Zinc)10 mg 25 mg tab10 mg/day with meal for 1/12-Zinc deficiency  eg 4/12 (i.e. 4 months), 5/52 (i.e. 5 weeks), 2/7 (i.e. 2 days) *Careful monitoring is necessary with long-term therapy of oral steroids, 1/12 after therapy started, then every 3/12 (CBC, U&E, LFT, serum cortisol level, urinalysis, BP and weight). Check adrenal function before stopping oral steroids. Table 4. Antibacterial drugs used in oral medicine AntibacterialGeneric nameDoseUsesContraindication/ drug interactionNatural penicillins Phenoxymethyl penicillin Benzylpenicillin  Penicillin-V Penicillin-G  250-500 mg tab 1X4 on empty stomach for 5/7 300,000 units, single im injection  Narrow spectrum Severe dental infections Dental infections in CTX patients NUG Submaxillary cellulitis (Ludwigs angina) Acute osteomyelitis of the jawsAllergies Renal insufficiency Oral contraceptives Warfarin Tetracycline Aminopenicillins (Flumox)Amoxicillin Ampicillin Flucloxacillin + Amoxicillin Flucloxacillin or Dicloxacillin250-500 mg caps 1X3/day for 5/7 (ampicillin on empty stomach) 250 mg caps 250 mg caps 250-500 mg caps 1X4/day on empty stomach for 5/7Amoxicillin better absorbed than ampicillin Bactericidal Broad spectrum Dental infections Can be used safely in pregnancy SialadenitisAllergies Renal insufficiency GIT disease Infectious mononucleosis Alcohols Oral contraceptives Warfarin Amoxicillin and clavulanic acid ( penicillinase resistant penicillin)Augmentin375-625 mg tab 1X3/day for 5/7Bactericidal Dentoalveolar abscess Sinusitis TonsillitisAllergies Renal insuficiency Liver disease Oral contraceptives WarfarinCephalosporins (cross sensitivity with penicillin) Cephalexin 250-1000 mg caps 1X4/day for 5/7 Bactericidal Act as penicillin-G substitute Only used when indicated Allergies Renal disease Haemorragic tendency Pregnancy Probenecid (gout drug) Erythromycin TetracyclineMacrolidesErythromycin stearate Azithromycin or Clarithromycin 250-500 mg caps 1X3/day for 5/7 (with meals) 500 mg as a single doseBacteriostatic Narrow spectrum As an alternative to penicillin for prevention of endocarditis Nursing mother Liver disease Skin sensitivity to sun Carbamazepine Phyenytoin Theophyllines (asthma drug) Digoxen WarfarinLincosamidesClindamycin 150-450 mg caps 1X4/day for 5/7 600 mg as a single dosePost surgical extractions Bone or joint infections Anaerobic infections Sinusitis As an alternative to penicillin for prevention of endocarditis Nursing mother Liver disease Kidney disease Stomach disease Pseudomembranous colitis ErythromycinNitroimidazolesMetronidazole Rodogyl250 mg tab 1X3/day for 5-7/7 2x2mg tab/day for 5/7Active against anaerobes Dental infections in combination with amoxicillin (pericoronitis or acute dentoalveolar abscess) Aggressive periodontitis ANUG Nursing mother Epilepsy Liver/GIT disease Alcohols/Warfarin Lithium Unpleasant metallic taste Peripheral neuropathy after prolonged useTetracyclines Doxycycline Minocycline100 mg caps 1x2/day for 1/52 or 100 mg/day for 2/52 200 mg caps as initial dose, then 100mg 1x2/day for 4-15/7Bacteriostatic ANUG as an alternative to penicillin Aggressive periodontitis Can be used in renal impairment Cheilitis glandularisPregnancy < 12yrs old Photosensitivity Antacids Antiepileptics MethotrexateFluoroquinolonesCiprofloxacin 500-750 mg tab 1X2/day for 7-10/7Not common to treat dental infections PeriodontitisPregnancy <18 yrs old Photosensitivity Dairy products Antacids Iron or zinc supplements Theophylline (asthma drug) Probenecid (gout drug) WarfarinSerratiopeptidase (proteolytic enzyme)Danzen5 mg tab 1X3/day after meals for 5/7Postsurgical to prevent pain and swelling Enhance the action of antibiotics Dentoalveolar abscess Pericoronitis Periodontitis Tendonitis Sinusitis TonsillitisHypersensitivity Renal disease Liver disease Coagulation abnormality Warfarineg 4/12 (i.e. 4 months), 5/52 (i.e. 5 weeks), 2/7 (i.e. 2 days) Table 5. Antifungals and antivirals used in oral medicine Generic name/brand name Antifungals DoseUseIndicationsAmphotericin B (Fungilin, Fungizone)10 mg lozenges1x4/day for 10-14/7 (suck slowly)-Can use for the 1st 7 days in each month for persistent recurrent oral candidiasis -Oropharyngeal candidiasisMiconazole (Mycoheal, Daktarin)250 mg/ml oral gel 1x4/day for 1-2/52 -Denture stomatitis (apply to denture fitting surface) -Mild angular cheilitisNystatin (Mycostatin)500,000 u/ml lozenges 1x4/day for 2-4/52 (suck slowly)-Oropharyngeal candidiasis -Its effect is better than suspensionNystation suspension (Mycostatin) 100,000 u/ml oral rinse5ml swish and spit 1x3 for 2-4/52 (high sugar content needs good oral hygiene measures)-Oropharyngeal candidiasis -Candidiasis in patients with very dry mouth who cant suck lozenges -Black hairy tongueFluconazole (Diflucan)50, 150 200 mg tab2 tab loading dose (100 mg), then 50 mg/day for 7-14/7-Oropharyngeal candidiasis -Candidal leukoplakiaKetaconazole (Nizoral)200-400 mg tab 1tab/day for 10-20/7 (beware of hepatic impairment)-Systemic fungal infections -Chronic mucocutaneous candidiasisAntiviralsdoseUseIndicationsAcyclovir (Zovirax)5% creamApply to lesion 1x5/dayRecurrent herpes simplex that affects lips and skin (at early stage)Acyclovir suspension (Zovirax)125 ml (200 mg/5 ml) oral rinse1x5/day for 5/7-Oral viral infections Acyclovir oral (Zovirax) Valacyclovir Famciclovir200 mg caps 800 mg tab 800 mg tab 500, 1000 mg tab 500 mg tab1x5/day for 5/7 1x4/day for 5/7 1x5/day for 7-10/7 1000mg 1x3 for 7 days 500 mg 1x3 for 5 days 2000mg every 12 hrs for 1 day 1,500 mg, single dose 500 mg 1x3 for 7 days-Frequent herpes or intra-oral herpes -Primary herpes simplex or chickenpox in adults -Acute herpes zoster -Oral hairy leukoplakia Herpes zoster Chickenpox Herpes labialis -Herpes labialis -Herpes zostereg 4/12 (i.e. 4 months), 5/52 (i.e. 5 weeks), 2/7 (i.e. 2 days) Table 6. Peripherally acting analgesics used in oral medicine AnalgesicsGeneric name/ brand name DoseUsesContraindication/ drug interactionSalicylates Analgesics Anti-inflammatory Antipyretics Regular aspirin Diflunisal (dolobid, dolostop)75 mg tab, 1x4/day for 7/7 75 mg tab, 3/7as prophylactic 1g loading dose then 500 mg caps , 1x2/day for 5/7 on empty stomachMild to moderate dental pain TMJ pain Arthritis To prevent clot formation Severe dental pain (superior to aspirin or paracetamol) Long acting TMJ pain Arthritis Periodontitis Reyes syndrome in children Prolong bleeding time Peptic ulcers Kidney dysfunction Allergy Asthma Pregnancy Oral hypoglycemics Lithium Alcohol Warfarin Not recommended in children Prolong bleeding time (less effect than aspirin) Dry mouth Not used with paracetamol High BP medications (beta blockers, ACE inhibitors, diuretics)Anilines Analgesics Antipyretics Paracetamol/ Acetaminophen (Panadol, Calpol) Acetaminophen with codeine (Tylenol)500 mg tab every 4-6 hrs, not exceeding 4g/day or 8tab/day 300 mg + 30 mg one tab every 4-6 hrs not exceeding 4g/dayMild to moderate dental pain The safest during pregnancy and in elderly TMJ pain Severe dental pain Best tolerated Long-term use lead to renal toxicity Drug overdose causes severe liver damage Hepatitis Alcohol WarfarinNSAIDs Analgesics Anti-inflammatory AntipyreticsIbuprofen (Brufen, Advil) Naproxen sodium (Proxen, Nubain) Memfenamic acid (Ponstan) Celecoxib (Celebrex) Rofecoxib (Viox)200-400 mg tab1x3/day for 3/7 220-440 mg 1x2/day for 3/7 250 mg 1x4/day for 1/52 100-200 mg 1x2/day 50 mg /day for 3/7Acute dental pain Post surgery TMJ pain Not recommended for children under 14yrs Mild to moderate dental pain Contraindicated for CABG patients Long-term use Not recommended for acute dental pain or post surgery Chronic facial pain Chronic pain of TMJ Short-term use Long duration of action Acute dental pain and post surgery Patients allergic to aspirin should avoid NSAIDs Prolong bleeding time Dry mouth Abdominal pain Peptic ulcers Kidney dysfunction Oral hypoglycemics High BP medications Methotrexate Asthma Pregnancy Lithium Alcohol Warfarin Patients allergic to sulfonamide may also be allergic to celecoxib Lower incidence of stomach and intestinal ulcers Lower incidence of stomach and intestinal ulcers eg 4/12 (i.e. 4 months), 5/52 (i.e. 5 weeks), 2/7 (i.e. 2 days) Table 7. Mouth washes, oral gel, and lozenges used in oral medicine Generic nameBrand nameUsesEffectsBisquanide Chlorhexidine digluconate 0.02% Hexetidine 0.2%  Gar Garol (sugar free) Sensi Kin (alcohol free) Lacalut fresh (alcohol free) Corsodyl Eludril Oraldene DAD Hexoral RAS Antiplaque Anticaries Gingivitis Oral infections Improve wound healing Halitosis Antiplaque GingivitisStaining of teeth, restorations, and tongue Increased calculus deposition Taste alteration Burning sensation Contraindicated if pregnant or nursing Contraindicated in CTX-induced mucositis or xerostomia Use after rinsing with water and after brushing Doesnt cause staining Less effective than chlorhexidineQuaternary ammonium compound Cetylpyridinium chloride (CPC) Sidium benzoateListermint Search Macleans active TriclosanAntiplaque Anticaries Gingivitis Taste alteration Phenolic essential oils Thymol Menthol Eucalyptol Methyl salicylateListerine Chloraseptic Philstryn DettolRAS Antiplaque Anticaries Gingivitis Halitosis Sore throat Geographic tongueContraindicated in patients with xerostomia or dental erosion, due to low oral pH Oxygenating (peroxidase agents) Hydrogen Peroxide Oxy-M (alcohol free) Oxifresh Peroxyl Gingivitis Halitosis (neutralises sulfa compounds) Oral sores Xerostomia Coated tongue Reduce stains For soaking dentures Rapidly degraded Long- term use may cause dental erosion due to low pH Rinse after brushing Use once a day only Overuse may damage filiform papillae, and cause dry mouthAluminum chlorate Potassium aluminum sulphate Sansilla (20 drops in glass of water) Lethana Antiplaque Gingivitis Halitosis Acute stomatitis Astringent Antiseptic Temporary burning, itching, prickling, or tingling in treated areas May cause severe allergic reactionsPovidine-iodine 1% IodophoreBetadine Povidine Philadine Povicenter Piodin PerimedAntibacterial Antifungal Antiviral Gingivitis Oral ulcers Sore throat Radiation and CTX mucositisAllergic reaction can occur in sensitised individuals Contraindicated in patients with thyroid diseaseFluoride Acidulated phosphate fluoride Sodium fluorideProtect Reach Fluocaril ACTAnticaries Teens with bracesShould avoid swallowing Strengthen tooth enamelSodium bicarbonate  ?Mucositis Oral ulcers Xerostomia Coated tongueReduce acidity in mouth Reduce dental erosion Potassium nitrate Potassium chlorideEmofluor (alcohol free)Dentinal hypersensitivity Allergy Do not use more than 4 weeksHyaluronic acid Hyaluronan Xylitol  Gengigel oral rinse (alcohol free)Gingivitis Periodontitis Receding gums Oral ulcers OLPUse 3-4 times daily for 3-4 weeks after brushing teeth No side effectsPolyvinyl pyrolidon (PVP)Aloclair (alcohol free)RAS Oral ulcersFilm coating for pain relief Xerostomia (oral dryness) Bioactive enzymes Artificial saliva Saliva stimulating  Biotene dry mouth Biotene oral balance gel Salivart spray onto tongue and buccal mucosa Salivasure lozenges (previously Salix SST) (up to 10/days)Oral dryness due to aging, DM, and drugs Salivary gland dysfunction Sjogrens syndrome Sore throat Post- irradiation XerostomiaSoothes and protects tissues against minor irritations, sensitivity and burning sensation,s and promotes healing Increase viscosity Protects between brushings Analgesics Benzydamine hydrochloride Lidocaine hydrochloride  HYPERLINK "http://www.catalog.md/drugs-ingredients/rhubarb-extract.html" Rhubarb extract and  HYPERLINK "http://www.catalog.md/drugs-ingredients/salicylic-acid.html" Salicylic acid Povidone-Iodine Lidocaine and Chlorhexidine Tantum Verde Difflam Citrolin-F (alcohol free) Cetrina Pyralvex (paint) Betadine (paint) Trachisan sore throat gargleRadiation-induced mucositis Oral ulcers Tonsillitis BMS Fissured and geographic tongueOral and throat pain relief Avoid prolonged useAnaestheticsdoseUsesIndicationsHaemodialysate/Polidocanol Anti-inflammatory (Solcoseryl) dental adhesive paste1x5/day after meals (dry the lesion and apply the paste with a wet fingertip) -Traumatic oral ulcers -Painful RAS -Painful lip lesions -Denture pressure sores -Dry socket -Teething pain -Dressing after scalingLidocaine hydrochloride 2% (Xylocaine Viscous) Dyclonine hydrochloride 0.5% (Dyclone)solution oral spray lozenges1x4/day for 2 min before meals and spit out. Apply it with a cotton swab in children in order not to swallow it 1x4/day before meals-Widespread painful oral and throat ulcerations or mucositisBenzocaine (Cepacol, chloraseptic) 10 mg lozengesPRN before meals (not more than 12/day)-Painful oral and throat lesions Mouth washes containing more than 25% alcohol could increase the risk of oral and pharyngeal cancers by about 50%; therefore, the use of mw that does not contain alcohol may be equally effective Medicated mw is to be used only for a short-term, as prolonged use may cause undesirable side effects Young children should not use mw because they are not able to spit out properly Mechanical plaque control (regular brushing and flossing) is necessary and not replaceable by mw Table 8. Tooth pastes and tooth brushes used in oral medicine Uses/constituentBrand nameAnti-plaque/gum disease Cetylpyridinium chloride (CPC) Chlorhexidine digluconate Sodium benzoate Peroxidase agents Phenolic essential oilsLacalut Akiv, Corsodyl dental gel, Paradontax, Parodium, Elgydium, Pate gingivale, el-cemed total care, Pyodontyl, HiGeen.Anti-cavity (with fluoride) Stannous fluoride Sodium fluoride Monofluoride phosphate Lacalut fluoride, Elgydium, Aquafresh Iso-Active, Colgate Total, Floucaril.Anti-cavity (without fluoride) Aquafresh cavity protection, Aim anticavity, Ultrashine radiance.Anti-sensitivity Potassium nitrate Sodium citrate Strontium Calcium carbonate ArginineLacalut sensitive, Synsodyne sensitive, Emofluor paste, Emofluor gel (apply with fingertip to sensitive teeth after Emofluor paste at night), Sensigel gel (apply with fingertip to sensitive teeth after usual brushing at night), Colgate sensitive Pro-relief, HiGeen, Protect.Whitening/anti-stain Baking soda Hydrogen peroxideLacalut white, Sensodyne white, Advance white (Arm and Hammer), Bevely Hills formula, Halazon white, Elgedium bicarbonate, Pearl drops, Aquafresh, Colgate advance white, Close-Up, Pearl drops, HiGeen, Oxyfresh, Crest.SLS-free for xerostomia Chlorhexidine digluconate potassium nitrate, sodium fluoride Bioactive enzymes Kin gingival, Sensi Kin (with chlorhexidine) Pro-Enamel sensodyne (with fluoride) Biotene Dry mouth, OraMD, Tom's of Maine.SLS-free natural tooth paste Zendium, Arm and Hammer's Advance White for sensitive teeth with fluoride, Perigel, Enamel saver, Jason, Peelu, Homeodent , Real Purity, Natural. Tooth brushes Soft (gum lesions) Medium (normal) Hard (heavy smokers) Lacalut, Sensodyne, Aquafresh, Elgydium, Trisa, Oral-B, Reach, Butler gum, Ionic.  Dental health care in adults The amount of toothpaste or gel needed on brush for effective cleaning should only be pea-sized Gels can be more abrasive than pastes because of the silica (sand) used to make them Although the current levels of peroxide in toothpaste are safe, peroxide toothpastes are controversial Flossing at least once a day at night after brushing is very important because it removes food and plaque from between teeth where even the best toothbrush and toothpaste are ineffective Studies suggest that plaque (bacteria) regrow on clean teeth about 4 hours after brushing Dental health care in children Once the child has a few teeth, his parent can start brushing his teeth with water and a soft-bristled toothbrush until he is old enough and ready to take on the responsibility himself, which is usually around age 7 or 8 years Toothpaste without fluoride should be used for children under age 6 years Always have the child to rinse and spit out toothpaste after brushing Precautions Major brand toothpastes or mw are loaded with potentially harmful ingredients that enter the blood stream and build up in body organs; some of these ingredients are considered to be carcinogenic Toxins and chemicals in tooth pastes include sodium fluoride, triclosan, propylene glycol, diethanolamine (DEA), FD&C blue dyes1&2, hydrated silica, and SLS (the most dangerous); all of these common ingredients have been found to be harmful to humans Table 9. Emergency kit for dental surgery Equipments 1A bag valve mask (BVM or Ambu bag) is a hand-held device used for artificial ventilation. It is self-inflating with room air or from an oxygen source2Brook airway (a tube for use in mouth-to-mouth resuscitation)3Oropharyngeal airway (OPA, oral airway, or Guedel pattern airway) (sizes 1, 2 and 3) is a medical device used to maintain a patent (open) HYPERLINK "http://en.wikipedia.org/wiki/Airway" \o "Airway"airway4Pulse Oximeter consists of a probe attached to the patient's finger or ear lobe which is linked to a computerised unit that indirectly monitors the oxygen saturation of a patient's HYPERLINK "http://en.wikipedia.org/wiki/Blood" \o "Blood"blood 5Cricothyroid puncture needles to make incision through the HYPERLINK "http://en.wikipedia.org/wiki/Skin" \o "Skin"skin and HYPERLINK "http://en.wikipedia.org/wiki/Cricothyroid_ligament" \o "Cricothyroid ligament"cricothyroid membrane to establish a patent HYPERLINK "http://en.wikipedia.org/wiki/Airway" \o "Airway"airway during certain life threatening situations, such as airway obstruction6Portable defibrillator (incorporating ECG printout)7Portable oxygen delivery system8Venous access cannulae (venflons, 16 and 22 gauge)9Intravenous infusion sets/ Microdrip sets10Tourniquet, stethoscope and sphygmomanometer to measure blood pressure11High volume aspiration with suction catheters and Yankauer sucker12Disposable syringes (2, 5, 10 and 20 ml sizes)13Needles (19, 21 and 23 gauge) and butterflies14BM sticks for rapid assessment of blood sugar levels by a quick finger prickDrugs (it is essential that stocks are replaced when expiry dates are passed)1Adrenaline injection (1:1000 or 1mg/1ml)2Hydrocortisone sodium succinate (100 mg)3Anti-histamine injection (chlorpheniramine 10 mg/ml)4Diazepam injection (5 mg/ml)5Glucose injection (10% solution) and glucose powder for oral use (50 g for one drink)6Glucagon injection (1 mg/im)7Atropine injection (0.5 mg/im)8Sorbitrate tablets (2.5-5 mg/sublingual)9Nitroglycerine tablet (0.5 mg/sublingual)10Pethidine (25-50 mg/iv) Table 10. Antibiotic prophylactic regimens for dental procedures by American Heart Association SituationAgentRegimen Single dose 30-60 minutes before procedureAdultsChildrenOralAmoxicillin2 g50 mg/kg Unable to take oral medication Ampicillin 2 g im or iv 50 mg/kg im or iv Cefazolin or ceftriaxone 1 g im or iv 50 mg/kg im or iv Oral (allergic to penicillins or ampicillin) Cephalexin*2 g50 mg/kgClindamycin 600 mg20 mg/kgAzithromycin (Zomax) or Clarithromycin 500 mg15 mg/kgUnable to take oral medication (allergic to penicillins or ampicillin)Cefazolin or ceftriaxone 1 g im or iv 50 mg/kg im or iv Clindamycin 600 mg im or iv 20 mg/kg im or iv  *Or other first or second generation oral cephalosporin in equivalent adult or paediatric dosage; cephalosporins should not be used in an individual with a history of anaphylaxis, angioedema, or urticaria following penicillin or ampicillin Table 11. American Heart Association recommendations for antibiotic prophylaxis Antibiotic prophylaxis with certain dental procedures is needed for patients withProsthetic heart valve or prosthetic material used in valve repair. Previous infective endocarditis. Cardiac transplantation recipients who develop cardiac valvular disease. Congenital heart disease only in the following categories: -Unrepaired or incompletely repaired cyanotic congenital heart disease, including those with palliative shunts and conduits. -Completely repaired congenital heart disease with prosthetic material or device, whether placed by surgery or catheter intervention, during the first 6 months after the procedure (prophylaxis is reasonable because endothelialisation of prosthetic material occurs within 6 months after the procedure). -Repaired congenital heart disease with residual defect at the site or adjacent to the site of a prosthetic patch or a prosthetic device (which inhibit endothelialisation). Antibiotic prophylaxis is recommended for dental procedures that involve manipulation of: -Gingival tissue. -Periapical region of teeth. -Perforation of the oral mucosa. Antibiotic prophylaxis is not recommended for the following dental procedures: -Routine anaesthetic injections through noninfected tissue. -Taking of dental radiographs. -Placement of removable prosthodontic or orthodontic appliances. -Adjustment of orthodontic appliances. -Shedding of deciduous teeth. -Bleeding from trauma to the lips or oral mucosa. Antibiotic prophylaxis with dental procedures is no longer needed for patients withMitral valves prolapse. Rheumatic heart disease. Bicuspid valve disease. Calcified aortic stenosis. Congenital heart conditions such as ventricular or atrial septal defect, and hypertrophic cardiomyopathy. Coronary artery bypass grafting, angioplasty, or stent. Table 12. Haematology and biochemistry profiles ContentsType of testHb RCC HCT (PCV) MCV MCH MCHC WCC and DWCC Blood film Platelet count ESRHaematology profile CBC or FBPSerum iron (preferably fasting) TIBC Saturation (%) Serum ferritin Serum vitamin B12 Red cell folate Reticulocyte count (recommended 5-7 days after the start of treatment to detect early response)Haematinic profile Iron studiesCBC Reticulocyte count Direct antiglobulin test Serum bilirubin (direct and indirect) Serum haptoglobin Urinary urobilin and urobilinogen (fresh urine)Haemolytic profileCBC PT PTT Thrombin time Bleeding time Fibrinogen Coagulation profileFactor VIII Von Willebrand factor antigen Ristocetin cofactor activityHaemophilia/von Willebrand screenPlasminogen Alpha2-antiplasmin Tissue plasminogen activator Plasminogen activator inhibitorFibrinolytic profilePT PTT Thrombin time Fibrinogen Antithrombin III Lupus anticoagulant Protein C Protein S Activated protein C resistanceThrombotic risk profile Total lymphocyte count CD4 lymphocytes CD8 lymphocytes CD4/CD8 ratioLymphocyte subset ImmunophenotypingBilirubin ALP ALT (SGPT) AST (SGOT) GGT Total protein Albumin GlobulinLiver profileMCV ALT (SGPT) AST (SGOT) Urate Triglycerides GGT Carbohydrate-deficient transferring Blood alcoholAlcohol use profileCK CK-MB activity LDH Troponin TCardiac profileFasting blood sugar Serum creatinine HbA1c Urine creatinine Urine albumin (microalbumin) Urine albumin/creatinine ratioDiabetes mellitus monitoring profileCalcium Phosphate Albumin ALP (total and bone isoenzyme) Acid phosphatase (bone isoenzyme)Bone profileTotal cholesterol HDL-cholesterol HDL/cholesterol ratio LDL-cholesterol TriglyceridesLipid profileFree T3 Free T4 TSHThyroid profileCBC Cholesterol Triglycerides Calcium Phosphate Urea Urate Creatinine Glucose Total protein Albumin Globulin Bilirubin ALP ALT (SGPT) AST (SGOT) GGT Screening test       PAGE \* MERGEFORMAT 99 !"&LMNOZ`bop  ( ) 2 ̸裙}oh]R]>&h2@he;5CJ OJQJ\^JaJ h;#dh CJaJh;#dhmmCJaJ h;#dhmmh;#dhmm5CJ\aJhMhUJ5CJ \aJ hMhmm5CJ \aJ h;#dh>5\ hmm5\h;#dhUJ5CJ \aJ &h2@hmm5CJ,OJQJ\^JaJ, hd65CJ,OJQJ\^JaJ,h 5CJ,\aJ,h;#dhmm5\h;#dhmm5CJ \aJ !LMNOp $dhgdmm$dha$gdUJ$dha$gdmm $a$gdmm $A$^a$gdmm $A$^a$gd_R( 2 3 4 5 > Z [ s t $ A$^`gde;gde;$A$gde;$A$^`gde;$ & FhA$gdqO$dha$gde; $a$gde; $a$gdu$dha$gd 2 4 5 [ q r s t  4 [ o ʹyj]R]]A]0 h;#dhe;CJ^JaJnH tH  h;#dhe;CJ^JaJmH sH h;#dhe;mH sH h;#dhe;CJ^JaJh;#dhe;CJOJQJaJ h;#dhe;CJOJPJQJaJ h;#dhe;'h;#dhe;CJ[^J_H,aJnH tH &h2@he;5CJOJQJ\^JaJ h 55CJOJQJ\^JaJ&h2@hR65CJOJQJ\^JaJh;#dhe;6]h;#dh;.6]h;#dhe;5CJ \aJ   4 [ o   . G a x $ & FhA$gdqO$A$gdd$ A$^`gde;$A$gde; ( ) * + [ \ 2345FGz78AS})*+,.1׸uh2=^5CJ \aJ nH tH  h~5\h2@he;OJPJQJ^Jh;#dhdPJ he;PJ h 5PJh;#dhe;PJh2@he;5OJQJ\^J h;#dhdhe;h~&h2@he;5CJOJQJ\^JaJh;#dhe;5\hd h;#dhe;-   : E d ~  ) * + [ \ h t $A$gde;$ & FhA$gdqO$A$gdd$A$gde;$A$gd~ #345FGYiz$ & FhA$gdqO$A$gdd$A$gde;78KWk +ASj} $A$^gde;$A$gdd$ & FhA$gdqO$A$gde;}*+,-./0?@Dbh$d$A$Ifgdv- $A$a$gd2=^ $A$a$gde;$A$gd~$A$gdd$A$gd 5$A$gde;12?@Dbh45=bcdiͻxk`hR5CJ\aJh;#dhR0JRCJaJhv-CJaJh;#dhRCJaJmH sH "h;#dhv-5CJ\aJnH tH h;#dhRCJaJnH tH h;#dhRCJaJ"h;#dhR5CJ\aJnH tH "h;#dhe;5CJ\aJnH tH "h#Cthe;5CJ \aJ nH tH h+5CJ \aJ nH tH %7((($d$A$Ifgdv-kd$$Iflֈ0@ '2  ~ t0)44 laytv-(kd$$Iflֈ0@ '2  ~ t0)44 laytv-$d$A$Ifgdv-5=c$d$A$Ifgdv-cdi7((($d$A$Ifgdv-kd$$Iflֈ0@ '2  ~ t0)44 laytv-(kd$$Iflֈ0@ '2  ~ t0)44 laytv-$d$A$Ifgdv-*1RWlmqͻߝͻ껝~ͻ߻ߝpͻ߻h;#dhR6CJ]aJh;#dhR0J5CJ\aJhR5CJ\aJnH tH h;#dhRCJaJnH tH h;#dhRCJaJmH sH "h;#dhR5CJ\aJnH tH "h;#dhv-5CJ\aJnH tH h;#dhRCJaJhRCJaJh;#dhR5CJ\aJ,$d$A$Ifgdv-+7((($d$A$Ifgdv-kd$$Iflֈ0@ '2  ~ t0)44 laytv-+1SWl$d$A$Ifgdv-lmq5&&&$d$A$Ifgdv-kd$$Iflֈ0@ '2  ~ t0)44 laytv-&kd$$Ifl^ֈ0@ '2  ~ t0)44 laytv-$d$A$Ifgdv-$d$A$Ifgdv-#047((($d$A$Ifgdv-kd$$Iflֈ0@ '2  ~ t0)44 laytv-#$&04KNOWXY]^3458FѻѬܙsܬѬcѬѬܬh;#dhR0J5CJ\aJ,h;#dhR0J>*B*CJaJmH phsH h;#dhRCJaJmH sH %jh;#dhRCJUaJmH sH h;#dhRCJaJnH tH h;#dhR5CJ\aJhRCJaJh;#dhRCJaJ"h;#dhR5CJ\aJnH tH "h;#dhv-5CJ\aJnH tH &4KOXY(kd$$Iflֈ0@ '2  ~ t0)44 laytv-$d$A$Ifgdv-Y]$d$A$Ifgdv-7((($d$A$Ifgdv-kd$$Iflֈ0@ '2  ~ t0)44 laytv-45(kd| $$Iflֈ0@ '2  ~ t0)44 laytv-$d$A$Ifgdv-58GQ_tx$d$A$Ifgdv-FQ`sx67;PSd³}obh;#dhRCJ_HaJh;#dhR5CJ\aJh;#dhR0J6CJ]aJh;#dhR6CJ]aJhRCJaJnH tH h 5CJaJnH tH hR5CJ\aJnH tH "h;#dhv-5CJ\aJnH tH h;#dhRCJaJh;#dhRCJaJnH tH "h;#dhR5CJ\aJnH tH  5&&&$d$A$Ifgdv-kdn $$Ifl1ֈ0@ '2  ~ t0)44 laytv-(kdd $$Iflֈ0@ '2  ~ t0)44 laytv-$d$A$Ifgdv-$d$A$Ifgdv-7;7((($d$A$Ifgdv-kdV $$Iflֈ0@ '2  ~ t0)44 laytv-;PSef(kdH $$Iflֈ0@ '2  ~ t0)44 laytv-$d$A$Ifgdv-defj236FJ`adstuw;Ͱ͖͖͡;͖q;͖͖dq;h;#dhR0JRCJaJ"h;#dh,%5CJ\aJnH tH $h;#dhR0J>*B*CJaJphh;#dhRCJaJjh;#dhRCJUaJh;#dhR6CJ]aJh;#dhRCJaJnH tH "h;#dhR5CJ\aJnH tH "h;#dhv-5CJ\aJnH tH h;#dhRCJaJmH sH 'fj$d$A$Ifgdv-367((($d$A$Ifgdv-kd:$$Iflֈ0@ '2  ~ t0)44 laytv-6FJ`a(kd,$$Iflֈ0@ '2  ~ t0)44 laytv-$d$A$Ifgdv-adtw$d$A$Ifgdv-5&&&$d$A$Ifgdv-kd$$Iflֈ0@ '2  ~ t0)44 laytv-(kd$$Iflֈ0@ '2  ~ t0)44 laytv-$d$A$Ifgdv-23567MQbchijmnz{ <=AWX\ѳh;#dhRCJaJmH sH hRCJaJnH tH h;#dhR5CJ\aJhR5CJ\aJnH tH h;#dhRCJaJnH tH "h;#dhv-5CJ\aJnH tH h;#dhRCJaJ"h;#dhR5CJ\aJnH tH 5$d$A$Ifgdv-377((($d$A$Ifgdv-kd$$Iflֈ0@ '2  ~ t0)44 laytv-7MQij(kd$$Iflֈ0@ '2  ~ t0)44 laytv-$d$A$Ifgdv-jn{$d$A$Ifgdv-7((($d$A$Ifgdv-kd$$Iflֈ0@ '2  ~ t0)44 laytv-(kd$$Iflֈ0@ '2  ~ t0)44 laytv-$d$A$Ifgdv- =AW$d$A$Ifgdv-WX\ot7((($d$A$Ifgdv-kd$$Iflֈ0@ '2  ~ t0)44 laytv-\ot,-1JKLMNOP̽۲ۓ۽۽۠۽۲۲۠yk_Qh;#dhe;5CJ,\aJ,h+5CJ,Z\aJ,h;#dhe;5CJ\aJh;#dhe;CJaJhR5CJ\aJnH tH h;#dhR0JRCJaJ"h;#dhv-5CJ\aJnH tH h;#dhRCJaJh;#dhRCJaJnH tH h;#dhRCJaJmH sH "h;#dhR5CJ\aJnH tH $h;#dhR0J56CJ\]aJt(kd$$Iflֈ0@ '2  ~ t0)44 laytv-$d$A$Ifgdv-$d$A$Ifgdv-7((($d$A$Ifgdv-kd$$Iflֈ0@ '2  ~ t0)44 laytv--1KL(kd$$Iflֈ0@ '2  ~ t0)44 laytv-$d$A$Ifgdv-LMNOPQklm~'$ & F@hA$a$gdqO $A$a$gd;. $A$^gd> $A$^gdlM$dha$gdlM $A$^gde;$A$gde;PQSYcijklm|}~κ|nZF2$h;#dht5CJ \aJ &h#Cthd5CJ OJQJ\^JaJ &h#Cth$5CJ OJQJ\^JaJ &h#Cth),5CJ OJQJ\^JaJ h;#dh>5CJ \aJ hg75CJ \aJ h;#dh 5CJ,\aJ, h 55CJ,OJQJ\^JaJ,&h#Cthd65CJ,OJQJ\^JaJ,&h#Cth 5CJ,OJQJ\^JaJ,&h#Cthz5CJ,OJQJ\^JaJ,h;#dh 5CJ,\aJ,h;#dh-5CJ,Z\aJ, IJf *?MNO]}ֹ|ujaXh;#dhW _Hh;#dh-"_Hh;#dh)mH sH  h;#dh_"N h;#dh-" h;#dhO h;#dhkh;#dhk_Hh;#dh2g_H h 5_Hh;#dhTe_H h;#dh2g h;#dhTeh;#dho%LmH sH h;#dh2gmH sH h;#dh-"mH sH h;#dhdmH sH h;#dhI_Hh;#dhImH sH "=>  |}&01:IS_`y    0 M s t ŔӍӆ}h;#dhx_H h;#dho%L h;#dh/ h;#dh6Bh;#dhsx$_Hh;#dh_H hvn<_Hh;#dh#T_Hh;#dhO_H h;#dh#T h;#dh 1 h;#dhx h;#dh-"h;#dh)_Hjh;#dh-"U_Hh;#dh-"_H/  C3b $a$gd;.$A$^`a$gd>$A$^`a$gd;.$ & FBhA$^ha$gdqO$ & FAhA$^ha$gdqO $A$a$gd;. !!!ӽraPD8D+heThCCJ^JaJh^CJPJ^JaJheTCJPJ^JaJ heTh) CJ^JaJmH sH heTh CJ^JaJmH sH h^CJ^JaJmH sH heThgLCJ^JaJmH sH *h;#dht5CJ OJPJQJ\^JaJ *h*>ho%L5CJ OJPJQJ\^JaJ *h*>hk@5CJ OJPJQJ\^JaJ *h*>hh5CJ OJPJQJ\^JaJ h;#dh>CJ^JaJh$CJ^JaJ!!-!_!`!c!!!!!!!!!!! """""#"$"ѷĝyj^jRjCRhBh*{CJPJ^JaJhBCJPJ^JaJh^CJPJ^JaJh;#dh*{CJPJ^JaJh;#dho%LCJ^JaJh;#dhvCJ^JaJheTCJ^JaJheTh) CJ^JaJheTho%LCJ^JaJheTh*{CJ^JaJheThvCJ^JaJ heThvCJ^JaJmH sH h5yCJaJheTheTCJaJheThCCJaJ$"-"."J"L"o""""##########$$$$A$B$`$k$}$~$$ǺxqmqiqbWLWh) h3?mH sH h) hgLmH sH h;#dh h )h2o h;#dhvh;#dhO_H h5y_H hO_H hB_HhB h*{_Hh;#dh_"N_Hh5yCJ^JaJh^CJ^JaJh;#dh+\CJ^JaJhOCJ^JaJhBhOCJ^JaJhBh^CJPJ^JaJhBCJaJhBhBCJaJ ###$a$k$$$0%:%;%xxxoo $A$a$gd{a $ & Fhdd-DA$M [$\$a$gdqO$dd-DA$M [$\$a$gd{a $ & Fhdd-DA$M [$\$a$gdqO$dd-DA$M [$\$a$gd-$ A$^`a$gd5y $$$$$%(%.%/%0%;%%%%%%%%%%%9&:&<&S&T&a&k&&&&&&&'''*'+','9'W'X'Y''ϽƫϢϙχρ{rrrrh;#dh_H h2o_H hC_Hh;#dh 1_Hh;#dhsx$_Hh;#dh/_Hh;#dhkZ8_Hh;#dh=/_Hh;#dh~_Hh;#dhg_Hh;#dh;18_Hh;#dhk@_H h;#dhk@ h;#dh h%/h91 h;#dhgLh) h) h) ,;%%9&&''''''](^(h(i(($a$gd$a$gd{a$A$^`a$gd>$A$^`a$gd{a$ & FhA$a$gd2o$ & FhA$a$gd>3K$ & FhA$a$gd{a'''''''''''((((E(M(\(^(g(i(l(s(t(Ͼzl^M< h;#dho%LCJOJQJ^JaJ h;#dh_"NCJOJQJ^JaJhCJOJQJ^JaJh,%CJOJQJ^JaJ h;#dh CJOJQJ^JaJ h;#dhk@CJOJQJ^JaJ h;#dhV|CJOJQJ^JaJ h;#dhtCJ OJQJ^JaJ h*>hk@CJ OJQJ^JaJ &h*>hk@5CJ OJQJ\^JaJ h;#dh>5CJ\^JaJhk@5CJ\^JaJt(((((((()^)_)))**w*x************+ĽĴocZQZJ h;#dh3?h;#dhEL2_Hh;#dh3?_Hh;#dht5\^Jh*>hk[O5OJQJ\^Jh*>h),5OJQJ\^Jh*>h$5OJQJ\^Jh;#dh{a5\^Jh;#dhWk%_Hh;#dhk@_H h;#dho%Lh;#dho%L_H h;#dho%LCJOJQJ^JaJ h;#dh CJOJQJ^JaJ h;#dhk@CJOJQJ^JaJ()_)i))x******++++ $A$a$gd $A$a$gd;.$ A$^`a$gd;.$ A$^`a$gd{a $hA$^ha$gd{a$ & FhA$a$gdqO$dd-DA$M [$\$a$gd{a++m+++++++++++++++++w,,,,#-$-_-j-k----------.෮wkd h;#dh|mh;#dht5\^Jh*>h;5OJQJ\^Jh*>hg<5OJQJ\^Jh;#dh>CJ^JaJhOCJ^JaJh;#dho%L_Hh;#dhO_H h;#dh h;#dh_"Nh h;#dh0 h;#dh h;#dhJ& h;#dhph;#dhEL2_Hh;#dh3?_H%+/,v,w,,,_-`-j-k------1111 $A$a$gd;.$ A$^`a$gd>$ A$^`a$gd;. $A$a$gd;.$ & FDhA$a$gdqO..(.).*.\.{...../ /B///+0,0<0=0000000000011 111111b1z111111ȺȳȦjh;#dhsMU h;#dho%L h;#dh  h;#dhsM h;#dh_"Nh;#dhgSCJ^JaJ h;#dhgS h;#dhWP h;#dh>^ h;#dhp[ h;#dh L h;#dhVT h;#dhNT h;#dh=S h;#dhn3' h;#dh|m h;#dhR,1A1b11111112)3*34353]333$4$ & FG hA$^ha$gdqO$ A$^`a$gd{a$ & FF hA$a$gdqO$ A$^`a$gd;.$ & FEhA$a$gdqO111111124292I2P222222222233$3%3*343ҸsfYfLh;#dhVTCJ^JaJh;#dhRCJ^JaJh;#dh@uCJ^JaJh;#dhCJ^JaJ h;#dhgSCJ^JaJmH sH h;#dh;CJ^JaJh;#dhRL_CJ^JaJh;#dho%LCJ^JaJh;#dhgSCJ^JaJh;#dh|mCJ^JaJh;#dhsMCJ^JaJ h;#dhsMjh;#dhsMUh;#dhsM0J>*B*ph435363?3\3^3m333333333333333333$4̿ٲzg\OBh;#dhp[CJ^JaJh;#dh wCJ^JaJh;#dhv.CJaJ$h;#dh w0J>*B*CJaJph$h;#dh10J>*B*CJaJphh;#dh wCJaJjh;#dh wCJUaJh;#dh1CJaJh;#dhWCJ^JaJh;#dhzyqCJ^JaJh;#dh=SCJ^JaJh;#dh0CJ^JaJh;#dhCJ^JaJh;#dh!CJ^JaJ$4%4&4>4@4a8b8l8m88L9M9W9X9:;;<<@<;=$ & FhA$a$gdqO$ & FhA$a$gdqO$ & FHhA$a$gdqO $A$a$gd{a $A$a$gd> $A$a$gd;.$4%4&4=4>4?4@4]4^4_4d4444444ǯug\Q\F7F7jh;#dh)UmH sH h;#dh)mH sH h;#dhmRmH sH h;#dhmH sH h;#dhZx5\mH sH h;#dhZxmH sH h;#dhWCmH sH "h;#dhZx5CJ \aJ mH sH "h;#dh95CJ \aJ mH sH .h*>ht5CJ OJQJ\^JaJ mH sH .h*>h95CJ OJQJ\^JaJ mH sH "h;#dh>5CJ \aJ mH sH h{a5CJ \aJ mH sH 45 555b5c5r5s5v5w5555555)6*6:6A6B6D6\66666R7S7777777777G8H8ӵӪӔrgh;#dhmH sH $h;#dh0J>*B*mH phsH jh;#dhUmH sH h;#dhmH sH h;#dhmH sH h;#dhT>mH sH h;#dh=mH sH $h;#dh;0J>*B*mH phsH h;#dh)mH sH jh;#dh)UmH sH $h;#dh)0J>*B*mH phsH (H8T8U8V8_8a8b8k8w8888888888 9!999:9M9W9X9{9|999ӽzgg\\M\Mjh;#dhmRUmH sH h;#dhmRmH sH $h;#dh0:0J>*B*mH phsH $h;#dh( U0J>*B*mH phsH jh;#dh0:UmH sH h;#dh( UmH sH h;#dh0:mH sH h;#dh_"NmH sH h;#dhmH sH h;#dhT>mH sH h;#dhmH sH jh;#dhUmH sH $h;#dh0J>*B*mH phsH 99999/:0:9:::`:g::::::::::::;;<;G;H;\;];;;;;;;;;;;;ȲȲȔynch;#dhA<mH sH h;#dh;mH sH hmH sH $h;#dh;0J>*B*mH phsH h;#dhnmH sH $h;#dhFd0J>*B*mH phsH jh;#dhFdUmH sH h;#dhnh;#dhFdmH sH h;#dhmRmH sH jh;#dhmRUmH sH $h;#dhmR0J>*B*mH phsH &;<<<<*<+<6<=<?<@<a<b<<<<<<< ======;=S=q=r===s^s^)jh;#dhCJU^JaJmH sH h;#dhCJ^JaJmH sH h;#dhCJ^JaJh;#dhSmH sH $h;#dh)0J>*B*mH phsH jh;#dh)UmH sH h;#dh;mH sH h;#dhT>mH sH h;#dhmH sH h;#dh( UmH sH h;#dh9mH sH h;#dh)mH sH ===>>>>> >>> >F>I>^>e>f>k>l>zjZSLEL>EL7 h;#dhWP h;#dh; h;#dhS h;#dh=S h;#dhvEh*>hg<5OJQJ\^Jh*>h'>5OJQJ\^Jh*>h-R5OJQJ\^Jh;5OJQJ\^Jh;#dh>5CJ\^JaJh5CJ\^JaJh;#dh)CJ^JaJ h;#dhCJ^JaJmH sH )jh;#dhCJU^JaJmH sH 0h;#dh0J>*B*CJ^JaJmH phsH ;=>>>>> >@@@@A AAAA$ & F hA$a$gdqO $A$a$gd;.$ A$^`a$gd;$ A$^`a$gd>$ A$^`a$gd;.$ & F hA$a$gdqOl>>>????@@@@@@@@ AAAAA0A5ALAMARApAtAuAvAAAAAABȺֳrereXh;#dh;CJ^JaJh;#dhvCJ^JaJh;#dh[CJ^JaJh;#dh<CJ^JaJh;#dhRCJ^JaJh;#dh)CJ^JaJh;#dhZL^CJ^JaJ h;#dh h;#dhZL^ h;#dhc h;#dh< h;#dh_"N h;#dh>^ h;#dhZ h;#dhR h;#dhT9a h;#dhS h;#dh)"BBBNBUBdBeBtBuBvBBBBBBBBBBBʽp[pF(h;#dhQ*56CJOJQJ\]aJ(h;#dh/x56CJOJQJ\]aJ(h;#dhc56CJOJQJ\]aJ(h;#dh<56CJOJQJ\]aJ(h;#dh!56CJOJQJ\]aJ h;#dh< h;#dh!h;#dh<CJ^JaJh;#dhWPCJ^JaJh;#dh!CJ^JaJ h;#dhZL^ h;#dh) h;#dhc h;#dh;ABeBfBuBvBBBCPCCCC(D)D4D5D $hA$^ha$gd;.$ & FhA$a$gd;.$ & FhA$]ha$gd;.$ & FhA$]ha$gd;.$ A$^`a$gd;.$ & FhA$a$gdqOBBBBCCNCOCCCCCCCCC&D'D)D3D4D5D>D@DQD_DmDrD~sgs\sQh;#dhbmH sH h;#dhQ*mH sH h;#dhZH*mH sH h;#dhZmH sH h;#dhCJ^JaJh;#dhZL^CJ^JaJh;#dh'>CJ^JaJ h;#dh; h;#dh! h;#dh< h;#dh^w(h;#dh!56CJOJQJ\]aJ(h;#dh<56CJOJQJ\]aJ(h;#dhS56CJOJQJ\]aJrD|D}DDDDDDD)E+ESEXEYEbEEEEEEEE.F/F0FkFlFmFpFFFʾʳʨʖ}p`Th;#dht5\^Jh*>hg<5OJQJ\^Jh;5OJQJ\^J h;#dh>h=D h;#dhv h;#dh=D h;#dh)h;#dhsmH sH h;#dh=mH sH h;#dh\mH sH h;#dh)H*mH sH h;#dh)mH sH h;#dh_"N h;#dhZ h;#dh'>h;#dhZmH sH h;#dhSmH sH 5DD0FkFlFmFnFoFpFFFhHiHsHr$ A$^`a$gd;.$ Zda$gd;.$ ZA$^a$gd;.$ A$a$gd;$ A$a$gd;. $A$a$gd> $A$a$gd;.$ & FhA$a$gdqO$ & FhA$^ha$gdqO FFFFFFFFFF/GEGFGGGGGGGHHbHeHhHiHrHtHķĪ|q|fXKh;#dh_"NCJ^JaJh;#dh)5\^JaJh;#dht9CJaJh;#dhVCJaJh;#dh;CJaJh;#dh.kDCJaJh;#dh)CJaJh;#dhjuCJ^JaJh;#dh*CJ^JaJh;#dh6CJ^JaJh;#dhB CJ^JaJh;#dh.kDCJ^JaJ h;#dh.kDCJ^JaJmH sH h;#dhB CJ^JaJmH sH sHtHIIIIII&JpJqJ{J|JKKK*K+KcMdMnM $A$a$gd> $A$a$gd;.$ & F hA$a$gdqO$ & FI hA$a$gdqO$ A$^`a$gd;.tHuHHH I IbIcIyIIIIIIIIIIII J J$J%J&J@JgJ沥~q~~fUJh;#dh5 CJaJ h;#dh5 CJ^JaJmH sH h;#dh.kDCJaJh;#dhp:hCJ^JaJh;#dh.kDCJ^JaJh;#dh/VaCJ^JaJh;#dhCJ^JaJh;#dh^CJ^JaJh;#dh=SCJ^JaJh;#dh,o5CJ^JaJh;#dhv.CJ^JaJh;#dh(QCJ^JaJh;#dh*CJ^JaJh;#dhRCJ^JaJgJnJpJqJzJ{J|J}JJJJJJJKKKK'K*K+K2Kö{k[OBh;#dhHCJ^JaJh;#dht5\^Jh*>h!A5OJQJ\^Jh*>hg<5OJQJ\^Jh;#dh>5\ hv5\ h;#dh)L h;#dh.# h;#dh' h;#dh7 h;#dh/Va h;#dhWVh;#dhCJ^JaJh;#dh0<CJ^JaJh;#dh=SCJ^JaJh;#dh^CJ^JaJh;#dh5 CJaJh;#dh;CJaJ2KQKRKKKKKL;L$ & F hA$a$gdqO$ & F hA$a$gdqO$ A$^`a$gd;.MMMMNNNN N!N"N#N-N.N6N9N:N>Nͼͣ⒄wj]jPC6h;#dhh)CJ^JaJh;#dhWCJ^JaJh;#dh0CJ^JaJh;#dhCJ^JaJh;#dh=voCJ^JaJh;#dhHCJ^JaJh;#dhW<CJ^JaJ h;#dhWCJ^JaJmH sH 0h;#dhH0J>*B*CJ^JaJmH phsH h;#dhHCJ^JaJmH sH )jh;#dhHCJU^JaJmH sH h;#dhcCJ^JaJmH sH h;#dhcCJ^JaJ>N?NBNNNNNNNNNNO OOOOO-O6OYO\O`OaOnOyO}OOOOٿٲreXKh;#dhVtmCJ^JaJh;#dh~CJ^JaJh;#dhCJ^JaJh;#dh=CJ^JaJ h;#dhVtmCJ^JaJmH sH h;#dhP"*CJ^JaJmH sH h;#dh0CJ^JaJmH sH h;#dhCJ^JaJh;#dh# GCJ^JaJh;#dhd9CJ^JaJh;#dh=voCJ^JaJh;#dhh)CJ^JaJh;#dhNRCJ^JaJOOOOOOOOOOOOOO2P=PLPMP_PbPPPPPPBQRQSQ\Qνqjc\c\c\c\cU\N\ h;#dhx h;#dhKC h;#dh/H h;#dh=' h;#dh0h;#dht5\^JmH sH &h*>hh)5OJQJ\^JmH sH &h*>hO5OJQJ\^JmH sH &h*>hUm5OJQJ\^JmH sH  hg15OJQJ\^JmH sH  h;#dhh)h*>h;#dh0CJ^JaJh;#dhLeCJ^JaJh;#dhh)CJ^JaJ\QQQQQQRR%RDRQR^RoRxRyRzR{RRRRRRRRRRRRRRRۼtgtZtMgh;#dhuCJ^JaJh;#dhHCJ^JaJh;#dhCJ^JaJh;#dhh)CJ^JaJh;#dh-_Hh;#dhO_H h;#dh- h;#dhO h;#dh(U h;#dhh;#dhOCJ^JaJh;#dh_"NCJ^JaJh;#dh0_Hh;#dh/H_Hh;#dhl+g_H h;#dh0 h;#dh/H h;#dh\| h;#dh+OnRoRyRzRRRRRRRRRRR>S$ & F hA$a$gdqO$ & FJh7$8$A$H$^ha$gdqO$ & FJhA$^ha$gdqO$ A$^`a$gd;. $7$8$A$H$a$gd;. $A$a$gd;.RRRRRRRS=S>S?SdSfSjSSSSSSSSSSTTiTnT|T}TT¹ymf]T]h;#dh>:3_Hh;#dh9M_H h;#dhmh;#dh55\_Hh;#dh{_Hh;#dh5_H h;#dh; h;#dh{ h;#dh) P h;#dhkYh;#dh;_Hh;#dhT__Hh;#dh._Hh;#dhkY_H h;#dh'w h;#dh+h;#dhCJ^JaJh;#dhHCJ^JaJh;#dhh)CJ^JaJ>STiTUVZWX?XoXXXXXr $7$8$A$H$a$gd> $7$8$A$H$a$gd;.$ & F:h7$8$A$H$a$gdqO$ & F hA$a$gd;$ & F h7$8$A$H$a$gdqO$ & F hA$a$gdqO$$ & F hdd-D7$8$A$H$M [$\$a$gdqO TTTT UU+U5UAUCUXUvUwUxUUUUUUUUUU VVVV'V(VFVZV[V\VbVdVhVsV|V|sjsas|sh;#dhwmA_Hh;#dh_Hh;#dh+_Hh;#dho0O_H h>3K_Hh;#dh>3K_Hh;#dhw_Hh;#dhH6d_Hh;#dh6U_Hh;#dhW_Hh;#dh _Hh;#dh_Hh;#dh)_Hh;#dh_Hh;#dh._Hh;#dht@_Hh;#dh9M_Hh;#dhju_H%|VVVVVVVVVVVVWW+W7Whh 5OJQJ\^Jh*>hUm5OJQJ\^Jh*>hG45OJQJ\^Jh*>hb#05OJQJ\^J h>_H h__Hh;#dht@_Hh;#dh;_Hh;#dh__H"XYY\\^ ^^^}__````` $hA$^ha$gd> $hA$^ha$gd;.$ & F hA$a$gdqO$dK-DA$M a$gd;.$ A$^`a$gd;.$ A$^`a$gd:+\\\\h\\\\^]_]n]o]q]r]]]]]]]^^^^$^4^5^]^_^k^^^^|_}_2`3````````򸱸򪡘~~~x hd_Hjh;#dhdUmH sH h;#dhdmH sH h;#dhd_Hh;#dh^_H h;#dh^ h;#dh+( h;#dh2E h;#dh]h;#dhwmH sH jh;#dh;wUmH sH h;#dh;wmH sH h;#dhw h;#dh;w h;#dh_"N+``````&a?a@aaabLbMbbbbbbb c ccϻ|mbVbKbVK@bVbh;#dh~(CJaJh;#dh6gCJaJh;#dh&CJH*aJh;#dh&CJaJh;#dhgCJaJmH sH h;#dhdCJaJmH sH h;#dhX CJaJmH sH h;#dh]CJ^JaJnH tH h;#dht5\^JnH tH &h*>ht5OJQJ\^JnH tH &h*>h&5OJQJ\^JnH tH &h*>h_5OJQJ\^JnH tH h;#dh>_Hc:c;c>cGcHcZc\cccccccccccccdd%d&dddedrdsdddddddd e e e}}rgh;#dh=CJaJh;#dh^/CJaJh;#dh&{CJaJh;#dh&CJaJh;#dh~(CJaJh;#dh3CJH*aJh;#dhiCJaJh;#dhdCJaJh;#dh3CJaJhFCJaJh;#dh~uCJH*aJh;#dh~uCJaJh;#dh,CJaJh;#dh?-CJaJ% eee@eAePeRe`eaeceeeteueze}eeeeeeeeeff&f-f?f@fCfFfVfWf`faf{ffվճըվ՝վՕɾti^h;#dh`YiCJaJh;#dhiCJaJh;#dhdCJaJh;#dhDCJaJh;#dh,CJaJhGPCJaJh;#dhK[CCJaJh;#dhCJaJh;#dh_9CJaJh;#dh&CJaJh;#dh3CJH*aJh;#dh3CJaJh;#dh&0J/6CJ]aJh;#dh30J/6CJ]aJ$ffffffffff#g$g&g'gFgIgYgZgggiggggghhMhNhOhhhhhhhh7i8iYiaibiiijilini꜌vȁh;#dh^/CJaJh;#dhQCJaJh;#dhQ0J/6CJ]aJh;#dh=CJaJh;#dhqCJaJh;#dh5CJaJh;#dhCJaJh;#dh_9CJaJh;#dh`YiCJH*aJh;#dh&CJaJh;#dh`YiCJaJh;#dh>:3CJaJ,niiiiiiiiiij%j&jCjDjKjLjQjVj~jjjjjjjjjkkkk k-k1k߽߲߽ߧ߽߽ߜzodYh;#dhl#CJaJh;#dhqCJaJh;#dhA,CJaJh;#dh0pCJH*aJh;#dh>:3CJaJh;#dh0pCJaJh;#dh=CJaJh;#dhiCJaJh;#dhCJaJh;#dhQCJH*aJh;#dhDCJaJh;#dh-CJaJh;#dhQCJaJh;#dhdCJaJh;#dh,CJaJ"1k2knkokkkkkkkkkkclrllllllll$m`mnҼұҢҊyh]R]G>h;#dh$_Hh;#dhmH sH h;#dh:CJaJh;#dh(CJaJ h;#dh:qCJ^JaJmH sH  h;#dh_"NCJ^JaJmH sH h;#dhq;_Hh;#dh-CJaJmH sH h;#dhZCJaJmH sH h;#dhHRCJaJh;#dhWCJaJh;#dhP"*CJaJh;#dhq;CJaJh;#dhl#CJaJh;#dh0pCJaJh;#dh0pCJH*aJ`llll$m`mnnnnnnjo.p$ & F hA$a$gdqO$ & FhA$a$gdqO$ & FKh7$8$A$H$a$gdqO$ & FK hA$a$gdqO$ A$^`a$gd;. $A$a$gd;.$ A$^`a$gdFnInJnSnZn\nnnnnnnnnnnn'o(oAohoiojoooooooȽyrkcrkc[TkckMk h;#dh@u h;#dhh;#dhH*h;#dh%H* h;#dh% h;#dh h;#dh)CJ^JaJmH sH  h;#dh%CJ^JaJmH sH  h;#dhiCJ^JaJmH sH  h;#dh:qCJ^JaJmH sH h;#dhmH sH h;#dh_Hh;#dhmH sH h;#dh_Hh;#dh;_Hh;#dhIW_Hh;#dh:q_Hop ppp%p,p.p9pIpTpZp\pbpwpxppppppppppppq=q>q?qLqMqOqPqZq[qeqnqqҽ䑆{tmt h;#dh_"N h;#dh\ch;#dhimH sH h;#dhmH sH  h;#dh/i=h;#dh)mH sH h~MmH sH h;#dhE1mH sH h;#dhE1 h;#dhm_> h;#dh h;#dh h;#dh h;#dhl#hF h;#dh h;#dh% h;#dh h;#dh)'.ppOqPqZq[qqr)suvvx yyJzz{||$ & FhA$a$gdqO$ & F?h7$8$A$H$a$gdqO$ & FhA$^ha$gdqO $A$a$gd;.$ & F hA$a$gdqOqqqqqq'rFrnrorrrrrr)sCsDs}s~ssssssssttt t-t/t~mH sH h;#dh h;#dh0J>*B*phjh;#dhU h;#dh2  h;#dh h;#dhW h;#dhih;#dhZmH sH h;#dhZ h;#dh\ch;#dh\cH*%ttttttttttu)uBuCuDuLucuiujuuuuuuuuv(vRvTvcvvvvvOwPwwxx x1xNxǾзЯЯзШСзНС~u~h;#dhJ_Hh;#dh_H hQo_Hh;#dh}_H h;#dhnhQo h;#dhV~I h;#dh h;#dhH* h;#dhWh;#dh_Hh;#dhT?_H h;#dhjh;#dhUh;#dh0J>*B*phh;#dh-o0J>*B*ph*NxPxxxxxxxx y yAyJyRyTyiyjykyyyyyyyyyyyDzHzIzJzfzgzzzzzü㠕wwpiiib h;#dhrY h;#dhW2 h;#dh%hFmH sH h;#dh mH sH h;#dh)~JmH sH h;#dh%mH sH h;#dh h;#dh)~J h;#dh h;#dhJ[ h;#dhb h;#dh] h;#dhh;#dhCJaJ h;#dhJ h;#dhihlh;#dh_Hh;#dhW_H%zzzzz{{#{${%{+{{{{{{||'|(|J|M|N|S|X|k|l|||||||||||뵮ٮٮ٪{meZh;#dhmH sH hJmH sH h;#dht5CJ \aJ &h*>h5CJ OJQJ\^JaJ &h*>hm5CJ OJQJ\^JaJ h;#dh>hi h;#dh h;#dh h;#dh?S h;#dhvh;#dhi0J>*B*ph h;#dhijh;#dhiU h;#dhW2 h;#dhrY h;#dhiy]#||||/0:;ՀրsZ $hA$^ha$gdO $hA$^ha$gd;.$ & FhA$a$gdJ$ & FhA$a$gd"B $A$a$gd;. $A$a$gd>||||;}<}F}G}w}z}}}}}}}}}}A~B~O~P~~~~~~~~~67CD/09;UԀր꽶Ꙏx h;#dh7hJh;#dh7mH sH h;#dh_"NmH sH h;#dhmH sH  h;#dh"=h;#dhA,mH sH  h;#dh~>h;#dh~>mH sH $h;#dh0J>*B*mH phsH jh;#dhUmH sH h;#dhmH sH h;#dhV4GmH sH /րǁ @LMbfg ^_ghȽ׽odoh;#dh mH sH $h;#dhx0J>*B*mH phsH jh;#dhxUmH sH h;#dh"=mH sH h;#dh1emH sH h;#dhC3rmH sH h;#dh mH sH h;#dhxmH sH h;#dh%h"BmH sH hJmH sH h;#dh mH sH h;#dhpmH sH h;#dhw mH sH 'hrstȃɃ̓΃ڃEFOPQVYZ;<CDWXQRVW`oŲԧŲŲŗŲŲŲŲŲhJmH sH hmH sH h;#dh mH sH $h;#dhx0J>*B*mH phsH jh;#dhxUmH sH h;#dhxmH sH h;#dh1emH sH h;#dhC3rmH sH h;#dhpmH sH ;oՆֆ܆݆߆ '(>BXZ[\‡ˇՇڇ݇ (^픉~ulh;#dhR_Hh;#dh92_Hh;#dh92mH sH h;#dhx mH sH h;#dhpmH sH h;#dhOmH sH h;#dh"=mH sH h;#dhC3rmH sH $h;#dhx0J>*B*mH phsH jh;#dhxUmH sH h;#dh1emH sH h;#dhxmH sH hJmH sH *(!z ֋5s*yy $A$a$gd;. $A$a$gd>*$ & F hhddd-DA$M [$\$^ha$gdqO*$ & F hhddd-DA$M [$\$^ha$gdqO$hddd-DA$M [$\$^ha$gd;. ^m!">CKLRSmȉ҉b EKRĻ|of]TfTh;#dhq_Hh;#dh}_Hh;#dh5o_Hh;#dhv_HmH sH h;#dhQ_Hh;#dha_Hh;#dhv_Hh;#dh _Hh;#dh`_Hh;#dhuC_Hh;#dh^_Hh;#dh}H_Hh;#dhjT4_Hh;#dh=_Hh;#dhV_Hh;#dh"=_Hh;#dhpc_H hJ_Hh;#dh92_HR[Ջ֋ *+,]25OPsۍ܍Ddfhqrsܽ~uukh;#dh`H*_Hh;#dh"h^_Hh;#dh @_H hJ_H h;#dh=h;#dh=_HhJ h;#dhvh;#dhv_H h"B_H hLd_Hh;#dhm_Hh;#dhi,_Hh;#dh`_HmH sH h;#dhfj_Hh;#dh}_Hh;#dh`_Hh;#dhT_H)s stďŏ EFLMOPː̐ѐҐԐՐ,-/0klqrtu‘ ̟̽̽̽̽̽̽̽̽̽̽̽̽̽̽̽̽̽̽̽h;#dhpmH sH $h;#dh-0J>*B*mH phsH jh;#dh-UmH sH h;#dh-mH sH h;#dh]h;#dht5CJ \aJ &h*>h-5CJ OJQJ\^JaJ > !/0VWNORS`a+45_`ޘߘ89EFrrҼҵ҉~҉ҵh;#dhR/mH sH h;#dh~?mH sH h;#dh_"Nh;#dh-0J>*B*phjh;#dh-U h;#dh-h;#dh]mH sH h;#dh:YmH sH h;#dh-mH sH $h;#dh-0J>*B*mH phsH jh;#dh-UmH sH 1*+56[rϛ&'#Qa$ & F?hA$a$gdqO $hA$^ha$gd;.$ & F>hA$^ha$gdqO$ & FbhA$a$gdqO $A$a$gd;.r)*}~'DH#<=z{ȝɝӝԝڝ۝./67OQGHWXY]^ğşƟǟȟ#hlm̽h;#dhqmH sH hhh;#dh~?mH sH h;#dh-$h;#dh-0J>*B*mH phsH jh;#dh-UmH sH h;#dh-mH sH FmѠޠ23Wfڡۡẉͣ(3489@m,ԥİ̥̞̥̆{ttmf[h;#dh8zmH sH h;#dh8z h;#dhF h;#dhb(h;#dh^v!mH sH h;#dh~? h;#dh0CJOJQJ^JaJ h;#dhN9 h;#dh0h&h*>h-5CJ OJQJ\^JaJ h-mH sH h;#dh-$h;#dh-0J>*B*mH phsH jh;#dh-UmH sH h;#dh-mH sH #aޠ23ר&^˪ժ֪ $A$a$gd;. $ & F1a$gdqO$ & F\hA$a$gdqO$a$gd;. $A$a$gd $A$a$gd;. $A$a$gd:+$ & F?hA$a$gdqOHIabhmn̦ͦ%'Įըר$%&4@\]é˪ r幰||uunu| h;#dh$ h;#dhF h;#dh-_HmH sH h;#dh_"Nh;#dh-mH sH h;#dh_"NmH sH h;#dh-H*_Hh;#dh-_H h;#dh-jh;#dh8zU h;#dh8z$h;#dh8z0J>*B*mH phsH h;#dh8zmH sH jh;#dh8zUmH sH + r«IJKLXYtϬi $A$a$gd> $A$a$gd;.$ & F3hA$a$gdqO $A$a$gd $A$a$gd> $A$a$gd;.$ & F2hA$^ha$gdqOr«!IJLXYsάitîĮȮɮȻȮȣug`V`V`h;#dh /5\ h;#dh /h;#dht5CJ \aJ &h*>h /5CJ OJQJ\^JaJ h;#dh>h /h;#dh-0J>*B*phjh;#dh-Uh;#dhq_HmH sH h;#dht_HmH sH h;#dh-_HmH sH hmH sH h>mH sH h;#dh-0J6 h;#dh-h;#dh-mH sH 0øN) $ & F:h7$8$H$^ha$gdqO $ & F9a$gdqO $7$8$A$H$a$gd;.$h7$8$A$H$^ha$gd;.$ & F_h7$8$A$H$a$gdqO$a$gd;. $A$a$gd;. $A$a$gd;. QR]^įůЯѯ/0:k|56&1nqo|̴ ijSƻ h;#dhB h;#dh<h;#dh /H*h;#dh /mH sH  h;#dh h;#dhd hHh;#dh /0J>*B*phjh;#dh /U h;#dh / h;#dhp>SԶն#$DE %&/_`MN)AB Yqľĵ穥眩眘穆 h;#dhYHR h;#dhd h;#dh /mH sH h:+h;#dh /_H,hh,h;#dh /H*h;#dh^v!_H h_Hh;#dh /_Hh;#dh /0J>*B*phjh;#dh /U h;#dh / h;#dh_"Nh;#dh /mH sH 2 DLϼм(bm||t$a$gd;.$ & FZhA$a$gdqO$ & FZh7$8$A$H$a$gdqO$-DM a$gd7r $A$a$gd;. $A$a$gd> $A$a$gd;.$ & F:h^ha$gd$ & F:h^ha$gdqO$ & F:h7$8$H$^ha$gdqO IJKLz}ϼмԿտ߿[c򷣕||m|f____ h;#dh< h;#dhjuh;#dht0J>*B*phjh;#dhtU h;#dh`B h;#dhth;#dht5CJ \aJ &h*>ht5CJ OJQJ\^JaJ h>5CJ OJQJ\^JaJ h;#dh%]hh;#dh /mH sH h;#dh /H*mH sH h;#dh /H* h;#dh / h;#dhYHR",-@AAF'(\_l1>m"#&򽷰򛐁n$h;#dh@0J>*B*mH phsH jh;#dh@UmH sH h;#dh@mH sH h;#dh@ h;#dhF, h;#dho h;#dh_ h__Hh;#dht_H h;#dh_"N h;#dhK[Ch;#dht0J>*B*phjh;#dhtUh_ h;#dht h;#dh5|+m1;E34PQH $7$8$A$H$a$gd;. $A$a$gd 7 $A$a$gd> $A$a$gd;. $ & F.a$gd,My $ & F.a$gdqO$a$gd;. $ & F-a$gd $ & F-a$gdqOhipq|}:;TU)*Em#$1(DEMOPʹʹʹʹʳjh(h(U h(h(h( ht_H,h;#dhK[C_H,h7DnhSh;#dht_H, h;#dhK[Chh;#dht0J>*B*ph h;#dhtjh;#dhtU>P/0134PQ56wx|} Uνss`sUQh 7h;#dhtUmH sH $h;#dh H0J>*B*mH phsH jh;#dh HUmH sH h;#dh HmH sH h;#dh[ h;#dh Hh;#dht5CJ \aJ &h*>h H5CJ OJQJ\^JaJ h>5CJ OJQJ\^JaJ h;#dh(_H,h,Myh(h(h(0J>*B*phjh(h(U h(h(UG^nr!"efpqXYcdZ#$GH;; h;#dhV9:h;#dhV9:_Hh;#dh H_Hh;#dh_"NPJh;#dh HPJ h;#dhtUh;#dh H0J>*B*phjh;#dh HU h;#dh}lh 7mH sH h;#dh[ h;#dh Hh;#dh HmH sH 5HITUGepq$ & F5hA$^ha$gdqO $A$a$gd;.$ & F4hddA$[$\$^ha$gdqO$ & F4hdd7$8$A$H$[$\$^ha$gdqO$ & F4h7$8$A$H$^ha$gdqO $7$8$A$H$a$gd;.+F-5K ͺܯܯܨܖ|undh;#dh H5\ h;#dhi_ h;#dh%;h;#dh H0J>*B*phjh;#dh HUh;#dh^mH sH h;#dh] h;#dhV9:h;#dhV9:mH sH $h;#dh H0J>*B*mH phsH jh;#dh HUmH sH h;#dh HmH sH h;#dh Hh;#dh HPJh;#dhi_PJ">z{:DEg-$ & F6hA$a$gdqO$dd7$8$A$H$[$\$a$gdT4$ & F]hA$^ha$gdqO $A$a$gdUI $A$a$gd> $A$a$gd;. $A$a$gd;.$Ayz%&hi{|8KZ[=> -./CƿƸƴƴƴƥƥƥƞƚƞƞƓƊƃ|h&h*>ht 5CJ OJQJ\^JaJ h;#dht h;#dhth;#dh|N PJ h;#dh_"NhT4 h;#dhi_jh;#dh|N UhUIh,]V h;#dh h;#dhB h;#dh|N h;#dht5CJ \aJ &h*>h|N 5CJ OJQJ\^JaJ h>5CJ OJQJ\^JaJ &-./CDGHRS $ & F7hA$^ha$gdqO$ & FhA$a$gdqO $7$8$A$H$a$gds $7$8$A$H$a$gd;. $A$a$gd> $A$a$gd{a $A$a$gd;.CD ()34;< GHQRSY6>A !-.㝔㉐ゐ h;#dh^ h;#dhshsh;#dh]_Hh;#dht _H h;#dh_"N h;#dh, h;#dh? h;#dhi_h;#dht 0J>*B*phjh;#dht U h;#dhc. h;#dht h;#dht mH sH h;#dhvEmH sH 3.046OP"#jkwx OPTUW·¤··¤·򠙅wnh;#dh=^PJh;#dht5CJ \aJ &h*>h=^5CJ OJQJ\^JaJ h;#dhscph=^$h;#dht 0J>*B*mH phsH h;#dht mH sH jh;#dht UmH sH h;#dht 0J>*B*phjh;#dht U h;#dh0 h;#dht h;#dh^)V $7$8$A$H$a$gd-T$ & F[h7$8$A$H$^ha$gd $ & F[h7$8$A$H$^ha$gdqO $7$8$A$H$a$gd;. $A$a$gdUI $A$a$gdscp $A$a$gd;.$ & F7hA$^ha$gdqOT"A!MN (1 [f 4EHS,f h;#dh^h;#dh=^_Hh;#dhI&PJh;#dh~\PJ h PJh;#dhqPJh;#dh_"NPJh;#dh=^CJOJQJaJ h}PJ h],PJh;#dh=^PJhUI h;#dh=^4y $A$a$gdscp $A$a$gd;. $A$a$gd;.$ & F0hA$a$gdqO$ & F0h7$8$A$H$a$gdqO $7$8$A$H$a$gd;.$h7$8$A$H$^ha$gd;.$ & F/h7$8$A$H$^ha$gdqO78  \]lmNODEMN()deklƼƵƪƪƪƪƔƪƪƪƪƪƪƪƪƪƪƪƪ h;#dhDh;#dh^0J>*B*phjh;#dh^U h;#dh~\h;#dh^5\ h;#dh^h;#dht5CJ \aJ &h*9h^5CJ OJQJ\^JaJ hscp5CJ OJQJ\^JaJ :& j 3    ep   $% $A$a$gd $A$a$gdscp $A$a$gd{a $A$a$gd;.$ & F^hA$a$gdqO $ & F8a$gdqO$a$gd;. $A$a$gd;.HIXY1C'(./LmnJ K Q R     7 8 A B K j       * +     / 0 3      ʿh;#dh^mH sH h;#dh~\mH sH h;#dh^mH sH h;#dh~\ h;#dhnh;#dhnmH sH h;#dh^_H, h;#dh_"NhJgh;#dh^0J>*B*ph h;#dh^jh;#dh^U8   1 2 < = M N           UVcdegclm   ̯̯̙̒ hscp5CJ OJQJ\^JaJ h;#dhw h;#dh^h;#dh^0J>*B*phjh;#dh^Uh;#dh~\mH sH h;#dh~\ h;#dh^$h;#dh^0J>*B*mH phsH jh;#dh^UmH sH h;#dh^mH sH * $%#$+,WB~,-{|>̽̽׶ׯׯפם׫םםיx h;#dh_"Nh;#dh?C0J>*B*phjh;#dh?CUh h;#dhu h;#dh~\h h;#dh?C h;#dhh;#dhw0J>*B*phjh;#dhwU h;#dhwh;#dht5CJ \aJ &h*9hw5CJ OJQJ\^JaJ .23=>|W X b c  !g!!;"##$$$ & F;hA$a$gdqO$ & F<hA$a$gdqO $A$a$gd;.>28L_ijz%&-. !g!!!!!!!;"""""" # ######$$ȹȹ𲧲ȁhm`ohw0J>*B*phhzhm`oh;#dhm`o0J>*B*phjh;#dhm`oU h;#dhm`oh;#dhw0J>*B*phjh;#dhwUh;#dhJ.CJOJQJaJ h;#dhJ. h;#dh?C h;#dhwh;#dhw_H0$$$$$g%i%j%%%%&B&C&&&&''''((s((B)\)))**!+*+++h+++-,,Ʋvohha h;#dh_"N h;#dhr h;#dh?h;#dhr_H h:_Hh;#dh~\_H h;#dh h:h;#dhwmH sH h;#dht5CJ \aJ &h*9hw5CJ OJQJ\^JaJ hscp5CJ OJQJ\^JaJ h;#dhw5\ h;#dhw ht_Hh;#dhw_Hh;#dh?C_H&$h%i%j%%% +!+++,++++++-,,,$ & FahA$^ha$gdqO$ & FahA$^ha$gdqO$ & F`hA$a$gdqO $A$a$gd;. $A$a$gd: $A$a$gdscp $A$a$gd;.$ & F;hA$a$gdqO,,,,-------5555.6/696:66$ & FLhA$a$gdqO $7$8$A$H$a$gd;. $A$a$gd;. $A$a$gd8 $A$a$gd:$ & F=hA$a$gdqO $A$a$gd;.,,,,------------.C.D.N.O.T.U.oaZSHSH9HSHh;#dhCg0J>*B*phjh;#dhCgU h;#dhCg h;#dh%;h;#dht5CJ \aJ &hH5h+/5CJ OJQJ\^JaJ &hH5h5CJ OJQJ\^JaJ h;#dhz5CJ \aJ h;#dh3&K5CJ0\aJ0h;#dh 5CJ0\aJ0&hH5hz5CJ0OJQJ\^JaJ0h;#dh 5CJ0\aJ0 h;#dhh h:_Hh;#dhw_H h;#dhwU........./g////00M0U000001415191:1;11111111b2i2u2v222222223333S3T3_3`333333333üʵ h;#dh g h;#dh' h;#dhh8 h;#dh h;#dhX h;#dh*Y h;#dh%; h;#dhu" h;#dhsh;#dhCg0J>*B*phjh;#dhCgU h;#dhCg=33444424@4D4K44445555566666.6/68696:666666677»´틄yqmimim^hcv6hNsPmH sH hNMhNsPhNMmH sH h;#dhmH sH h;#dh h;#dhh;#dh7._Hh;#dh8v_Hh;#dhi_H h;#dhi h;#dh_"N h;#dh*Y h;#dhIw h;#dh^ h;#dhu" h;#dh'h;#dhCg0J>*B*ph h;#dhCgjh;#dhCgU#67888859v99:/;0;1;J;L; $A$a$gdH5$ & F<hA$a$gdqO$ & F<h7$8$A$H$a$gdqO$ & FhA$a$gdqO $A$a$gdNsP $A$a$gd;.$ & FLh7$8$A$H$a$gdqO$ & FLhA$a$gdqO7777U8^8_8`8d8888888888888899 9 99999(93949h9s9t9u9v99993:4:»ɷɷɰ¢ɷɛ}vkkjh;#dhCgU h;#dh0 h;#dhh;#dh S_H h;#dh]4 h;#dh~ h;#dhC- h;#dh/m h;#dhl\ h;#dh@3ha h;#dh  h;#dh h;#dhCghNsPhcv6h\^pmH sH hcv6_Hhcv6hcv6_HhQO+ hcv6hNM hcv6h\^p*4:5:=:>:?:B:h:k::::/;0;1;I;J;K;L;^;h;i;t;;;;T<[<c<g<ɾɷ{m_XXQQJJ h;#dh"= h;#dh h;#dh)Y(h;#dhC-5CJ \aJ h;#dh5CJ \aJ &hH5ht5CJ OJQJ\^JaJ &hH5h5CJ OJQJ\^JaJ &hH5hH55CJ OJQJ\^JaJ h;#dhIwha h;#dhkP h;#dh0 h;#dhCgjh;#dhCgUh;#dhCg0J>*B*phh;#dh00J>*B*phg<}<~<<<<<<<<)===========t>>>'?+?.?^?m?x?y?z??????????@@@@3@>@@@@@@˼䮧䮠֙ hs_Hh;#dhIG_H h;#dhIG h;#dh_"N h;#dhf> h;#dh  h;#dh h;#dhh;#dhs0J>*B*phjh;#dhsU h;#dhC- h;#dhs h;#dh"= h;#dhX h;#dh g h;#dhCg3L;@@@@}@@@@@%A&A1A2AA$BBB$ & FhA$a$gdqO$ & FhA$a$gdqO$ & F>h7$8$A$H$a$gdqO$ & F=h7$8$A$H$a$gdqO $A$a$gd;. $A$a$gds@#A$A&A0A1A2AAAfAAAA$B%BRBYBfBgBhBmBBBBBBBBBWCXC{C}C~CCCCúʖʝʝߏ߈yk]kh;#dhNz@5CJ \aJ h;#dht5CJ \aJ h;#dh>_H hq_H h;#dh h;#dhx h;#dhd h;#dhh h;#dhi1_Hh;#dhx_Hh;#dh:^_H h;#dh:^ h;#dh> h;#dh h;#dhC- h;#dhCg h;#dh ghx/mH sH h;#dh gmH sH #B}C~CCCCCGGGG>H?HIHJHzH{HHHH:JLL$ & FhA$a$gdqO $A$a$gdx/ $A$a$gdt $A$a$gd;.$ & Fh7$8$A$H$a$gdqOCC,DPDcDoDpDDDDDDE ERESE`EaEwE}EEEEEEEEEEEFF FF+F,FwFxFFFUGWGGGGGGGGGGHHjh;#dhx/U h;#dhx/hx/ h;#dhZ T h;#dhH h;#dhi1 h;#dhn1 h;#dhhthZVh;#dhCg0J>*B*phjh;#dhCgU h;#dh$h0 h;#dh0 h;#dhCgh^n4H H H7H;H=HJHPHxHyHzH{HHHHHIIZI[IdIeIIIIIIII9J:J;JJJJJJJJJJJJJ6K7K=K>Kxxxh;#dhCg0J>*B*ph h;#dh@3hNhCg0J>*B*phjh;#dhCgU h;#dhCghN h;#dhD h;#dh h;#dh/@hx/mH sH h;#dhx/mH sH hx/ h;#dhx/jh;#dhx/Uh;#dhx/0J>*B*ph/>K^K_KKKKKKKLLLLLLL#L$L%L+LJLkLlLLLLLLLMMNMMMMMMͿtat$h;#dh)_0J>*B*mH phsH h;#dh)_mH sH jh;#dh)_UmH sH h;#dh)_ h;#dh*B*phjh;#dhCgU h;#dhCg#LL$L%LPQQQ[Q;RER>SSSTTT U4VVW$ & FNhA$a$gdqO $hA$^ha$gd;.$ & FMhA$a$gdqO$-DM a$gd7r$-DM a$gd| $A$a$gdH5 $A$a$gd;.MMMMM:N;N=N>NjNkNlNnN~NNNNNNNNNN@O{OOOOOOOWPXP`PaPPPPPPPQQQZQ[QrQsQֹֹğ֛sjh|hlUmH sH h|hlmH sH h|hl h|h_"NhH5h;#dhhmH sH h;#dhCg0J>*B*phjh;#dhCgUh;#dhmH sH h;#dh=I h;#dhCg h;#dhl h;#dhP  h;#dhM h;#dh h;#dhr-sQQQQQQQ$R%R.R/R5R8R9R;RERWRvRRRRRRRRRSS5S6S:S;STT;T*B*mH phsH jh;#dh)_UmH sH h;#dh=ImH sH h;#dh)_mH sH h;#dh%T h|hlh|h=ImH sH $h|hl0J>*B*mH phsH jh|hlUmH sH h|hlmH sH $kTlTpTqTTTTTUUU U7U8UUUUUUUUUUU4VWWKWLWQWRWWWWWWWXX]XǿǴǴǩxxexxxexx$h;#dhC;0J>*B*mH phsH jh;#dhC;UmH sH $h;#dh90J>*B*mH phsH jh;#dh9UmH sH h;#dh9mH sH h;#dhC;mH sH h-tmH sH h;#dhzmH sH h;#dhmH sH $h;#dh0J>*B*mH phsH jh;#dhUmH sH ']X^XgXhXnXsXtXXXXXXYYYY$Y&Y'YVY[Y\YYYYYYҼҵtmf[T[E[Th;#dhr0J>*B*ph h;#dhrjh;#dhrU h;#dhCg h;#dhxh;#dht5CJ \aJ &hH5hvT:5CJ OJQJ\^JaJ &hH5hCg5CJ OJQJ\^JaJ hH55CJ \aJ h;#dhP h;#dhUmH sH h;#dhQmH sH h;#dhC;mH sH $h;#dhC;0J>*B*mH phsH jh;#dhC;UmH sH WYYY&Y'Yffff?ghhhhijj j j$ & FhA$a$gdqO$ & FOh7$8$A$H$a$gdqO $A$a$gd"v $A$a$gdH5 $A$a$gd;.$ & FNhA$a$gdqOYYZZ2Z3ZZZZZZZZZZZZZ[?[@[G[H[I[][^[[[[[[[*\+\8\9\\\\\\\]]] ]I]J]]]]]]]]]]^ ^^0^7^8^U^V^^^»ɻɴɻɻɻ h;#dhCg h;#dh:u h;#dhy$ h;#dhj h;#dht? h;#dh  h;#dh:h;#dhr0J>*B*ph h;#dhrjh;#dhrUB^^^^__%_&_(_)_b_c_h_i_o_p________3`4`A`B`T`Y`Z````` h;#dh~{- h;#dhvT: h;#dh}hqh;#dhCg0J>*B*phjh;#dhCgU h;#dhCgh"vD^eeeeeee"f#f)f*ffffffffffg?gggghhhhhthuhhhhhhhhhhhhúzsl h;#dhZoB h;#dhTh;#dhy$_Hhyh;#dhy$0J>*B*phjh;#dhy$U h;#dhy$h;#dhP _Hh;#dh:u_Hh;#dh>_H h;#dh> h;#dh_"N h;#dhP  h;#dh%>h;#dhCg0J>*B*phjh;#dhCgU h;#dhCg*hhhhhhh2i3i;i*B*mH phsH jh;#dh:UmH sH h;#dh:mH sH h;#dh h;#dhI h;#dh+ h;#dhX h;#dh:u h;#dhP h;#dhCg0J>*B*phjh;#dhCgU h;#dhCg) jkkl$mmnooooovvvv;x{x$ & FhA$a$gdqO $A$a$gdA= $A$a$gdH5 $A$a$gd;. $hA$^ha$gd;.$ & Fh7$8$A$H$a$gdqO$ & FhA$a$gdqOZkckdkkkkkll l lllllh;#dh_Hh{8 h;#dh0nh1 h;#dhg h;#dh-@Y h;#dhd#`h;#dhCg0J>*B*phjh;#dhCgU h;#dhCg h;#dhy h;#dhjh;#dhUh;#dh0J>*B*ph,nnnnooZo[ocodoooooo ppppppppppppppp q qIqJqRqSqqqqqqqs!sʶyyr h;#dhI2 h;#dh"h;#dh:f0J>*B*phjh;#dh:fU h;#dh:f h;#dhSh;#dht5CJ\aJ&h Vh"5CJ OJQJ\^JaJ hH55CJ\aJh;#dhF_H h;#dhP h;#dhP 0J>*B*phjh;#dhP U+!s"ssssssssWtXtttuttt&u'u3u4u?u@uwuxu|u}u~uuuuuuuuuuvvQvRvZv[vovpvvvvvvvvvww\w]wwww̹̽̽̽̽׮ק̽ h;#dhS h;#dh&m h;#dhXehHhA=h;#dh:f0J>*B*phjh;#dh:fU h;#dh:fh;#dhI20J>*B*ph h;#dhI2jh;#dhI2U9wwwwwwwwwx:x;x{x|x}xxxxxxxxyyyy yyGyfyjykyyy z!zп{tЂmmЂibb[ h;#dhK. h;#dhDsch h;#dhm h;#dhK h;#dh h;#dhC&hH5h]5CJ OJQJ\^JaJ &hH5h:f5CJ OJQJ\^JaJ h;#dht5CJ \aJ h;#dh+5\ h;#dh&m h;#dh:fjh;#dh:fUh;#dh:f0J>*B*phh;#dhso0J>*B*ph#{x|x}xxx}}}}S}T}^}_}}~ ~~~i~jk $A$a$gd;.$ & F#hA$a$gdqO$ & FhA$a$gdqO$ & FPhA$^ha$gdqO $A$a$gdQ5 $A$a$gd;.!z)zFzazbzzzzzzzzz {,{=|]|s|||||||||}}}D}E}T}^}_}b}e}k} ~~~zsslse h;#dh h;#dhW{ h;#dhOV h;#dh"h^ h;#dh9 h;#dh_"N h;#dh h;#dhY0J>*B*phjh;#dhYU h;#dhK. h;#dhYhQ5 h;#dh)h;#dhDsc0J>*B*phh;#dh:f0J>*B*phjh;#dh:fU h;#dhR h;#dh:f'~!~'~(~)~H~~~~~~~~~  +/DZdjklmwxyҼ~j\U h27h27h;#dht5CJ \aJ &hH5hT$5CJ OJQJ\^JaJ &hH5h:f5CJ OJQJ\^JaJ hH55CJ \aJ h%5CJ \aJ h;#dhR h;#dhb h%_H h;#dh<h;#dhOV0J>*B*phjh;#dhOVU h;#dhK. h;#dh/m h;#dhe h;#dh_9 h;#dhOVkmxyłς)34 r#$ & Fhddd-DA$M [$\$a$gdqO$ & FhA$a$gdqO$-DA$M a$gd;.$-DM a$gd$-DM a$gd;.$A$gd27 $A$a$gd;. $A$a$gdH5 $  A$a$gd% FGPQTV[rvyˀ̀  WXcdefxDEPQUVžי h;#dh \nh27h;#dh:f0J>*B*phjh;#dh:fU h;#dhR h;#dh:f h;#dhGNh\& h27h\& h27h27hh270J>*B*ph hh27jhh27U7ÂĂł΂ς*34;<@A)34AKQRWׄ؄䲣䲣䜕wneh;#dh=/_Hh;#dh#W_Hh;#dh4_H h;#dh-D h;#dh4 h;#dh#W h;#dh h;#dhT$h;#dh4_0J>*B*phjh;#dh4_U h;#dh \n h;#dhR h;#dh"h^ h;#dhGNh h;#dh_"N h;#dh4_ h;#dh(] h;#dh:f h;#dhK.$؄    +,.nbd܇yzʿ{{tmf_fmXmQmQ h;#dhq h;#dhvF h;#dhm h;#dhw` h;#dh h;#dh+ h;#dhI7 h;#dh[] h;#dh+ h;#dh&hH5ht5CJ OJQJ\^JaJ &hH5h+5CJ OJQJ\^JaJ hH55CJ \aJ h;#dh#W_Hh;#dh-D_Hh;#dh~_Hh;#dh \n_Hh;#dh4_Hh;#dh"h^_H,.WXbcŊƊЊъ#$./ $A$a$gdjf $A$a$gd;.$ & F$hA$a$gdqO$ & FhA$a$gdqO $A$a$gd;. $A$a$gdH5ˈ&'VVWXaƊЊъ!#$./0gh KLUV\^y{֯֨֯ݡݨyry h;#dh' h;#dhch;#dh#W0J>*B*phjh;#dh#WU h;#dh0 h;#dhO h;#dh#W h;#dhhj8 h;#dh [ h;#dhI7 h;#dh_"N h;#dhXe h;#dh+ h;#dh+ h;#dhvF h;#dh h;#dhq h;#dh*όЌьҌjkpqrwύӍ.56мvvgv`YYRYKGh\ h;#dhB h;#dhes h;#dh\y$ h;#dhP|h;#dh2T0J>*B*phjh;#dh2TU h;#dhhn h;#dh2Th;#dhpCJ aJ h;#dhp5CJ \aJ &hjfht5CJ OJQJ\^JaJ &hjfh\y$5CJ OJQJ\^JaJ h%5CJ OJQJ\^JaJ h;#dh#W5\ h;#dh| h;#dh#W h;#dhx ЌҌ!ܕƘ $A$a$gdjf$ & FhddA$[$\$a$gdqO$ & FhddA$[$\$a$gdqO$ & FQhA$a$gdqO $A$a$gd\ $A$a$gd;. $A$a$gd%6BEFGQRdeCD֐ݐ/0;<>KLʑˑ45Ւג򶧶򠕠vmh;#dh^n_Hh;#dhS_H h;#dhSh;#dh.V0J>*B*phjh;#dh.VU h;#dh.Vh;#dh\y$0J>*B*phjh;#dh\y$U h;#dh h;#dh'E h;#dh [ h;#dh h;#dh^n h;#dh#u$ h;#dhM h;#dh\y$ h;#dhB*ג=C !z{ĔŔєҔ56>?PQەܕݕ23»zozo`jh;#dh UmH sH h;#dh mH sH h;#dh mH sH h;#dhS_H$h;#dhS0J>*B*mH phsH jh;#dhSUmH sH h;#dhSmH sH h;#dhP| h;#dh\y$ h;#dh#u$ h;#dhhn h;#dh_"N h;#dhSh;#dh#u$_Hh;#dh G&_Hh;#dhS_H%3|}+.AMߗGHLMŘƘטؘ!"ȿwlaXIIjh;#dhSUmH sH h;#dhF6]_Hh;#dh^nmH sH h;#dhmmH sH h;#dhesmH sH h;#dhSmH sH h;#dhSh;#dh_Hh;#dh.V_H h;#dh\y$h;#dhmH sH h;#dhh;#dhS_Hh;#dh mH sH $h;#dh 0J>*B*mH phsH jh;#dh UmH sH h;#dh mH sH "./5  "+CJȚɚʚCEQRȿzsdzdzdzdQ$h;#dhG0J>*B*mH phsH jh;#dhGUmH sH h;#dhGh;#dhGmH sH h;#dh\y$0J>*B*phjh;#dh\y$U h;#dh\y$ h;#dhqH} h;#dh h;#dhP|hjfh;#dh.V_Hh;#dhSmH sH h;#dhmH sH jh;#dhSUmH sH $h;#dhS0J>*B*mH phsH JɚǛm=Rcde&'12$ A$^`a$gd|$ A$^`a$gdjf$ A$^`a$gd;.$A$^`a$gd;.$ & F%hA$a$gdqO $A$a$gd;.ƛǛ]^ijm89՝֝=JKȽӮӮuib[ h;#dhj| h;#dhJh;#dhGH*mH sH $h;#dhqVd0J>*B*mH phsH $h;#dhG0J>*B*mH phsH $h;#dhc6M0J>*B*mH phsH jh;#dhc6MUmH sH h;#dhqVdmH sH h;#dh~mH sH h;#dhc6MmH sH h;#dhGh;#dhGmH sH jh;#dhGUmH sH "KOWXYcd{|ßğϟПџQRĠƠPQ`acderhjfhjf5OJQJ\^Jh;#dh\y$CJ^JaJ h;#dh^n h;#dh(.$h;#dhG0J>*B*mH phsH jh;#dhGUmH sH h;#dhGmH sH h;#dhCdh;#dh.V0J>*B*phjh;#dh.VU h;#dh@U h;#dhj| h;#dh.V)ehlmȡɡRSijssesPsP)jh;#dhCJU^JaJmH sH hi_CJ^JaJmH sH h;#dhCJ^JaJmH sH h;#dh;<CJ^JaJ h;#dh;<CJ^JaJmH sH h;#dhCJ^JaJmH sH h;#dhT.fCJ^JaJmH sH h;#dht5\^Jhjfh5OJQJ\^Jhjfh;<5OJQJ\^Jhjfh\y$5OJQJ\^JSXYkl+,89klɣʣ8}ݤޤ ()-xh;#dhdCJ^JaJh;#dh'ECJ^JaJh;#dhCJ^JaJ h;#dhT.fCJ^JaJmH sH h;#dhCJ^JaJmH sH h;#dhCJ^JaJmH sH )jh;#dhCJU^JaJmH sH 0h;#dh0J>*B*CJ^JaJmH phsH (-./tu &'|}ϦԦզ"#%&'0Hڰڰɟڰɟڰɒxkh;#dhT.fCJ^JaJh;#dh_"NCJ^JaJh;#dh\iCJ^JaJh;#dh.K2CJ^JaJ h;#dh;<CJ^JaJmH sH 0h;#dh0J>*B*CJ^JaJmH phsH h;#dhCJ^JaJmH sH )jh;#dhCJU^JaJmH sH h;#dh[CJ^JaJmH sH #HZoptu§Χϧۧܧ#$%/023@3˲˃veXeGeX h;#dh !CJ^JaJmH sH h;#dh[CJ^JaJ h;#dh[CJ^JaJmH sH h;#dhT.fCJ^JaJ*hKa0J>*B*CJ^JaJmH phsH 0h;#dhT.f0J>*B*CJ^JaJmH phsH 0h;#dh>0J>*B*CJ^JaJmH phsH )jh;#dhT.fCJU^JaJmH sH hKahKahKaCJaJ h;#dhT.fCJ^JaJmH sH 2223=>ĩae$A$^`a$gd;.$ & F hA$a$gdqO$ A$a$gd;.$ A$^`a$gd;.$ & FR hA$a$gdqO3<=>Bkléĩҩܩީ^_`bs󲥘~qdqqh;#dhCJ^JaJh;#dhujCJ^JaJh;#dh]HCJ^JaJh;#dh(7CJ^JaJh;#dh\iCJ^JaJh;#dh)CJ^JaJh;#dh@UCJ^JaJh;#dhMHCJ^JaJh;#dh[CJ^JaJh;#dhCJ^JaJh;#dh.K2CJ^JaJh;#dh\y$CJ^JaJ#s{|}deëʫ0ٿٲ٥ul_RHR_R_hC_CJ^JaJh;#dhpCJ^JaJh;#dhNCJ^JaJhi_5\^Jhjfht5OJQJ\^Jhjfh.,5OJQJ\^Jhjfhjf5OJQJ\^Jh;#dh+mCJ^JaJh;#dh;CJ^JaJh;#dhbFCJ^JaJh;#dh.K2CJ^JaJh;#dh\y$CJ^JaJh;#dhI*CJ^JaJh;#dh'ECJ^JaJJKUVdzȳӳԳ${$ & F hA$a$gdqO$ A$^`a$gd;.$ A$^`a$gd[$A$^`a$gdi_$A$^`a$gdjf$A$^`a$gd;.0>EFXYEFyzήϮЯׯدݯ˾˰˰˰˰˰ˣ{nah;#dh4{CJ^JaJh;#dh "CJ^JaJh;#dhmCJ^JaJh;#dh1nCJH*^JaJh;#dh1nCJ^JaJh;#dhSJ*CJ^JaJh;#dhCJH*^JaJh;#dh'ECJ^JaJh;#dhCJ^JaJh;#dhNCJH*^JaJh;#dhNCJ^JaJh;#dhBJCJ^JaJ$(?CFQTtڰ۰,-ijjkuxµ¨ܵܛsssff\fOh;#dhpCJ^JaJh[CJ^JaJh;#dh%CJ^JaJh;#dh`tCJH*^JaJh;#dhSJ*CJ^JaJh;#dh7,CJ^JaJh;#dhmCJ^JaJh;#dh'ECJ^JaJh;#dh`tCJ^JaJh;#dhCJ^JaJh;#dh "CJ^JaJh;#dhNCJ^JaJh;#dhjuCJ^JaJhZnyCJ^JaJѲزIJKTųȳɳҳӳԳ浨sf\OBh;#dh%CJ^JaJh;#dh%CJ^JaJhzCJ^JaJh;#dhlCJ^JaJh;#dhvkCJ^JaJh;#dh_CJH*^JaJh;#dh_CJ^JaJh;#dh_"NCJ^JaJh;#dh8CJ^JaJh;#dhCJ^JaJh[CJ^JaJh;#dh+CJ^JaJh;#dh'ECJ^JaJh;#dhpCJ^JaJh;#dh1nCJ^JaJԳ Wz|ҵӵԵյݵ޵ fl̿wcUNNGN h;#dh h;#dhi.+h;#dht5CJ \aJ &hjfhP+5CJ OJQJ\^JaJ &hjfh85CJ OJQJ\^JaJ &hjfhjf5CJ OJQJ\^JaJ h;#dhN5\h:hz h;#dh@ h;#dhC5h;#dhC CJ^JaJh;#dh8CJ^JaJh;#dh%CJ^JaJh;#dhq4 CJ^JaJh;#dh`tCJ^JaJ(ҵӵԵݵ޵\¿ÿ$ & FS hA$a$gdqO $A$a$gd: $A$a$gdjf $A$a$gd;.$ & FhA$^ha$gdqO$ & FhA$^ha$gd:$ A$^`a$gd;.̶+3=>@DFVӷڷYZ[ѹ#ij~56MNjh;#dhy_!UmH sH h;#dhmmH sH h;#dhy_!mH sH h;#dh61 h;#dhEl h;#dh8 h;#dhoK h;#dh' h;#dh8 h;#dhLB h;#dhh h;#dhLh h;#dhi.+ h;#dhy_!1()34 $c.<[\z{ÿžŰŜuh[Nh;#dhmCJ^JaJh;#dhElCJ^JaJh;#dh@uCJ^JaJh;#dhCJ^JaJh;#dh03CJ^JaJh;#dh_"NCJ^JaJh;#dh8CJ^JaJ h;#dh61 h;#dhMc h;#dhm h;#dh@u h;#dh8 h;#dhy_!h;#dhy_!mH sH jh;#dhy_!UmH sH $h;#dhy_!0J>*B*mH phsH ÿοϿX/0:;z $A$a$gd;.$ hA$^h`a$gd;.$ & FT hA$a$gdqO$ & FU hA$a$gdqO$ A$^`a$gd;.$ & FhA$a$gdu$ A$^`a$gduÿϿX/09:;M&ּxmYE7h;#dhy_!5CJ \aJ &hjfht5CJ OJQJ\^JaJ &hjfhy_!5CJ OJQJ\^JaJ hjf5CJ \aJ h;#dhY5CJ\^JaJh;#dhC5CJ^JaJh;#dhYCJ^JaJh;#dhi.+CJ^JaJh;#dh{nCJ^JaJh;#dh%CJ^JaJh;#dhy_!CJ^JaJh;#dhMcCJ^JaJh;#dhu_H h;#dhuh;#dhuCJ^JaJ&`$ & F hA$a$gdqO$ & FhddA$[$\$a$gdqO$ & F hA$a$gdqO$ A$^`a$gd;. $A$a$gd;. $A$a$gdjf&4>&,DJKMNU^;!0]^Ϻϯxh;#dhw @mH sH h;#dhOi h;#dh^3bh;#dhOmH sH h?mH sH h;#dhmH sH h;#dh^3bmH sH h;#dh- h;#dh@ h;#dh&Ir h;#dh3 h;#dhG& h;#dhO h;#dhE h;#dh h;#dhy_! h;#dhu*!:;<= ߽԰|kTAT$h;#dh 0J2CJ^JaJmH sH -jh;#dh 0J2CJU^JaJmH sH h;#dh CJ^JaJmH sH h;#dh/aCJ^JaJh;#dh CJ^JaJh;#dhuCJ^JaJh;#dh_"NCJ^JaJh;#dh+CJ^JaJh;#dhy_!mH sH h;#dh680J$6]h;#dh^3bmH sH h;#dh+mH sH h;#dhw @mH sH h;#dh"mH sH  -ABYZ\]нqcVI*B*CJ^JaJmH phsH '-1D`aoͷޖ|obUH;U;Uh;#dhy_!CJ^JaJh;#dh@uCJ^JaJh;#dhOiCJ^JaJh;#dh%_HmH sH h;#dh|A_HmH sH h;#dhN_HmH sH h;#dho_HmH sH h;#dhoCJ^JaJ&h;#dho6CJ]^JaJmH sH *h;#dho0J/6CJ]^JaJmH sH h;#dhYUCJ^JaJmH sH h;#dhoCJ^JaJmH sH h;#dhl%CJ^JaJmH sH (*+,ٿٲٲ١reULhjf5\^Jh;#dh5CJ\^JaJh;#dhy_!CJ^JaJh;#dhO%CJ^JaJ h;#dh8CJ^JaJmH sH h;#dhy_!CJ^JaJmH sH h;#dh1\CJ^JaJmH sH h;#dh8CJ^JaJh;#dh(CJ^JaJh;#dhC5CJ^JaJh;#dh1\CJ^JaJh;#dh6WCJ^JaJh;#dh%CJ^JaJ*+,-.RS$ A$^`a$gd)$ A$^`a$gd;.$A$^`a$gd%$A$^`a$gdjf$A$^`a$gd;.$ & F hA$a$gdqO,.5QRS:H\vk|÷yl__yRh;#dh_"NCJ^JaJh;#dhCJ^JaJh;#dhOCJ^JaJh;#dh4 CJ^JaJh;#dh%inCJ^JaJhePCJ^JaJh;#dh9ACJ^JaJh;#dhz(CJ^JaJh;#dht5\^Jhjfh+m5OJQJ\^Jhjfh\y$5OJQJ\^Jhjfhz(5OJQJ\^Jh%5OJQJ\^J  !-23>DEFGHQRSb|ž̍sfYsh;#dh8*CJ^JaJh;#dh5CJ^JaJh;#dho<CJ^JaJh;#dht?CJ^JaJh;#dh0VCJ^JaJh/ h;#dhO h;#dhSh% h;#dhy` h;#dhy_! h;#dhfi5 h;#dhh;#dh%CJ^JaJh;#dhCJ^JaJh;#dhy_!CJ^JaJh;#dhz(CJ^JaJ"GHRS2xyz23 $A$a$gdjf $A$a$gd;.$ & F& hA$a$gdqO$ & F! hA$a$gdqO$ A$^`a$gd;. $A$a$gd/$ A$a$gd;./02xyz"-8:b®~wpwpipb[bpwpippTpM h;#dh) h;#dhZ h;#dh h;#dh) h;#dhJm h;#dhW h;#dhW, h;#dhH h;#dh4h;#dht5CJ \aJ &hjfh55CJ OJQJ\^JaJ &hjfhjf5CJ OJQJ\^JaJ h;#dho<5\h;#dho<CJ^JaJh;#dhLCJ^JaJh;#dh)YCJ^JaJh;#dh8*CJ^JaJ!.r23<=>A[\m IJUVZq}ǺԭԦvi\v\h;#dhkjCJ^JaJh;#dh%CJ^JaJh;#dhLCJ^JaJ h;#dhVV6 h;#dh@N h;#dhi h;#dhP5 h;#dhZ h;#dh$h;#dh%inCJ^JaJh;#dh$dbCJ^JaJh;#dhZCJ^JaJh;#dhP5CJ^JaJh;#dh_"NCJ^JaJ h;#dh2h"n h;#dh3=>mIJUV -$ & F"hA$^ha$gdqO $A$a$gd;.$ A$a$gd;.$ & FVhA$a$gdqO$ & FV hA$a$gdqO$ A$^`a$gd;.$ A$^`a$gdjf }~  +,-̽tjtc\UcNcGc h;#dhb h;#dh-M h;#dh% h;#dhp h;#dh8*hCJ^JaJh;#dhLCJ^JaJh;#dh-M@CJ^JaJh;#dh%@CJ^JaJh;#dhi@CJ^JaJh;#dhkj@CJ^JaJh;#dhL@CJ^JaJh;#dh^CJ^JaJh;#dhiCJ^JaJh;#dhkjCJ^JaJh;#dh [CJ^JaJ-Ygopq01;Xl /efghiuv̲̿zqg]gSgSgqh;#dh>G@]h;#dh @]h;#dhL@]h;#dhL@h;#dh)YCJ^JaJh;#dh8*CJ^JaJh;#dhL@CJ^JaJh;#dhK>@CJ^JaJh;#dhK>CJ^JaJh;#dh%inCJ^JaJh;#dhLCJ^JaJh;#dh@h;#dhK>@ h;#dh@N h;#dh-M h;#dh)Y /Swxx$ & FXhA$^ha$gdqO $A$a$gd;. $A$a$gd $A$a$gdN& $A$a$gd;.$ A$^a$gd;.$ & F"hA$^ha$gdqO$ & F' hA$a$gdqO$ & FW hA$a$gdqO %&)CMknoqu\gϻvogg\UNUGUGU h;#dhH h;#dhX h;#dh &h;#dhLmH sH hmH sH h;#dhL%h;#dh~ mH sH h;#dhL%mH sH h;#dh&hN&ht5CJ OJQJ\^JaJ &hN&hs5CJ OJQJ\^JaJ &hN&hX85CJ OJQJ\^JaJ hN&5CJ \aJ h;#dh{xCJ^JaJ h;#dhK>h;#dhK>@h;#dh @JW_`I\y'EGJήΡߖuߖjc_XTM h;#dhNh] h]h]h8{ h;#dh]Bh;#dhIRmH sH h;#dhLmH sH h;#dh_9mH sH h;#dh^mH sH h;#dh:mH sH h;#dh#&0J3mH sH $h;#dh#&0J>*B*mH phsH h;#dh#&0J2mH sH !jh;#dh#&0J2UmH sH h;#dh rmH sH h;#dhXmH sH h;#dh#&mH sH J_`ab{| =>itUV繮vohv h;#dhL h;#dh_"Nh;#dhLmH sH $h;#dhX80J>*B*mH phsH jh;#dhX8UmH sH h;#dhX8mH sH h;#dhQ,mH sH h;#dh#&mH sH h;#dh_A h;#dhj.[ h;#dh h;#dh@u h;#dhIR h;#dh>G h;#dhN h;#dh]Bh]#,-8NZ[45DE`a  PQVWYZ  !hituwx˹ h;#dhy{ h;#dhIR h;#dh]B h;#dh'h;#dh^mH sH h;#dhL$h;#dhL0J>*B*mH phsH h;#dhLmH sH jh;#dhLUmH sH ?wx8CDNOu\$ & F)hKK-DA$M a$gdqO$ & F(hA$^ha$gdqO $A$a$gd;.$ & F,hA$a$gdqO$ & F+hA$^ha$gdqO$ & F*hA$^ha$gdqO $A$a$gd;..68B_degsx 1CNOYtuy@AȺֶ򺨝xxiijh;#dh"UmH sH h"mH sH h;#dh"mH sH h;#dh,{h;#dh,{mH sH h;#dh_AmH sH h;#dh% h;#dh_xh" h;#dh' h;#dhf] h;#dh h;#dhu h;#dh8g h;#dhe1 h;#dhC h;#dhIR h;#dhy{ h;#dhk(AJK\;<IJLMNOPQRTȽwl^PE:h:+5CJ,\aJ,hN&5CJ,\aJ,h;#dh*5CJ,\aJ,h;#dh*5CJ0\aJ0h;#dhhCJ aJ "h"hz5CJ \aJ mH sH h;#dh^$h;#dh^0J>*B*mH phsH jh;#dh^UmH sH h;#dh$mH sH h;#dh^mH sH h;#dhCemH sH h;#dh"mH sH jh;#dh"UmH sH $h;#dh"0J>*B*mH phsH LMNO/$ & FchA$a$gdmv* $A$a$gdg+n $A$a$gd)V $A$a$gdV $A$a$gd:+ $A$a$gd:+ $A$a$gd;. $A$a$gd;.$ & FYhA$^ha$gdqOTUe~PQcdervĶ|uncncTcncncTcnMn h;#dhXh;#dhF0J>*B*phjh;#dhFU h;#dhF h;#dhKh;#dht5CJ \aJ &hN&hF5CJ OJQJ\^JaJ h:+5CJ OJQJ\^JaJ h;#dhzh;#dhh5CJ \aJ &hN&hz5CJ,OJQJ\^JaJ,&hN&hz5CJ(OJQJ\^JaJ(&hN&h-R5CJ(OJQJ\^JaJ(vw &-37BC{|}̳̳̝̖̾̾̈̄yncyh;#dh{mH sH h;#dh(nvmH sH h;#dhFmH sH hl h;#dh; h;#dh* h;#dh& h;#dhbh;#dhF0J>*B*phjh;#dhFU h;#dh\ h;#dhx h;#dhFh;#dhKmH sH h;#dhK0J>*B*ph h;#dhKjh;#dhKU%cdxy{|Sclrs{/HнЪߌߌynch;#dh>mH sH h;#dh{mH sH h)V mH sH h;#dhXmH sH h;#dh(nvmH sH hlmH sH h;#dhMomH sH $h;#dhMo0J>*B*mH phsH $h;#dh ; 0J>*B*mH phsH jh;#dh ; UmH sH h;#dh>mH sH h;#dhFmH sH h;#dh ; mH sH &HI_`jkt89"ʽ坖|xq h;#dh)V hT h;#dh"=0J>*B*phjh;#dh"=U h;#dh"=hlmH sH h;#dh\mH sH h;#dh{0JmH sH h;#dhF0JmH sH h)V mH sH $h;#dhF0J>*B*mH phsH h;#dhFmH sH jh;#dhFUmH sH ,"7pfgqrDEPQiknrw 49vvh;#dh>mH sH $h;#dh>0J>*B*mH phsH h;#dh>0JmH sH !jh;#dh>0JUmH sH h;#dhXmH sH h;#dhFmH sH h`Rh;#dh"=0J>*B*phjh;#dh"=U h;#dh"=h"=hT h;#dh`Rh)V .9cj:F,tvwSTԽzsl]R]h;#dh#KmH sH jh;#dh#KUmH sH h;#dh#K h;#dh* h;#dhLQj h;#dhX h;#dh_ h;#dhP`U h;#dhF h;#dhwEhmv* h;#dh+ h;#dh(0% h;#dh_"N h;#dhxhVmH sH hn\'mH sH h;#dhOmH sH h;#dhxmH sH h;#dh>mH sH h;#dhFmH sH /uvq  _ $A$a$gd $ & FAhA$a$gdqO $  A$a$gd($ & FBhA$a$gdqO$ & F@hA$a$gdqO $A$a$gd;.$ & FchA$a$gdqOTopq$%<=?pq Z[fg+,-./023̺thhh]0J>*B*phhhh*0J>*B*ph h;#dh*hhhLQj0J>*B*phjh;#dhLQjU h;#dh] h;#dhLQjh;#dh*mH sH h;#dh#Kh;#dh#KmH sH jh;#dh#KUmH sH $h;#dh#K0J>*B*mH phsH -   +,2?PT^_`/0yzɾ܆sܾhYhYjh;#dhUmH sH h;#dhmH sH $h;#dhF0J>*B*mH phsH jh;#dhFUmH sH hhmH sH h;#dhMmH sH h;#dhLmH sH h;#dh,mH sH h;#dhFmH sH h;#dhP`UmH sH h(mH sH h;#dh_ mH sH h;#dh#KmH sH h;#dh(nv h;#dhLQjz56FGHIMNĹĦĹޞӈ~s_Qh;#dht5CJ \aJ &h hF5CJ OJQJ\^JaJ h 5CJ \aJ h;#dh_ 5\h;#dhFmH sH h;#dh(nvmH sH hhmH sH $h;#dhL0J>*B*mH phsH h;#dhLmH sH jh;#dhLUmH sH h;#dhmH sH jh;#dhUmH sH $h;#dh0J>*B*mH phsH =>HI'(9$ & FhA$^ha$gdqO $hA$^ha$gd;.$ & FChA$a$gdqO $A$a$gd8v $A$a$gd;. $A$a$gdW $A$a$gd;.  !0opqSTDceK L      ĸ򧠙򠒋} h;#dhV h;#dh*B*phjh;#dh$,U h;#dh ; h;#dhuB h;#dh$, h;#dhG+k            , K O m n w z  NO ^_jkpqͽ{h;#dh:^r0J>*B*ph h;#dhc(h;#dh"_0J>*B*phjh;#dh"_Uh h;#dh: h;#dh^R h;#dh"_h;#dh:^r_Hh;#dh<_H hNU_Hh;#dhV_Hh;#dhC-"_Hh;#dh,_Hh;#dh"__H. 2<IS-;<=>H߿ͣvjaXQ h;#dh8vh0J$6]h8v0J$6]h;#dhf0J$6]h;#dh:^r0J$6]h;#dh0J$6] h;#dh h;#dh h;#dh_"N h;#dhHg h;#dh_ h;#dhF h;#dh< h;#dh>V h;#dhX h;#dh^RhW h;#dh: h;#dh"_jh;#dh"_Uh;#dh;0J>*B*phHI68'( #$%.89kqĽ稯稯h 5CJ \aJ h;#dhV h;#dhm h;#dh, h;#dh:^r h;#dhG h;#dh$, h;#dh h;#dh. h;#dhF h;#dhMhjY h;#dh_ h;#dh//!!!!!!!!^""-#$%%(%)% $hA$^ha$gd;.$ & FDhA$^ha$gdqO $A$a$gdFh $A$a$gd  $A$a$gd;. $A$a$gd;.*6ENnpyVW\]hpwxbcmnھڥڥڷڥڥڥڥڋ||h;#dhq0J>*B*phjh;#dhqUh;#dhW 0J>*B*phjh;#dhW U h;#dh[ h;#dhq h;#dhdq h;#dhHV h;#dhm h;#dhqkR h;#dhW h;#dhtCJ aJ &h hF5CJ OJQJ\^JaJ 0%&Qtu9:EFYZ E ]^efgw̶̯̽̽̽̽ׯׇ̨̽ h;#dh0Th;#dh0J>*B*phjh;#dhU h;#dh h;#dhdq h;#dhZh;#dh%0J>*B*phjh;#dh%U h;#dh%h;#dhq0J>*B*ph h;#dhqjh;#dhqU2de hiuvx = > E K |         5!6!8!!!ݼ򵮼򮼧h;#dhF_Hh;#dh _Hh;#dh_H h;#dh,N h;#dhc( h;#dhF h;#dh!FE h;#dh9h;#dhdq0J>*B*phjh;#dhdqU h;#dhdq h;#dh0T h;#dh ; h;#dh h;#dh*B*ph h;#dhEjh;#dhEU %%%%%%%%&&F&G&O&Q&S&T&U&g&&&&&&/'0'1'2'C'D'۽Ȫ۽ꍆ|q]Oh;#dht5CJ \aJ &h hc^5CJ OJQJ\^JaJ h 5CJ \aJ h;#dhH5\ h;#dhO h;#dhc^h;#dhM+mH sH h;#dhHmH sH $h;#dh ; 0J>*B*mH phsH h;#dhS<mH sH $h;#dhc^0J>*B*mH phsH jh;#dhc^UmH sH h;#dhOmH sH h;#dhc^mH sH )%%&0'1'2'C'D'//001222233$ & FGhA$a$gdqO$ & FdhA$a$gdqO $A$a$gd9I $A$a$gd  $A$a$gd;. $7$8$A$H$a$gd;.$ & FEhA$^ha$gdqOD'Y'\'i'o'p'}'~'''''''((=(>(F(G(I(J(((((((((7):)))) *-*2*~w~peh;#dhfmH sH h;#dhE h;#dh"A~ h;#dhM9 h;#dh h;#dh ; $h;#dh@0J>*B*mH phsH jh;#dh@UmH sH h;#dh"A~mH sH h;#dh@mH sH h;#dhtmH sH h;#dh@ h;#dh/ h;#dhc( h;#dht h;#dhc^ h;#dh%2*3***********++++6+8+O+n++++++ ,r,,,,,--_-`-k-墛~s~le h;#dh1 h;#dh)h;#dhM9mH sH h;#dheImH sH h;#dhE h;#dh"A~h9I h;#dh h;#dh$h;#dhf0J>*B*mH phsH h;#dhmH sH h;#dh"A~mH sH $h;#dhc(0J>*B*mH phsH h;#dhfmH sH jh;#dhfUmH sH #k-n-w-x-----....2.8.@.A.G.H.I.J.........////F/G/O/P/V/W/////////˵{t h;#dhc^ h;#dhbh;#dh)FmH sH h;#dhc(mH sH h;#dhxkmH sH h;#dhM9h;#dhbmH sH h;#dh mH sH h;#dhfmH sH jh;#dhfUmH sH $h;#dhf0J>*B*mH phsH $h;#dh 0J>*B*mH phsH -///00#0$0000000011#1111112222%2&2.2H2[2^2_2c2o222ΰΥݞݐ~wpwlwlwew^l h;#dhg h;#dhe<h&2 h;#dhl h;#dh yB h;#dhj*. h;#dhHh9I h;#dh0 h;#dhW h;#dh h;#dh mH sH $h;#dh0 0J>*B*mH phsH h;#dh0 mH sH jh;#dh0 UmH sH h;#dh5 h;#dhx h;#dh_"N h;#dh+ h;#dheI$22233(353:3`3333333333333334 44K4L4V4W4X4Z4r44ظ몱xmbWh;#dh!$mH sH h;#dheImH sH h;#dhlmH sH h;#dhj*. h;#dhHhk>h&20J5\hk>0J5\hk>h&2 h;#dh ; h;#dhIz h;#dhc^ h;#dhf h;#dhl h;#dhmh;#dhmmH sH h;#dh/mH sH hk>mH sH h;#dhg h;#dh:a h;#dh yB!33K4L4W4X4r445555<<<$-DA$M a$gd9K$-DA$M a$gd;. $A$a$gd  $A$a$gd;. $ & FFa$gdqO$ & FFh7$8$A$H$a$gdqO $7$8$A$H$a$gd;.$ & FGhA$a$gdqO44444444Q5R5f5g555555556666r77777;ؾؠxjc\cUc\cUJUJjh;#dhq(?U h;#dhq(? h;#dh$ h;#dhc h;#dht5CJ \aJ &h h$085CJ OJQJ\^JaJ &h hF5CJ OJQJ\^JaJ h 5CJ \aJ $h;#dh yB0J>*B*mH phsH jh;#dh yBUmH sH h;#dhmH sH h;#dh yBmH sH h;#dh!$h;#dh!$mH sH h;#dh$08mH sH 777777?8@8E8F8^8w8}8~88888889 99999::::<<<<<<<<<<<<<<=üüø|u h;#dhZm" h;#dhPM h;#dh h;#dhL h;#dh/ h;#dh8l h;#dhc h;#dh$08 h;#dh_"Nh Vh9K h;#dhE h;#dhF h;#dh13 h;#dhD h;#dhc( h;#dhq(?jh;#dhq(?Uh;#dhq(?0J>*B*ph,<<<<<<3==>> ??? $ & FHa$gdY $ & FHa$gdqO$ & FHh-DA$M a$gdqO$ & Feh-DA$M ^ha$gdqO $A$a$gd;.$-DA$M a$gd;.$a$gd;.$-DA$M a$gd V === ===l=n======>>>> >k>l>>>>>>>>>>> ? ? ??]?^?־τsle^ h;#dhLZ h;#dhh h;#dh/ h;#dh1CJOJQJ^JaJ h;#dh; h;#dhY h;#dh ; hhh;#dh0J>*B*ph h;#dhjh;#dhU h;#dhcCJOJQJ^JaJ h;#dh1 h;#dh5 h;#dhc h;#dhPM h;#dhM1 h;#dhZm" h;#dha#?]??????JJ)J K*K)LMNNXNYN $ & FJhdd-DA$M [$\$a$gdqO$a$gd;. $A$a$gd;. $A$a$gd  $A$a$gd;.$ & FIh-DA$M a$gdqO^?n?{????????????[@\@h@i@j@y@}@AAAA͹vvcvXMXBXh;#dhmH sH h;#dhmH sH h;#dh'vmH sH $h;#dh0J>*B*mH phsH jh;#dhUmH sH h;#dhmH sH h;#dh8 h;#dht5CJ \aJ &h h5CJ OJQJ\^JaJ &h hP`U5CJ OJQJ\^JaJ &h hF5CJ OJQJ\^JaJ h;#dh 5\ hF5\ h;#dh/ h;#dhFAA`AaAbAAAAAAAAA*B+B/B0B5B6B7B8BYBZBBBBBBB C CCCOCyCC5D6Dððݒxxexxxex݇݇$h;#dhrA0J>*B*mH phsH jh;#dhrAUmH sH h;#dhrAmH sH h;#dhXmH sH $h;#dhIL0J>*B*mH phsH $h;#dh0J>*B*mH phsH jh;#dhUmH sH h;#dhmH sH h;#dh mH sH h;#dh'vmH sH h;#dh'v0J3mH sH $6D@DXDDDDBEhEEEEEEFFPFQFVFWFYFZFFFFFFFFFFFFFFFG=G洩|||qjcj h;#dh  h;#dhrAh;#dhILmH sH $h;#dhrA0J>*B*mH phsH jh;#dhrAUmH sH h;#dhXmH sH h;#dhrAmH sH h;#dh mH sH h;#dhV+_HmH sH h;#dh)_HmH sH h;#dh_HmH sH h;#dhX_HmH sH h;#dh _HmH sH $=G@G]G^GGGGGGGHH)H*H+HyHzHHHHHIIIIIIIJJ(J)JCJlJmJJJJJ Küüõüü{{h{$h;#dhX0J>*B*mH phsH jh;#dhXUmH sH h;#dhXmH sH h;#dhW= h;#dht+ h;#dh_"Nh h;#dh h;#dhH2 h;#dh 7 h;#dh&eO h;#dhn`R h;#dhh;#dhrA0J>*B*phjh;#dhrAU h;#dhrA h;#dhV+' K*K4KOKPKKKKKKKKKKK L LL'L)L9L:LLLʹyqجgVIVh;#dhnt0J2mH sH !jh;#dhnt0J2UmH sH hS0J2mH sH hSmH sH h;#dh<0J3mH sH $h;#dh<0J>*B*mH phsH $h;#dh0J>*B*mH phsH h;#dh<0J2mH sH !jh;#dh<0J2UmH sH h;#dh h;#dhnt h;#dh<h;#dhntmH sH h;#dh<mH sH hS h;#dh6LLLLLLLLMM MMMMMM_M`MtMuMMMMM̧̿̿{h[PEPh;#dhamH sH h;#dhmH sH h;#dh0J3mH sH $h;#dh0J>*B*mH phsH h;#dh0J2mH sH !jh;#dh0J2UmH sH h;#dhnt0J3<mH sH h;#dhnt0J2mH sH h;#dhntmH sH h;#dhnt0J3mH sH !jh;#dhnt0J2UmH sH hS0J>*B*mH phsH $h;#dhnt0J>*B*mH phsH MMMMM N NNN%N-NLNNNXNYNNNNNNNO%OCODOOOѱѤ⒋~q~d~q~d~qWJh;#dh_9_HmH sH h;#dht_HmH sH h;#dhQz_HmH sH h;#dh 7_HmH sH h;#dh_HmH sH h;#dh6 h;#dh&eOh;#dhntmH sH h;#dh<0J3mH sH $h;#dh<0J>*B*mH phsH h;#dh<0J2mH sH !jh;#dh<0J2UmH sH h;#dh<mH sH h;#dhmH sH hSmH sH YNNNDOOOOOOVVWsWtW~WW XX Y$ & FKhA$a$gdqO $ & Ffa$gdqO $ & Ffa$gdZ.$a$gd;. $A$a$gd [" $A$a$gd  $A$a$gd;. $A$a$gd;.$ & FhA$a$gdqOOOOOOOOOOOOOO0P?PAP\PaPiPlPPPPPPPP.Qмxqjqcq\qUqNqNqjGj h;#dhH h;#dh h;#dhg h;#dhV+ h;#dh' h;#dh h;#dh h;#dhF h;#dhH0h;#dht5CJ \aJ &h hH05CJ OJQJ\^JaJ &h hF5CJ OJQJ\^JaJ &h ht5CJ OJQJ\^JaJ h 5CJ \aJ h;#dh&eOmH sH h;#dht_HmH sH h;#dhe_HmH sH .Q0QQQQQ0R1ReR]S^S}TTTT$UKULUUUUU V V@VAVKVLVVVVVVVVVVVVVVVWrWsWtW~WȺݺݺݏ| h;#dh`#Oh VhZ.h?_ h;#dh L6 h;#dh_"N h;#dh: h;#dh@Ic h;#dhX%h;#dhbH* h;#dhb h;#dhu h;#dh) h;#dhXL h;#dh {+ h;#dh h;#dh^ h;#dhV+ h;#dh h;#dhH.~WWWWWWWWWW(X)XTXUX^X_XhXlXnXqXXXXXXXXX YYYKY\Y]Y^YiYYYYYiZwZxZZZZZ.[/[ֳֺ֯Ȩ~ hQ9h[` hQ9hV+ hQ9ho$ hQ9hQ9 hQ9h` hQ9hW. h;#dhTh` h;#dhK h;#dh'l h;#dh h;#dhV+ h;#dhX% h;#dh+a h;#dhg h;#dh`#O h;#dh[` h;#dh h;#dh0 Y YYYYYiZZ.[[[[[[OiPiZi[i5j $A$a$gd;. $A$a$gdRQ $A$a$gdh$ & FLhA$a$gdQ9$ & FLhA$a$gd`$ & FLhA$a$gdqO $A$a$gd;. $hA$^ha$gd;./[9[`[j[r[[[[[[[[[[[[[[@\A\P\Q\c\m\\\\\] ]İzkkXkMkkXkh;#dhmH sH $h;#dhy 0J>*B*mH phsH jh;#dhy UmH sH h;#dhhmH sH h;#dhhh;#dhy mH sH h;#dhNmH sH h;#dht5CJ \aJ &hhhF5CJ OJQJ\^JaJ hQ9hh5CJ \aJ hQ9h`#O hQ9hE hQ9hi hQ9h[`hQ9h~BmH sH hQ9h~[ ]Q]R]V]k]]G^P^[^^^j^k^u^w^^^^^ _____R_\_a_q_z____``"`5`U`V`u`ʿտʸզ}p}Պiib h;#dhp h;#dhF4h;#dhp_HmH sH h;#dh~_HmH sH h;#dh~ h;#dhe h;#dh_9 h;#dhxh;#dhxmH sH h;#dhV+ h;#dhNh;#dhhmH sH h;#dhNmH sH h;#dh~mH sH h;#dhHgU h;#dhH h;#dh(5ch;#dhymH sH %u`v`````VaWaaaaaaabbbbbbbbcbqbrb~bbbbbbcccRcScYcZccccccc)d*dDdEdddddddddddddee̽̽̽׶̽ׯר h;#dhx h;#dhF h;#dh& h;#dh_9 h;#dhph;#dhP<0J>*B*phjh;#dhP<U h;#dhP<h;#dhH0J>*B*ph h;#dhHjh;#dhHU<eeee;eDeSeqeueeeeeeee>f?f@ffffff&g+gcggggggg'h)h5hhhhhhOiPiYiZi[iĹĮĹĹģĘĐωĘ{t h;#dh] h;#dh_"N h;#dhy h;#dhBAhRQmH sH h;#dhV+mH sH h;#dh]mH sH h;#dhymH sH h;#dhBAmH sH h;#dhwumH sH h;#dhwu h;#dhh h;#dhQTS h;#dhc( h;#dhF h;#dhx h;#dhHgU-[ij5j6jAjjjjjjj1kkkWlXlklllmlqlrlxlyllllllllllllllllllm8mPmRmSmտʦՆՆw՘sssh4h;#dhD0J>*B*phjh;#dhDU h;#dh& h;#dho2 h;#dhvF h;#dhy h;#dhLh;#dhBmH sH h;#dhLmH sH h;#dh:h. h;#dhD h;#dhP< h;#dhhh;#dhhmH sH h;#dhpmH sH ,5j6j@jAjjj1kXlRmSm]m^mQnYo+ppppqq $A$a$gdh$ & FhA$a$gdqO$ & FMhA$a$gd4 $ & FMa$gdqO$ & FMhA$a$gdqO $A$a$gd;. $A$a$gd;.Sm]m^m_mtmummmmmmmmmmm@nFnPnQnknsntnnnnoXoYoooͺܯܙ܎܃|u|mi܃^Ojh hwuUmH sH h hwumH sH hv5hv5mH sH h;#dhF4 h;#dhW=h;#dh}mH sH h;#dhV+mH sH h;#dh&mH sH h;#dhF4mH sH h;#dhc(mH sH $h;#dh:0J>*B*mH phsH jh;#dh:UmH sH h;#dh:mH sH h;#dhYw!mH sH h;#dhYw! h;#dhxD ooop p pp+pBpCpDpEpppppppppppppppqwmbN&hhhP5CJ OJQJ\^JaJ hh5CJ \aJ h;#dhxD 5\h h}5\mH sH h hYw!mH sH $h h}0J>*B*mH phsH jh h}UmH sH h h1mH sH h h}mH sH h h$mH sH $h hwu0J>*B*mH phsH jh hwuUmH sH h hwumH sH qq qqqEqJqVqgrhrsssssstt#t:t;t*B*phjh;#dhS6U h;#dhS6 h;#dhb(0yyyyyyyyyyyyy z1z2z3z4z>z?zzzzzzzzzzzzzz򸤐|ng`g`U`gh;#dhqbmH sH h;#dhqb h;#dhFh;#dht5CJ \aJ &hhhF5CJ OJQJ\^JaJ &hhh:B5CJ OJQJ\^JaJ &hhhh5CJ OJQJ\^JaJ h;#dhS6aJ h;#dh\f h;#dh h;#dhS6 h;#dhx h;#dh_"N h;#dh} h;#dh7 h;#dh+ h;#dhy6 qyyyyyyyy3z4z>z?zzzzzz@AKL $A$a$gd;.$-DA$M a$gd;. $A$a$gd'D $A$a$gdh $A$a$gd;. $A$a$gd}^zzzz#{&{'{,{-{h{i{n{o{s{t{{{{{{{|||||||||0}1}d}0~Q~~~¯¯¯ܨ~ululh;#dh<\_Hh;#dha0_H h;#dh<\ h;#dhS | h;#dh=$ h;#dh7 h;#dh h;#dhS h;#dh3$h;#dh,@0J>*B*mH phsH jh;#dh,@UmH sH h;#dhmH sH h;#dh:BmH sH h;#dh,@mH sH h;#dhD h;#dh,@*16:`n*  ԃՃ:;mnɅ^_?@A̷̾mb[ h;#dh`h;#dh3mH sH $h;#dh`0J>*B*mH phsH jh;#dh`UmH sH h;#dhCmH sH h;#dh`mH sH h;#dhe_ h;#dhph'D h;#dh' h;#dhU h;#dh h;#dhY @h;#dhp_Hh;#dhC_Hh;#dh_Hh;#dh<\_Hh;#dh_H#AJK`ano҈ӈ߈F[ST]_`opѾѾѾ밥Ѿ랥}}jh;#dh)UmH sH h;#dh)mH sH h;#dhu h;#dhDh;#dhUmH sH h;#dhU h;#dh$h;#dh0~0J>*B*mH phsH jh;#dh0~UmH sH h;#dh0~mH sH h;#dh0~ h;#dh h;#dh_"N*L~ST_`cXȏ$ & FOh-DA$M a$gdqO$ & FNh-DA$M ^ha$gdV$ & FNh-DA$M ^ha$gdqO$-DA$M a$gd;.$ & FghA$a$gdqO56?ABMP^acdhiʋˋ͋΋vwόی ӡӖӎzjގ_ӎӎh;#dhc(mH sH h?_0J>*B*mH phsH ' *h!~!h)0J>*B*mH phsH hVmH sH h;#dh ,mH sH h;#dhumH sH 'h;#dh)0J>*B*H*mH phsH $h;#dh)0J>*B*mH phsH h;#dh)mH sH jh;#dh)UmH sH $h;#dh;0J>*B*mH phsH %X\]Íʍˍ&'<=ˎ͎̎׎؎/0}~yrk`h;#dh)>mH sH h;#dh3 h;#dhDhi|bmH sH h;#dh'mH sH $h;#dhi|b0J>*B*mH phsH $h;#dhJ0J>*B*mH phsH h;#dhi|bmH sH jh;#dhi|bUmH sH $h;#dhhJ0J>*B*mH phsH jh;#dhhJUmH sH h;#dhhJmH sH h;#dhu!ƏǏȏ]^bcjklm?A֑ &1PQZнП߂{t{m{tft__m_ h;#dh) h;#dhi h;#dhV+ h;#dh` h;#dhhJ h;#dh)>h;#dh,o5mH sH h;#dhhJmH sH h;#dhV+mH sH $h;#dh)0J>*B*mH phsH $h;#dh9I0J>*B*mH phsH jh;#dh9IUmH sH h;#dh)>mH sH h;#dh9ImH sH h;#dhFmH sH "ȏAC^$ & FhhA$a$gdqO$ & FhhA$a$gd~ $A$a$gd;. $A$a$gd;.$-DA$M a$gd;.$ & FOh-DA$M a$gdqO$%?@\]ɓ̓IJ\u³³¬͗͞{t{m{f_f{f h;#dhI| h;#dhP h;#dhe_ h;#dhJ h;#dh h;#dhN- h;#dh( h;#dh{ h;#dhI+ h;#dhH[S h;#dhc( h;#dhqh;#dh,x'0J>*B*phjh;#dh,x'U h;#dh,x'&hOhF5CJ OJQJ\^JaJ h;#dht5CJ \aJ h;#dhF5\$Vino͖ܖ ./z3=p˼뵮򧠙|qfh;#dhV+mH sH h;#dhQmH sH h;#dhI|mH sH h;#dh{mH sH h;#dh$^ h;#dh{p h;#dh.7 h;#dhI| h;#dh( h;#dhQh;#dh{0J>*B*phjh;#dh{U h;#dhV+ h;#dhc( h;#dh+ h;#dh{ h;#dhJ h;#dh{+%pqʙ˙ԙՙיVWhi{~ٚښǼyrkd`dUdUjh;#dhI|Uh~ h;#dhI| h;#dh58 h;#dh_"Nh;#dhUMmH sH h;#dhH[SmH sH h;#dhI|mH sH $h;#dh.70J>*B*mH phsH jh;#dh.7UmH sH h;#dh.7mH sH h;#dh$^mH sH $h;#dh{0J>*B*mH phsH h;#dh{mH sH jh;#dh{UmH sH #$gjmnʛ˛]nqr˝̝͝ @B߿ߴ~sh]h;#dhN-mH sH h;#dhumH sH h;#dh;mH sH h;#dhbmH sH h;#dh{ mH sH h;#dhgmH sH h;#dh{p h;#dh,x' h;#dhXx h;#dh58h h;#dhH[S h;#dh'Dh'D h;#dhV+ h;#dhg)~ h;#dhI|jh;#dhI|Uh;#dhI|0J>*B*ph!̝͝G۠Zm$ & FRhA$^ha$gdqO$ & FRhA$^ha$gdqO $A$a$gdM$ & FPhA$a$gd$ & FPhA$a$gdqO $A$a$gd;.BC VW_`xy̟͟ϟП,-.EFGHؠ٠۠  ҿ𬡴塴h;#dhb_Hh;#dh{ mH sH hmH sH h;#dhV+mH sH h'DmH sH h;#dhgmH sH $h;#dhb0J>*B*mH phsH $h;#dhg0J>*B*mH phsH h;#dhbmH sH jh;#dhbUmH sH 0!XYZ ().7;@CTWm{ӽө|uuncXTM h;#dh,x'hMh;#dheNmH sH h;#dhgmH sH h;#dheN h;#dh{ph;#dhT_Hh;#dheN_Hh;#dh G&_Hh;#dh{ _Hh;#dhXx_Hh;#dhb_Hh;#dh{ mH sH h;#dhV+mH sH h;#dhTYmH sH h;#dhbmH sH h;#dhg_H h;#dh{ h;#dh.7h;#dh.7mH sH âȢѢQR_opq|ƣ$'EKLVv~ȼֵ֮ȠȠ|ungchb h;#dhe h;#dh_9 h;#dhzVh;#dhV+0J5\h;#dh0J5\h;#dh"g0J5\ h;#dhS h;#dh%! h;#dh"g h;#dhV+h;#dhXx0J5\ h;#dh h;#dhw h;#dhXx h;#dh,x' h;#dh h;#dh 1 h;#dhc( h;#dhDW&~ǤȤɤͤؤݤ1ABk÷îâ~rgXgXjh;#dhFUmH sH h;#dhFmH sH h;#dhw0J5\h;#dhc(0J5\h;#dhXx0J5\h;#dh0J5\h;#dhzV0J5\hb0J5\h;#dh6V"0J5\h;#dh"g0J5\ h;#dh{p h;#dhS h;#dh=/ h;#dh"g h;#dh%! h;#dh h;#dhzVkCDEUV01;<$ & FThA$^ha$gdqO $A$a$gdM $A$a$gd;. $A$a$gdK $A$a$gdO $A$a$gd;.$ & FQhA$a$gdqO%)CDETUVuʼrk`U`J;J;jh;#dh)UmH sH h;#dh)mH sH h;#dh2mH sH h;#dhKZmH sH h;#dh%!h;#dht5CJ \aJ &hOh%!5CJ OJQJ\^JaJ &hOhF5CJ OJQJ\^JaJ &hOhO5CJ OJQJ\^JaJ h;#dhF h;#dhh;#dh_Hh;#dhmH sH jh;#dhFUmH sH $h;#dhF0J>*B*mH phsH   \]lm}~ۧܧ #$EFΨȽvk`kQjh;#dhYUmH sH h;#dhV+mH sH h;#dhmH sH $h;#dhK 0J>*B*mH phsH $h;#dhS]0J>*B*mH phsH jh;#dhS]UmH sH h;#dhS]h;#dhS]mH sH h;#dhYmH sH h;#dhIbmH sH h;#dh)mH sH jh;#dh)UmH sH $h;#dh)0J>*B*mH phsH GHRSno©éөԩ(ABǪȪ"ȽȶwhwhUhw$h;#dhNI0J>*B*mH phsH jh;#dhNIUmH sH h;#dhNImH sH $h;#dh:0J>*B*mH phsH jh;#dh)UmH sH h;#dh)mH sH h;#dh h;#dhrh;#dhJmH sH h;#dhrmH sH $h;#dhY0J>*B*mH phsH jh;#dhYUmH sH h;#dhYmH sH "&_b $%*/@GȵȪןzzgz\UN h;#dh4 h;#dh_h;#dh*6mH sH $h;#dh;0J>*B*mH phsH jh;#dhqUmH sH h;#dhL&=mH sH h;#dhqmH sH h;#dhimH sH h;#dhqYmH sH $h;#dh)0J>*B*mH phsH jh;#dh)UmH sH h;#dh)mH sH h;#dhIbmH sH h;#dhNImH sH hKmH sH !45GHЭѭCFGHs ǯޯ߯jkŰư /0򺳺򒇒xq h;#dhh;#dhG"0J>*B*phjh;#dhG"U h;#dhG"h;#dh*60J>*B*phjh;#dh*6U h;#dh h;#dh*6 h;#dhR h;#dhe_ h;#dhV+ h;#dh: h;#dhij h;#dhi h;#dh_ h;#dh4 h;#dhL&=*01:BXpqPQVWY|ŲŲŲ߫wwdw$h;#dhc0J>*B*mH phsH jh;#dhcUmH sH h;#dhcmH sH h;#dhG"mH sH hMmH sH h;#dh%! h;#dh3}$h;#dh%!0J>*B*mH phsH jh;#dh%!UmH sH h;#dhL&=mH sH h;#dh%!mH sH h;#dh_"NmH sH h;#dh_mH sH "EFOQRX`fxyԳճ޳߳DEZ[\nz{ȴɴ״شٴ ȴ۩ꞓۓ}}yrk h;#dhNd h;#dh0hOuh;#dh3}mH sH h;#dh?mH sH h;#dh4mH sH h;#dh_mH sH h;#dhmH sH 'h;#dhc0J>*B*H*mH phsH $h;#dhc0J>*B*mH phsH jh;#dhcUmH sH h;#dhcmH sH h;#dhNdmH sH *.034STX\]d !",rsȶɶӶԶٶڶ#$01Z[bch·ͨ͡ttiih;#dhe_mH sH $h;#dh?0J>*B*mH phsH h;#dh?mH sH jh;#dh?UmH sH h;#dh4 h;#dhG"hNdmH sH h;#dhijmH sH h;#dhNdmH sH h;#dhXq h;#dhOuhOumH sH h;#dhv mH sH h;#dh0 h;#dhNdhOu&"!",-J./0DEFGYZ $A$a$gdO $A$a$gdg1 $A$a$gd;.$ & FShA$a$gdqO $A$a$gd;.$ & FThA$^ha$gdqO$ & FThA$^ha$gdOuhimn{ ,-./HIJ{|͸θ޸߸ ./01žŷŷŷŬŃŷŷq_"h;#dhvE5CJ,\aJ,mH sH "h;#dh?5CJ,\aJ,mH sH h;#dh4$h;#dh_0J>*B*mH phsH jh;#dh_UmH sH h;#dh_mH sH h;#dh_ h;#dh h;#dhG"h;#dh?mH sH hdh,b h;#dhV+h;#dh0< h;#dh0h;#dh0mH sH 134CDEFGYZkmrs{ϹƲwpf_X_QM_F?4h;#dhnmH sH h;#dhqg h;#dhP`Uh%@ h;#dh%@ h;#dh3n h;#dhnh;#dhP`U5\ h;#dhjh;#dhtCJ aJ &hOh/N5CJ OJQJ\^JaJ h;#dhg15\ h/N5\hh5CJ \aJ &hOhj5CJ,OJQJ\^JaJ,&hOh 5CJ,OJQJ\^JaJ,&hOh_5CJ,OJQJ\^JaJ,"h;#dh[5CJ,\aJ,mH sH Ϲй GVZ`<=CDQYfĽ˶vgvgjh;#dhp-xUmH sH h;#dhp-xmH sH h;#dhJ{T h;#dhjh;#dhjU h;#dh h;#dhGx h;#dh} h;#dh2B h;#dhj h;#dhht h;#dh3n h;#dhn$h;#dhn0J>*B*mH phsH h;#dhnmH sH jh;#dhnUmH sH !  %'+0hiſο78PQ/09:;xxqxqxmxbxbxb^hM6jh;#dhhtUhmE h;#dh} h;#dhht h;#dh_"N h;#dh1 h;#dhp-xjh;#dhjU h;#dh h;#dhjh;#dh2BmH sH hM6mH sH h;#dhp-xmH sH jh;#dhp-xUmH sH $h;#dh0J>*B*mH phsH $h;#dhp-x0J>*B*mH phsH "Z,]HRm$ & FUhA$a$gdqO$ & FUh-DA$M a$gdqO$ & FVh-DA$M a$gdqO$ & Fih-DA$M a$gdqO$dd-DA$M [$\$a$gd;. $A$a$gd%@;<]^di67;FHRSim~DzդǤǝǤ}yr h;#dhGxh h;#dh>8h|c h|ch|c h;#dhl h;#dh h;#dhj h;#dh1 h;#dh5 h;#dhr h;#dh; h;#dhm h;#dh] h;#dhZU h;#dh3nh;#dhhtmH sH h;#dhZUmH sH h;#dhht h;#dhF,8:lm Wl9:;FGeüõ瘣} h|c5CJ OJQJ\^JaJ h;#dhj5\jh;#dhjU h;#dh2Bh;#dh3nmH sH h;#dhC= h;#dhl h;#dh]jh;#dhUh;#dhmH sH h;#dh1 h;#dhjhmE h;#dhGx h;#dh-W;./9:VWab $A$a$gd;. $A$a$gd|c $A$a$gdO$x-D@&A$M a$gd;.$ & FUhA$a$gdqO$%+,023pqwx"#kùsh]sVO h;#dhlN h;#dhHoh;#dhhmH sH h;#dhXmH sH $h;#dhqg0J>*B*mH phsH jh;#dhqgUmH sH h;#dhqgmH sH h h;#dhUy- h;#dh: h;#dhjh;#dhP`U5\ h;#dhhh;#dht5CJ \aJ &hOhh5CJ OJQJ\^JaJ &hOhj5CJ OJQJ\^JaJ k'()^#$\]^+,-./89:PYVWab·°©ޞޞީީׅ~ׅ~wpwpwpw h;#dh h;#dhy$@ h;#dh_"N h;#dhhh;#dhfcfmH sH h;#dhUy-jh;#dhjU h;#dhfcf h;#dhJ{Th;#dhlNmH sH h;#dhlN h;#dh>8 h;#dh@h h;#dhh h;#dhjh;#dhh_Hh;#dhh_Hh;#dhlN_H,b[\fs  :; :CD&FI\^űţxqmibbb^hU! h;#dh0\6hP0h:W_ h;#dh:W_h;#dhmAH* h;#dha h;#dhCU h;#dhmA h;#dhG h;#dh/oh;#dht5CJ \aJ &hOh%@5CJ OJQJ\^JaJ &hOhj5CJ OJQJ\^JaJ hO5CJ \aJ h;#dh M& h;#dh h;#dh h;#dhj$b\HJTU$ & FhA$^ha$gdqO $A$a$gd! $A$a$gd;. $ A$a$gd;. $A$a$gdP0 $A$a$gdO $A$a$gd;.$ & FWhA$a$gdqO,CNrsHIJSTDe%  ݬhB5CJ PJ\aJ h;#dhB [h;#dhjH* h;#dhj h;#dhd h;#dhih h;#dhmA h;#dh&w h;#dhv* h;#dhJ{T h;#dh%@ h;#dh_"N h;#dh!<- h;#dha h;#dhRL h;#dhG h;#dh0\6+  !b $h1$^ha$gd;.$ & Fvh1$^ha$gdqO $1$a$gd;. $A$a$gd $A$a$gdB $A$a$gd;. $hA$^ha$gd;.$ & FXhA$a$gdqO $A$a$gd;.'45;0Q "&+stUkrsԾ}}}vovvhvaXXOh;#dh@h_Hh;#dh@_H h;#dh%I h;#dh_- h;#dh{@ h;#dhjh;#dh@U h;#dh@h;#dhmH sH h;#dh@mH sH h;#dhPJh;#dht5CJ PJ\aJ *hBh5CJ OJPJQJ\^JaJ *hBh@5CJ OJPJQJ\^JaJ *hBhP`U5CJ OJPJQJ\^JaJ sy #$P`abk|}YZȽմՓ՚}}j}_}}h;#dh-mH sH $h;#dh@0J>*B*mH phsH jh;#dh@UmH sH h;#dh{@ h;#dhCUh;#dh@mH sH h;#dh%I_H h_Hh;#dh=/_Hh;#dh%ImH sH h;#dh%I_HmH sH h;#dh@h;#dh@h_Hh;#dh_-_Hh;#dh"_Hh;#dh@_H%Z`aij !"&KN{j\{K h;#dheo0CJOJQJ^JaJhX2CJOJQJ^JaJ h;#dhTqCJOJQJ^JaJ h;#dhOCJOJQJ^JaJ h;#dh_"NCJOJQJ^JaJ h;#dhB [CJOJQJ^JaJ h;#dh@h;#dh_-mH sH hAmH sH h;#dhVBmH sH h;#dh@mH sH jh;#dh@UmH sH $h;#dh@0J>*B*mH phsH NAB_`abcmŷ֑fffUD3 h;#dheo0CJOJQJ^JaJ h;#dh_-CJOJQJ^JaJ h;#dhRlCJOJQJ^JaJ1jh;#dhRlCJOJQJU^JaJmH sH "hJACJOJQJ^JaJmH sH (h;#dhWCJOJQJ^JaJmH sH h;#dhOCJOJQJ^JaJhX2CJOJQJ^JaJ h;#dhB [CJOJQJ^JaJ(h;#dhRlCJOJQJ^JaJmH sH (h;#dheo0CJOJQJ^JaJmH sH mxɴɢp^M?1?Mh$?CJOJQJ^JaJh-&CJOJQJ^JaJ h;#dhOCJOJQJ^JaJ"h$?CJOJQJ^JaJmH sH "hmCJOJQJ^JaJmH sH (hmhmCJOJQJ^JaJmH sH hmhmmH sH "h-&CJOJQJ^JaJmH sH (h;#dheo0CJOJQJ^JaJmH sH (h;#dhWCJOJQJ^JaJmH sH h;#dheo0CJOJQJ^JaJ h;#dh_-CJOJQJ^JaJ&cefiknpͼwhhUhwMBh;#dhYmH sH hmH sH $h;#dhO0J>*B*mH phsH jh;#dhOUmH sH h?mH sH h;#dhumH sH h;#dheo0mH sH h;#dh>nmH sH h;#dhOmH sH h;#dh&CJOJQJ^JaJ h:ThOCJOJQJ^JaJ h:Th_-CJOJQJ^JaJ h:Th:TCJOJQJ^JaJ h;#dhOCJOJQJ^JaJ&f3)1,67HIJa $A$a$gdB 7$a$gd;.$ & FhA$a$gd~$ & FwhA$^ha$gdqO$ & FYhA$a$gdqO $ & FYa$gdqO $1$a$gd;.35STUz%&)=>)*Y`n鱞tlah;#dhN}mH sH hpbmH sH h;#dhW=mH sH jh;#dh>UmH sH hpb0J>*B*mH phsH $h;#dhO0J>*B*mH phsH jh;#dhOUmH sH hphmH sH h;#dh@hmH sH h;#dhmH sH h;#dh>mH sH h;#dhOmH sH hmH sH hJ"ny1259=CDL_bcְָ˥|mmZmRGh;#dhmH sH hpbmH sH $h;#dhO0J>*B*mH phsH jh;#dhOUmH sH h;#dhemH sH h;#dh_9mH sH h;#dh{mH sH hZlmH sH h;#dhOmH sH hmH sH $h;#dh0J>*B*mH phsH h;#dhmH sH jh;#dhUmH sH h>mH sH h;#dh>mH sH h^4mH sH ,67 tu %&uv|sl|||| h;#dh@hh;#dh>_H h;#dh>h;#dh&0J>*B*phjh;#dh&Uh ; h;#dhT h;#dh&huc h;#dhvF h;#dh h;#dh+; h;#dhTqCJOJQJ^JaJ h;#dh&CJOJQJ^JaJh;#dhOmH sH h;#dh@mH sH *  +X`loyz{~HIJP`abܿzfXh;#dhP`U5CJ \aJ &hBht5CJ OJQJ\^JaJ &hBhf.25CJ OJQJ\^JaJ &hBhm5CJ OJQJ\^JaJ hB5CJ \aJ h;#dh h;#dh mH sH h;#dh  huchuch~ huch huch  h;#dhT h;#dh{@ h;#dh> h;#dh+;h*ac2yz$hhA$]h^ha$gd7$ & F[hA$]a$gdqO$ & F[hA$a$gdqO $hA$]ha$gd7 $A$]a$gd7 $hA$]ha$gd;. $A$a$gd;.bcyzGHKLMX[\vw )*ŶŶŶŶōŶŶł{tmt{f h;#dh h;#dh@h h;#dh|s h;#dhih;#dhimH sH h;#dh mH sH h;#dhj.[mH sH $h;#dh90J>*B*mH phsH jh;#dh9UmH sH h;#dh9mH sH h;#dhm5\ h;#dhmh;#dhAI5\ h;#dhAIh;#dhAI5CJ \aJ #*8OPVjpqr,0>?o()ʿʸѪtetejh;#dh UmH sH h;#dh mH sH h;#dh h;#dh_"Nh;#dhTqmH sH h;#dhzmH sH h;#dhS=! h;#dhf.2 h;#dh G& h;#dh2G} h;#dhBhT h;#dh h;#dhih;#dhimH sH h;#dh%pmH sH h;#dh%ph;#dhmH sH ! "023*HIJY\xyz|u|ung`Y h;#dh- h;#dhT ^ h;#dhN} h;#dhJ+` h;#dhB h;#dh@h h;#dhXl h;#dh|s hT_H h4+_Hh;#dhXl_Hh;#dh>S/_Hh;#dh@h_Hh;#dhW_H h;#dh%p h;#dhW h;#dh hcAmH sH jh;#dh UmH sH $h;#dh 0J>*B*mH phsH "F[{~JK^_`a/0Ļ˲}vkhB5CJ \aJ h;#dhT ^ h;#dhN}h;#dhe_Hh;#dh_9_Hh;#dh|s_Hhh H*_Hh;#dh'x_Hh;#dh _Hh;#dh-_H h;#dh>S/ hT_H hb_Hhb h;#dh  h;#dhoh;#dh>S/_H h;#dh- h;#dh|s"F/0>?()*+5,||||||$-DM a$gd;. $A$a$gdB $A$a$gd;.%$ & FZhddd-DA$M [$\$^ha$gdqO'$ & FZhddd-DA$M [$\$]^ha$gdqO$ & FZhA$]^ha$gdqO 0=>?N$%^_deg=VWüxmxm^mxmxm^mh;#dhC0J>*B*phjh;#dhCU h;#dhC h;#dh!S h;#dhm_ h;#dhez h;#dh h;#dh.Wh;#dh10J>*B*phjh;#dh1U h;#dh1 h;#dh[h;#dht5CJ \aJ &hBh[5CJ OJQJ\^JaJ &hBh15CJ OJQJ\^JaJ $MNZ\XYchvw34:;ST  "#$'(+458=>h;#dhJF}0J>*B*phjh;#dhJF}U h;#dhJF} h;#dh $h[ h;#dh_"Nh~ h;#dh/ih;#dh $0J>*B*phh;#dhC0J>*B*phjh;#dhCU h;#dhChb867 )*+,/?C!";<'(012:ƿưƿƿưƿ}rh;#dhSXmH sH h;#dh0J>*B*phjh;#dhU h;#dhh h;#dh3i h;#dhhh;#dh10J>*B*ph h;#dh1jh;#dh1U h;#dh[ h;#dh@hh;#dhJF}0J>*B*phjh;#dhJF}U h;#dhJF}+,<o"#12 deo $7$8$A$H$a$gd9t $7$8$A$H$a$gd;. $A$a$gd;K $A$a$gdB $ & F]a$gdqO $A$a$gd;.$ & F\hA$a$gdqO$ & F\h-DA$M a$gdqO:@nopr !"#012CIQcIPgܴܿ~wpwpib^biWi h;#dhN}h;K h;#dh;K h;#dh1 h;#dhia h;#dh<(h;#dht5CJ \aJ &hBh<(5CJ OJQJ\^JaJ &hBh15CJ OJQJ\^JaJ hB5CJ \aJ h;#dhCmH sH h;#dhCh;#dh.WmH sH h;#dhSXmH sH h;#dh h;#dho h;#dh;XmH sH "5,/BFHJȠp\&hBhoY5CJ OJQJ\^JaJ &hBh#+5CJ OJQJ\^JaJ hB5CJ \aJ h;#dhia5\ h;#dh7 h;#dhThoh;#dhomH sH h;#dhoh97 h;#dh97 h;#dhia h;#dhIe h;#dh9t h;#dh<( h;#dh_"N h;#dhA h;#dh1 h;#dh?opJ $A$a$gdo $A$a$gdB $A$a$gd;. $hA$]ha$gd;.$ & F^h7$8$A$H$^ha$gdqO$ & Fjh7$8$A$H$a$gdqO $7$8$A$H$a$gd;.=@pvCDUV^k~67ü{tmbSbSjh;#dhmEUmH sH h;#dhmEmH sH h;#dh``D h;#dhmE h;#dhnlh;#dheaJ h9taJh;#dhomH sH h;#dh_9aJh;#dhSaJ h;#dhS h;#dh1cI h;#dh#+ h;#dh7h;#dht5CJ \aJ &hBhoY5CJ OJQJ\^JaJ &hBh75CJ OJQJ\^JaJ 7GHJXL_en}ȿxoiob[boboxPh;#dhmH sH h;#dhe h;#dhU h97_Hh;#dhU_Hh;#dhwLmH sH h;#dh_"NmH sH h;#dhojmH sH h;#dh``DmH sH h;#dhC_Hh;#dhS_Hh;#dh``D_Hh;#dhmE_Hh;#dhGmH sH h;#dhmEmH sH jh;#dhmEUmH sH $h;#dhmE0J>*B*mH phsH Lr } $A$a$gdB $A$a$gd;.$ & F`-DM a$gdqO*$ & F_ hhddd-DA$M [$\$^ha$gdqO$dK-DA$M a$gd97$dK-DA$M a$gd;. 9JKLMn+345IUɾɫ|uung`YRYg h;#dhC h;#dh$ h;#dhq h;#dhX< h;#dh h;#dhh;#dh)KmH sH h;#dhmH sH h;#dhL# h;#dh97h97 h;#dh9h;#dh9mH sH h97mH sH h;#dh hmH sH h;#dh1mH sH h;#dh$_Hh;#dhC_H h#_Hh;#dh_Hh;#dh&mH sH Unpqr $ B C b i          2      ' ( Ʋ}vohoh_Vh;#dhi~_Hh;#dhZx_H h;#dh9 h;#dhu" h;#dhN} h;#dh^; h;#dh_9 h;#dh h;#dhi~ h;#dh^; h;#dhO h;#dhtCJ aJ &hBhO 5CJ OJQJ\^JaJ hB5CJ \aJ h;#dh};mH sH h;#dhmH sH h;#dh1mH sH h;#dhX< h;#dhL#!( L    4 x              ?Qqrs27D»޴~wp~~ h;#dh4[/ h;#dh ho- h;#dho-h;#dhQ_Hh;#dh _Hh;#dhU1_Hh;#dhu _H h;#dhU1 h;#dh_"N h;#dhu" h;#dh h;#dh^; h;#dh h;#dh1 h;#dhSh;#dh_Hh;#dh_Hh;#dhZx_H,  rsnyz5$ & Flh-DA$M ^ha$gdqO$ & Fk-DM a$gdqO$ & FkhA$a$gdqO $A$a$gd;.$-DA$M a$gd;..67P[]\bmnxyz ž||uqujf_j h;#dh~h]\K h;#dhz5hyXH h;#dh5 h;#dhS h;#dh h;#dh aCJOJQJ^JaJ h;#dhu" h;#dh1 h;#dh G& h;#dhu h;#dh  h;#dh{ohX!h: h;#dh:h4[/ h;#dh4[/ h;#dhU1 h;#dhZ4hNhOho- h;#dho-%<=Vbc>`fĸҬқ򔍆نyrr h;#dh3h;#dh5 (_Hh+ h;#dh5 ( h;#dh1 h;#dh:+ h;#dhS@h;#dhN25\h;#dhN20J5\h;#dh]\K0J5\ h;#dh]\K h;#dh~ h;#dhN2 h;#dh 6h]\K h;#dh a h;#dh4= h;#dhz5 h;#dh* D/e= $ bA$a$gdup$ & FnhA$a$gdqO$-DA$M a$gd;.$ & FmhA$a$gdqO $A$a$gd+ $A$a$gd;."#$D/ADeuv-4blƻذ؝Ѩ򖏈 h;#dhO h;#dhxD h;#dhd\ h;#dhz5hehemH sH hfhG$h@J h;#dh1heh'xmH sH hehumH sH h;#dh~hehY4h1 h;#dhe h;#dhdI h;#dh5 ( h;#dhKG0?Aewy$<=>ȵۉwwpepeh;#dhlpV_HaJ h;#dhh;#dhoJ_HaJ h;#dhoJ h;#dh}U h}U_Hh;#dh}U_Hhaha_HaJhahY4_HaJhah}U_HaJh}U_HaJh;#dhY4_HaJhY4_HaJh;#dh}U_HaJha_HaJh;#dh_Hh;#dhlpV_H%)*+?DFTmqdz|uunj_WL_h;#dh*mH sH h?mH sH h;#dh> mH sH h? h;#dh? h;#dh1 h;#dh> h;#dhz h;#dhSh;#dht5CJ \aJ &hNChS5CJ OJQJ\^JaJ &hNCh15CJ OJQJ\^JaJ &hNChNC5CJ OJQJ\^JaJ h;#dhShuphk6o_HaJh;#dhk6o_HaJ h;#dhk6o*+^_ij    < F G ;! 0J>*B*mH phsH jh;#dh> UmH sH h;#dh umH sH hJ9mH sH h;#dh:h;#dh> mH sH h;#dh:mH sH !  GJLSVWZqr+/\]_hͷ͖ͬͬ͡؏؈zszhzhjh;#dh])U h;#dhi~ h;#dh]) h;#dh_"N h;#dhWH h;#dh=oh;#dh=omH sH h;#dhi~mH sH h;#dh])mH sH h;#dhx8mH sH h;#dhYxmH sH h;#dh%SmH sH h;#dhYx h;#dh1jh;#dh1Uh;#dh10J>*B*ph#    : < E F G      !!!!!;!*B*phI!J!W!Z!]!!!!!!!!!!###2#F#N#O###############ػ~vii`Wi`ii`i`h;#dhkz0_Hh;#dhzv_Hjh;#dhEuU_Hh`mH sH h;#dh h;#dh@_Hh;#dhd_Hh;#dh` O_Hh;#dh'x_Hh;#dhR-_Hh;#dh_Hh;#dhEu_H h;#dh>h;#dhR-_HmH sH h;#dhm_HmH sH h;#dh_HmH sH h;#dht5CJ \aJ "###$$$$)$*$m$n$|$}$$$$$$$$$% %%%U%V%`%a%c%d%%%%%%%%%%&&& &&&&&&&'&ķķķķķķ计͔֡֡֡֡֡蔋} h;#dh@ h;#dhtl4h;#dhtl4_Hjh;#dhEuU_Hjh;#dhmU_Hh;#dhd_Hjh;#dh>U_Hh;#dh>_Hh;#dhzv_Hh;#dhm_Hh;#dh _Hh;#dhEu_Hh;#dh`_H h`_H1'&(&W&v&)'0';'<'='C'f'h'i''''''''((((( (!("(-(m(n(o(x(y(z((((ɳ¬¬£|ungugu h;#dh h;#dhEu h;#dhmh;#dha_Hh;#dh@_H h;#dhR- h;#dh_"N h;#dhoYh;#dh>_H h;#dh 2h;#dh)0J>*B*ph h;#dh)jh;#dh)U h;#dhi~ h;#dh! h;#dhPN, h;#dh@ h;#dh>h;#dh _H%J!((!("(n(o(y(z(((((^))* * ** *P,Q,[,\, $A$a$gdNC $A$a$gd;.$ & FahA$^ha$gdqO $A$a$gd;. $A$a$gd`((((1):)^)_)g)p)))))))** * *** *4*6*[*\*f*****++<+M+O+P+R+ȴzszszleeee h;#dhC h;#dhA{ h;#dh! h;#dhJrh;#dhoY5\ h;#dhwEh;#dht5CJ \aJ &hNChwE5CJ OJQJ\^JaJ &hNCh+5CJ OJQJ\^JaJ hNC5CJ \aJ h;#dh[=5\ h;#dh 2 h;#dh_"N h;#dh h;#dhm h;#dhsc=&R+++++++ ,$,O,P,Q,Z,e,l,,,,,,- -(-)-a-b-k-l-m-y-------ݺ볬nZ&hXqhP5CJ,OJQJ\^JaJ,&hXqhz5CJ,OJQJ\^JaJ,h;#dh[5CJ,\aJ,h;#dhh5CJ,\aJ, h;#dhh h;#dhN} h;#dh1 h;#dhA{ h;#dh_Tr h;#dh: h;#dh_"N h;#dhi~ h;#dh` O h;#dh h;#dhM.h;#dh>mH sH h;#dhKmH sH h;#dhY{mH sH h;#dhBmH sH h;#dhmH sH h;#dhM.mH sH %000,16171B1C1s1t1u11111111111j2k2o2u22222223/3y33333ռծծգvk`kh;#dhmmH sH h;#dhRmH sH h;#dhmH sH h;#dhE),H*mH sH h;#dhE),mH sH h;#dh+8^mH sH h;#dh:mH sH h;#dh5 h;#dh: h;#dh+8^h3. h;#dhQ h;#dh h;#dhRh;#dhKB*CJaJph h;#dhU h;#dh h;#dhE),%00+1,16171t11Z22/3y333333%6&6066$a$gd;. $A$a$gdXq$ & FhA$^ha$gdqO$ & FhA$a$gdqO$a$gd;. $A$a$gd;. $A$a$gd;.33333333333 44-4.40414=4K4L444444͹ungngnXXEX$h;#dhx8.0J>*B*mH phsH jh;#dhx8.UmH sH h;#dh(x h;#dh^Ah;#dhXmH sH h;#dhx8.h;#dh^AmH sH h;#dhx8.mH sH h;#dh: h;#dhL"h;#dhqB5CJ \aJ &hXqhL"5CJ OJQJ\^JaJ &hXqhx8.5CJ OJQJ\^JaJ &hXqhXq5CJ OJQJ\^JaJ h;#dhE),mH sH 44 555/505q555$6%6&6/606g6u6666667f7g777777788vgvgTgvgvg$h;#dhD0J>*B*mH phsH jh;#dhDUmH sH h;#dhDmH sH h;#dhhB h;#dh(xh;#dh(x_H,h;#dhhB_H,h;#dh:_H, h;#dhL" h;#dh_"NhXq h;#dhx8.h;#dh(xmH sH h;#dhx8.mH sH h;#dhY{ h;#dhD h;#dhb h;#dhzeYh;#dhbmH sH 667p8z889k9l999??%?&?n?o?y?z??$@%@/@$ & Fdh^ha$gdqO $A$a$gd$ A$a$gd;. $ & Fba$gdqO $ & Fca$gdqO$a$gd;.88888L8M8p888992999k9l9z9{999999k]N?Nh;#dhdB*CJaJphh;#dhx8.B*CJaJphh;#dhqB5B*\ph'hXqhd5B*OJQJ\^Jph'hXqhhB5B*OJQJ\^JphhXq5B*\ph h;#dh(x h;#dhF^ h;#dhb h;#dhD h;#dh], h;#dhzeYh;#dhzeYmH sH h;#dhDmH sH jh;#dhDUmH sH $h;#dhD0J>*B*mH phsH 9999999:: :%:p:q:r:u:::λΨwhUF7h;#dh&B*CJaJphh;#dhx8.B*CJaJph%h;#dhzJB*CJaJmH phsH h;#dhzJB*CJaJphh;#dhdB*CJaJphh;#dhN}B*CJaJph%h;#dhy zB*CJaJmH phsH %h;#dhB*CJaJmH phsH %h;#dh4B*CJaJmH phsH %h;#dhx8.B*CJaJmH phsH h;#dh&l)B*CJaJphh;#dhoYB*CJaJph:::::::;;);*;e;f;k;l;;;;;;; < <J<K<Q<R<[<\<<<<<<<<(=)=/=0=Z====ζζζζζζζζζζζζ}nh;#dhYSB*CJaJphh;#dhzJB*CJaJph%h;#dh+B*CJaJmH phsH ,h;#dhx8.0J>*B*CJaJmH phsH .jh;#dhx8.B*CJUaJmH phsH %h;#dhx8.B*CJaJmH phsH h;#dhx8.B*CJaJphh;#dh,B*CJaJph+=;><>a>b>>>>>>> ? ??????$?%?)?.?D?m?ζζζζΌ}n_P=P=%h;#dhB*CJaJmH phsH h;#dhB*CJaJphh;#dhhBB*CJaJphh;#dh_"NB*CJaJphh;#dh85B*CJaJph%h;#dh%^"B*CJaJmH phsH ,h;#dhx8.0J>*B*CJaJmH phsH .jh;#dhx8.B*CJUaJmH phsH %h;#dhx8.B*CJaJmH phsH h;#dh&B*CJaJphh;#dhzJB*CJaJphm?o?x?y??? @@%@0@1@<@H@M@h@n@o@ôåÒlYF3F%h;#dh+B*CJaJmH phsH %h;#dh%B*CJaJmH phsH %h;#dhYSB*CJaJmH phsH %h;#dhx8.B*CJaJmH phsH %h;#dh-yB*CJaJmH phsH %h;#dh%^"B*CJaJmH phsH h;#dhB*CJaJphh;#dhYSB*CJaJphh;#dhrB*CJaJphh;#dh&[B*CJaJphh;#dh5B*CJaJphh;#dhhBB*CJaJph/@0@p@@@@@AAAABBCBMBqBBBBBB $ 7A$a$gd;.$ & FphddA$[$\$a$gdqO$-DA$M a$gd;. $A$a$gd;.$ & Feh^ha$gdqO$a$gd;.o@p@q@y@~@@@@@@@@@@@@@@@@A(A-A6ARAïÇykd]VdOHOAO h;#dhO h;#dh7) h;#dhx8. h;#dhN} h;#dhahi h;#dhih;#dhi5CJ \aJ h;#dhx8.5CJ \aJ &hXqhqB5CJ OJQJ\^JaJ &hXqhN}5CJ OJQJ\^JaJ &hXqhahi5CJ OJQJ\^JaJ &hXqhx8.5CJ OJQJ\^JaJ h;#dh855\h;#dh-yB*CJaJphh;#dh85B*CJaJphRAZAAAAAAAAAABBBMBSBBBBBBBB*B*mH phsH jh;#dhr UmH sH h;#dh2; h;#dhX h;#dh G& h;#dho h;#dh5 h@ h;#dhr h;#dh5 mH sH h;#dhr mH sH "KKKKKLLL'L/L>LBLCLOLUL]L^LLLMMMMM:N\NNNNNOO_OpOqOOOOOOO}voh} h;#dh: h;#dhj h;#dhxO h;#dh h;#dhh;#dh:{mH sH h;#dho h;#dh2; h;#dh_9 h;#dh) h;#dhJlh;#dhzH* h;#dhzh;#dh2;mH sH h;#dhjmH sH jh;#dhjUmH sH $h;#dhj0J>*B*mH phsH (OOOO'P)PPPPPQGRMR{RRRTSUSVS_SSSSSSTTTiTjTzT{T|TTTwwdw$h;#dh0J>*B*mH phsH jh;#dhUmH sH h;#dh WmH sH h;#dh[xjmH sH h;#dh WmH sH h;#dhmH sH h;#dh_"NmH sH h;#dh5\ h;#dh#h;#dh G&mH sH h;#dh#mH sH h;#dh h;#dh2; h;#dhj h;#dh"TTTTTTCUDUEUFUHURUSUTU}UUUUUUUUUUUUUUUUUUU"V#VǼ~s埔h~]h;#dhemH sH h;#dh:mH sH h;#dhxOmH sH h;#dhmmH sH h;#dhQ7mH sH h;#dhBmH sH h;#dhB h;#dhhh;#dh[xjmH sH h;#dhmH sH h;#dh WmH sH $h;#dhb0J>*B*mH phsH h;#dhbmH sH jh;#dhbUmH sH "SUU#VVW|X}XXX)YY:Z[[[[``` $A$a$gdXq$ & Ffh^ha$gdqO$ & FfhA$^ha$gdqO$ & FfhA$^ha$gdqO $A$a$gd;. $A$a$gd;.$ & FghA$^ha$gdqO#V[V\VwVzVVVVVWWWWWWWWLXMX{X|X}XXXXXXXXXXXYY(Y)Y0Yѷꥷўvkh;#dh WmH sH h;#dhmH sH h;#dhd h;#dhN h;#dh&h;#dhH* h;#dhh;#dhemH sH h;#dh9;h;#dhBmH sH h;#dhH* h;#dh h;#dhh;#dhfmH sH h;#dhf h;#dheh;#dhQ7H* h;#dhQ7$0Y1Y|Y}YYYYYY9Z:ZVZ\Z]ZkZsZvZwZZZZZZZZ[[[6[<[=[[[[[[[[[[[副{tmf h;#dh h;#dhe h;#dh_9 h;#dh h;#dh4h;#dh mH sH $h;#dhxO0J>*B*mH phsH h;#dhH* h;#dhh;#dh W5\ h;#dh Wh;#dhdmH sH $h;#dh W0J>*B*mH phsH h;#dh WmH sH jh;#dh WUmH sH ([[[[[[\\\,\8\C\L\M\\\\\\\\\\\\\]]I]J]͹xiiViiiViKiih;#dh G&mH sH $h;#dhG0J>*B*mH phsH jh;#dhGUmH sH h;#dh[mH sH h;#dh:mH sH h;#dh@mH sH h;#dhGmH sH h;#dh@h;#dhqB5CJ \aJ &hXqh@5CJ OJQJ\^JaJ &hXqh]5CJ OJQJ\^JaJ &hXqh525CJ OJQJ\^JaJ hXq5CJ \aJ J]S]T]]]]]]]]]]2^3^9^:^D^E^^^^^^^^^^__f_g_r_s_____ӽӲzodo] h;#dh]h;#dhXmH sH h;#dh@mH sH h;#dh)mH sH $h;#dh ]0J>*B*mH phsH jh;#dh ]UmH sH h;#dhdmH sH h;#dh ]mH sH h;#dhX^mH sH h;#dh5:mH sH h;#dhGmH sH jh;#dhGUmH sH $h;#dhG0J>*B*mH phsH $____A`C`d`e````````````4a5a*B*mH phsH jh;#dhC,UmH sH h;#dhC,mH sH h;#dh@mH sH h;#dhX^mH sH h;#dhX^ h;#dh_"N h;#dhC, h;#dh ] h;#dhr?h;#dhr?mH sH h;#dh)mH sH h;#dh]h;#dh]H*```WaXabacamanaaaaadbbbbbbhh $ 7A$a$gdXq $ 7A$a$gd;.$ & FhhA$^ha$gdqO $A$a$gdT $ & FrhA$a$gdqO $A$a$gd;.naqaza{aaaaaaaadbebrbbbbbbbbbbbbbbbc꺨{tmf\Qh;#dhimH sH h;#dhi5\ h;#dhi h;#dh` " h;#dhoYh;#dhqB5CJ \aJ &hXqhd.5CJ OJQJ\^JaJ hXq5CJ \aJ h;#dh]h;#dhX^mH sH h;#dhC, h;#dhr?$h;#dhC,0J>*B*mH phsH jh;#dhC,UmH sH h;#dhC,mH sH h;#dhr?mH sH ccc cVcWchciccccccccccc'd(d.d/d1d`dhdkdddeeeefffffBgggggg꽲m$h;#dh` "0J>*B*mH phsH jh;#dh` "UmH sH h;#dh h;#dh h;#dh` " h;#dhva h;#dhsGh;#dhsGmH sH h;#dh` "mH sH $h;#dhi0J>*B*mH phsH jh;#dhiUmH sH h;#dhimH sH h;#dh8mH sH *ggg4h=hhhhhhhhhhhhii]i~iiiiiiijj^j_jbjcjjjjjj»ɭɦɟɖ}}v}o}d}d}djh;#dh0U h;#dhg h;#dh>z h;#dh0h;#dh_Hh;#dhg>_Hh;#dh0_H h;#dh h;#dh) h;#dhg> h;#dhd. h;#dh h;#dh_"N h;#dh h;#dhsG h;#dhju h;#dh` "h;#dh` "mH sH jh;#dh` "UmH sH $hhhiiiiijkkklCllll $A$a$gdwbT $A$a$gd;. $ & Fia$gdqO$ & FshA$a$gdqO$-A$^`-a$gd;.$ & FthA$a$gdqO $ 7A$a$gd;. $A$a$gd;.jjjjjkkkkkkkkkkkl*l-lClNl[lzlllllĵĵě{pepZI hJ5CJ OJQJ\^JaJ hwbT5CJ \aJ h;#dhv7mH sH h;#dh0mH sH h;#dh0xmH sH h;#dh>z h;#dh h;#dh0 h;#dhd.$h;#dhsG0J>*B*mH phsH jh;#dhsGUmH sH h;#dhsGmH sH h;#dhd.mH sH h;#dh _Hh;#dh0_Hh;#dh0x_Hh;#dhmH sH lllllllmmbmmmoo5p*B*mH phsH jh;#dh:UmH sH h;#dh:mH sH h;#dh)h;#dhLmH sH h;#dhL h;#dhsP h;#dhk@ h;#dhg h;#dh` h;#dh]POy]y^y_y`ydygyhyiyjypyyyyyyyzz>z?z@zKz\z`zazzɵ{tplte\SSJSh;#dhPJh;#dhwI~PJh;#dh)*PJ h;#dh)*hKHh, h;#dh"Hh;#dh#PJh;#dh 7PJ hxePJh;#dhqB5CJ \aJ &hh,65CJ OJQJ\^JaJ &hh 5CJ OJQJ\^JaJ h5CJ \aJ h;#dhQ5\h;#dh 5CJ \aJ &hhQ5CJ,OJQJ\^JaJ,zzzzzzzzzzz{*{+{6{={H{O{d{e{f{ܰ{m{\K\8$h;#dh 7CJOJPJQJ^JaJ h>h>CJOJQJ^JaJ h>h 7CJOJQJ^JaJh>CJOJQJ^JaJ h;#dh 7CJOJQJ^JaJ$h;#dh#CJOJPJQJ^JaJ h;#dh CJOJQJ^JaJ h;#dhktCJOJQJ^JaJh;#dh:PJh;#dh"HPJh;#dh_"NPJh;#dh PJh;#dh#PJh;#dh 7PJh;#dh`PJzz{ {*{+{f{g{h{|{}{||||}}}}O}P}Z}[}}$ & Flh7$8$A$H$a$gdqO $7$8$A$H$a$gd;. $$a$gd> $$a$gd;.f{g{h{{{|{}{{{{{0|O|||lYH7H& h;#dh CJOJQJ^JaJ h;#dh1fCJOJQJ^JaJ h;#dh 7CJOJQJ^JaJ$h;#dh 7CJOJPJQJ^JaJ*h;#dhkt5CJOJPJQJ\^JaJ$h;#dhktCJOJPJQJ^JaJ*h;#dhqB5CJ OJPJQJ\^JaJ *hhkt5CJ OJPJQJ\^JaJ *hh#5CJ OJPJQJ\^JaJ $h5CJ OJPJQJ\^JaJ *h;#dh 75CJOJPJQJ\^JaJ ||||}}}N}O}Z}[}c}p}}}}}}}}}}޺yrkyrdrr[H;h5CJ PJ\aJ $h;#dh 7CJOJPJQJ^JaJh;#dh 7PJ h;#dh h;#dhlA h;#dh 7 h;#dh1f h;#dh# h;#dh#CJOJQJ^JaJ h;#dh 7CJOJQJ^JaJ h;#dh1fCJOJQJ^JaJ h;#dh CJOJQJ^JaJ$h;#dhktCJOJPJQJ^JaJ h;#dhktCJOJQJ^JaJ h;#dh_"NCJOJQJ^JaJ}}}}~~fgqrۂ9:DĒ̈́$ & FhA$a$gdqO $A$a$gd8!$ & FhA$^ha$gdqO $A$a$gd< $A$a$gd $A$a$gd;. $$a$gd;.$ & Flh7$8$A$H$a$gdqO}}}~~~~~~;~R~S~T~W~X~~~~~~~Ծsj_XQMB9h;#dh35SPJh;#dh35SmH sH h35S h~Dh-P1 h;#dh-P1h;#dh-P1mH sH h;#dh xPJh;#dho-B5PJ\h;#dho-BPJh;#dhwg5PJ\ h53h53h53 h53PJh;#dhwgPJh;#dhqB5CJ PJ\aJ *hhwg5CJ OJPJQJ\^JaJ *hhy35CJ OJPJQJ\^JaJ *hh 75CJ OJPJQJ\^JaJ QRWXnpƀր4:KRX{|~&üʵüή}wlh;#dh&NmH sH h PJh mH sH h;#dhsmH sH hqQmH sH h;#dha'6ha'6h< h;#dh)* h;#dh]& h;#dhj*B*phjh~Dh~DU h~Dh~D h35SPJ&&+]dfgpqrÂڂۂ89:DEH~ʿ}rg}\}M}Mjh;#dhj*B*mH phsH $̈́ׄ؄Ʌʅ{Æ7ه5$[$\$a$gd;.$ & FhA$a$gd#C$ & FhA$a$gdqO$ & FhA$a$gd`# $A$a$gdE $A$a$gd;.Æӆن  457J`d‡ևׇه345n$hh 7CJ OJPJQJ^JaJ *hh 75CJ OJPJQJ\^JaJ $h)T5CJ OJPJQJ\^JaJ h;#dh\f5PJ\ h;#dh^ h;#dhC.h;#dh7_H h#C_Hh;#dhbO_Hh;#dhwK_Hh;#dh_Hh;#dh+PC_Hh;#dheX_H'8ƉAKïmYC<5.' h;#dh3 h;#dhbO h;#dh_"N h;#dhz*hs4h5CJOJPJQJ\^JaJ&hs4hes5CJOJQJ\^JaJ*hs4hes5CJOJPJQJ\^JaJ*hs4hU5CJOJPJQJ\^JaJ*hs4h 75CJOJPJQJ\^JaJ&hs4hs45CJOJQJ\^JaJ&hs4h35CJOJQJ\^JaJ*hs4hbO5CJOJPJQJ\^JaJ$hhbOCJ OJPJQJ^JaJ @AKL݊+,-CDIJT $A$a$gdV $A$a$gd $A$a$gd;.$ & Fm[$\$a$gdqO$[$\$a$gd;. $A$gds4KLfi܊݊)*+,-ABCDX򻴭mWG>h;#dhx+PJh;#dhqB5CJ PJ\aJ *hhx+5CJ OJPJQJ\^JaJ *hhb5CJ OJPJQJ\^JaJ *hhp5CJ OJPJQJ\^JaJ h5CJ PJ\aJ h;#dhb}Z h;#dh! h;#dh 7 h;#dhGv h;#dh-h;#dh,6PJh;#dhPJh;#dhbPJ h;#dh h;#dhYv h;#dhb h;#dhbOXYhtۋ܋ߋt&'5=O./FGHJSTUefۻ˔˔˔ˋypj⟴ah;#dhCCPJ h4PJh;#dhb}ZPJh;#dhGvPJh;#dh_"NPJh;#dhLKPJjh;#dho1xU h;#dhI h;#dh0Z h;#dh@ h;#dh gh;#dhIPJ h;#dhX h;#dho1xh;#dh gPJ h;#dhph;#dho1xPJh;#dhpPJh;#dhx+5PJ\&TUŽ͎ΎVڏ23456@AՒ.$ & FwhA$a$gdG$ & FwhA$a$gdH]$ & FwhA$a$gdqO $A$a$gd)T$ & FvhA$a$gd4$ & FvhA$a$gdqO $A$a$gd;.Ž͎̎Ύ֎َڎ 0Vُڏۏ136@AD Ւ239qȻ~xqjcj_j[qjhRhH] h;#dh h;#dh48 h;#dhhW h)TPJh: h;#dhzcA h;#dhU h;#dhh)T h;#dhGv h;#dhoh;#dhu_Hh;#dhzcA_Hh;#dh O0J2mH sH h;#dh_Hh;#dhumH sH h;#dhE-PJh;#dhLKPJh;#dhpPJh;#dho1xPJ#qrsƓ͓ۓ+,-.Ŕ UlroaZSLHh`Bu h;#dhKy h;#dhQb2 h;#dh}Th;#dhqB5CJ \aJ &hh}T5CJ OJQJ\^JaJ &hhQb25CJ OJQJ\^JaJ &hh5CJ OJQJ\^JaJ h;#dhDPh;#dhhW_H hS_Hh;#dhDP_Hh;j3 h;#dh;j3 h;#dhhG h;#dhH]hH] h;#dh48 h;#dhu/ h;#dhU.A# $7$8$A$H$a$gd)T$ & Fnh7$8$A$H$a$gd`Bu$ & Fnh7$8$A$H$a$gdqO $7$8$A$H$a$gd`Bu $7$8$A$H$a$gd $7$8$A$H$a$gd;. $A$a$gd;.$ & FwhA$a$gdqOr֕וٕ 8JxyȖɖ!ESh|~˗ϗЗї!ʿտyrkdk h;#dh* h;#dheR h;#dh_"N h;#dh;j3h`Bu h;#dhD h;#dhd$h;#dhs#30J>*B*mH phsH jh;#dhs#3UmH sH h;#dhomH sH h;#dhs#3mH sH h;#dhEmH sH h;#dhWTmH sH h;#dhDmH sH h;#dh?F h;#dhU h;#dhKy&!*AtĘŘؘ̘٘͘"#/0BCә"./Mннн򯫤򯶯p$h;#dh!"0J>*B*mH phsH jh;#dh!"UmH sH h;#dh!"mH sH h;#dhE h;#dhQb2h`Bu h;#dh* h;#dh;j3$h;#dh;j30J>*B*mH phsH jh;#dh;j3UmH sH h`BumH sH h;#dh;j3mH sH h;#dheR h;#dh,o5,#$./uNOPghǠȠQ$ & Fxh7$8$A$H$^ha$gdqO $7$8$A$H$a$gd$ & Fph7$8$A$H$a$gdg@$ & Fph7$8$A$H$a$gdQ$ & Fph7$8$A$H$a$gdqO $7$8$A$H$a$gd;.MN\]IJSTZ_`Ԝ !fgqru͝ǸǸǚxǸǸmǸǸbZhwmH sH hwhQmH sH hwhwmH sH $hwhlA0J>*B*mH phsH jhwhlAUmH sH hwhlAmH sH $hwhE0J>*B*mH phsH jhwhEUmH sH hwhEmH sH h;#dh!"mH sH $h;#dh!"0J>*B*mH phsH jh;#dh!"UmH sH #֝͝םܝݝ67KLMNOPfgh~ϞОp`WNEN>7 h;#dh! h;#dhuh;#dhUPJh;#dhbPJh;#dhGPJh;#dhqB5CJ PJ\aJ *hhG5CJ OJPJQJ\^JaJ *hhb5CJ OJPJQJ\^JaJ *hh5CJ OJPJQJ\^JaJ h_Nh;j3mH sH h;#dhQmH sH $hwhQ0J>*B*mH phsH jhwhQUmH sH hwh_NmH sH hwhQmH sH Оޞʟ-8^ƠǠʠˠΠՠנ۠ޠ 7Xklrsʡˡסء˹˰钉ٽ~hR h;#dhD!{h;#dh gPJh;#dhuPJ h;#dhW h;#dh! h;#dhM Th;#dhM TPJh` h;#dh g h;#dh_"N h;#dhU h;#dhX h;#dhbh;#dh!PJh;#dhbPJ h;#dhS" h;#dhu1Q̡͡סء-ӢԢբ $7$8$A$H$a$gd$h7$8$A$H$^ha$gd;.$ & Fqh7$8$A$H$a$gdqO$ & Fqh7$8$A$H$a$gdR $7$8$A$H$a$gd;.$ & Fxh7$8$A$H$^ha$gdqO-.8<=QRSaikxy{}~ŢʢѢҢӢԢբ¶ymaTh5CJ PJ\aJ h;#dhEy5PJ\h;#dhW5PJ\ h;#dh[ h;#dh h;#dhU h;#dhEy h;#dhH h;#dhW h;#dhD!{h;#dhD!{0J/6]h;#dhEy0J/6]h;#dhW0J/6]h;#dhgPJh;#dh}TPJh;#dhWPJh;#dhPJ h;#dhb h;#dh gբtdqru}̤&4=CVWXYZi̾ӰӰ̰̾Ӟ̰̰̰̓̚ӈt&hh8<5CJ OJQJ\^JaJ h5CJ \aJ h;#dh>h, h;#dh?Rh)T h;#dh! h;#dhVo h;#dh_"N h;#dh\, h;#dhX h;#dhb h;#dh~h;#dhqB5CJ PJ\aJ *hhb5CJ OJPJQJ\^JaJ (|}~?XYZrt $A$a$gd $A$a$gd;.$ & Fh7$8$A$H$a$gd, $7$8$A$H$a$gd)T $7$8$A$H$a$gd_N $7$8$A$H$a$gd;.iqrstȥ٥ڥEJRef *+CKSXlԨʼ{rir`YRR h;#dh+ h;#dhIh;#dhI_Hh;#dhM_Hh;#dh<_Hh;#dh5Wz_Hh;#dh _Hh;#dh PJ h;#dh h;#dhI h;#dhh;#dh<5\ h;#dh<h;#dh5CJ \aJ h;#dhUHP5CJ \aJ &hhqB5CJ OJQJ\^JaJ &hhUHP5CJ OJQJ\^JaJ ԨըB@B$%aboprsƬǬ̬ͬUXhirstĽtmf_f_ h;#dh @ h;#dh> h;#dh_"Nh;#dh~.CJOJQJaJh& h;#dh~. h;#dh!\E h;#dh"[n h;#dhCh;#dhj0J>*B*phjh;#dhjU h;#dhj h;#dhds h;#dhD h;#dhd h;#dhD h;#dhH h;#dh=4#h;#dh _Hh;#dho_H%thist'ݰ!ѱ78BC$ & Frhd d`A$[$a$gdqO$ & FrhA$a$gdqO $$a$gd;.$ & FhA$a$gdqO $A$a$gd;. $A$a$gd&AL߮ $%&';ATV\defjuv{»|sj|c\ h;#dh8< h;#dhh;#dhb_Hh;#dh[_H h&_Hh;#dhFc_Hh;#dhA~_Hh;#dh8<_Hh;#dh,_H h;#dh, h;#dhyF h;#dhFc h;#dhQ) h;#dh>CJOJQJ^JaJ h;#dh>CJOJQJ^JaJ h;#dh> h;#dh @ h;#dhI h;#dh%4!Pi°ް,1N~±ñαϱѱ678BCelز-.qr槕{t h;#dhwh;#dhN0J>*B*phjh;#dhNU h;#dhwhfK h;#dh  h;#dhN h;#dh h;#dhb h;#dh%4 h;#dhA~ h;#dhSL h;#dhH h;#dhFc h;#dhyF h;#dh8< h;#dh,jh;#dh,U-Cز-EYZ[noǸȸeAW$ & FshA$^ha$gdqO $A$a$gd\C $A$a$gd;.$ & FzhA$a$gdYe$ & FzhA$a$gdFs$ & FzhA$a$gdqOųƳгѳҳ۳!"BCEFĴŴƴST`abu׵XззС|СxxhYehfKhFsh?0J>*B*phjh;#dh?U h;#dh * h;#dh?hFshN0J>*B*phjh;#dhNU h;#dhw h;#dh' h;#dhN h;#dhe+^h;#dhw0J>*B*ph h;#dhwjh;#dhwU+XYZ[mno˶ůymbWbLb=b=jh;#dhUmH sH h;#dh-mH sH h;#dh5HmH sH h;#dhmH sH h;#dhv5PJ\h;#dhvmH sH h;#dhpPJh;#dhJPJh;#dhvPJh;#dhqB5CJ PJ\aJ *h\Chv5CJ OJPJQJ\^JaJ *h\ChJ5CJ OJPJQJ\^JaJ h\C5CJ PJ\aJ h;#dh 5PJ\hfKhv5PJ\,23ƸǸȸ˸eiqù@mȥzqhq_REqh;#dh-PJmH sH h;#dhV*PJmH sH h;#dhV*PJh;#dh-PJh;#dhpPJ h;#dh$G h;#dhph;#dhV*mH sH h;#dh-mH sH h;#dh> h;#dh_"N h;#dh h;#dhe h;#dh_9 h;#dh5Hh;#dh5HmH sH h;#dhmH sH jh;#dhUmH sH $h;#dh0J>*B*mH phsH m*:?NWXYbcdgֻ׻0[\]^꿸vc$h;#dhpCJOJPJQJ^JaJh;#dhpPJh^ h;#dhoh;#dhJmH sH h;#dh> h;#dhJ h;#dh- h;#dhp h;#dh5H h;#dhV*h;#dhV*PJ$h;#dhV*0J>*B*mH phsH jh;#dhV*UmH sH h;#dhV*mH sH h;#dh6mH sH #WXcdֻ]^_wxվ A $7$8$A$H$a$gd^ $7$8$A$H$a$gd)T $$a$gd;.$ & FthA$a$gdqO $7$8$A$H$a$gd;.^_gkvwxkoԾվ־߾ԫwnwnwgcg\X\QJC h;#dha#o h;#dhp h;#dh_"Nh^ h;#dhh)T h;#dhD+h;#dhGPJh;#dhpPJh;#dha#o5PJ\ h)TPJh;#dha#oPJh;#dhqB5CJ PJ\aJ *h\Cha#o5CJ OJPJQJ\^JaJ $h)T5CJ OJPJQJ\^JaJ *h\Chp5CJ OJPJQJ\^JaJ *h\Ch\C5CJ OJPJQJ\^JaJ   !@LM\mn   .1<DOPQSTij紨o*h\Ch>5CJ OJPJQJ\^JaJ *h\Chp5CJ OJPJQJ\^JaJ h\C5CJ PJ\aJ h;#dhp5PJ\h;#dhpPJ h;#dhR; h;#dh-H h;#dhm h;#dh* h;#dh> h;#dha#o h;#dhph^ h;#dh h;#dh|%ABLM RSTkl^_ijIJU $1$a$gd;.$1$7$8$A$H$a$gd\C$1$7$8$A$H$a$gd;.$ & Fuh7$8$A$H$a$gdqO $7$8$A$H$a$gd;.jkl-AB]^_hij~żtaP? h;#dh(CJOJQJ^JaJ h;#dh V5CJOJQJ^JaJ$h;#dh(CJOJPJQJ^JaJ$h;#dh_"NCJOJPJQJ^JaJ$h;#dhACJOJPJQJ^JaJh;#dhMPJ h;#dh(h;#dhTPJh;#dh(PJh;#dhpPJh;#dhVo5PJ\h;#dhVoPJh;#dhqB5CJ PJ\aJ *h\ChVo5CJ OJPJQJ\^JaJ ~HJTUVWdrɶɶɡyhWFhWFh h;#dhACJOJQJ^JaJ h;#dh V5CJOJQJ^JaJ h;#dhpCJOJQJ^JaJ$h;#dhACJOJPJQJ^JaJ(h;#dhACJOJQJ^JaJmH sH (h;#dhTCJOJQJ^JaJmH sH $h;#dh V5CJOJPJQJ^JaJ$h;#dhTCJOJPJQJ^JaJ$h;#dh(CJOJPJQJ^JaJ h;#dhTCJOJQJ^JaJUVLMWX|}rs}~?@A $ & Fa$gdqO$a$gd;. $A$a$gd\C $A$a$gd;. $1$a$gd;.DiV@-$h;#dh#CJOJPJQJ^JaJ*h;#dhfS5CJOJPJQJ\^JaJ$h;#dhfSCJOJPJQJ^JaJ*h;#dh V55CJ OJPJQJ\^JaJ *h;#dh>5CJ OJPJQJ\^JaJ *h\ChqB5CJ OJPJQJ\^JaJ *h\Chp5CJ OJPJQJ\^JaJ #h\Chp<CJ OJQJ^JaJ #h\Ch\C<CJ OJQJ^JaJ hpCJ aJ $h;#dhpCJOJPJQJ^JaJ DNOS56JKLMǴǡwbbH2h;#dhi5CJOJPJQJ\^JaJmH sH (h;#dhVXCJOJQJ^JaJmH sH (h;#dh1ZCJOJQJ^JaJmH sH (h;#dhiCJOJQJ^JaJmH sH $h;#dhiCJOJPJQJ^JaJ$h;#dh9LCJOJPJQJ^JaJ$h;#dhpCJOJPJQJ^JaJ$h;#dhMCJOJPJQJ^JaJ$h;#dh;CJOJPJQJ^JaJMVWX_|}һҨlWBWB-(h;#dh<CJOJQJ^JaJmH sH (h;#dhVXCJOJQJ^JaJmH sH (h;#dhiCJOJQJ^JaJmH sH $h;#dh>CJOJPJQJ^JaJ$h;#dhiCJOJPJQJ^JaJ*h;#dh;5CJOJPJQJ\^JaJ$h;#dh;CJOJPJQJ^JaJ,h;#dhVXCJOJPJQJ^JaJmH sH ,h;#dh;CJOJPJQJ^JaJmH sH ,h;#dh_"NCJOJPJQJ^JaJmH sH `adefpqs|}~ҽҠxeR=(h;#dh#CJOJQJ^JaJmH sH $h;#dhpCJOJPJQJ^JaJ$h;#dh#CJOJPJQJ^JaJ$h;#dhiCJOJPJQJ^JaJ(h;#dhCJOJQJ^JaJmH sH 8h;#dhi0J>*B*CJOJQJ^JaJmH phsH (h;#dhiCJOJQJ^JaJmH sH 1jh;#dhiCJOJQJU^JaJmH sH (h;#dhhJCJOJQJ^JaJmH sH $?@AQRaџщs]G4$h;#dhlCJOJPJQJ^JaJ*h;#dhqB5CJ OJPJQJ\^JaJ *h\Ch5CJ OJPJQJ\^JaJ *h\Ch\C5CJ OJPJQJ\^JaJ *h;#dh5CJOJPJQJ\^JaJ(h;#dhCJOJQJ^JaJmH sH 8h;#dh#0J>*B*CJOJQJ^JaJmH phsH (h;#dh#CJOJQJ^JaJmH sH 1jh;#dh#CJOJQJU^JaJmH sH AQREFPQ"#-.`ab{|}~$a$gd?$ & Fzh^ha$gdqO$a$gd;.agj-.EFŰŝssVsA,(h;#dhiTCJOJQJ^JaJmH sH (h;#dhCJOJQJ^JaJmH sH 8h;#dh#2P0J>*B*CJOJQJ^JaJmH phsH 1jh;#dh#2PCJOJQJU^JaJmH sH h;#dh(CJOJQJ^JaJ$h;#dh(CJOJPJQJ^JaJ(h;#dh]CJOJQJ^JaJmH sH (h;#dh#2PCJOJQJ^JaJmH sH $h;#dhlCJOJPJQJ^JaJ$h;#dh#2PCJOJPJQJ^JaJ'-.34[z{|ðs^sI4(h;#dh9LCJOJQJ^JaJmH sH (h;#dhMCJOJQJ^JaJmH sH (h;#dh]CJOJQJ^JaJmH sH (h;#dhICJOJQJ^JaJmH sH (h;#dhCJOJQJ^JaJmH sH $h;#dhCJOJPJQJ^JaJ$h;#dhCJOJPJQJ^JaJ$h;#dh/oCJOJPJQJ^JaJ(h;#dhXCJOJQJ^JaJmH sH (h;#dh#2PCJOJQJ^JaJmH sH /DFOPDzu`J7$h;#dh_"NCJOJPJQJ^JaJ+h;#dh;CJH*OJQJ^JaJmH sH (h;#dhYCJOJQJ^JaJmH sH (h;#dhUCJOJQJ^JaJmH sH $h;#dhUCJOJPJQJ^JaJ(h;#dhCJOJQJ^JaJmH sH (h;#dh#2PCJOJQJ^JaJmH sH $h;#dh/oCJOJPJQJ^JaJ$h;#dhCJOJPJQJ^JaJ$h;#dh1ZCJOJPJQJ^JaJPQWdmǴǡ{fQCJOJPJQJ^JaJ$h;#dhYCJOJPJQJ^JaJ$h;#dh(CJOJPJQJ^JaJ$h;#dh_"NCJOJPJQJ^JaJ$h;#dhlCJOJPJQJ^JaJ$h;#dh/oCJOJPJQJ^JaJ$h;#dh]CJOJPJQJ^JaJ"#-./_abi֬mWD.*h\Chs/5CJ OJPJQJ\^JaJ $h\C5CJ OJPJQJ\^JaJ *h;#dhY5CJOJPJQJ\^JaJ(h;#dh]CJOJQJ^JaJmH sH $h;#dhYCJOJPJQJ^JaJ,h;#dhICJOJPJQJ^JaJmH sH (h;#dhICJOJQJ^JaJmH sH (h;#dhYCJOJQJ^JaJmH sH (h;#dhCJOJQJ^JaJmH sH (h;#dh6lpCJOJQJ^JaJmH sH iyz{|2ԾlWF1W h;#dh?8OCJOJQJ^JaJ(h;#dhCJOJQJ^JaJmH sH h;#dhCJOJQJ^JaJ(h;#dh?8OCJOJQJ^JaJmH sH $h;#dhQCJOJPJQJ^JaJ*h;#dh+5CJOJPJQJ\^JaJ$h;#dh+CJOJPJQJ^JaJ*h;#dhqB5CJ OJPJQJ\^JaJ *h\Ch+5CJ OJPJQJ\^JaJ *h\Chs/5CJ OJPJQJ\^JaJ *h\Ch5CJ OJPJQJ\^JaJ 2S`aEFڰڛyyyhWhyhWhFh h;#dhT[CJOJQJ^JaJ h;#dhMCJOJQJ^JaJ h;#dhtCJOJQJ^JaJ h;#dhQCJOJQJ^JaJ h;#dh?8OCJOJQJ^JaJ(h;#dhs/CJOJQJ^JaJmH sH (h;#dhxCJOJQJ^JaJmH sH (h;#dhT[CJOJQJ^JaJmH sH (h;#dh?8OCJOJQJ^JaJmH sH h;#dh~CJOJQJ^JaJ *25;<rs٫p_N@N/p/ h;#dhxCJOJQJ^JaJh?CJOJQJ^JaJ h;#dhxv`CJOJQJ^JaJ h;#dhCJOJQJ^JaJ h;#dhT[CJOJQJ^JaJ(h;#dhxv`CJOJQJ^JaJmH sH (h;#dh_"NCJOJQJ^JaJmH sH (h;#dhCJOJQJ^JaJmH sH 0h;#dht0J>*B*CJOJQJ^JaJph h;#dhtCJOJQJ^JaJ)jh;#dhtCJOJQJU^JaJs}~=>?˸p_N=N h;#dhQCJOJQJ^JaJ h;#dhXCJOJQJ^JaJ h;#dh*FCJOJQJ^JaJ h;#dhxCJOJQJ^JaJ h;#dhCJOJQJ^JaJ$h;#dhCJOJPJQJ^JaJ$h;#dhpTCJOJPJQJ^JaJ$h;#dh>CJOJPJQJ^JaJ$h;#dhXCJOJPJQJ^JaJ h;#dhtCJOJQJ^JaJ h;#dhT[CJOJQJ^JaJ~?q13=>$1$7$8$A$H$a$gd;. $ & Fya$gdqO$ & Fxh^ha$gdqO$a$gd;.pqrɸɸɧppWpA*h;#dh:5CJOJPJQJ\^JaJ0h;#dhX0J>*B*CJOJQJ^JaJph)jh;#dhXCJOJQJU^JaJ h;#dhxv`CJOJQJ^JaJ h;#dhQCJOJQJ^JaJ h;#dh5CJOJQJ^JaJ h;#dhs/CJOJQJ^JaJ h;#dhXCJOJQJ^JaJ$h;#dh>CJOJPJQJ^JaJ$h;#dhCJOJPJQJ^JaJABCHԾhQ<'(h;#dhr.CJOJQJ^JaJmH sH (h;#dhCJOJQJ^JaJmH sH ,h;#dhxv`0J<CJOJQJ^JaJmH sH ,h;#dh0J<CJOJQJ^JaJmH sH *h;#dhxv`5CJOJPJQJ\^JaJ$h;#dhxv`CJOJPJQJ^JaJ*h;#dhqB5CJ OJPJQJ\^JaJ *h\Chxv`5CJ OJPJQJ\^JaJ *h\Ch5CJ OJPJQJ\^JaJ *h\Ch\C5CJ OJPJQJ\^JaJ HI45>?ly{#(ѡyb,h;#dhr.0J<CJOJQJ^JaJmH sH (h;#dhxv`CJOJQJ^JaJmH sH $h;#dhMCJOJPJQJ^JaJ$h;#dh!`CJOJPJQJ^JaJ8h;#dhr.0J>*B*CJOJQJ^JaJmH phsH (h;#dhr.CJOJQJ^JaJmH sH 1jh;#dhr.CJOJQJU^JaJmH sH !/13<=²{jYF9,h;#dhJ0PJmH sH h;#dh!`PJmH sH $h;#dhCJOJPJQJ^JaJ h;#dh lCJOJQJ^JaJ h;#dhmbaCJOJQJ^JaJ h;#dhCJOJQJ^JaJ$h;#dh!`CJOJPJQJ^JaJ$h;#dh_"NCJOJPJQJ^JaJhCJOJPJQJ^JaJh!CJOJPJQJ^JaJ,h;#dhr.0J<CJOJQJ^JaJmH sH ,h;#dhw0J<CJOJQJ^JaJmH sH =>>TV`ad~ٽ螓}rgXXjh;#dhAUmH sH h;#dh(mH sH h;#dhImH sH h;#dh@mH sH h;#dhMmH sH h;#dhmH sH h;#dhAmH sH h;#dhqmH sH h;#dh@_Hh;#dh s_H$h;#dh!`0J>*B*mH phsH jh;#dh!`UmH sH h;#dh!`mH sH h;#dh>PJmH sH >UV`aJ$dh$A$Ifgdz $dhA$a$gdB$1$7$8$A$H$a$gdEd$1$7$8$A$H$a$gd;.$ & F{hA$a$gdqO$ & F{hA$a$gd)T $%&/IJKTӽyhyZOZD4h;#dhB0J5CJ\aJh;#dhBCJaJhB5CJ\aJh;#dhB5CJ\aJ h hBCJOJQJ^JaJ&h hB5CJOJQJ\^JaJ hB5CJ\_HaJmH sH &h;#dh" v5CJ\_HaJmH sH h;#dhF98mH sH h;#dhImH sH h;#dhMmH sH h;#dhimH sH jh;#dhAUmH sH $h;#dhA0J>*B*mH phsH -$dh$A$Ifgdz kd$$Ifl_\>~ j'@ N N (0(44 lap(ytz *HYJLHijkvP\o}jor㿳㿳h;#dhB5CJ\aJh;#dhBCJaJmH sH hBCJaJmH sH h;#dhBCJaJmH sH hBCJaJh;#dhBCJ_HaJh;#dhBCJaJh;#dhBCJaJ h;#dhB7*HYcdefgpqz<$dh$A$Ifgdz y^OOOOOOO$dh$A$Ifgdz kd$$Ifl\>~ j'@ N N 0(44 laytz 4Kax^OOOOOOO$dh$A$Ifgdz kdc$$Ifl\>~ j'@ N N 0(44 laytz xyG^OOOOOO$dh$A$Ifgdz kd$$Ifl\>~ j'@ N N 0(44 laytz GHjvQ^OOOOOOOO$dh$A$Ifgdz kd$$Ifl\>~ j'@ N N 0(44 laytz QpOkd$$Ifl\>~ j'@ N N 0(44 laytz $dh$A$Ifgdz CDESjOkd;$$Ifl\>~ j'@ N N 0(44 laytz $dh$A$Ifgdz +zOkd$$Ifl\>~ j'@ N N 0(44 laytz $dh$A$Ifgdz -$dh$A$Ifgdz kd$$IflG\>~ j'@ N N (0(44 lap(ytz  (l  Z[`acdfp    GHôÕôÊh;#dhBCJaJ%jh;#dhBCJUaJmH sH hBCJaJmH sH h;#dhBCJaJmH sH h;#dhBCJaJhBCJaJh!phBCJaJhBCJOJQJ^JaJ h;#dhBCJOJQJ^JaJ6)m$ dh$A$Ifgdz $dh$A$Ifgdz  ^OOOOOOOO$dh$A$Ifgdz kd $$IflG\>~ j'@ N N 0(44 laytz ghq$dh$A$Ifgdz $dh$A$Ifgdz *s^OOO<$ dh$A$Ifgdz $dh$A$Ifgdz kdt!$$Ifl\>~ j'@ N N 0(44 laytz s^OOOOOOO$dh$A$Ifgdz kd*"$$Ifly\>~ j'@ N N 0(44 laytz 346Irs/CU`]~ -6˾˰ˀˀˀˀˀqjh;#dhBCJUaJh;#dhBCJaJ h hBCJOJQJ^JaJ&h hB5CJOJQJ\^JaJh;#dhB5CJ\aJh;#dhBCJ_HaJh;#dhBCJaJhB0J]CJaJh9hB0J]CJaJhBCJaJh9hBCJaJ,sK@@@ $dhA$gdBkd"$$Ifl\>~ j'@ N N 0(44 laytz $ dh$A$Ifgdz -27C$ dh$A$Ifgdz $dh$A$Ifgdz $A$gdB $dhA$gdB CDU`-$dh$A$Ifgdz kd#$$Ifl\> ^% F@ @  (0`'44 lap(ytz `h<kd$$$Ifl\> ^% F@ @ 0`'44 laytz $ dh$A$Ifgdz $dh$A$Ifgdz (A\$ dh$A$Ifgdz $dh$A$Ifgdz \]^OOOO<$ dh$A$Ifgdz $dh$A$Ifgdz kd%$$IflL\> ^% F@ @ 0`'44 laytz  "+C^OOOOO$dh$A$Ifgdz kdC&$$Ifl \> ^% F@ @ 0`'44 laytz CeK<<<$dh$A$Ifgdz kd'$$Ifl\> ^% F@ @ 0`'44 laytz $ dh$A$Ifgdz  -6<kd'$$IflU\> ^% F@ @ 0`'44 laytz $ dh$A$Ifgdz $dh$A$Ifgdz 6<Rp$ dh$A$Ifgdz $dh$A$Ifgdz  #$1C^OOOOOOOO$dh$A$Ifgdz kd($$Ifl\> ^% F@ @ 0`'44 laytz  WX69:Cghi!-.YZҿҲҧttfҿҿh;#dhB5CJ\aJ h hBCJOJQJ^JaJ&h hB5CJOJQJ\^JaJh;#dhB5CJ\aJh;#dhBCJaJh;#dhBCJPJaJh;#dhBCJaJhBCJaJh;#dhBCJaJ$h;#dhB0J>*B*CJaJphjh;#dhBCJUaJ#CWo$ dh$A$Ifgdz $dh$A$Ifgdz 56789i^SSSSSF $dA$gdB $dhA$gdBkdS)$$Ifl\> ^% F@ @ 0`'44 laytz i$dh$A$Ifgdz -$dh$A$Ifgdz kd*$$IflG\>2 R&   (0(44 lap(ytz ,?Xijk$dh$A$Ifgdz ^OOOOOOOO$dh$A$Ifgdz kd<+$$Ifl \>2 R&   0(44 laytz `a&0AZ~DN%YcGH5ԾԱԧߏhxb4hBCJaJhIhBCJPJaJhBCJPJaJh;#dhBCJPJaJhBCJaJh;#dhB5CJ\aJh;#dhBCJaJhBCJaJh;#dhBCJaJh;#dhB6CJ]aJ8WxyzOkd,$$Ifl=\>2 R&   0(44 laytz $dh$A$Ifgdz   Okd,$$Ifl=\>2 R&   0(44 laytz $dh$A$Ifgdz &027>BOkd-$$Ifl=\>2 R&   0(44 laytz $dh$A$Ifgdz OkdL.$$Ifl\>2 R&   0(44 laytz $dh$A$Ifgdz 0KuvOkd/$$Ifl\>2 R&   0(44 laytz $dh$A$Ifgdz */Okd/$$Ifl\>2 R&   0(44 laytz $dh$A$Ifgdz /4@AZEkd0$$IflN\>2 R&    ((44 lap(ytz $dh$A$Ifgdz '89DNO_`}~vzkd1$$Ifl\>2 R&   (44 laytz $dh$A$Ifgdz &Z[vvvvvvvvvvvv$dh$A$Ifgdz zkd72$$Ifl\>2 R&   (44 laytz [\d|vzkd2$$Ifl\>2 R&   (44 laytz $dh$A$Ifgdz HI7m{vkkk^RRR $$A$Ifgdz $dA$gdB $dhA$gdBzkdu3$$Ifl\>2 R&   (44 laytz $dh$A$Ifgdz 569BkmQbnw!#/45Uu '(FUyz^iKZhi&4ٺh;#dhB0J6CJaJh0uhBCJaJhB5CJ\aJh;#dhB5CJ\aJ h hBCJOJQJ^JaJ&h hB5CJOJQJ\^JaJh;#dhBCJaJhBCJaJ; $$A$Ifgdz kd4$$Iflr2 ' 2  t200*44 lap2ytz   FGHlm} $$A$Ifgdz %9BOPQb>kdg5$$Iflr2 ' 2 t00*44 laytz $$A$Ifgdz bcdenw"#/0a $$A$Ifgdz ,5IRST $$A$Ifgdz TUuJ>>>>>> $$A$Ifgdz kdC6$$Iflr2 ' 2 t00*44 laytz (<E $$A$Ifgdz EFUyzJ>>>>>> $$A$Ifgdz kd7$$Iflr2 ' 2 t00*44 laytz  ",CP] $$A$Ifgdz ]^iJ>>>>>> $$A$Ifgdz kd7$$Iflr2 ' 2 t00*44 laytz   JKZh $$A$Ifgdz H<<<<< $$A$Ifgdz kd8$$IflXr2 ' 2 t00*44 laytz 9Rhrs $$1$A$Ifgdz $$A$Ifgdz &4567H<<<<< $$A$Ifgdz kd9$$IflAr2 ' 2 t00*44 laytz 789A_`abcy !+=OWq $$A$Ifgdz 4@^x05EFVW"01.BC &.4<=%;+ + - / 2 3    ˺˩˛h;#dhBCJaJh$ghB5CJ\aJ h hBCJOJQJ^JaJ hB5CJOJQJ\^JaJ&h hB5CJOJQJ\^JaJh;#dhB5CJ\aJh;#dhBCJaJhBCJaJ8J>>>>>> $$A$Ifgdz kd:$$Iflr2 ' 2 t00*44 laytz >Ms $$A$Ifgdz "1@TzJ>>>>>> $$A$Ifgdz kds;$$Iflr2 ' 2 t00*44 laytz  $$A$Ifgdz CJpJ>>>>>> $$A$Ifgdz kdO<$$Iflr2 ' 2 t00*44 laytz  .<T] $$A$Ifgdz ]^J??00$dh$A$Ifgdz $dhA$gdBkd+=$$Iflr2 ' 2 t00*44 laytz  $dh$A$Ifgdz %;-$dh$A$Ifgdz kd>$$IflJ\} #  (0$44 la^p(ytz ;AJ^lOkd,?$$Ifl\} #  0$44 la^ytz $dh$A$Ifgdz &]uvOkd?$$Ifl\} #  0$44 la^ytz $dh$A$Ifgdz  +,9Okd@$$Iflg\} #  0$44 la^ytz $dh$A$Ifgdz 9D   + 3 OkdxA$$Ifl\} #  0$44 la^ytz $dh$A$Ifgdz 3 > u        Okd>>>>> $$A$Ifgdz kdH$$Iflr@ `'b2  t0)44 laytz 78Se/AHPRdm~PQ  GHCFKLMtt&h hB5CJOJQJ\^JaJ hB5CJOJQJ\^JaJ&h;#dhB5CJOJQJ\^JaJhBCJaJ h;#dhBCJOJQJ^JaJh;#dhBCJZaJo(hBCJaJh;#dhBCJaJh;#dhB5CJ\aJh;#dhBCJaJ,ESefg!LUVijy $$A$Ifgdz H<<<<< $$A$Ifgdz kddI$$IflXr@ `'b2  t0)44 laytz /01ARSTnopqrst~ $$A$Ifgdz  $6CLMvwx $$A$Ifgdz )*9Qu  -4?HPYZ $$A$Ifgdz CDEFH===== $dhA$gdBkdDJ$$Iflr@ `'b2  t0)44 laytz MU\t,<K[bvwy}}!>mn>?CMXy޼hSFhB5CJ\aJh;#dhBCJaJhBCJaJh;#dhBCJaJh;#dhB5CJ\aJ&h hB5CJOJQJ\^JaJhBCJOJQJ^JaJ h hBCJOJQJ^JaJ hw>hBCJOJQJ^JaJ3 $$A$Ifgdz + $$A$Ifgdz kd$K$$Ifl\"`'    t(0>+644 lap(ytz -KT\]^_`abko $$A$Ifgdz owxy}3DV}  $$A$Ifgdz  !>?^ny[OOOOOOOO $$A$Ifgdz kdNL$$Ifl\"`'   t0>+644 laytz OkdM$$Ifl\"`'   t0>+644 laytz $$A$Ifgdz !.8?CNYdnz $$A$Ifgdz yz+HISTde}*+OPfx{W}3i> Q R ߻힑߻h;#dhB0JRCJaJh;#dhB0JR5CJ\aJh;#dhBCJ_HaJh;#dhBCJaJhSFhB5CJ\aJhSFhBCJaJh;#dhB5CJ\aJh;#dhBCJaJhBCJaJ9+4<[OOOOOOOO $$A$Ifgdz kdM$$Ifl\"`'   t0>+644 laytz <=>Iq}+e $$A$Ifgdz efxyz{[OOOOOOOO $$A$Ifgdz kdN$$Ifl\"`'   t0>+644 laytz  X|$$-DA$IfM gdz $$A$Ifgdz |}[OOOOOOOO $$A$Ifgdz kdrO$$Ifl\"`'   t0>+644 laytz  3i $$A$Ifgdz [OOOOOOOO $$A$Ifgdz kd;P$$Ifl\"`'   t0>+644 laytz  % = > Q R h MkdQ$$Ifl\"`'   t0>+644 laytz $$A$Ifgdz R g h r ~       !! !F!W!X!j!k!l!m!v!!!!!"+"4"B"p"q"r""""""(#/#S#T#p#########?$@$$$$$ѰưѢhshBCJaJhshB5CJ\aJhBCJaJhNhB5CJ\aJh;#dhBCJaJh;#dhB5CJ\aJhhB5CJ\aJh;#dhBCJaJhBCJaJ8h r ~        OkdQ$$Ifl\"`'   t0>+644 laytz $$A$Ifgdz  ! !(!E!F!W!X!c!OkdR$$Ifl\"`'   t0>+644 laytz $$A$Ifgdz c!k!l!m!!!!!!!!"" $$A$Ifgdz ""+"C"G"S"p"q"[OOOOOO $$A$Ifgdz kdcS$$Ifl\"`'   t0>+644 laytz q"r"""""""""[OOOOOOOO $$A$Ifgdz kd,T$$Ifl\"`'   t0>+644 laytz """""""'#(#T#d########W$j$$$ $$A$Ifgdz $$$$$$$$$%[OOOOOOOO $$A$Ifgdz kdT$$Ifl\"`'    t0>+644 laytz $$$$$%%%%#%$%)%*%s%t%~%%%%%%%%%%& &&#&)&*&F&&&&&ΰΰݕ݊݊|n`nh;#dhB5CJ\aJhshB5CJ\aJhNhB5CJ\aJh;#dhBCJaJh[=hBCJaJhB0J>*B*CJaJph$hYhB0J>*B*CJaJphhYhBCJaJjhYhBCJUaJhBCJaJh;#dhBCJaJh;#dhB0J5CJ\aJ#%%%%%%%%%%% &*&F&R&^&b&&&& $$A$Ifgdz &&&&&&[OOOO $$A$Ifgdz kdU$$Ifl\"`'   t0>+644 laytz &&&'+ $$A$Ifgdz kdV$$Ifl\"`'     t(0>+644 lap(ytz &''''('w''''(,(.(0(N(W(X(d(f(z() ))<)>)J)a)b)c)r))))*1*F*H*`********+++++++++ԭ hB5CJOJQJ\^JaJ&h hB5CJOJQJ\^JaJh;#dhB5CJ\aJhr`yhB5CJ\aJhB5CJ\aJh;#dhBCJaJhshB5CJ\aJhBCJaJhshBCJaJ5'''('v'w'''''''' $$A$Ifgdz ''(,(-(.(/(0(X(a([OOOOOOOO $$A$Ifgdz kdW$$Ifl\"`'    t0>+644 laytz a(b(c(d(e(f(q(z((()=) $$A$Ifgdz =)>)J)b)c)i)r)))[OOOOOOO $$A$Ifgdz kdX$$Ifl\"`'    t0>+644 laytz )))**6++[O>>>>$ & FhA$^hgdB $hA$^hgdBkd{Y$$Ifl\"`'    t0>+644 laytz +++++++DkdRZ$$Ifl0@ R&   t0&644 lapytz $dh$A$Ifgdz $$A$Ifgdz $A$gdB+++++,,,,,,,,,,,,-U-V-----...\.]...o/q//////}000佨~phhBCJaJhhB5CJ\aJ(h;#dhBCJOJQJ^JaJmH sH (h;#dhBCJOJQJ^JaJmH sH )h;#dhB0JXB*CJaJmH phsH h;#dhBCJaJmH sH h;#dhB5\h;#dhB5CJ\aJh;#dhBCJaJ h hBCJOJQJ^JaJ(+,.,H,X,j,,,,-,->-V--r}kd[$$Ifl0@ R&  t0&644 laytz $d$A$Ifgdz ---.rr$d$A$Ifgdz }kd[$$Ifl0@ R&  t0&644 laytz ...).8.B.T.].p/ppppppp$d$A$Ifgdz kdO\$$Ifly0@ R&  t0&644 laytz p/q////~0rrrr$d$A$Ifgdz }kd\$$Ifl0@ R&  t0&644 laytz ~0000000191c1rrrrrZZr$d$-DA$IfM gdz $d$A$Ifgdz }kd]$$Ifl0@ R&  t0&644 laytz 00000000000011)18191Q1a1b1d11111111122%2]2^2222̚Œ̚ŒshhhBCJaJh;#dhB5CJ\aJhYzhBCJaJh;#dhB5CJ\aJh;#dhBCJaJmH sH h7/hBCJaJhhB5CJ\aJh;#dhB5\h;#dhBCJaJhn'khBCJaJhBCJaJhYehBCJaJhB5CJ\aJ$c1d1112rrr$d$A$Ifgdz }kd^$$Ifl0@ R&  t0&644 laytz 22%282I2^222rrrrra$d$A$Ifa$gdz $d$A$Ifgdz }kd^$$Ifl0@ R&  t0&644 laytz 22222333455#5wwfffffww$ & FhA$^hgdB$A$gdBkdK_$$Ifl0@ R&  t0&644 laytz 2k557777788D8c8e8g8x8y8888889?9@9A9R9ʴ~pep^eQe^eh;#dhBCJ_HaJ h;#dhBh;#dhBCJaJh;#dhB5CJ\aJ h hBCJOJQJ^JaJ hB5CJOJQJ\^JaJ&h hB5CJOJQJ\^JaJh;#dhB5CJ\aJhBCJaJh;#dhBCJaJhhBCJaJmH sH !hhB0JUB*CJaJphhhBCJaJ#56P6666i7e8g8i88888 $$A$Ifa$gdz $ hA$^hgdB $dA$gdB$ & FhA$^hgdB$A$gdB$A$gdB$ & FhA$gdB 888@9 $$A$Ifgdz jkd_$$Ifl$# t0#644 lazytz @9A9C99uu $$A$Ifgdz }kdn`$$Ifl0*$! t0#644 lazytz R999999::J:K:Q:R:S:T:V:e: ; ;E;F;K;L;N;O;Q;w;;;;;;;;;)<*<?<@<W<X<<<<<<<<====<===>=@=r=s=t=v=========0>ʷʷʷʷʷh;#dhBCJ_HaJ$h;#dhB0J>*B*CJaJphjh;#dhBUhBCJaJ h;#dhBh;#dhBCJaJ h;#dhBCJ_HaJmH sH C999S:ug $$@&A$Ifgdz $$A$Ifgdz }kd a$$Ifl0*$! t0#644 lazytz S:T:V:N;ui $$A$Ifgdz $$A$Ifgdz }kda$$Ifl0*$! t0#644 lazytz N;O;Q;<ui $$A$Ifgdz $$A$Ifgdz }kdEb$$Ifl0*$! t0#644 lazytz <<<=ui $$A$Ifgdz $$A$Ifgdz }kdb$$Ifl0*$! t0#644 lazytz =====ui $$A$Ifgdz $$A$Ifgdz }kdc$$Ifl0*$! t0#644 lazytz ==>=@=s=ui $$A$Ifgdz $$A$Ifgdz }kdd$$Ifl0*$! t0#644 lazytz s=t=v==ui $$A$Ifgdz $$A$Ifgdz }kdd$$Ifl0*$! t0#644 lazytz ====ui $$A$Ifgdz $$A$Ifgdz }kdVe$$Ifl0*$! t0#644 lazytz ===1>ui $$A$Ifgdz $$A$Ifgdz }kde$$Ifl0*$! t0#644 lazytz 0>1>2>d>e>>>>>>>>>>7?8?9?d?e??????????@@A@B@D@`@a@b@d@w@@@@@@@@@@@@@AAAA*hGhB5CJOJQJ\^J_HaJhGhB5CJ\_HaJh;#dhB5CJ\aJh;#dhB5CJ\_HaJh;#dhBCJaJmH sH h;#dhBCJ_HaJ h;#dhBh;#dhBCJaJ41>2>5>d>ui $$A$Ifgdz $$A$Ifgdz }kdf$$Ifl0*$! t0#644 lazytz d>e>h>>ui $$A$Ifgdz $$A$Ifgdz }kd-g$$Ifl0*$! t0#644 lazytz >>>>ui $$A$Ifgdz $$A$Ifgdz }kdg$$Ifl0*$! t0#644 lazytz >>>>8?sss $$A$Ifa$gdz }kdgh$$Ifl0*$! t0#644 lazytz 8?9?;?d?| $$A$Ifgdz $$A$Ifgdz jkdi$$Ifl$# t0#644 lazytz d?e?g??ui $$A$Ifgdz $$A$Ifgdz }kdi$$Ifl0*$! t0#644 lazytz ????ui $$A$Ifgdz $$A$Ifgdz }kd(j$$Ifl0*$! t0#644 lazytz ????ui $$A$Ifgdz $$A$Ifgdz }kdj$$Ifl0*$! t0#644 lazytz ???A@ui $$A$Ifgdz $$A$Ifgdz }kdbk$$Ifl0*$! t0#644 lazytz A@B@D@a@ui $$A$Ifgdz $$A$Ifgdz }kdk$$Ifl0*$! t0#644 lazytz a@b@d@@ui $$A$Ifgdz $$A$Ifgdz }kdl$$Ifl0*$! t0#644 lazytz @@@@ui $$A$Ifgdz $$A$Ifgdz }kd9m$$Ifl0*$! t0#644 lazytz @@@@ui $$A$Ifgdz $$A$Ifgdz }kdm$$Ifl0*$! t0#644 lazytz @@@@uu $$A$Ifgdz }kdsn$$Ifl0*$! t0#644 lazytz @@@@@@AAAyqeXXyy $dA$gdB $hA$^hgdB$A$gdB$A$gdB}kdo$$Ifl0*$! t0#644 lazytz A]ApAqA{AAAA$dh$7$8$A$H$Ifa$gdz $dh$7$8$A$H$Ifgdz $7$8$A$H$gdBAnAoApAqAzA{AAAAAAAAAAAAAAAAAAAABBBB B"B3B5B6B7BPBQB]B_BpBrBsBxBBǺ~~~~~~~~~~~~qh;#dhBCJ_HaJh;#dhB_H h;#dhBh;#dhB5CJ\_HaJh;#dhB5\_Hh;#dhB5CJ\_HaJh;#dhBCJ_HaJ*h hB5CJOJQJ\^J_HaJhBCJOJQJ^J_HaJ$hGhBCJOJQJ^J_HaJ,AAAAAAlXXXX$dh$7$8$A$H$Ifgdz kdo$$Ifl4F\ d6$`N ` t0(#    44 lazytz AAAAAAAYEEEEE$dh$7$8$A$H$Ifgdz kdnp$$Ifl4\\ d 6$ N  t0(#44 lazytz AABBB!B"B4B5B[GGGGGGG$dh$7$8$A$H$Ifgdz kdEq$$Ifl\\ d 6$N  t0(#44 lazytz 5B6B7BPBQB^B_BqBYEEEEEE$dh$7$8$A$H$Ifgdz kdr$$Ifl4\\ d 6$`N  t0(#44 lazytz qBrBsBxBBBBBEkdr$$Ifl42\\ d 6$ N  t0(#44 lazytz $dh$7$8$A$H$Ifgdz BBBBBBBBBBBBBBBBBBBBBB CCCCCC C>C?CgCCCCCCCCCCCCCCCC$DCDJDKDLDMDYDZDDDDDD̯h;#dhBCJaJ$h;#dhBCJOJQJ^J_HaJhBCJ_HaJh;#dhBCJ_HaJhBCJ_HaJ h;#dhBh;#dhBCJ_HaJh;#dhB_H;BBBBBBBBEkds$$Ifl4\\ d 6$`N  t0(#44 lazytz $dh$7$8$A$H$Ifgdz BBBBBBCCC[GGGGGGG$dh$7$8$A$H$Ifgdz kdt$$Ifl4\\ d 6$ N  t0(#44 lazytz CC C?CgCCCCCGkdSu$$Ifl4\\ d 6$ N  t0(#44 lazytz $dh$7$8$A$H$Ifgdz CCCCCCCCCGkd!v$$Ifl4\\ d 6$`N  t0(#44 lazytz $dh$7$8$A$H$Ifgdz CCCCCCDDG;;; $7$8$A$H$gdBkdv$$Ifl4\\ d 6$ N  t0(#44 lazytz $dh$7$8$A$H$Ifgdz DDDDDDDFyFzFFF&H'HHH,I4IFITIqIxIIIII)J/JMJSJJJJJJJKKKKnKoKǴڧ𧠧|||rrrrrrrrrrrrhBCJ_HaJh;#dhBCJ_HaJhBCJ_HaJhzhBCJ_HaJ h;#dhBh;#dhBCJ_HaJ$h hBCJOJQJ^J_HaJ$hB5CJOJQJ\^J_HaJ*h hB5CJOJQJ\^J_HaJh;#dhB5CJ\_HaJ,EEE>FyFF&HH-IFIqIIIl$ $7$8$A$H$Ifgdz 7$$7$8$A$H$If^gdz $$7$8$A$H$Ifgdz $d$7$8$A$H$Ifgdz 7$h$7$8$A$H$If^hgdz $h$A$If^hgdz $ & Fhd$7$8$A$H$IfgdB I)JMJJJJKKJjkdCx$$Ifl$$ t0$644 laytz 7$ ~$7$8$A$H$If^gdz 7$$7$8$A$H$If^gdz 7$ -$7$8$A$H$If^gdz KoKpKKKKKALyLlllllQ$ & Fhd$7$8$A$H$IfgdB$ & Fhd$A$IfgdBlkdx$$Ifl$$ t0$644 laytz $d$A$Ifgdz oKpKLLyLzLLLLLLLLLLLMM'M0M1M3M{MMMM NNNNNNNNNNN O O OSOTOŴŦ}r}rj}rjr}r}jr}}r}}r}hBCJaJh;#dhBCJaJh;#dhBCJZaJh;#dhB5CJZ\aJh;#dhB5CJ\aJh;#dhB5CJ\aJ h hBCJOJQJ^JaJ&h hB5CJOJQJ\^JaJh;#dhB_HhBCJ_HaJh;#dhBCJ_HaJ h;#dhB)yLzL{L|L}LLLLLLLxpppp``$$Ifa$gdz $A$gdB$7$8$A$H$^gdB $7$8$A$H$gdBjkdKy$$Ifl$$ t0$644 laytz LLLLLLLLLMMM'M}mmmmmmmmmmm$$Ifa$gdz kdy$$IfTl0^(#V t V0644 latytz 'M2M3MSMXMgMvMMMM NNmkdnz$$IfTl0^(#V t V0644 latytz $$Ifa$gdz NNN0NINoNNNN}mmmmmmm$$Ifa$gdz kd{$$IfTl0^(#V t V0644 latytz NNNNNNNN O}mmmmmmm$$Ifa$gdz kd{$$IfTl0^(#V t V0644 latytz  O OO7OTOvO}mmam $$A$Ifgdz $$Ifa$gdz kdQ|$$IfTl0^(#V t V0644 latytz TOuOvOwOOOOOOLPMP`PaPyPzP{PPPPPP.Q/QQQQQQQQQQQQQQcRdRRRRRRRRRSSISJSWSXSYSlSmS|S}S~SSSTT"T#T$T%T׹h;#dhBCJaJhBCJaJh;#dhBCJaJh;#dhBCJZaJh;#dhB5CJZ\aJh;#dhB5CJ\aJCvOwOOOOOO}mmmmm$$Ifa$gdz kd|$$IfTl0^(#V t V0644 latytz OOOOO PP.P8PBPaPzP}mmmmmmmmmm$$Ifa$gdz kd}$$IfTl0^(#V t V0644 latytz zP{PPPPPPP}mmmmmm$$Ifa$gdz kd4~$$IfTl0^(#V t V0644 latytz PPPPQ QQQ&Q/Q=Q}mmmmmmmmm$$Ifa$gdz kd~$$IfTl0^(#V t V0644 latytz =Q>QBQMQXQ^QlQqQQQQ}mmmmmmmmm$$Ifa$gdz kdv$$IfTl0^(#V t V0644 latytz QQQQQQQ}mmmmm$$Ifa$gdz kd$$IfTl0^(#V t V0644 latytz QQRRR(RERdRR}qaaaaaa$$Ifa$gdz $$A$Ifgdz kd$$IfTl0^(#V t V0644 latytz RRRRRRRR}mmmmmm$$Ifa$gdz kdY$$IfTl0^(#V t V0644 latytz RRSS,ST?TͼxgVE4# jhbbhz <CJUaJ jܒhbbhz <CJUaJ j4hbbhz <CJUaJ jhbbhz <CJUaJ jhbbhz <CJUaJ j@hbbhz <CJUaJ jhbbhz <CJUaJ jhbbhz <CJUaJ jJhbbhz <CJUaJ jhbbhz <CJUaJ jhbbhz <CJUaJ jVhbbhz <CJUaJ jhbbhz <CJUaJ ?T@TATBTCTDTFTGTITJTLTMTOTRTSTjTkTmTnTqTrTsTʶhBZmHnHujhJAUhJAhz jhz U&h;#dh_:5CJ\_HaJmH sH jhbbhz <CJUaJ&jіhbbhz 5<CJU\aJ j&hbbhz <CJUaJE0P1h:p>. A!"#$% (2*2DpH 00P1h:p+. A!"#$% (2*2DpE0P1h:p+. A!"#$% (2*2Dp$$If!vh552 55 55~ #v#v2 #v#v #v#v~ :V l t0)552 55 55~ aytv-$$If!vh552 55 55~ #v#v2 #v#v #v#v~ :V l t0)552 55 55~ aytv-$$If!vh552 55 55~ #v#v2 #v#v #v#v~ :V l t0)552 55 55~ aytv-$$If!vh552 55 55~ #v#v2 #v#v #v#v~ :V l t0)552 55 55~ aytv-$$If!vh552 55 55~ #v#v2 #v#v #v#v~ :V l t0)552 55 55~ aytv-$$If!vh552 55 55~ #v#v2 #v#v #v#v~ :V l t0)552 55 55~ aytv-$$If!vh552 55 55~ #v#v2 #v#v #v#v~ :V l^ t0)552 55 55~ aytv-$$If!vh552 55 55~ #v#v2 #v#v #v#v~ :V l t0)552 55 55~ aytv-$$If!vh552 55 55~ #v#v2 #v#v #v#v~ :V l t0)552 55 55~ aytv-$$If!vh552 55 55~ #v#v2 #v#v #v#v~ :V l t0)552 55 55~ aytv-$$If!vh552 55 55~ #v#v2 #v#v #v#v~ :V l t0)552 55 55~ aytv-$$If!vh552 55 55~ #v#v2 #v#v #v#v~ :V l1 t0)552 55 55~ aytv-$$If!vh552 55 55~ #v#v2 #v#v #v#v~ :V l t0)552 55 55~ aytv-$$If!vh552 55 55~ #v#v2 #v#v #v#v~ :V l t0)552 55 55~ aytv-$$If!vh552 55 55~ #v#v2 #v#v #v#v~ :V l t0)552 55 55~ aytv-$$If!vh552 55 55~ #v#v2 #v#v #v#v~ :V l t0)552 55 55~ aytv-$$If!vh552 55 55~ #v#v2 #v#v #v#v~ :V l t0)552 55 55~ aytv-$$If!vh552 55 55~ #v#v2 #v#v #v#v~ :V l t0)552 55 55~ aytv-$$If!vh552 55 55~ #v#v2 #v#v #v#v~ :V l t0)552 55 55~ aytv-$$If!vh552 55 55~ #v#v2 #v#v #v#v~ :V l t0)552 55 55~ aytv-$$If!vh552 55 55~ #v#v2 #v#v #v#v~ :V l t0)552 55 55~ aytv-$$If!vh552 55 55~ #v#v2 #v#v #v#v~ :V l t0)552 55 55~ aytv-$$If!vh552 55 55~ #v#v2 #v#v #v#v~ :V l t0)552 55 55~ aytv-$$If!vh552 55 55~ #v#v2 #v#v #v#v~ :V l t0)552 55 55~ aytv-$$If!vh552 55 55~ #v#v2 #v#v #v#v~ :V l t0)552 55 55~ aytv-$$If!vh552 55 55~ #v#v2 #v#v #v#v~ :V l t0)552 55 55~ aytv-$$If!vh552 55 55~ #v#v2 #v#v #v#v~ :V l t0)552 55 55~ aytv-$$If!vh5@ 55N 5N #v@ #v#vN :V l_ (0(5@ 55N ap(ytz $$If!vh5@ 55N 5N #v@ #v#vN :V l0(5@ 55N aytz $$If!vh5@ 55N 5N #v@ #v#vN :V l0(5@ 55N aytz $$If!vh5@ 55N 5N #v@ #v#vN :V l0(5@ 55N aytz $$If!vh5@ 55N 5N #v@ #v#vN :V l0(5@ 55N aytz $$If!vh5@ 55N 5N #v@ #v#vN :V l0(5@ 55N aytz $$If!vh5@ 55N 5N #v@ #v#vN :V l0(5@ 55N aytz $$If!vh5@ 55N 5N #v@ #v#vN :V l0(5@ 55N aytz $$If!vh5@ 55N 5N #v@ #v#vN :V lG (0(5@ 55N ap(ytz $$If!vh5@ 55N 5N #v@ #v#vN :V lG0(5@ 55N aytz $$If!vh5@ 55N 5N #v@ #v#vN :V l0(5@ 55N aytz $$If!vh5@ 55N 5N #v@ #v#vN :V ly0(5@ 55N aytz $$If!vh5@ 55N 5N #v@ #v#vN :V l0(5@ 55N aytz #$$If!vh5 5F5@ 5@ #v #vF#v@ :V l (0`'5 5F5@ / ap(ytz $$If!vh5 5F5@ 5@ #v #vF#v@ :V l0`'5 5F5@ / aytz $$If!vh5 5F5@ 5@ #v #vF#v@ :V lL0`'5 5F5@ / aytz $$If!vh5 5F5@ 5@ #v #vF#v@ :V l 0`'5 5F5@ / aytz $$If!vh5 5F5@ 5@ #v #vF#v@ :V l0`'5 5F5@ / aytz $$If!vh5 5F5@ 5@ #v #vF#v@ :V lU0`'5 5F5@ / aytz $$If!vh5 5F5@ 5@ #v #vF#v@ :V l0`'5 5F5@ / aytz $$If!vh5 5F5@ 5@ #v #vF#v@ :V l0`'5 5F5@ / aytz #$$If!vh5 55 5 #v #v#v #v :V lG (0(5 55 5 ap(ytz $$If!vh5 55 5 #v #v#v #v :V l 0(5 55 5 aytz $$If!vh5 55 5 #v #v#v #v :V l=0(5 55 5 aytz $$If!vh5 55 5 #v #v#v #v :V l=0(5 55 5 aytz $$If!vh5 55 5 #v #v#v #v :V l=0(5 55 5 aytz $$If!vh5 55 5 #v #v#v #v :V l0(5 55 5 aytz $$If!vh5 55 5 #v #v#v #v :V l0(5 55 5 aytz $$If!vh5 55 5 #v #v#v #v :V l0(5 55 5 aytz $$If!vh5 55 5 #v #v#v #v :V lN ((5 55 5 / ap(ytz $$If!vh5 55 5 #v #v#v #v :V l(5 55 5 / aytz $$If!vh5 55 5 #v #v#v #v :V l(5 55 5 / aytz $$If!vh5 55 5 #v #v#v #v :V l(5 55 5 / aytz $$If!vh5 55 5 #v #v#v #v :V l(5 55 5 / aytz Q$$If!vh5555 52 #v#v#v#v #v2 :V l  t200*5555 52 ap2ytz $$If!vh5555 52 #v#v#v#v #v2 :V l t00*5555 52 aytz $$If!vh5555 52 #v#v#v#v #v2 :V l t00*5555 52 aytz $$If!vh5555 52 #v#v#v#v #v2 :V l t00*5555 52 aytz $$If!vh5555 52 #v#v#v#v #v2 :V l t00*5555 52 aytz $$If!vh5555 52 #v#v#v#v #v2 :V lX t00*5555 52 aytz $$If!vh5555 52 #v#v#v#v #v2 :V lA t00*5555 52 aytz $$If!vh5555 52 #v#v#v#v #v2 :V l t00*5555 52 aytz $$If!vh5555 52 #v#v#v#v #v2 :V l t00*5555 52 aytz $$If!vh5555 52 #v#v#v#v #v2 :V l t00*5555 52 aytz $$If!vh5555 52 #v#v#v#v #v2 :V l t00*5555 52 aytz #$$If^!vh555 5 #v#v#v #v :V lJ (0$555 5 a^p(ytz $$If^!vh555 5 #v#v#v #v :V l0$555 5 a^ytz $$If^!vh555 5 #v#v#v #v :V l0$555 5 a^ytz $$If^!vh555 5 #v#v#v #v :V lg0$555 5 a^ytz $$If^!vh555 5 #v#v#v #v :V l0$555 5 a^ytz $$If^!vh555 5 #v#v#v #v :V l0$555 5 a^ytz $$If^!vh555 5 #v#v#v #v :V l0$555 5 a^ytz #$$If^!vh555 5 #v#v#v #v :V lN (0$555 5 a^p(ytz $$If^!vh555 5 #v#v#v #v :V lk0$555 5 a^ytz $$If^!vh555 5 #v#v#v #v :V l0$555 5 a^ytz $$If^!vh555 5 #v#v#v #v :V l0$555 5 a^ytz Q$$If!vh555b52 5 #v#v#vb#v2 #v :V l  t20)555b52 5 ap2ytz $$If!vh555b52 5 #v#v#vb#v2 #v :V l t0)555b52 5 aytz $$If!vh555b52 5 #v#v#vb#v2 #v :V lX t0)555b52 5 aytz $$If!vh555b52 5 #v#v#vb#v2 #v :V l t0)555b52 5 aytz ($$If!vh5 5 55 #v #v #v#v :V l  t(0>+65 5 55 ap(ytz $$If!vh5 5 55 #v #v #v#v :V l t0>+65 5 55 aytz $$If!vh5 5 55 #v #v #v#v :V l t0>+65 5 55 aytz $$If!vh5 5 55 #v #v #v#v :V l t0>+65 5 55 aytz $$If!vh5 5 55 #v #v #v#v :V l t0>+65 5 55 aytz $$If!vh5 5 55 #v #v #v#v :V l t0>+65 5 55 aytz $$If!vh5 5 55 #v #v #v#v :V l t0>+65 5 55 aytz $$If!vh5 5 55 #v #v #v#v :V l t0>+65 5 55 aytz $$If!vh5 5 55 #v #v #v#v :V l t0>+65 5 55 aytz $$If!vh5 5 55 #v #v #v#v :V l t0>+65 5 55 aytz $$If!vh5 5 55 #v #v #v#v :V l t0>+65 5 55 aytz $$If!vh5 5 55 #v #v #v#v :V l t0>+65 5 55 aytz $$If!vh5 5 55 #v #v #v#v :V l t0>+65 5 55 / aytz $$If!vh5 5 55 #v #v #v#v :V l t0>+65 5 55 aytz 6$$If!vh5 5 55 #v #v #v#v :V l  t(0>+65 5 55 / ap(ytz $$If!vh5 5 55 #v #v #v#v :V l t0>+65 5 55 / aytz $$If!vh5 5 55 #v #v #v#v :V l t0>+65 5 55 / aytz $$If!vh5 5 55 #v #v #v#v :V l t0>+65 5 55 / aytz $$If!vh5 5#v #v:V l  t0&65 5pytz $$If!vh5 5#v #v:V l t0&65 5ytz $$If!vh5 5#v #v:V l t0&65 5ytz $$If!vh5 5#v #v:V ly t0&65 5ytz $$If!vh5 5#v #v:V l t0&65 5ytz $$If!vh5 5#v #v:V l t0&65 5ytz $$If!vh5 5#v #v:V l t0&65 5ytz $$If!vh5 5#v #v:V l t0&65 5ytz $$If!vh5 5#v #v:V l t0&65 5ytz $$Ifz!vh5##v#:V l t0#65#azytz $$Ifz!vh55!#v#v!:V l t0#655!azytz $$Ifz!vh55!#v#v!:V l t0#655!azytz $$Ifz!vh55!#v#v!:V l t0#655!azytz $$Ifz!vh55!#v#v!:V l t0#655!azytz $$Ifz!vh55!#v#v!:V l t0#655!azytz $$Ifz!vh55!#v#v!:V l t0#655!azytz $$Ifz!vh55!#v#v!:V l t0#655!azytz $$Ifz!vh55!#v#v!:V l t0#655!azytz $$Ifz!vh55!#v#v!:V l t0#655!azytz $$Ifz!vh55!#v#v!:V l t0#655!azytz $$Ifz!vh55!#v#v!:V l t0#655!azytz $$Ifz!vh55!#v#v!:V l t0#655!azytz $$Ifz!vh55!#v#v!:V l t0#655!azytz $$Ifz!vh55!#v#v!:V l t0#655!azytz $$Ifz!vh5##v#:V l t0#65#azytz $$Ifz!vh55!#v#v!:V l t0#655!azytz $$Ifz!vh55!#v#v!:V l t0#655!azytz $$Ifz!vh55!#v#v!:V l t0#655!azytz $$Ifz!vh55!#v#v!:V l t0#655!azytz $$Ifz!vh55!#v#v!:V l t0#655!azytz $$Ifz!vh55!#v#v!:V l t0#655!azytz $$Ifz!vh55!#v#v!:V l t0#655!azytz $$Ifz!vh55!#v#v!:V l t0#655!azytz $$Ifz!vh55!#v#v!:V l t0#655!azytz $$Ifz!vh55!#v#v!:V l t0#655!azytz $$Ifz!vh5N 55#vN #v#v:V l4 t0(#++5N 55azytz $$Ifz!vh5N 555#vN #v#v#v:V l4 t0(#++5N 555azytz $$Ifz!vh5N 555#vN #v#v#v:V l t0(#5N 555azytz $$Ifz!vh5N 555#vN #v#v#v:V l4 t0(#+5N 555azytz $$Ifz!vh5N 555#vN #v#v#v:V l42 t0(#+5N 555azytz $$Ifz!vh5N 555#vN #v#v#v:V l4 t0(#+5N 555azytz $$Ifz!vh5N 555#vN #v#v#v:V l4 t0(#+5N 555azytz $$Ifz!vh5N 555#vN #v#v#v:V l4 t0(#+5N 555azytz $$Ifz!vh5N 555#vN #v#v#v:V l4 t0(#+5N 555azytz $$Ifz!vh5N 555#vN #v#v#v:V l4 t0(#+5N 555azytz $$If!vh5$#v$:V l t0$65$ytz $$If!vh5$#v$:V l t0$65$ytz $$If!vh5$#v$:V l t0$65$ytz $$If!vh5$#v$:V l t0$65$ytz $$Ift!vh5V5#vV#v:V l t V065V5atytz $$Ift!vh5V5#vV#v:V l t V065V5atytz $$Ift!vh5V5#vV#v:V l t V065V5atytz $$Ift!vh5V5#vV#v:V l t V065V5atytz $$Ift!vh5V5#vV#v:V l t V065V5atytz $$Ift!vh5V5#vV#v:V l t V065V5atytz $$Ift!vh5V5#vV#v:V l t V065V5atytz $$Ift!vh5V5#vV#v:V l t V065V5atytz $$Ift!vh5V5#vV#v:V l t V065V5atytz $$Ift!vh5V5#vV#v:V l t V065V5atytz $$Ift!vh5V5#vV#v:V l t V065V5atytz $$Ift!vh5V5#vV#v:V l t V065V5atytz $$Ift!vh5V5#vV#v:V l t V065V5atytz $$Ift!vh5V5#vV#v:V l t V065V5atytz $$Ift!vh5V5#vV#v:V l t V065V5atytz $$Ift!vh5V5#vV#v:V l t V065V5atytz $$Ift!vh5V5#vV#v:V l t V065V5atytz Dd ^  3 ,bullet_arrow"@@Dd \  3 *star_orange"@@Dd Z  3 (ads_circle"@@Dd \  3 *star_orange"@@Dd Z  3 (ads_circle"@@Dd \  3 *star_orange"@@Dd Z  3 (ads_circle"@@Dd \  3 *star_orange"@@Dd Z   3 (ads_circle"@@Dd \   3 *star_orange"@@ Dd Z   3 (ads_circle"@@ Dd \   3 *star_orange"@@ Dd Z   3 (ads_circle"@@ Dd \  3 *star_orange"@@ Dd Z  3 (ads_circle"@@Dd \  3 *star_orange"@@Dd Z  3 (ads_circle"@@Dd \  3 *star_orange"@@Dd Z  3 (ads_circle"@@Dd \  3 *star_orange"@@Dd Z  3 (ads_circle"@@Dd \  3 *star_orange"@@Dd Z  3 (ads_circle"@@Dd X  3 &mr_bullet"@@DdT  C "A mso1"@@bP @]p8Uwj! nP @]p8UwPNG  IHDR exsRGBPLTE';bRQxx,+yy;bqpbbuvZZLLxwjjNNA@zzmm^_ywyxxwRR,*++X6 cmPPJCmp0712tRNS0JIDAT]= PԘc FF??!*pkjjp $i( w?ѹ|L Յ{Qd:$~9lwVİCSLQE|18RK篽CPגZd?۵*$`IENDB`DdZ  C (Aart99C6"@@b{C]qMF9! n{C]qMF9PNG  IHDR [A0PLTE91޵k1)cZ!gj!tRNSܘ cmPPJCmp0712Om9IDATcx L= f ի1{^{$W+'BMw8{*IENDB`Dd R  3 bullet"@@^^ 666666666vvvvvvvvv666666>66666666666666666666666666666666666666666666666hH666666666666666666666666666666666666666666666666666666666666666662 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~_HmH nH sH tH N`N ZNormal$A$CJ_H,aJmH sH tH b@b Heading 1$$dh@&A$a$5\^J _HaJ!mHnHul@l  ) Heading 2$$<@&$56CJOJ PJQJ \]^JaJbb F Heading 3$$<@&5CJOJ QJ \_HaJff y Heading 4$$<@&5CJOJPJQJ\^JaJhh *' Heading 5$<@&$56CJOJPJQJ\]^JaJb@b 1' Heading 6$<@&5CJOJPJQJ\^JaJDA`D Default Paragraph FontRi@R  Table Normal4 l4a (k (0No List d/@d $List)$5$7$8$9DH$^`CJ [^J _HaJ tH6U@6 7;0 Hyperlink >*B* phV`V Yi No Spacing$A$CJ_H,aJmH sH tH R!RHeading 1 Char5CJ\^J aJ!mHnHuL^@2L @0 Normal (Web)$ddA$[$\$_HVP@BV * Body Text 2 $A$a$B*CJ _HaJ phtHNQN *Body Text 2 CharB*CJ aJ phtHJQbJ D0 Body Text 3$xCJaJDqD D0Body Text 3 Char CJ_H,aJNZ@N ~ Plain Text$A$CJOJ QJ ^J _HaJBB ~Plain Text Char OJ QJ ^J VV yHeading 4 Char"5CJOJPJQJ\^J_H,aJv>v &: Title($<5$7$8$9DH$a$)5CJ KHOJQJ[\^J _HaJ&tHRR &: Title Char%5CJ KHOJQJ[\^J aJ&tH.O. % mw-headline*W@* %`Strong5\JJ FHeading 3 Char5CJOJ QJ \aJ\\ )Heading 2 Char(56CJOJ PJQJ \]^J_H,aJbb")0Header!$ 9r A$'CJOJ QJ ^J _HaJmHnHtHuJ!J!)0 Header CharOJ QJ ^J mHnHtHuR2R )mmpara#$dP A$B*OJQJ^J_Hph8OA8 ) mmdefinition16]*Q* )symbol1;<a< O< superscript2 CJH*aJTrT O<bodycopy'$d,<A$CJOJQJ_HaJ>B> )0 Body Text($x@@ (0Body Text Char CJ_H,aJ\\ 'Heading 5 Char(56CJOJPJQJ\]^J_H,aJBB - content1CJOJQJaJo(ph..  editsection> @> .0Footer-$ H$:: -0 Footer Char CJ_H,aJ.X@. 3@Emphasis6]44 ipa1OJPJQJ^Jo(VV 'Heading 6 Char"5CJOJPJQJ\^J_H,aJ8O!8  screen_use1 <6O16  print_use1 <XAX 7mmpopup1/5;CJ\aJphfffq r@.Q. 7mmlabel1ph,Oa, 7 mmdrugtermH@rH rd List Paragraph7$^  Qdesc,, WXitalic16]NN mN table-title25CJOJQJ\^JaJo(XX mN tabledata1;$dDA$CJOJQJ^J_HaJ4O4 r.goog_qs-tidbit88 tgoog_qs-tidbit-1  ytextFVF 0FollowedHyperlink >*B*ph:: 9fadewordcontainer88 W. ja50-ce-inf1CJaJ@"@ ,%norm6B$A$ CJ_HaJ(1( "organism.A. cbmlink1 ;phX:Q: cbmicroorganism26]DbD ^ ja50-ce-para1 F$,A$_H>q> I mmhheadtitle1 56\]0a0 >0 HTML Cite6]>> O firstI$ddA$[$\$_H22 ( linkexpanded2$$ iil_ad122 ,N stbuttontext1ZZ ~mmfheadM$d,-A$5B*OJQJ\^J_Hph^^ ~mmfigureN$d,,A$!B*CJOJQJ^J_HaJph333bb ~ mmfigurelastO$d,A$!B*CJOJQJ^J_HaJph333(( FbulletedBB zhighlightedsearchtermO! Hqftj3j G Table Grid7:VS0SPBP %9 red-smallT$ddA$[$\$ B*_Hph.OQ. ?.t110CJaJph4a4 genesymbol26]"q" 8zklink*O* i#dgelb1phķTYT Zv"0 Document Map Y$CJOJQJ^JaJRR Yv"0Document Map CharCJOJQJ^J_H,aJ00  } mmdefinition +:st&o& BtxtbasePK![Content_Types].xmlj0Eжr(΢Iw},-j4 wP-t#bΙ{UTU^hd}㨫)*1P' ^W0)T9<l#$yi};~@(Hu* Dנz/0ǰ $ X3aZ,D0j~3߶b~i>3\`?/[G\!-Rk.sԻ..a濭?PK!֧6 _rels/.relsj0 }Q%v/C/}(h"O = C?hv=Ʌ%[xp{۵_Pѣ<1H0ORBdJE4b$q_6LR7`0̞O,En7Lib/SeеPK!kytheme/theme/themeManager.xml M @}w7c(EbˮCAǠҟ7՛K Y, e.|,H,lxɴIsQ}#Ր ֵ+!,^$j=GW)E+& 8PK!Ptheme/theme/theme1.xmlYOo6w toc'vuر-MniP@I}úama[إ4:lЯGRX^6؊>$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3ڗP 1Pm \\9Mؓ2aD];Yt\[x]}Wr|]g- eW )6-rCSj id DЇAΜIqbJ#x꺃 6k#ASh&ʌt(Q%p%m&]caSl=X\P1Mh9MVdDAaVB[݈fJíP|8 քAV^f Hn- "d>znNJ ة>b&2vKyϼD:,AGm\nziÙ.uχYC6OMf3or$5NHT[XF64T,ќM0E)`#5XY`פ;%1U٥m;R>QD DcpU'&LE/pm%]8firS4d 7y\`JnίI R3U~7+׸#m qBiDi*L69mY&iHE=(K&N!V.KeLDĕ{D vEꦚdeNƟe(MN9ߜR6&3(a/DUz<{ˊYȳV)9Z[4^n5!J?Q3eBoCM m<.vpIYfZY_p[=al-Y}Nc͙ŋ4vfavl'SA8|*u{-ߟ0%M07%<ҍPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 +_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!Ptheme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] OQsL  G   ...12 1Fd\P !$"$'t(+.143$44H89;=l>BBrDFtHgJ2KM>NO\QRT|V?X\`c efni1knoqtNxz|րho^Rs rmrSPUC.  >$,U.374:g<@CH>KMsQkT]XY^^ehZkn!sw!z~؄6ג3"KeS-H3s0Գÿ& ,}-JATvH"9Tz k H!q#%D'2*k-/247=^?AA6D=G KLMO.Q~W/[ ]u`e[iSmoquyzApB~"0h1Ϲ;kbsZNmnb*0:7U( I!#'&(R+-.03489:=m?o@RAwDGKOT#V0Y[J]_nacgjl`r&uewOyzf{|}&KXqr!M͝ОբiԨXm^j~DMaPi2sH=54 MyR $&+02R90>ABDoKTO%T2T?TsT+.05;CIOV_efgijkmoprtvwyz{|}~    !"$%&')*,-./01345789:;=>?@ABDEFGHJKMOPQRSTUWXY[\]^_abcdeghiklmopqrtuvwyz{|}~     !"#$%'()*+-/9?KR^o~ }c+l4Y5;f6a7jWtL ;%(+1$4;=A5DsHnMO>SX`.p|*a mH-$,6L;BLW j{xk2ÿ3w/)%3<?YN Y5jqLȏZba,o J!\,06/@BFSU`hluz}̈́T.#QtCWAUA~>xGQsC`\C6Ci/[bTE]7];93  e { 2 h w D  +Eo <e|h  c!"q""$%&&''a(=))++-.p/~0c122#58@99S:N;<===s===1>d>>>8?d????A@a@@@@@AAAA5BqBBBCCCDEIKyLL'MNN OvOOzPP=QQQRRXS}SS%TsT,-/12346789:<=>?@ABDEFGHJKLMNPQRSTUWXYZ[\]^`abcdhlnqsux  #(+26<CILNVZ`fjnsx &,.012345678:;<=>@ABCDEFGHIJLMNOPQSTUVWXYZ[\]_`abcdefghijklmnpqrstuvwxyz{|}] =)))+++,,--b-r-v----).A.R////G0T00000 191{1111/2922222;3G3\333a4444 55q555EFFT^UnUqUUU2XXXCk}kkP2|א!. ɒCDQ]i8Xc{×ϗP`RXk+8kɛݜ(.t&|Ԟ"tΟ۟#/M(3_U,Z4D` PVY ht@J;IPcvBcxH_j8fqDPSo$<Zf+/2_/y5FMN ^jpV\wbm%t9EY ]edhuqFS = F I   2"""""#%_%w%%%&I&&&&&''F'O'V'''#(((,Q-f-////?0E0}0006k667[8h89999*:5:Y:::: ;;>P>V>Y>>>>>>]????@)@lBBBCCC9DDDDE EE_EtEE FFS@TPTTTUuXXXVYYYYZZZbZqZZZZ[R[Y[[[[D\\\dddteeegghDhhhhhhnJnTnWnnnnno,shsnsssssstt^~~~`nҀ߀o5Ahʃv\…ʅ&<ˆ׆/}]j$?\npʑԑVhْ#mʓBV_x̗ϗ,G \l}۟EGRn¡ӡAǢjŨpPVEQԫޫDZzȬ׬ȮӮٮ#0{Ͱްϱ <C h/9ɽս2pw|Y`A_%=bt%uGKv($^dVMZ[Xv3:S "=)!'06GNv N)m|U`c hK,,,f////00223)3e3k3333 4J4Q4[4444(5/5a6666 77]AAAFCCCLiLzLLLL0Q|QQvRRRLTTTTTTUIUSUU2V9VDVVVWfWrWX4YZ`c#)s2J2Q2 3E3K33333)4?4W444sLXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX'*1!  /XR$a[c@)rI@g]/R$K@M {jR@ 0(  B S  ?H0(  sL_GoBack1128TreatmentSurgicalCareF6SEC6Pathophysiology Prognosis OLE_LINK12howisDiffuse_scleroderma$Limited_scleroderma.2FCREST_syndromeMorphea.2Flinear_scleroderma Presentationu11IntroductionFrequency"IntroductionFrequencyInternationalIntroductionMortalityMorbidityIntroductionRaceIntroductionSexClinicalPhysicalClinicalCausesIntroductionPathophysiologyClinicalHistoryIntroductionAge1129_PictureBullets) qynntq2I\\\````aa^jX'LtL ) qynntq2I\\\````aa^jXBLtL#*D O v     * E R e k # /    . Q ] AO 35dlmstv?LQb1<\h>J mw*3HR'##33GGMMNN[[cch$hhhh innpppppp8rCrttQxYx yyyyzz||v~/M`hy%&03;<FĴŴʹILM[_iDN.8/67ADKLV+ -75;FNQXbl~   "  nwqxy.......///%/(///0000 111(15'577QIZILLLLXXZccc d,d0d;dggiqoqwwww7wCwmwwwywwzzz{epZdeoΟ $dn+4DEP#,3=z!*.83<BE'34; { R]W^z6F4>?J4 ; #138--44K7[7B(B4C7CNN OOiRwRee"h(hSo_oaojozoooooooooooooooooooorrhكڃ|݄̗,͜לEL!Ǣ039CNQdtilӺݺ",5BU t~U`06du[dfk~0=+4U_N\7B) 4     D M _ l  { bmq~<HV`))++&./.y11SSZZdd~~-67A"(ڇ* *bqבJSǕ֕P[\e ݚZghq7@X]NT\dŬT` clֶ߶`iAPirsyJBLCLELFLHLILKLLLNLOLRLnLqLtL"&qucj^^< =0=%,8888ۋKS:B 9A^`EG  FN##o0w099L<Z<<<<<DD'LBLCLELFLHLILKLLLNLOLqLtL3333333333333333333333333333333333!(>[+25) 0 = d     l m   X Y 4 5 ef`aijWXKQ /ak0;^ i _!i!""####w$$`%i%%%))))))*+5+&,@,/m0M1V16 688 99f:t::;p>>i@t@AAC+CdEoE F.FFFFFoJJJJJJJJPQTTXXddffPi[ittxxzs+6'3,ˢ£LYðд,U(bm1;4Q$Ueqk:E &e %  23>Xcj!#,###$$%%k**--0013L38888&929z??D%DQI[I;JEJQ'Q^^``b bggnnr)ruuTu_umwywzz)|4|}.}Ƃт$-҄!e'2Ϧ ȫԫ÷Ϸ0;&.Sz3>-xDO(v > I  ( )2D'(**L,X,--4444 77B)B C*CNFYFFFGGNNtO~O QQSSPa[a6bAbSe^ehiqqqq4r>rrrAL•͕EV1<0DGZHRW`!&Jcz0?,#2eon x   <E<J "  " "Q$\$%%((++&.0...p0z0l117&78899C:M:::7=B=>>VK`KHMSM}PPSSXXZZ``aacddd`jkjkkKqLqrrhs}sttuugzrz||ZAJ-DN6APhȘ͙֙՚it8C[oȰTl_JVMXAR#.b|~HYayz)mhq*esh(A]+<1jBvA'~\dmHlBw,U<Fz^Acy1zJT^J&] D>uE"K5EP 8   L j      $ bw^n?z} >h FlrTdW *(X z  !>!r!##j$$,%V%%%8&]&d))**-#-..00A1C111T2V2O3Q3445@5t5v555552656e6h66697;7e7777B89c999s:: ;g;;==pCCDDEEEFFFF G7GwGGGBH{HHH/I>IIIIIEJJJJ,KYKmK~KL'LBLCLELFLHLILKLLLNLOLqLtL))**, , . 1 ggggzzpkk  44NNsOtO̓΃cYnYIIJBLCLCLFLFLOLRLnLqLtLsY$#OWuzl$Ѝ}1f?j޺#Wd+h.hp@rEJ5 NDidxfd X$5܂vj8=g$ Y,ne(xQ 22fRE  'NZVCD]=@t6ǘt#Mج7kwSfhL`%# |WE 5T a&5 8,{zq **to-z @:K ""7Z 갳 :X QDLX I cW `b > zJ@ \3 D##p& 0RVl.&+l@_CwpKr:U~\n~p ΅?8hT=A:b@"|.h=ik={*G~68%Toq2*FKOR'bHINZk>j+4wVI2(~–`Hp&#(gE^7fQQZ&s"MҁOɞ J-n/vZRSR(X]f~Jbs^8)\?tiF>r) rTH|^ 7l(]uZf*2Rx`& q,AO_b3bsacDĄ{krv'8:,\$5 >.Dv'KZOo2RL/A(Nf, 9G( *$?\~[ >H 85 轺 / !*!n\**/"x V?"]"V1"4{"s6z"˾4%":hd2#"VtZ#2}#^y~#F)X9 #|" $E:'aT$Dzb$Twh $ T%(%`~U%&&,R '!|^D+ '8k#'F  N' { h'r~Y'~/(=I)T=F)}(l)-)_'*x)X*=:[c*@zg*.Rq*[*,ex2*xGVE+/7Y,> ,0^-ʥ;b-8aq-8M_-z5R.yRC'.ފ.=E.O(Wj.9KI.|`Jp.|_.X>.Lx..>-qM.o}/Xy/,:N/0@02x0B$){:1زbLJ*1w:zm1}s1.lK2赂#sJg2r12l$-W730W`.I3pfl3dg.q3`#psIS3DR3U++3Vw4X6d 4Ϥ(4kdU4Zz[Ey4^fl4RZ44Mg4rwF+:4M\S@52Oc\L5x6i5=5 i515JQ4~6*z]6Vl6 rT6x8~[B7?F2sN7/!7B`/[7g.8Oxd`9hjة h9fNz49k" :m0 :\Iz:pp:,!:T.:~1;;f\U;& b;]n;(HX<6ah<J)<\Oj3=]b5Qc=wX>Pcdd>,p>_(!! ?'R?h?jV l4?jF@R%a@pz#AdrAJBƽW&C3[gCH<5czCu~Ct@Slf(D^e5DndDn6!X`,El@E@BEt6zEX6:6pAFNBxF~DF^AG6jAiGrJd*GOH> hxHU-}HP HHqpOH s%xKIh\Ij jJ'_sJTl*ZJ$\.K.`FMzKNbpuK~P4~K~0RKK"MDKBLe!LܐJT8LLv .HLX@zyTLBR:Li86(8Mn>HM^H|MV> M^CxJNR2N8@cN¿KOZ %OtR57OD GROH(_OV_OPZvJO8g(PD(kYPJ]uPMtQ 6(?Q.6:QPbWRf:R^XJR$`K8S=rS:-nSNUV3k&T^~.+Tnj`[TdžNPdT̖:VTܭy AQU4 UP~0p0U: WVUg6HVB=YW`HjWBP,fvW⍚5;W4(e6Wb€MW2a`WxF=W0V'\X6o %tXV; tIXyWqBYiE,,Yt6vxY@fX!@ZHVYZp'tCwZN<sZT8@2:][C8GK[% Bt/[|4~_z&`2`:[`7:a$AaPW[b8C+cζs7cDx1r>YP\#s% hs |s4gsY:EXW!tf ?Kt.DLOtʌYau.ҽ#zufТ_#uj[vھ#wRA@dlw_]waELxL,&Hy yajy( =yn+z5+`#z !k7zr@zrfpGz N/&{,p{nˎ9'|{5| :? }R0Z~0}O=}^wxI~9-~|DQ~Ui:/94":hX9jE$ X: Z6V 4,Ln& hh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hH^`OJQJo(hH^`OJ QJ ^J o(hHop^p`OJQJo(hH@ ^@ `OJQJo(hH^`OJ QJ ^J o(hHo^`OJQJo(hH^`OJQJo(hH^`OJ QJ ^J o(hHoP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhhh^h`CJOJQJo(hH88^8`CJOJ QJ o(o^`CJOJQJo(  ^ `CJOJQJo(  ^ `CJOJQJo(xx^x`CJOJQJo(HH^H`CJOJQJo(^`CJOJQJo(^`CJOJQJo(hh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hH^`CJOJQJo(0^`0o(.pp^p`CJOJQJo(@ @ ^@ `CJOJQJo(^`CJOJQJo(^`CJOJQJo(^`CJOJQJo(^`CJOJQJo(PP^P`CJOJQJo(hh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHh^`CJOJQJo(hH^`CJOJ QJ o(opp^p`CJOJQJo(@ @ ^@ `CJOJQJo(^`CJOJQJo(^`CJOJQJo(^`CJOJQJo(^`CJOJQJo(PP^P`CJOJQJo(hh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhhh^h`CJOJQJo(hH88^8`CJOJ QJ o(o^`CJOJQJo(  ^ `CJOJQJo(  ^ `CJOJQJo(xx^x`CJOJQJo(HH^H`CJOJQJo(^`CJOJQJo(^`CJOJQJo(h^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^h`OJQJo(hH8^8`OJ QJ ^J o(hHo^`OJQJo(hH ^ `OJQJo(hH ^ `OJ QJ ^J o(hHox^x`OJQJo(hHH^H`OJQJo(hH^`OJ QJ ^J o(hHo^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hH^`OJQJo(hH^`OJ QJ ^J o(hHop^p`OJQJo(hH@ ^@ `OJQJo(hH^`OJ QJ ^J o(hHo^`OJQJo(hH^`OJQJo(hH^`OJ QJ ^J o(hHoP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hH^`OJQJo(hH^`OJ QJ ^J o(hHop^p`OJQJo(hH@ ^@ `OJQJo(hH^`OJ QJ ^J o(hHo^`OJQJo(hH^`OJQJo(hH^`OJ QJ ^J o(hHoP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhhh^h`CJOJQJo(hH8^8`o(^`o(. ^ `OJPJQJ^Jo(-  ^ `CJOJQJo(xx^x`CJOJQJo(HH^H`CJOJQJo(^`CJOJQJo(^`CJOJQJo(h^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hH ^`OJQJo(^`OJ QJ ^J o(o p^p`OJQJo( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJQJo( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJQJo(hh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`CJOJQJo(hH^`CJOJ QJ o(op^p`o(.@ @ ^@ `CJOJQJo(^`CJOJQJo(^`CJOJQJo(^`CJOJQJo(^`CJOJQJo(PP^P`CJOJQJo(h^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHh h^h`o(hH. 8^8`hH. L^`LhH.  ^ `hH.  ^ `hH. xL^x`LhH. H^H`hH. ^`hH. L^`LhH.hh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hH^`CJOJQJo(h^`CJOJQJo(hHpp^p`CJOJQJo(@ @ ^@ `CJOJQJo(^`CJOJQJo(^`CJOJQJo(^`CJOJQJo(^`CJOJQJo(PP^P`CJOJQJo(h^h`OJQJo(hH8^8`OJ QJ ^J o(hHo^`OJQJo(hH ^ `OJQJo(hH ^ `OJ QJ ^J o(hHox^x`OJQJo(hHH^H`OJQJo(hH^`OJ QJ ^J o(hHo^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hH h^h`OJQJo(8^8`OJ QJ ^J o(o ^`OJQJo(  ^ `OJQJo( ^ `OJ QJ ^J o(o x^x`OJQJo( H^H`OJQJo(^`OJ QJ ^J o(o ^`OJQJo(hh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhhh^h`CJOJQJo(hHX8^8`o(^`CJOJQJo(  ^ `CJOJQJo(  ^ `CJOJQJo(xx^x`CJOJQJo(HH^H`CJOJQJo(^`CJOJQJo(^`CJOJQJo(hh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHh^h`OJQJo(hH8^8`OJ QJ ^J o(hHo^`OJQJo(hH ^ `OJQJo(hH ^ `OJ QJ ^J o(hHox^x`OJQJo(hHH^H`OJQJo(hH^`OJ QJ ^J o(hHo^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hH8^8`5OJPJQJ^Jo(" h^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhhh^h`CJOJQJo(hH88^8`CJOJ QJ o(o^`CJOJQJo(  ^ `CJOJQJo(  ^ `CJOJQJo(xx^x`CJOJQJo(HH^H`CJOJQJo(^`CJOJQJo(^`CJOJQJo(h^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hH^`OJQJo(hH^`OJ QJ ^J o(hHop^p`OJQJo(hH@ ^@ `OJQJo(hH^`OJ QJ ^J o(hHo^`OJQJo(hH^`OJQJo(hH^`OJ QJ ^J o(hHoP^P`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhhh^h`CJOJQJo(hH88^8`CJOJ QJ o(o^`CJOJQJo(  ^ `CJOJQJo(  ^ `CJOJQJo(xx^x`CJOJQJo(HH^H`CJOJQJo(^`CJOJQJo(^`CJOJQJo(h^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hH^`OJQJo(hH^`OJ QJ ^J o(hHop^p`OJQJo(hH@ ^@ `OJQJo(hH^`OJ QJ ^J o(hHo^`OJQJo(hH^`OJQJo(hH^`OJ QJ ^J o(hHoP^P`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hH^`CJOJQJo(^`CJOJ QJ o(opp^p`CJOJQJo(@ @ ^@ `CJOJQJo(^`CJOJQJo(^`CJOJQJo(^`CJOJQJo(^`CJOJQJo(PP^P`CJOJQJo( h^h`OJQJo(8^8`OJ QJ ^J o(o ^`OJQJo(  ^ `OJQJo( ^ `OJ QJ ^J o(o x^x`OJQJo( H^H`OJQJo(^`OJ QJ ^J o(o ^`OJQJo(^`OJQJo(hH^`OJ QJ ^J o(hHop^p`OJQJo(hH@ ^@ `OJQJo(hH^`OJ QJ ^J o(hHo^`OJQJo(hH^`OJQJo(hH^`OJ QJ ^J o(hHoP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJQJo(hHh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhhh^h`CJOJQJo(hH88^8`CJOJQJo(^`CJOJQJo(  ^ `CJOJQJo(  ^ `CJOJQJo(xx^x`CJOJQJo(HH^H`CJOJQJo(^`CJOJQJo(^`CJOJQJo(hh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHhh^h`OJQJo(hHh8^8`OJ QJ ^J o(hHoh^`OJQJo(hHh ^ `OJQJo(hHh ^ `OJ QJ ^J o(hHohx^x`OJQJo(hHhH^H`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJQJo(hH^e5DO_x`q*-z DFZR]iJ5z"$]"n8=lf(D6HV& 02(~%a@~C-{d\#s' h91O4hdJN$5\.K(l) AQU!*!&]uWRd 43aUoQQ:Ul]n; .HLPdTej hsL9 #*nRa`Wz49(%~d%xKI2.I3yl@EK\q>.1"e!L_Oc\L5x1 1cndDXW!tdrA[gCl47Z dU4A6W@z =y ,;Y8e/r**/"@0d2#15[*'Kb _#u++3 h'=5k#'3k&T=}`!7ZkTdw4K8SC+cq2`Hhiz#AsY[v/(Yau.h12jJ=YW>ryTLs '#wx0r:UY'5;WJ)<=hxHu2{\N/zm1 g+I5fik=VYZod7(h :MWW57Ot#\?jAiGW&CBEHjW5g#(gqM.zq C'.[B7_-5 Qc=$ AGFMzK):[`T%f b;xI~zq~Kt/[VUX`,E2}#zl^R.:4!k7zJOj3=~#!:H@&hR35|#zu6(8MR2NCD]E`j(?Qb> MM#q-KOuK6zE*G :&+\XV s@fdlw& qjy %Oz:b$|sp |7g=rS-~^ d`9HywX>GK[\U;p:Y,kYP{:1 Ugs\nxY'aT$=E.Wj._Cl@9G( d+h7sZ)X*:Mhg%"_sJ :X T6% _b\/ OH?"'8tZ#$m luPE+W z#5\_.Xy/,FgOIX.q3fvW(4|WE 7Y,g(P$]hQ~]wfVii:Ze\iFK2dE~m3?8.+T:L%# LX Z46OW}1A(acELx J-l6.D)\~[ X kE  X]fHM: +4w/e6:Q94RpJ?KtI)GzLoupR?9'|:hgAaK ?dix HHOl~1;=Wa p/&{r2*[bJRKOR-}H@tqBY{koj@56i5[c*q|Sh~tQah<jE:akwd>4~_2RcNp.U%&=EN]dg4W73xF\3 /[7;b-_:l{"qLxf0^-)Il]:VTp{HIx.OH" ${-nSH|Mh $+`#z}/\IE,,Yzg* GROsJg2(^ i5vn+zJB!@ZH Ey4l4?O9eMDK~0}LJ*1fl3E^4~6>wZ%rJ@ 2sN7JT8L$5tXWe]"qUlr:][D+ 'HX<KK                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           ^8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     4a                                                                                                                                                                                                                                                                                       :R                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       $=                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  ,Hh+$+!.[KObV}Vh\^_qn :DJ3+lLKG4kF sj,g0y*h4q c$|UPeh(>5`+c <i]w2U#T2(3K+3o+v;P>~[ dd,DE_GMdq?WY+"[DJ5A[f1<dd00FfXhKlsG*s{tJI}"vzwtC UF0Jx  --a+'@ xxc=H+ N|H8E% ?8 9\B# @Ogq p3/ZM;jj!w@qC(aDglT; UTfZelr <+l)vL bqZ~T5bU<+~)i{XN0h$h$J r <iQ]Ds4_(IE0h$h$^,4&z3>LzGRr  * f,,7(HN/X <i N^Y u@k'+T2\6C{v:8];CMNj@6_J z pe.{upe_k4R(wwm V`#*vOP4HkIq;|81p87$im# p2d xx Ms9 dd?$n/0ZI dd Lc(vJq ZZU`K&: dd#xu xxROQ ' (p46pc<>D6ph _6C7Am xxTGo IiLJ?YQA_sFlC?Xm6Aj +cP :+'= \f <iwls B9T:T;0#=!P4QY&>9E\U/|!Az f0IUWX<20G <iHY dd\E TO~|!FOq%3UK iZ;Ynf^x0^o~*?Jm Kny"sYx]U]4:s  -[(cdt)cM-]]y2RP~#h<@C A@CCE(9Ig8i MgK![(w!XYX ddn"2rk#L( mTa@ ;| B [[`P-#metfrsf# pzHXGu2NukxTun cN_s9nc6JD4}l^<:mvdHK/OB&bZ(wF4n R~['+pQcgT!Y $bX!9j$CH:(1 +JbI-DES(hQBniEYiy.)G Z4"(7ea{28D'j>[ MC6J D i; ,/H X-u <i!FI /~k\ )Iztph II:j aD{ 8J3 +c -3~xxw V $Q [S. 7wP Ue%# V3AT 6: &EY g6* ~Y\K 77*O}4 [V^ `Qe ]l )Jw 1TY{w #@6x 8fP h$w !-b>D V"ne [yQn A(a e}v {`?w %dQ0 ; 9uJ41 5;. i2 & _ 2Dh Ol  + }*_xX1 AYAG D#)G \]-w <i{P 10dm $KM~ ZB< BW~DZM   >7 Nq 7AZ `} sI /iy p !. VafY t 2r ~BVA> { Eq+8, 4':r#: bS6Aj o@mQ{ } |]< p4LU ,Sn`L Y?%xt =NFAw e5o  N# Hf <iG3 M/~:> # pV dd{ ^c)# Ld3$6[ 8 v}zF;{U 4Wj@+#/-`t kme'VE0M nN]CGvX$;!C gq2<|sj!1#T>G7 F5]zDu <iwiJM$&[]g37e"Uus{ 41 M`uau8A+! .,0h$h$(?;N@>^o/P/Ppe.TQ8Wz0^hx`qk}3gsXKo?WT9a dd %\&NGB.z*E_6C*e<*a`t6/ 8~EFS{ i\1Ozq4lqz    Yp[Co88jWA3t+gdV)39.3OZEvQ ~ NNUHY ZZ&|"&`_Y!#D@G$j2SFY5V7.m9Uo4?IuLo$Oe\IMdl6Qq]CB*wErF>{X~&nY{>`sDWFeNAf*5 WEVc4:4#A6IgDWV"7xN)SFtA(PFN|<s|@lZ Zp*#*I0|E\)Qp*+$EAg6sSC 0o]WTvU!dv#@aC,.Guo;M((,/H 7An <i9dI;@0~K!-K!as0Pzy\_8fAl3QJ<* V~N^Q  KKV&,SQ`,/pQ -CXI'4`6IX*rwOv ~_i_5wmJ) 8]K/OyKf hhJ:3S`BQ,**V->GX8Zb&%Uid*"Y[>fuUA, <i*"X <iz2 t4 <i9Bf.]n6w^ ,TfZ&6%ML$5H&B* y=XK;"KOMV&]{p >\/i@M?-kiLJ <i!yU,3*ww'Na03Z F!O@}N+Xj4Ta6Zw,^4N!#NMg+$3HLw  Jt.aTI dd-g`@/BZ7R XmqWZU8iZcT-~j ~BMVlc5+h+W{b} h {_x^=`3h#Mz1~Rz43GYx$<F <iHr2 ddOJ|BP V*x\i_i7#eiql\8tp 1%`fsJ4SQv>@\~VcS.FML<5c/@)fM(;T@xGWU]F"oF5t#v^+l <i\#i  &4O#(-zqi]IpxlwE?+EHv xx/ C@#ZDwP:hH J @gjPwFj+[3u!S\{%elIcb9lT2\}Z,cXrcVe3[X$ <i !0w!W=n 9mmY{~ /X2}\pp )r$=QBp(>d+Ae38+f~#-pa0EU7aUa\Y!kVlCP[V^ xf"KE Hy u-SA7 M1 +|JSPII*E9eq+'dJ IcpibH'4(';2MO<Er@SFI:]iJPX6TQT6: QTC$_0ke+rrM7tGB6Cu8K BXz}`'tkrtJa3(u-s{w<@,N , ?X [ =%W2@oVFa %Yps!FzPfOIY]5LFK |Uxy; & qEY]6+6bf.Q:^  dd;K[N;*1J$1WA9?^Zo d 'py"_=m51=@P8Dt-Y4H'_:j _*G -8=q[*1*F&A_30 <nsZB-}C]w24nE5k1#T0fIa;~d>HY ZZY]j;Jeqhf~mwbq/AB}{4"JhJ] k>  K,}i(lmID,*0FFbVXK; <iaasD3OL=QvS] PPGRbo*.ob%RzX0&Shrox6jXv^<st&bY?*,t+\]!_74 pa1gxUO4fH~6S3/t7*wI[K1oVl~h^}h.O , ~VFMFx7 {-45dd\6=g=cZ2pDML$$EsG?dA K4V!c:1]:{p M*,t"OfdYlgt ln+$qLntPpLpy"< nt"X9aIb1W7)  "9d"B:F"`[U:Xz}B/JX/Tl:^KI@`tAghJ w!<3o!D~bvS <iak;KC/:y"E*LH%rp)3 = @": 0fIK[v  QrSHD(3.UOV5dgqGs)vR:]{=')e :8]!{mNTP v"0000bru!HH:>G}Zm(iV-g`@ VcpvHL:T L(x  vUO  & ;' m# xy,+x7 8vG8 vQ +J#U CZ W;W ffffffffffff` e 'oTh1j S*t  (* j2v ag [[7 kK !A5` '7;1 qDk "SK!M? !!,Geq!6QV dd!!264 !CC!ZS!0vW,!T < ddY!."HjJFZ "CNY#"w5"N8 ddJR"CL# Z"V"m1 ,,1P"]4N" F=~!"6 "v"\}r9".-Z7"_B <dd00&"\x;bx"Eer:";40h$h$d"Ol Cq"MQ""3L:"D:Rg#6#O#9ZR# m+#MQF ddRG # Vf!#$%BC>#' a <iCL#f34l{#Z#i7#9`P-#eQbA Y9#?#2(34T#w`# Z2#C#* dd:#Q@2#IFWB#$T#+$i#M)D#QkLP##$gv$TIiu,$@#X$r$8+f84'$mEVX*$Z$D87$[ ddD$D$` 02kG$k\ JM$SiT$H{[$9T%<*j$NgW <i ~$k]S [$Fwf7>$3e4h$]qk=T$S.t$o@$g{$~Wp$$4 LN$%#-a %5%>"%C%%aK)Zb&%|-B 1% <t1%Xj0h$h$L%H9T%y ddUe%? xxi0r%w NEr%H6%p n~%>wY?%l$\[%:?o1@%g<a%q%#%Q:Qs%i%{~& h  ddK&$&EgC-V&,W)(&"ny5&@&IbiB& a,C&G3  F&r_st&F 4X~&cr/D&_=S&e h )&.)Zj&6 " dd\&=9o&taq'9<& Kf_&854&6CQ]Il&IMKKw'9?^ dd1'0;u. '1q'7!U'ay"9''/2Y3'bdF'6}4H')#N'yo <i@V' c3i'|J6_n'Kho'Ntaq'!y~N0h$h$='$n`'],'K'Zr W'4BqUo'BH{Hz'O='#$~'9'Ui4'R <i'ii8'KaIL:(BOI>D(om(]([E(uZ,I<( <i'!( '$(u} r$'(D$M((@Ja3(8v]9(L(Rz4Peh(I8j(vzo .Kx(L 8P(v -68(}4 ~(,xU (-OEi(P:O#(w=(fM}_(jA(U0UO(nx(?74z(PYP)ia'pU)&L_,W)X{O  M)6g#)F))i\-)O~Gy.)`313)/JW7)Qq3J)d4 faK)rbuL)=N)S>gUPU)Gw#k)Ixdt)8  )qA)c)+)'!() u?O)fx<%)Yp`-)M <i]),#`> <iR)nIlz)@)pDL*)^)Tf5N){Xb)YW)+z#*5 *X*3y*7*c1+*]J9#*g#)77*tkOH*F"`Af*5Q xx0*/-`{*Q>N*h0*nx(Q,*sG*P*x!3*/g*Zo#*@F3*Y#"nz*&Qq0h$h$/*ELyNH*:k$s*Q1*0~*7 :*~b~0*l`[*o+o/P7+~N(+ xy,+ M4+UCM7+B!_f :+:+r/@U<+R5AlKB+yN+ UPV+ su dd5Y+1O{$\+@$i+"z[hr+Y+6YH0h$h$$+<5+"W7+aMn+5M]D+P98A+DWc+` e P;+*IH+3J)>`+0xHEq+Y5['+ Kr8+<*j$s+xvG\+6+-(*4F 1E8 F&1O(1k"E M*1su81hi];|81xf7D1Cu[@Q1a17i1 :?o1m*7r1.Cy0c1(P ddm1O1,M1f1= dd|1zaEQ1KVA1Vg41(D,u-1w@L1"wQ11D,U2>`+t 2=  29e8>2gd#`"2uu9;42;-`7N?2 ,{J2&B*%0O2" <iW2}CX2l2sn2 Z"r2fu2%7[2>rM2}B2 7cZ2$E [`2'2Z[KO2`i2v/ IU2Tg `3Y dd%3@xHD(3N+ ,rmD3.F*L3}E\ R3)Y3Ve33+Bk}3K:-J3e5}<D3e3:cf3$nf3j3)/83X&@V3Y gA334z\+y3wM3dt|a3`+Y3UPV+3 BUX 4x[a 4!264M2nA4]R6J4I}zV4/|]3e4L)bMi4Z@`Uo4! t4x`1N54U)j 4m6=4gdVi4l04%R= <i&d4h=$z4dde dd>*4&\t468({47+?74#|yx4:`744Z@#sF 4wx.;4Sc1/4]Uo|J 5G8 A T5g"5e5r <i&{257HE5-0 ddTf5=.`j5*ql5)Wc5_i_5a2X5S\ dd5Md=A5'`<5G=z!A5>"%n5yN++5hL,KKC5IH+y5[@5x945X55D-w 6%7/J7 6!{`t6F*:6J|,"6Z@`GB6]||J6O C"p6KyP~6@~]N|6l6ND~_6xCV6t#uddI@6?6"$. J6M6\+0m6^Q67KB+,7o-Q 7- JWV"7r <i]g37< <i!47NJwVh:79#* >7X] B7r5M7e.wc7Y_vkFwf7~uli7\Tj7To7(7/TOT7K7Ui87 ,7g7@ (7;47h@A7sO7sV`7V7($Z[7|e: <im*7%7$+hA7Vs+GU85M}L 8EBF89(1G8@O_I8-W8U-V,[8k[Xef8u-1|g8>HY ZZ[m8=FG[Co8YSp8/*9u8 Jv8ZE8x81g8hMfE8/Ow ddk8>VN8d!8SCMy+83 dd:68K8GY8/g* )8 CvXXKK%9,7N 9d 9^0zD?93* dd9/*98h+9^=9.t=9/_jW`93P\}r9(Xruu9P9 rm8 9 OE <i'C959Px9LG!:930 <i 9y!9P!P Z9Fm9 _ 9{97RQ9^,R:=D_F*:? :"[:_FAS:#.;:&:':,4T-: :+Cp^:gr`:Z:+eD:su81z:CC!F:%K:9nir: 2J:TM :C4':v:J:" dd<:[#.;>54;w \x;$+3;_mWA$;@$|>;OVfK;f"U;9'z;.`j5K;x/,;4+X;vFV dd`-; H{;M;>q ;j'? ,p};+co;BrQ ;Tt=g{;a#U2U;17rX$;RM5;p04u <T <y"<+oS<a :;i =C`0 , ,=XqhI7=B*w'=UQbx"=Xf0#=P >*=Ib1/4=B:7=PE=}_(J=F%R=oU=$GU=z)"_=)#N'5c= @t]qk=7 6l=X1 9m=8o y=@[O=C#j=F"`Tt=EPg6=FEF =*h=AzE|=mtZ=F 1b=-xC^=5 UKz=n`I=$[B}>s2{]>Ky:>*uP _t0>4V ddz3>_`xImN>Y[>/]>p?@,#`>'j>5c=*Q>h,_ k>I >zOY'> %K>]T@ <i1I> s>vS">ImN>>?=S[>+>B>@&pF>0GX5 >Q>yy1R>`tTPY>D6$L@m@0@;Ky@E!P`X&@ NAYA>$EA&|"%7A#:jm?EA:{_=NFAF_FA9EQT OEk"EL%:y"E Us6E-OEGU=aPE1~0h$h$'VE8+"_E(RFOdEOLxE;s8~EuzaEm9#Eq1EXV&E(7UE+E[7.E;SyEp$K.IEUIxLEWB#F :^F%tr*F. &+F^4?Fa <i*0FF*|HLFqrTVFMFH}A(PF^vpU)SFKp_FN|x`FLEG4kF$}zFY]F? :$F M*1 <i$Fi.FV:-p5LFFjOQ F^x  rF%NK.UF,'Y2NFsaIFGoVF*ErF(RFFQ4AeF|5pMQF@FR}R0h$h$GF +GpGLGBC>#_*GN*>GxvGzq0h$h$tG$\+a*G_t0> +GYaVs+GvP!,G >\ dd20G2G~ N_FGO)=FG$FWOG ;^1TGf -[E_G)WWwGO~G] NG41IGLHGm:PnGlGHU5WBGTGPDGK>GGH'C9 ddH'H`:&>HuujdYFBH,"lgMHl~FVHlq6YHAjbbH85:{vdH[m8BH{H*L3*|H1h <i/4H8it`=H6=MHQJ$CHN|H!VXzHHH4C0h$h$0xH|p>1H15H V!H5M/zHw&nWuHA7HfX;e HQvH>p <i2HBOIOT70ZIuZ,I !Rm\,IvD %7/J 8J/$j9JJ$iKPT  Lzh`tL(L UGq%Lz9aH h3"4Lp4Lv >4LGKaIL!OLLFNL|iL$ZCPpL1]LI.:L wLK TLGYL~ oL&Dh~L .3L=H LxfLF 0wDML( M#_ M,N <iqaM`PMN*<(Mk !5M A xx?7M{#B$.8M`-)UCM$KMtRM e9yRM8kbjiM4;aM/2Mz MtZ=MIM. <BMAU}CMOLL5M,/TM!9IMom(`LMz(0h$h$/8 NwUuw N/Lr0Nny5&N%mKe Ng=-{ @,N:L$/N5 > <ix`1N^4NtK^5JN4 LNi|<K[N@k nN /k~N!y~NGsV~N@K5NNn1Pq{p=PX;:IP>HY ZZMMP:J:2RP8YZPJSP`,8YZP+cPrsfvPnJ^7wPPq2{P:(3P:)dy.P-G~t-{ xPLJLP Q wQ x']P L-P PPULZ/3Po5`P-XisP\U PNP(P(PjNPO1APxt P4Q[yQhS <iOQFf(ZQ-beMQ*@V $QRV'p*Q_q ddo-QiT;.Qy< p##2Qy07PQ/~VoXQZ@#sm\Qm5S--(jbQY9##]cQ %dQ\O>sBrQr~SQ~'0Qza\QsIK)Q2X5QhQel=QUQgT Q)OloR:Qsn9Q]>5QRpA%hRv;h*R[`m !Rbyy1R 9m*aRI8 xxBeR/4HD ?lRlR}R&+FR x%SR5`4RT]R:RiB&ARPMPR6* Rm)yRc<[Sii0h$h$SLl~S5 bSGVJ4SPDGm5SZ-DKKDES"><{FS oLk]S?m>W`S -C8cS=f^\jSkqSBjvSR)u-Se nSa1@uSs-S#[w;S0-;mRS{ff>"ShgSihST:Ty5`tT3y* xx TuSqTi9 $   TwT/,4T@%mNT?lRf"T ~ U#TXGu <i$a%T=A50+Tmpu.&L+TS.0e5v3TP4PX6T(;T^Gg2?TlZuNTnY{?PTT VT eSZTlEoqrT ]Xj,wT'u~sT(LYZTqiT.B xx/T=|z^T}A{ dd mT:( TA> ZZDT[O'oT%SR0h$h$gT U{Uua#UEU0U"v 2U4' BULdm7ZU\c]UO(Hp_Uq'7aUz?oUk^I^vpU,xUUe{U|z\}5 UL00h$h$Ux$<CU$ U!:97!UDUVU=[U#e^Ue y%Uj,x=Uu[{VW V6w>V2#A7V9b cVm\,I U-VMMPWEVXEVa\mEVCHVoU=MV.qPV6QV[V/bV#BcgVDjNJwVfK;2}V834}VCV yV4(i/~V4:vFVbVVEV5VVrP#CGVVgA3 <i5VP XVr:"pV~BVi}qV'rVKV-[AV])KV  ddJ8W_mW Ro"WqPV`U2W]uHU5WL`CW[xGWp,\W%vaWT$U WBsw]W8lKBMkW1oSW+rr5$W0vWP,0W7P0sNgWKWW (clWP(<)W*W;WvWWKe\ XWXHE5X3PC?X0nVX~(bFWX4u < ddk[X.UF ]XS:t6uX:^XZWARzXWm@A -X~D0GXLXcX%0O2 /X r# Y[Y,'YQe <ia%2Y/2Y%CYkw@"MDY1I>3GY1TY&`_YVCN,dY>zOY54&HYY!YPYY.YhFY i"Yi4 Y?olZJK 1ZPY>P'Z3;    .)ZLD.-Z+`dv/Z 03ZpB7Z]8Z7AZ'=0@HZ{P DHZ7D3\Z| `e]Z 9j^Zr,Dt&bZ)d rZ@G$#/[0*@[<>[?7M6O[ Hn[P{$6[e [[(uJe[% ~[=[<=h\4L\ML\l$\12\# ^3\w>@\8x80h$h$]uD\}E\% <iO\y R\TuV\M`Ke\Y3mi\5A[r\l\Zql\E l~\gd`4z\>*=G\l/qI\&d4 }\vW`ST]Eqhi] KPu]X01]q0h$h$]F^r@~] :8]gtrG]cnM]UfX]8]P>-]]30j^z?oUtK^H'H>^I l'Z'^1/4S@^-xC^4$ ,F^^T<dd00nJ^8C dd#e^j_=f^ 4x y^'0h^iJu^0m ^O}4 (^?j X^WDydt^  <i&^a&k&4^w 6 ;^  _&& __t$A_lDC$_A_Bl=D_t g&L_3i'h\^_XID Nob_6<_Mq_e[`:{_rx? ddH_l:^x\_\c@O_wh_N_/4=r_G _-3sh,__V4_j__+_CTY#_PLO I_gdV`i9m5`l`w l`e_k+`!z:`}-0CX-`E!P`(^sV`?9^=`>i[L` m>`Gv@8` !8y`-dd1`|| `$rK;-`q1EU`#dv'`j3O`L?9`*t S`_Kc dd(`zqG`kqS%a:' aXaL#-a-V&z9aW>a|k'aHa01QaFsa)N_a+)a5vza[V ddx[a+5--[a":7~a r8-Ta[@Q1QafCa4!,Ba9f. dda]Yasa*C ab@{IbLAjbeQb !-bE9dvbjj!9b5VV$RbIb[+bDe#sObF"`dmb4@dbb(1G8`b^)8kb]lFc4q c~ (ct>1PZ,c 4cL<5c5JN Bc\cy8dcNs@s9ncOMV_KcZc y0h$h$A8c54\cM n ^cn c5NNlIcW$@n cLPpSc+c t4 , PFd5x)dsPl| dA6Wv.ddv/Z}$do*F,dV3dOIW3d5dZ# 5dqV~;6doxIdc4Mdgduujd3A nd{w x2rd8 <iWDydZj:)d6 <i2dw=(kVdQa`dN :jQid*h\ds*N:d$h , KdW.E9d<%)LdQT) e!ejiM ez'9ezuC|O!e)QS.0eS]JfX;eekZ]es~-be wShddeMqne0Q,(LeEeoeDU ZZ}e7AeKO23zen~%De+euNTFe@&}eK;e2',h(eQem@^eG e#Ad4 fs{t0h$h$iff\fu\f 4?$f)sn3fbh/Kfk hh KfR:QhMfUfC%%_WfXfB!_fO:#iVaf-{ffWWwG dd;Ynf_aNf[hr+f QHf)f8e(f:cfxf+ov(aDg)pm^GghH <i6IgUPU)#NMgD&EPgVg* xx^Xg]gIGcgU.{ jg(Le <idogq ;S>g,!#g)EgD$(x<4`gW? @g[%agA8cTg/$O"g;.Qgt gN"<=hYFBH*hbUEh2',hfu2 wSh#EKh1hWmhr:h@8`uZhYZTx~h ah#m6hB}>Xh5 hV9<IhEVHh[h}ee h$h]9(&Dh8"z~h#@aQhB/sO K iib9l9ni&ciei8O:#i)G )i6grkh+i y0iJD{Z;i%hR J>iv=Ain'QiT]ia%2Y$ ei]{uniT]iTIiUij!ni>ii]()igsiiN|6ii_Fj.4(ip\oXjZjQ j $8: jj9J ddN :jcoDjK&`_jj_.<|sj{0Xj6x Ctj*>G xxj B?j3\ZBjt#:jnkgjZM /_jLP#DjAVmFjfwjQw <i:k3zeNk|knk{ <iO(k4qmv#ka&k:)Cn4kgeK(r7kp*akYA[bkDU ZZfkhWTok8~+qkpY_vkDJwgk3LFk Hk&25uPkNk ddxk${(2Y2Y2Y$2Y$@kV&,D Qk|1 kJ5kK/kDO> k1JOk<Nkcek:rE l]la+|lv:I l!lj02lclW N@lxNR5AlL*) <i1BAlCnIl_NMlCX-`2[lp};6[lvvsy'blE*@$jjlJxdgml*"D4}l}4ldmbBlBSD0dlFol2{,"l <ivlj^ZolR~Tl:.sl]8ZH h3lzv>ls6E04lHl![dYl'l7"rLl4l\mtt4qmlOUs%mQs Xm+uRzm0N  mm{<i9m) e0-;m8W?0AmW3d7Am"(Dmh0*o3Kml`@y< p!p,@&p(eRV'pD30ia'pzI}+p2NuV:-p|5pQBp5+CpHi]IpQ6/,XYpv>lIcp=Ujnprp\.{up\jS&]{p/B|p(mpx y^ pPkpqpp>pQp> pQXnl/qMkWMq5Y+_q :q#.J 4Bq \vvJqDVWq(z: L bq]uD\0,y|q|>;M;q-kqtA ::q8(qpXLq(`lq? !Eq  KKqQ F&Qq{;b?q$'(*qcXFOq ru} r|LH%r1-(rU$rZS!r17rh_(Xrr5Vr?6h@r8GRrkgr.?, rO}D dd:sEX,j,sz"70sd 97P0s-3si~;sgdV\O>s90@s|TgBsHBI'Ts!clOUs8-v-Xismo|Is.)sL/u dd;sCQs^ ddsns ssO[slsk#BQs)vtUe twit!S:t(&)tBBx0h$h$r,DtBF8Xt3zh`tt1%8it M)Izt&{25@}t-G~tg~ttS|G/ hht#t&^RtOdEAt/nv/#t=]I  dt"] 0h$h$t <i%t*wto-Zt ktG t wLetr tts @t2G.t,~t puL/u?&uKX-ut\/u}c2u}c2upB7Z dd&25uO[s0;u{p=P]zDuJ2Iugd#` KPu2?T\Wuumrbuo3Km sut#u~u5 *UuN)]uDR@0h$h$u*uN{UuqIwUu\f"vI <iEHvnv*Q_#vu$vA1_3vm8vz{z8vwA6WvrjXvP \v!dv:%0#dvSW3WovsT4 vNMlvAt*vNH* +'vdBv"vJ65viVC CvQ?8-v>4L/nv <iv3-#v*ak= v%K:vK[vNf Q w33~ wwD,>wtK0wnf@DJw\]-we.w{/wXR4w;6w Bc6H-s{FqI dd/x{RS${mi\P{SC{<(MS{G`@{PE=U{'}A{3C{-PW{nz*2{g{t64{b6p|w]W|Uuu|aKn 0|/-r=|R6J4zuC|a@\|_k|j 4<s|sGE{|hFYm|X/|]z0|S3,#|l2 <i]|O\0h$h$yl|G =|6}Wg_}/C }I}!47~4}+85M}HG|z\}.0Wg_}AB}1t}?ov}x~hT}u^p}#U (  AU}!5M} [$}i}<{FS }e}Qhb}pH}O{x\7}RM}Dje}jnpv ~t\/uj ~02l~t'.\z~m*aR1~No~-3~?I@33~hsI F=~rVN$@~ ^E~Xox4fH~O .a~hf~No~Up~N@l'u~ts~Tl~\|/~MB r~TTO~P'Z,~PR ~q-$;~2NF,~. J>i , [SZTw aD$pG3 bq/N:d{2^<qI+vP?Zw^N` <i aXaKc4[tCq"p:>mW_n'SWB5+oS< <i!Rn'Qim5r1_Af$32HpCJv8.BsPLg]C?$fk e[,1meq!}4B:7=_#^#_ (+x,0,4 57668?@ADEUGLLYVX`a|ckUqqstvwGzzbS^ be<+$&22G68CGJwKrRTVX[\^dTotvc.  zs\ "5(/0[9:;8<@BDFLOM=RRVv]^^cMchddTe{f/hlxoreszf{s{3H_]   ,Ry(()+,/01g4:U=K>CGKK9M UVVZ_`Bbkrsx7~CiT 2 L!)L)h)*i+-25;>t?bDcEwFN]_bc.hjl(w~z ; W ~`0G.&0()v**n03\@*D=DHDDQCS]TjTU.V^afgmgUjlnuJyz:{A{A %!"$ &(-0158 9C:S@E3HOPRSS}TGckdfh(iijn{ortG  $'}*G,5/M=?CLOWkllmnt vwK}6 il0,y,L-d//1(7u;@EFFK[LxORW1Z\^aOiYkApppsszvv|'     _      d! $ $ B' K- 2 93 p5 ; = ;H L N 9R QU ?GJNOaPRFVW YcioHos/q\ #y$$%P&)1+ ,6./02 =?D5H*MMzV`bhiinnnlq u/wxzQ  8abm!!,"m$*p,)8p:;?S@oPVRRWXYZ\g|m1txy  18(38,;<<k@CII~QQQRV[`dlBopu3} f ]&z)*+0=1 84=@@~DDDEHIJJLMNxPVx[^dddlm|nrvN|~,Sq)#>%- /(9=M>z>k@@@EGNSXYg\^^ilvweyq~q  !+$)*,:=DEFJLOOQQQRRRDUV'W.WVWZl\\[`*b*c=fCgjFl?vEy|f} u}$O)I*e/1k;7=@AZCJSSSTZCcc ejooqtvyzz fV!1757:<)>$?BBOF)TpT|TWW gjGkrstt bm1-.: >?_@KBDHBJKP^RS?WY&[]a^^_bc%fwj%m}mDqyo)iu!S!=$%6,/13=@DIwPR!TXZ^gOghnirt}x{}~|!%&(59:@ACFGAIJAK^T\1`sh?qtqs x  > !!K#q'(*S,///277E?F!NPtU[\^`irssuwy0dT-(b ##&i11>?FFUJ?MPcQQ?RTTW]cqeZiJr1z%}C  [I!"$$%v*013677>A@EI9LXd]_fg5lpqwB 3!!$G%'6)28?B\DDDKGHGNSU+\\dfgVjSp#$(v557ABCG!HMH!MN7OWRVVY[]_hnntr z i'(*,00296#;?"B*B7B;KgLINSN5OS-TU7YZ^_!`km{nokoqu~v  >      K" $ ' ]+ 7 : = ? 7C M 'N O O T T U )V ~\ i] 0g j j | J ?!!3!`!! !!!!^!Z!!W!!0 !"!U#!$!%!0!8!S=!k?!G!I!UJ!y_!If!f!n!^v!Yw!%z!!~!" "" "` "K"""+""8"u"w"!"C-"-"g."."20"48";"F"G"G"J"L"L"L"!O"S"V"6V"Y" ["%^"6_"_"m"Zm"u"ax"x"a # ####1"#"#D$#t.#.#=4#4#6#.9#n9#Y<#[<#E#~G#!H#H#K#L#N#$P#`#Rb#c#f#rj#l#/n#v#v#lw#+{#k|#z}#$$$ $_ $$!$%$2$u3$4$#:$1<$o<$J=$C$G$G$L$4O$V$Z$[$]l$ar$#u$w$sx$\y$%%%0%%%% %"!%#%h+%,%.%/%(0%4%*9%9%?%JB%F%F%G%H%DK%L%O%,U%U%X%nZ%a%Wk%k%k%,m%o%r% t%}%~%@&G & &*&z&?&&R&-&&&&&&&&!&"&#&)&,&I1&r1&2&4&@&E& G&>G&G&J& M&N&R&V&tX&!Y&yZ&ya&d&o&v&Rw&'c'z' ''t''"'0+'n3'6'2<'/M'NM'tP'\Q'^['n\'_'a'b'm',x'{'( ((5 (J((`(+((<(+(/(v2(5(i7(7(8(qP(|S(V()Y(a(b(c(,?,}B,C,D,F,sM,PN,P,P,Q,W,X,\,\,],l^,H_,'`,7b,1e,f,f,i,br,u,,?--|-- -'-99-!<-<-B-C-jH-/L-P-\-c-j-S/W/4[/\/^/_/g/h/)p/Ws/x/}//?000 0W00h!0b#0%0$'0.010350/8090i;0KA0UD0H0K0a0k09n0eo0@t0v0v0x0kz0}{0:11 11R1+1(0151+7191A1F1TG1XG1K1M1N1-P1mP1U1W1^1_1_1`1Fa1g1Iq1.x1'|122S2 2R22222t!2!2$2$2&2(2d*2f.25272 92:2=2hC2H2H2nJ2.K2EL2U23W2Qb2Pd2Cl2m2n2s2lt2t2u2x2ny2{|2o33U33p3B3p3@33s#3$3*3>:3p?3@3PA3F3G3yQ3a3c3;j3qs3u35w3x3y3(z3|3444<424\44_)4,4.4.414142464Y>4Q@4~E4F4G4>H4I4jT4-W4Z4]4]4]4]4^4 b4b4xb4ac4gd4tl4s4,w455 5 5 5Q5555z5&5)5,5758585O;5>=5>5J@5C5D5lR5R5.T5 V5jb5sb5d5$e5h5fi5wi5,o5hq5r5u5v5w5G6H66 66,6 6"6%6a'6*6-626766=6A6H6 L6R6R6R6S6T6VV6*X6[60\6]6`6J`6`6c6i6;l6 p6p6cv6y6 77 7 7 7777.727l57*67679797;7=7K7$N7UQ7Q7R7R7Z7I[7_7f7r7?u7Fu7Ex7{7{7~7898=84 8+8=8>88C88 #8$8&8/8$08;18`1848\5868F9898r:8-C8MK8>O8pP8.S8T8W8tY8kZ8\8]8"_8d8/d8dh8i8j8m8Yq8s8_s8bs8u8v899939N9# 9 9 9 9 9 9g9F99 9%9%91)93979=9A9F9J9Q9S9>Y9:\9a9(g9'm9>o9r9r9t90v9~9c: ::::&:n):*:+:0:Q3:Q4:5:6:6:48:8:V9:|9:::>:@:L:O:Q:vT:Z:^\:_:th:Jt:;~;? ; ;a;2;C;};O#;C$;%;%;"*;+;,;/;)2;F:;;;?;?;A;dD;D;G;M;N;R;dV;V;^;d;%h;k;q;nq;zr;v;{w;};<z <[ < <<"<"<'<\.<0<0<8<;<A<xC<O<P<8X<h^<Ab<e<(f<vn<#z<R~<<===f= ====)=="=;#=L&=)=-=/=/4=A5=r?=+B=C=wC=bD=H=J=N=Q=R=W=X=[=\=^=sc=/i= n=n=p=x={=>>r> >>f>%>%> '>(>+>6>E>L>nN>Q>4R>R>[>]>m_>hb>g>g>i>i>k>n>o>~>f>?u????$?&?F'?q(?(?0?5D?E?gF?S?W?\?c?h?rp?Dq?ix?Zz?~?i?@@w@ @w @Y @ @f@@@ @g@:@"@y$@,@-@1@]4@g5@:@b=@B@Q@R@S@Y@w\@c@h@o@`p@t@Nz@ @A$ AB A< AAA?ApAAA(A&A/+A5AN7AU9A;A@AAABAJANARA8VAWA\A^A^A_AzcA&fAjAwmArA|AmAAABBBQ B B B6BB?BBBB:&B6'Bo-B2B2B19B:BD;I=IIIKILIMIUIXIYI]Ir^I|aI1cIdIeI:rIGxI9{IV~IJJJhJJ J~ JCJJJ#J(J(J+JB/J;0J2J`3J3J:J?J@JAJBJCJFJ3PJXJ@aJzbJ&cJIcJcJhJiJGnJxqJ`sJ)~JLJJKp Kr K>KKKKK K"K3&KN&KP'K2(K)K>3KM3K9K@K AKAK8CKGKLK[K]\K`KhKhKlKrKvKQLqL"L L LL8LL~LLo%L'LV)L)Ld+L-L0L1L1LU4L7L9La?Lr?LBLeOLpOLVL]L ]L-^LfLiLUkLwL|L@~LLM~MMPMcM M$ M'MMMPMMM^%Mt,MA2Mc6MS?MAMAMBMTDMNM3SMVM?ZM]MeM gM1sMsMsMQvMzM@}M}M~MNNN N: N+N,N$NKNN_"N#N:%N&N,N/N/N@NDBNGNGNNNTNTNUNWNlXNZNZN^N:_N_NJbNdNjNzN}NOOVO` O O O OO.OOO O`#O:-O-/Oo0O1O7O?8Oj8O\?OkBOCOEOEOSBS CSHISPSSSQTSnYSH[S]SaSAbSdSfSfSgSuS7~S~S7SzT@TTZ TM TTCTTTTTVT&T2T3Tr8TATTTVTWT_TwbTWdTeT0fTiTpT'sTuTFvTwTJ{T}TS}Tb~TUUUU( U Uf UUUU UH!U@&Ub&U(U5U7U|8U9U;UdVAVIVKVLVDMVOVRVUVVVVWVZVZV,]VcVdVDfVmVmVlpVbqVvV}VzVWWWWW W WY W|WWWWW5"W(W *W1W3W6W7W:WDWDWFWFWFWGWIWKWzMWeTW>UW7[WxaWhW9jWqlWXX^XXXiX%X*X2X~7X7X7X;X?XHXPXWX7ZXaXfX_gXjXjXlXmXtXkY YhYYYP Y Y'Y*YD5Yh5Y:Y;YZ>Y>Y-@YmDYDY@HY&IYIYPY QYSYTYYY[Y[YMbYzeYpYqYtYwY|YYZPZZZ ZZZZ!Zg#Z$Zf+Z-Z/Z`7Z:Zj^XB^F^QG^G^ZL^N^2S^cT^hX^c^"h^Eh^j^k^y^}^~^__ __u__$_T_#_H%_)_+_-_4_6_:_>_?_u@_D_|H_J_RL_Q_W_:W_sY_w\_e_i_m_2t__y_|_N`` ```.`w``d#`%`'`J+`-`/`y0`6`B`|H`0O`[`h`i`6n`;r`qu`u`xv`x`y`$z`z`'|`~`ga?aaaK aaxa:aaKaJa a!a#a/au0aT9a>a_@aSDatFa>KaOaSaRUa/Vambafabgaiamauayazza{a9|aabbbKbb/bb+b,b,b02b^3b6bBbDbNEbVEbIb`RbZb>\bcb$dblbnbxbi|bfcpccczc5cGc1 c$c(c(c*c+c+c-c(5c7c;c;c>@cFc|FcFc@IcJc~Jc{Nc.Sc$TcXc\c^cbcbcdckcDscucwc,wcyc,~cddddd]ddd# d;#d'df5d5dH6d;d=dCdSDdFdJdLdPdQdqVdWd|^d^dbdmdqd}ududzd=}de/eKeeW&e0eL1e1e$:eU>e?eCeCeDeEeLeLeLeXeYeheBlenexe}effff$f(f*f-fT.f1f:f;f=fGf>JfSfyUf\ffcfjfOkfCqfrfi{f|f~f+gg gqgAgggg g"g'gl+g/g2g2gp:g~>gJ?g8AgPDgHg{HgJgNgPgQg agegmg ogwg&yg8hNhh1hh hhh#hphZ hc%h'h+h+h3hp:h=h3ChFhFhYIh Xh^h`hhhihnhWohoh5uhvhJ{h7|h|h?~h id i iAii3ii il"i/i/iBikCk]EkGkHkIkvRkVTkUkCYk[kgkgkqkvkwkxkxk }k<lllEl#lll l%l_*l//l1l2l3l16l8l=l=l@lDlJlLlNlRlJWlXl|^l_lalEelOelflmlpltlLvl!zl}l~lUm9m"m. mm@mmAmm9m!#m&mG'm2-m<1m9m=mJmPm"Qm bm+hmkmlmomoqmrmsmVtm}tm{m|mmn0nLnnnnnZ n!n%ng+n0n0n1n8n8n9n9n*?n7DnDnFnJnSLnTLn:Nn]Zn"[n \n_n_noen%intnxn{n^noHoVooSoboa#o%oy'o-o1o(2o2o5ok6o6oPoCoeIozIoMoPoQoDWoXo]om`oaococodoioooorosoItouovo=voUzo{o{o}optpppplpp!p(p0p6pQCp\^ps_pbpscpdpgphpfkpkpkp6lp,tp`upjwpxp|ppXq]qqqgqqzq(qq qqq&q4q6qE7q:q:qO=qcEq^HqHqNq=Pq!RqgSqXqrYqYqZq_qdqiqpqBqqrqtqvqxqzyq{q r- rDr*r/rC3r;r>Gr&IrJrLr*OrPr+Tr_TrVrXrYrYrQZr:^rararJkrprrrur8|r~r<rrsdsks s;ssJs. sX&s+)s.s0sK3sb8s2u>u@u`Bu CufMuUWu-Yu&]uk]uA`ubueufu)jujutluouzu~u" v4v5vvvYv3vv#v"v'vL+v/v/vp4v5v8vp>vGvOvVvVv[v\v ^v_vdavbvdv;ivhivjv=lvlv|mv(nvovovzvUwwwwww w&wq'wD.w1w7w-7wP7wn:w:w;wiCwHwHwIw\LwwRw>WwWwXwXwZwh\w^]w^w_wQew}qwqwywzw|wx{x;xkxx xi x x xSxxx#x$xw&x&x'xp-x/xb0x0xo1x$:xxEAxIxIxIxaKxQxTxUxVxXxZxZx[xcx fxkxVmxvxsxxY~xyy y y yyyy y8y"yj(yJ+y-y .y/y,;yyGyJyKy,MyRyXyfyZny|yzy z z zHzzzzA#zA$z*z0zZ3z3z5z7z8z8:z=zAzIz.OzPzPRzvUz5WzoWzYzezhzizjz|z~z{{S{Z{,{Y{{{{D!{m${A&{&{*{,{d-{j-{/1{4{F6{8{0;{)D{J{K{N{P{W{b{c{i{k{y{||S | ||||t|+|3-|0|s7||<|s?|(F|*G|EG|6H|H|\I|/Q|Q|V|Z|\| ]|mb|j|l|p|r|t|x|z|}|}I}}}}}} } }"}A2}*E}E}JF}2G}qH}K}N}S}|U}kW}Y}\}a}jc}\j}q}r}x}z}~}&}~~~~ ~~f!~C"~'~'~(~g)~*~,~/~1~;8~=~>~"A~A~E~G~wI~'J~K~R~S~DS~tT~U~)U~V~BY~+[~,a~]d~h~i~/o~z~/;YP l (+/.0999;:=d?FNLNNeRU+Y_`cjQmnPomspv>ya{|U) k }B%'(/8{89:@DgLPS UVWBY%[pfhimo qrsU}$$45v ;,>?g@vEFIJO S]C__J`KaeiSquw:z|mm5 "%M(,.689G>ABtEM`RVW]d'n9stvzz[ ^W !\$%&)2z3U4G0HIKKsQT"U]+_(bb\joltxS, p eg&')0N499AE9IJ0MKN`V5XoZZ]]c+dNdeiiojmou{/W[>)Z..01468M99F HHRfX&[`+aa]ddfgtjm}xxE9 Q4F#$&&H5 CO V\a]ibbbdfYim7rBsuvyp H!K'2(*N-15^7:-<AE1HGMRS T]]_bch instvvl@c ^bTb"l#0D>IRILQSTW ]ZefOotuw/yH<!|Qqc!"#&)2V5?DoK7N2P\SSTUXYvalj E aZ+,.1;=E>C??@@ADEILM\NNqOSW>ac j\lVooxp}9M K t(8Fb/s!%o&*-v.Y=>>?<@u@6EtQRxVYDcppcsz|~ \aDB(!!"-++8X88$;>BFIKO@OxQS _&__`EbSbf gLggktttvvy9{ w !##*$;$ *A,t-{-07:0??9@DFFTHVWb dDhmnowo^s_xHz* T$.12269 >DGIBKNR8SvW_azchkmmumptps '4"+,-f07138<=>mEEGBNOV[_bVdIgFh(l[pz{~ : U(5))-//e1)333475:"=ELLM-OO`PPf~u| <B"(*+,.X22:;<CDOH UVGXY&YZaaSil[m"n5 Z ( )AO~+$-I/F2{8OsPRAXYdg;hjzoquIvw{.M lSz#2&/;C6FGQQSbUV]]gitlqy{g~BT~&,J0P078:;CNDIRU`hkjoppp,twzL~{o-!$|))*d333456778>>?BHJOV7Wghckt{|.c&./0>558<<<>DGkHN}O RV[bcdne-hjpru}v } A &,` x!$}%%d.489/>%?@C^FYL[L8MNNNXOSaeijck*lHqrFuvT[  #F/B5C: <=>/@mECFVGHIIO PUPcPLVNWfghEiOkkpnpxyQ/ 8(.S2:-;;DE HHKrTiY[\dd&fIfg@hemYzo~h)-].7K=lAKCDE7JMGPGRTUYUYYachi+nno*qYs~vx #Q%+26728:z>~?ACCGCHWKaR8S0TjYZ\]`ii&t[y%{~U]{!#%\&&6))06q8:;;q>T??%@L@EVHDILSUUW[^agfpyq%O > );e` <#&s+,G/T/]/058:;CCGG HPJ8LLOQ?U]_Pdi h wbx#i#z003D47:>CDFH NQQSZ^[b7g>giV} Bl $'k+62o235<6f89?&BuBCC D=EH[IMU)a/cdhi/mmwx yyz|h|E !),-2N;~; <T>XDLPPVW]`bihnnfpUt0yRzh: %x,A.C.r. 79B;K;9AApBELRWWu]eg-oo/ G~"O%'>*11C55o7u8?8BF"GGaQ U\_pbghnot~4e i "()*<+24<BLOUQsSUWIX_YZ^fugklouP|: 00#+&&&'+48=5KNRW?X]]`b.djtmprrvv,xhx0c= D s$&)i++-f/ 267<? CEPZG[<\^"_efk\x}~ #6 |"'+/3;667 ;>?yAAC=DLPRSTWVdh imPyp~~` d ! ,.+0449:@ FPVS!`ak~rstux}.m5  $@(R)u++6::@PF&GI JTKKR^bd+e8gmqr8z0~?W5 JZ}$e%)22cAAHIRTV,YZ[^be/ijHkk0nU|} w9&239ADEFGGIYY_fiTlyl{}X/,P / o(X.vzU!S%,258w=ONUWzZ [\_,ffhmsqsNvxQz|6$&-'b6:8?FFsIzJKKUS+\aacdipl4w={~{v~ $d6u>>BDFE_IXNOQQX[$bfmnn`(h)%"%>&t)..]5566639>-?DELOOST[dk`p{l~ {= Vbg!%=&08VBK#KOiUZy\A]]^bOoI|b|R|I  )+,..236>OO&T_I`Wgrijjl1moppsYxxz': o|e ![##%|'/0W2*>&BBlDSLUnViYc]s]Wbb\cbcdmp@v|}: w N-Y!%49g<??~CCTHVZZgituxz|| [ 7O-/6'>C^DHILBM$PPMQQQSWZZ/\1\\^yyz=z~Nzf ZFH')./:::;=t?NCEGwLM OPTC``dIdfghik'lGosvwTx~'((*.,Z,/>?@ENRU&_b\f{iik{mowIw.}}Z; - b%U&)H*./0:;CCIGIRLNRESVY^-__abbjlrZuz }6 W$&;7v77xCuE;HLtMM4OVOT@UZEf0impOuuP}~Y@Jk.n!{+,A../03g<e?CD{HILOOQnS%TKYrY\]^_b^hmttlx\zu|~=N $/0+1%@!ALGRYSU YinoTqqqsvz{|}s Q.Z#T)*,.U166O:@CJEL|OOQR%S XZ[cdeffr7yq{}  ?wG#F"'')Q*-015d=AwE I"IIOP4T0Z_b?cfn%rswq%%z&&)V+..c.e00M68:AIJM+P6U[[i\^dgJgjjlmpomrrvg=%b% &22 88>KQ+U.ZZ`^ffhh%p{psgx{dm H%`)**,05678/@@AEDHKKMOWP(RS UUUWXapbFee2oCqtvy? cE2)G &+g3;=TAGzJPZU\UuW`bfimGouz|U' u5."l%I&{&((),q./1567<>G.GH2PmSV{WFZ]Z]l^_1`am4z{{/  !0*!.K.I; =?[@BBCCCHMOpPAS0]]]d;ehhTitX{\{||}}~ V c+-034X558<M?ByDXG X[imqbrw]h G K)P,--36:< C,EFHOrPU>[#b\hikrXwlz{&~g|%&S)0_1:^;E9Q-RR[Y\`aaghCjkppKrl{vC f!'2+2,X,/t1037;E;o<=EG7NNSX)Y^_egioqt}:i}_V { $X%&119Y<<n?@(DE HHJ_QQRRbVZhjopwwy{7ze)N"&&j'%*045:n:#CCCFuU/XYk]_bc.dhkslmoEq||C !%+1I77>??=AnE&H\N1Q'[]] agii)ookt&xz|~f7s'(()-.-/s/9;?CE_FZRD[^`daBe%kwwy?v9 >v"+/P3:<*>W? FLObOmPQ]iklmqsYv[zh- @Hw'],_.s/0O3_9>BIQ[a[a|ggiRlnmncqrr ! rXw # (*",-R-/i11,4L5,7 9:|:?SEIKP3QXijkjxm/ovnwO M e.a#&.,???JEHYR^SSWRXXqY_dgkm=qss4zz}~)|'9,$).00611X<>?E GwGK3LLTTU^u`tdf$gEg[suz{ 0- n!*,,/0E1{2 57J83:H;<ACCC7KlMNPfjmnrvAAIW`Ibifh)ikWqqq!{m)i\l(qd $'7)*+,Z./14587; @@ADEWWYZ_`bbfim=qqsxxD~~K)># ((*-}// 115T@AA]BEEHIWMM:TXraatbbcegimoLujuGx7 $4` j#$1P5&6w>>EI SKX]E_jauc0lKqr`s"viw|~ e $) .3?9<DOHLrQWVjXBYY\]c`Xgp(x^}}:"((',,,%4S<>>2@@FABDJKLWY$_bc6ggms~$"\%A0n133x:qBBFGH)JLW]adjMkktlmCostEuw@z7{5|Gq :u""-45:6=CH,NW^aYeFg2lt g!((*+}/T4A=H=?CDC #w#<$k.1356?@FG$I-M2TNTBU$X]^j_Kehen@oDppsxTX!;"%%'/4#78b<?EfKgVbW\`af{j9q:u||+ P  wv"(f/7:s;;yHHpQUbinj|- R !_%) --)5&7w;8O[^Ie_f"mm-tVxx5yI{u`l `sa!%,.53ACEAKMQaV)]__`b6g[jGzf (J;b"#$+.7./2|6>??!DoJLrM O!OpOPrRSUYp[)deefm oo vxxy{||~ Q|z^V+2R;;CCwERT(UXZj[7\agjmyz}= ea"?#$%+(11226>@$CEHSIlLLZefhjkm\ns}}~_+~ X-&h.>:>r?ABKL[`beWf~j+m qrsLtx0y~q %r Z$ ''+2-o-.92678:>4BtBHDIJhKKRSbXX\]aVkampqr ssuvwyz|}O3a +gqJ!R%+,16\;==0HHMM`RTCUdZi]]^bdZloorbvUy ~ */ $,%q's/s2;]=3?^@FG@QyUVY`anllqrs)vYvxy9Dr]4 !).02I35ICJpJ4MTY Z]i_ijsqsN}[~} rh ".Y47?M@G]HHIIIOTT[^Pb%cv"x" X%''((1#7E0NNP,QjQ$UX]e`m\notp{N)3hMM6  \ "#_$++11669;?D EH+MPTV[\__`pbdhqjjhm~xz~ OQ~b .E(1U80@BFFGIUM7P]Q`sdgh/l\oo!u%uywyy}I j)%w "#Q*134 7:cFL[3]bklnsx^ 0JS"u%/559:>bQRXZO[\qbcj kk6l(q&tz 1  6' .N226;99;<]?eCgEHbMeNOS_UUY\{\g^mr/z>zzz|} Mk&++1x889@@ABC7NT:UT[\ei ~<3 f :!+{, /p6@9;)<?IQTVIXZX[H^Bjk$l|lowwlxxz 3 g4 m$&M&'(o(B//T15e;=AKR]y`bmnoqxz|A V 9!K'+5,--?../7^8GG5MlNePQVikm >N &'+F/t/7:CLlLNRFWWSXX_h_\arduwUI >b%':+,157X89R?BHQUXRhlupu% { u .!!T$034;#<>>l?BGGHSI JzKK#T?U/oswuw=c IF"^%&06X:<X=:>1@@DDF>G?PSW[^_+a.qs t8v+w[  5.7g77|;;@AE FHIK)MMNODP#RUZc^`uj'klOrtv;  ' 8$%%'d),-;.I2v45Q6t???IV+WXoYa~jlmov y{P|2~hjN _ *367d9HNII2JZI[e3nEsvV o$%',/0L477}8*<<A>>(MmN)V[W bb>cgnopQqtx{}}~CLEL@'L'L'L'LsLh@UnknownG.Cx Times New Roman5Symbol3. *Cx ArialG=  jMS Mincho-3 fg7.@Calibri7. [ @Verdana;. *Cx HelveticaI. ??Arial Unicode MSC ArialMTArialM ATraditional Arabic7@CambriaK ASimplified Arabic?= *Cx Courier NewO"MS Sans SerifArial9Garamond5. .[`)Tahoma;WingdingsA$BCambria Math"1 hfr)F7 h27 h2!x4JJ 2q HP ?'LZZ2!xxAngular cheilitispalgateSamar                           ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~                                   ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~                                                               !  OM2 theory`    ( 4@HPXpalgateNormalSamar3804Microsoft Office Word@X"`@W@R:@'h7 Six chapters 2014 http://www.medicinenet.com/script/main/art.asp?articlekey=396! W%http://en.wikipedia.org/wiki/Anaemia! o-http://en.wikipedia.org/wiki/Organ_(anatomy)! R*http://en.wikipedia.org/wiki/Steatorrhoea! F &http://en.wikipedia.org/wiki/Diarrhea! 'P/http://en.wikipedia.org/wiki/Intestinal_villus! /d+http://en.wikipedia.org/wiki/Malabsorption! R*http://en.wikipedia.org/wiki/Inflammation!  e4http://en.wikipedia.org/wiki/Genetic_predisposition! z-http://en.wikipedia.org/wiki/Small_intestine! ^*http://en.wikipedia.org/wiki/Autoimmunity! h-http://en.wikipedia.org/wiki/Toxic_megacolon! p*2http://en.wikipedia.org/wiki/Liver_function_tests! 2d,http://en.wikipedia.org/wiki/Hypomagnesemia! N )http://en.wikipedia.org/wiki/Hypokalemia! F &http://en.wikipedia.org/wiki/Diarrhea! |,http://en.wikipedia.org/wiki/Renal_function! P)http://en.wikipedia.org/wiki/Electrolyte! ^*http://en.wikipedia.org/wiki/Autoimmunity! \&http://en.wikipedia.org/wiki/Genetics!  O/http://en.wikipedia.org/wiki/Colorectal_cancer! ~\2http://en.wikipedia.org/wiki/Remission_(medicine)! F &http://en.wikipedia.org/wiki/Diarrhea! |-http://en.wikipedia.org/wiki/Colon_(anatomy)! "o8http://en.wikipedia.org/wiki/Inflammatory_bowel_disease! G 7http://en.wikipedia.org/wiki/Adverse_effect_(medicine)! 3W},http://en.wikipedia.org/wiki/Terminal_ileum! Iz)http://en.wikipedia.org/wiki/Colonoscopy! xJw3http://en.wikipedia.org/wiki/Barium_follow-through! xt/http://en.wikipedia.org/wiki/Capsule_endoscopy! JFqBhttp://en.wikipedia.org/wiki/Anti-neutrophil_cytoplasmic_antibody! zn6http://en.wikipedia.org/wiki/Saccharomyces_cerevisiae! "tk,http://en.wikipedia.org/wiki/Cyanocobalamin! 6rh$http://en.wikipedia.org/wiki/Anemia! \e&http://en.wikipedia.org/wiki/Genetics! Rb*http://en.wikipedia.org/wiki/Inflammation! -J_+http://en.wikipedia.org/wiki/Immune_system! $@\0http://en.wikipedia.org/wiki/Autoimmune_disease! |Y-http://en.wikipedia.org/wiki/Colon_(anatomy)! SV%http://en.wikipedia.org/wiki/Symptom! [ S"http://en.wikipedia.org/wiki/Anus! .oP#http://en.wikipedia.org/wiki/Mouth! EM)http://en.wikipedia.org/wiki/Allopurinol! DJ*http://en.wikipedia.org/wiki/Barbiturates! .rG'http://en.wikipedia.org/wiki/Phenytoin! ZD&http://en.wikipedia.org/wiki/Steroids! ,|A,http://en.wikipedia.org/wiki/Antihistamines! G>)http://en.wikipedia.org/wiki/Epinephrine! (|;+http://en.wikipedia.org/wiki/Immunotherapy! r!8?http://www.medicinenet.com/script/main/art.asp?articlekey=9105! s"5@http://www.medicinenet.com/script/main/art.asp?articlekey=12953! I2>http://www.medicinenet.com/script/main/art.asp?articlekey=284! y#/@http://www.medicinenet.com/script/main/art.asp?articlekey=64425! N,>http://www.medicinenet.com/script/main/art.asp?articlekey=511! z$)?http://www.medicinenet.com/script/main/art.asp?articlekey=1908! z,&?http://www.medicinenet.com/script/main/art.asp?articlekey=1900! v #@http://www.medicinenet.com/script/main/art.asp?articlekey=41943! }( @http://www.medicinenet.com/script/main/art.asp?articlekey=15781! S/.http://en.wikipedia.org/wiki/Food_intolerance! -J+http://en.wikipedia.org/wiki/Immune_system! <l;http://www.nlm.nih.gov/medlineplus/ency/article/003895.htm! 6c;http://www.nlm.nih.gov/medlineplus/ency/article/003436.htm! 4c;http://www.nlm.nih.gov/medlineplus/ency/article/003416.htm! 6j;http://www.nlm.nih.gov/medlineplus/ency/article/003338.htm! 1i ;http://www.nlm.nih.gov/medlineplus/ency/article/003840.htm! 5h;http://www.nlm.nih.gov/medlineplus/ency/article/003009.htm! @'-http://en.wikipedia.org/wiki/Exocrine_glands! )U/http://en.wikipedia.org/wiki/Connective_tissue! /b$http://en.wikipedia.org/wiki/Mucosa! ^"http://en.wikipedia.org/wiki/Skin! 9w#http://en.wikipedia.org/wiki/Liver! +0http://en.wikipedia.org/wiki/Chronic_(medicine)! {-http://en.wikipedia.org/wiki/Acute_(medical)! V &http://en.wikipedia.org/wiki/Leukemia! 7w$http://en.wikipedia.org/wiki/Cancer!  w5http://en.wikipedia.org/wiki/Complication_(medicine)! H>http://www.medicinenet.com/script/main/art.asp?articlekey=336! O>http://www.medicinenet.com/script/main/art.asp?articlekey=476! H>http://www.medicinenet.com/script/main/art.asp?articlekey=361! JAhttp://www.medicinenet.com/script/main/art.asp?articlekey=120806! K 2http://en.wikipedia.org/wiki/Lung_transplantation! r?Qhttp://en.wikipedia.org/wiki/Cystic_fibrosis_transmembrane_conductance_regulator! R)http://en.wikipedia.org/wiki/Infertility! F &http://en.wikipedia.org/wiki/Diarrhea!  O/http://en.wikipedia.org/wiki/Failure_to_thrive! )v'http://en.wikipedia.org/wiki/Sinusitis! (h'http://en.wikipedia.org/wiki/Pneumonia! x*1http://en.wikipedia.org/wiki/Shortness_of_breath! u -http://en.wikipedia.org/wiki/Genetic_carrier! ~,http://en.wikipedia.org/wiki/Caucasian_race! ]&http://en.wikipedia.org/wiki/Fibrosis! V "http://en.wikipedia.org/wiki/Scar! %y(http://en.wikipedia.org/wiki/Prednisone! 4g,http://en.wikipedia.org/wiki/Corticosteroid! z(?http://www.medicinenet.com/script/main/art.asp?articlekey=2538! a*http://en.wikipedia.org/wiki/Lupus_pernio! N,.http://en.wikipedia.org/wiki/Erythema_nodosum! T"http://en.wikipedia.org/wiki/Rash! |!?http://www.medicinenet.com/script/main/art.asp?articlekey=3145! Y%http://en.wikipedia.org/wiki/Dyspnea! :|+http://en.wikipedia.org/wiki/Xerophthalmia! /'http://en.wikipedia.org/wiki/Arthritis! \*)http://en.wikipedia.org/wiki/Weight_loss! 30http://en.wikipedia.org/wiki/Fatigue_(physical)! i)http://en.wikipedia.org/wiki/Lymph_nodes! @"http://en.wikipedia.org/wiki/Lung! (b'http://en.wikipedia.org/wiki/Granuloma! [%http://en.wikipedia.org/wiki/Chronic! F*http://en.wikipedia.org/wiki/Asymptomatic! ?Y8http://en.wikipedia.org/wiki/Natural_history_of_disease! KBhttp://www.medicinenet.com/script/main/forum.asp?articlekey=32101! x+~@http://www.medicinenet.com/script/main/art.asp?articlekey=18262! N{Bhttp://www.medicinenet.com/script/main/forum.asp?articlekey=34434! OxBhttp://www.medicinenet.com/script/main/forum.asp?articlekey=26109! s%u@http://www.medicinenet.com/script/main/art.asp?articlekey=13931! =or+http://en.wikipedia.org/wiki/Mycophenolate! G o.http://en.wikipedia.org/wiki/Cyclophosphamide! Kl*http://en.wikipedia.org/wiki/Azathioprine! Hi*http://en.wikipedia.org/wiki/Methotrexate!  f4http://en.wikipedia.org/wiki/Raynaud%27s_phenomenon! |$c@http://www.medicinenet.com/script/main/art.asp?articlekey=42331! ~(`?http://www.medicinenet.com/script/main/art.asp?articlekey=1944! H]>http://www.medicinenet.com/script/main/art.asp?articlekey=315! HZ>http://www.medicinenet.com/script/main/art.asp?articlekey=336!  /W8http://en.wikipedia.org/wiki/Anti-centromere_antibodies! 'T;http://en.wikipedia.org/wiki/Anti-topoisomerase_antibodies! O Q%http://en.wikipedia.org/wiki/Morphea! v|N:http://www.sclero.org/medical/symptoms/dental/a-to-z.html periodontalK:http://www.sclero.org/medical/symptoms/dental/a-to-z.html dentalcariesiH:http://www.sclero.org/medical/symptoms/dental/a-to-z.html xerostomiafpE<http://www.sclero.org/medical/symptoms/sjogrens/a-to-z.html! xuB:http://www.sclero.org/medical/symptoms/dental/a-to-z.html microstomia$y?(http://en.wikipedia.org/wiki/Intestinal! @<"http://en.wikipedia.org/wiki/Lung! 2u9$http://en.wikipedia.org/wiki/Kidney! "b6#http://en.wikipedia.org/wiki/Heart! %u3+http://en.wikipedia.org/wiki/Sclerodactyly!  04http://en.wikipedia.org/wiki/Raynaud%27s_phenomenon! }"-@http://www.medicinenet.com/script/main/art.asp?articlekey=43240! ]*&http://en.wikipedia.org/wiki/Fibrosis! $@'0http://en.wikipedia.org/wiki/Autoimmune_disease! {$-http://en.wikipedia.org/wiki/Chronic_disease! =N!+http://en.wikipedia.org/wiki/AIDS_pandemic! w,http://en.wikipedia.org/wiki/Mortality_rate! S6)http://en.wikipedia.org/wiki/Breast_milk! H=.http://en.wikipedia.org/wiki/Preseminal_fluid! {+http://en.wikipedia.org/wiki/Vaginal_fluid! 5o#http://en.wikipedia.org/wiki/Semen! 6v#http://en.wikipedia.org/wiki/Blood! Y/ *http://en.wikipedia.org/wiki/Bodily_fluid! @8 -http://en.wikipedia.org/wiki/Mucous_membrane! ~5http://en.wikipedia.org/wiki/Transmission_(medicine)! -J+http://en.wikipedia.org/wiki/Immune_system! o)http://en.wikipedia.org/wiki/HIV_vaccine! >e;http://www.nlm.nih.gov/medlineplus/ency/article/000682.htm! 7c;http://www.nlm.nih.gov/medlineplus/ency/article/002230.htm! (b'http://en.wikipedia.org/wiki/Granuloma! w/http://en.wikipedia.org/wiki/Gumma_(pathology)! T)http://en.wikipedia.org/wiki/Spirochetes! =j+http://en.wikipedia.org/wiki/Fusobacterium! ;o'http://en.wikipedia.org/wiki/Halitosis! }%http://en.wikipedia.org/wiki/GingivaMarginal_gingivan1http://en.wikipedia.org/wiki/Interdental_papilla! 4`(http://en.wikipedia.org/wiki/Ulceration! Q&http://en.wikipedia.org/wiki/Necrosis! Z*http://en.wikipedia.org/wiki/Periodontium! Z*http://en.wikipedia.org/wiki/Periodontium! M%http://en.wikipedia.org/wiki/Gingiva! "n#http://en.wikipedia.org/wiki/Acute! FAhttp://www.medicinenet.com/script/main/art.asp?articlekey=109152! F)http://en.wikipedia.org/wiki/Amoxicillin! 4h(http://en.wikipedia.org/wiki/Ampicillin! L>http://www.medicinenet.com/script/main/art.asp?articlekey=748! V*http://en.wikipedia.org/wiki/Valacyclovir! 3'http://en.wikipedia.org/wiki/Aciclovir! v4@http://www.webmd.com/cold-and-flu/tc/sore-throat-topic-overview! -y'http://en.wikipedia.org/wiki/Ibuprofen!  _Bhttp://en.wikipedia.org/wiki/Non-steroidal_anti-inflammatory_drug! i@5http://en.wikipedia.org/wiki/Self-limiting_(biology)! @ *http://en.wikipedia.org/wiki/Transaminase! T#*http://en.wikipedia.org/wiki/Cell_nucleus! @&http://en.wikipedia.org/wiki/Inguinal! @ &http://en.wikipedia.org/wiki/Axillary! K*http://en.wikipedia.org/wiki/Splenomegaly! z'?http://www.medicinenet.com/script/main/art.asp?articlekey=2133! x"@http://www.medicinenet.com/script/main/art.asp?articlekey=26114! O>http://www.medicinenet.com/script/main/art.asp?articlekey=480! H>http://www.medicinenet.com/script/main/art.asp?articlekey=361! c"/http://dermnetnz.org/treatments/imiquimod.html! r/http://en.wikipedia.org/wiki/Medical_diagnosis! %e'http://en.wikipedia.org/wiki/Echovirus! )l$http://en.wikipedia.org/wiki/Tonsil! F0)http://en.wikipedia.org/wiki/Soft_palate! .o#http://en.wikipedia.org/wiki/Mouth! X2)http://en.wikipedia.org/wiki/Sore_throat! 5}#http://en.wikipedia.org/wiki/Fever! %t'http://en.wikipedia.org/wiki/Infection! O|%http://en.wikipedia.org/wiki/Blister! Oy>http://www.medicinenet.com/script/main/art.asp?articlekey=480! Fv*http://en.wikipedia.org/wiki/Asymptomatic! -Cs4http://en.wikipedia.org/wiki/Foot-and-mouth_disease! 3op'http://en.wikipedia.org/wiki/Acyclovir! %ym(http://en.wikipedia.org/wiki/Prednisone! qj/http://en.wikipedia.org/wiki/Vertigo_(medical)! Fg&http://en.wikipedia.org/wiki/Tinnitus! X?d)http://en.wikipedia.org/wiki/Hard_palate! Ta"http://en.wikipedia.org/wiki/Rash! X^*http://en.wikipedia.org/wiki/Erythematous! } [:http://en.wikipedia.org/wiki/Acute_facial_nerve_paralysis! kX5http://en.wikipedia.org/wiki/Vestibulocochlear_nerve! kU)http://en.wikipedia.org/wiki/Chicken_pox! _R&http://en.wikipedia.org/wiki/Shingles! TO!http://en.wikipedia.org/wiki/Ear! KL:http://en.wikipedia.org/wiki/Ramsay_Hunt_syndrome_type_II! XI&http://en.wikipedia.org/wiki/Zostavax! YF%http://en.wikipedia.org/wiki/Vaccine! 2CC/http://en.wikipedia.org/wiki/Ophthalmic_zoster! C@&http://en.wikipedia.org/wiki/Morphine! <x='http://en.wikipedia.org/wiki/Lidocaine! 9H:(http://en.wikipedia.org/wiki/Zinc_oxide! N$7-http://en.wikipedia.org/wiki/Calamine_lotion! ] 4&http://en.wikipedia.org/wiki/Antibody! R1!http://en.wikipedia.org/wiki/IgM! c.2http://en.wikipedia.org/wiki/Psychological_stress! r+7http://en.wikipedia.org/wiki/Immunosuppressive_therapy! 7w($http://en.wikipedia.org/wiki/Cancer! N%*http://en.wikipedia.org/wiki/Encephalitis! aN",http://en.wikipedia.org/wiki/Bell%27s_palsy! 1G4http://en.wikipedia.org/wiki/Postherpetic_neuralgia! I)http://en.wikipedia.org/wiki/Paresthesia! 4|+http://en.wikipedia.org/wiki/Hyperesthesia! F%http://en.wikipedia.org/wiki/Malaise! 5}#http://en.wikipedia.org/wiki/Fever! W&http://en.wikipedia.org/wiki/Headache! M "http://en.wikipedia.org/wiki/Axon!  &http://www.nhsdirect.nhs.uk/glossary/Immune systemS&http://en.wikipedia.org/wiki/Symptoms! Z&http://en.wikipedia.org/wiki/Ganglion! x+http://en.wikipedia.org/wiki/Viral_latency! Z4http://en.wikipedia.org/wiki/Varicella_zoster_virus! d+http://en.wikipedia.org/wiki/Viral_disease! 3o'http://en.wikipedia.org/wiki/Acyclovir! _%http://en.wikipedia.org/wiki/Therapy! X &http://en.wikipedia.org/wiki/Sedative! <y#http://en.wikipedia.org/wiki/Sleep! 9H(http://en.wikipedia.org/wiki/Zinc_oxide! N$-http://en.wikipedia.org/wiki/Calamine_lotion! @"http://en.wikipedia.org/wiki/Cure! T"http://en.wikipedia.org/wiki/Rash! L&http://en.wikipedia.org/wiki/Prodrome! %t'http://en.wikipedia.org/wiki/Infection!  O0http://en.wikipedia.org/wiki/Infectious_disease! G&http://www.nhsdirect.nhs.uk/glossary/ EpidemicO%http://en.wikipedia.org/wiki/Blister! Z4http://en.wikipedia.org/wiki/Varicella_zoster_virus! N*http://en.wikipedia.org/wiki/Encephalitis!  ~,http://en.wikipedia.org/wiki/Superinfection! 9o$http://en.wikipedia.org/wiki/Lesion! F%http://en.wikipedia.org/wiki/Debride! <x3http://en.wikipedia.org/wiki/Incision_and_drainage! 3o'http://en.wikipedia.org/wiki/Acyclovir! s,http://en.wikipedia.org/wiki/Antiviral_drug! F%http://en.wikipedia.org/wiki/Whitlow! U-http://en.wikipedia.org/wiki/Autoinoculation! mb+http://en.wikipedia.org/wiki/Thumb-sucking! O%http://en.wikipedia.org/wiki/Blister! 3o'http://en.wikipedia.org/wiki/Acyclovir! 9o$http://en.wikipedia.org/wiki/Lesion! A)http://en.wikipedia.org/wiki/Pharyngitis! +y(http://en.wikipedia.org/wiki/Adolescent! u/http://en.wikipedia.org/wiki/Primary_infection! ^-http://en.wikipedia.org/wiki/Lymphadenopathy! ,b(http://en.wikipedia.org/wiki/Stomatitis! 9(http://en.wikipedia.org/wiki/Gingivitis! 2b+http://www.umm.edu/ency/article/000643.htm! <l+http://www.umm.edu/ency/article/002982.htm! }r[http://health.nytimes.com/health/guides/test/upper-gi-and-small-bowel-series/overview.html! Zhttp://health.nytimes.com/health/guides/test/egd-esophagogastroduodenoscopy/overview.html! DAhttp://dermnetnz.org/immune/epidermolysis-bullosa-acquisita.html! O%http://en.wikipedia.org/wiki/Blister! ^"http://en.wikipedia.org/wiki/Skin! vS.http://en.wikipedia.org/wiki/Gluten-free_diet! R}&http://en.wikipedia.org/wiki/Bacteria! 4kz+http://en.wikipedia.org/wiki/Antibacterial! 5w.http://en.wikipedia.org/wiki/Diet_(nutrition)! 1nt(http://en.wikipedia.org/wiki/Medication! {q,http://en.wikipedia.org/wiki/False_negative! bn6http://en.wikipedia.org/wiki/Adult_linear_IgA_disease! \6k-http://en.wikipedia.org/wiki/Dermal_papillae! ph$http://en.wikipedia.org/wiki/Biopsy Skin_Biopsy-he$http://en.wikipedia.org/wiki/Gluten! jb3http://en.wikipedia.org/wiki/Vesicle_(dermatology)! A_"http://en.wikipedia.org/wiki/Itch!  `\$http://en.wikipedia.org/wiki/Herpes! OY)http://en.wikipedia.org/wiki/Herpesvirus! SV&http://en.wikipedia.org/wiki/Lymphoma! $yS(http://en.wikipedia.org/wiki/Intestinal! f P-http://en.wikipedia.org/wiki/Thyroid_disease! wM-http://en.wikipedia.org/wiki/Coeliac_disease! 7WJ0http://en.wikipedia.org/wiki/Gluten_sensitivity! 1nG(http://en.wikipedia.org/wiki/Medication! >pD/http://en.wikipedia.org/wiki/Immunosuppression! KA*http://en.wikipedia.org/wiki/Azathioprine! H>*http://en.wikipedia.org/wiki/Methotrexate! ?b;/http://en.wikipedia.org/wiki/Immunosuppressant! %y8(http://en.wikipedia.org/wiki/Prednisone! &n5'http://en.wikipedia.org/wiki/Urticaria! 9o2$http://en.wikipedia.org/wiki/Lesion! 0n/7http://emedicine.medscape.com/article/1062391-overview! S,:http://medical-dictionary.thefreedictionary.com/Pemphigus! -E)+http://en.wikipedia.org/wiki/Nikolsky_sign! ,p&$http://en.wikipedia.org/wiki/Bullae! =b#(http://en.wikipedia.org/wiki/Epithelium! <Q /http://en.wikipedia.org/wiki/Basement_membrane! 7`(http://en.wikipedia.org/wiki/Autoimmune! ~34http://www.webmd.com/eye-health/picture-of-the-eyes! QN"http://en.wikipedia.org/wiki/CD20! !n'http://en.wikipedia.org/wiki/Rituximab! *r#http://en.wikipedia.org/wiki/ELISA! #m(http://en.wikipedia.org/wiki/Desmosomes! R !http://en.wikipedia.org/wiki/IgG! )a0http://en.wikipedia.org/wiki/Immunofluorescence! O*http://en.wikipedia.org/wiki/Acantholysis! j3http://en.wikipedia.org/wiki/Vesicle_(dermatology)! -E+http://en.wikipedia.org/wiki/Nikolsky_sign! 8 1http://en.wikipedia.org/wiki/Haley-Haley_disease! #m(http://en.wikipedia.org/wiki/Desmosomes! [&http://en.wikipedia.org/wiki/Pathogen! &o(http://en.wikipedia.org/wiki/Contagious! q15http://en.wikipedia.org/wiki/Lichenoid_drug_reaction! /0http://en.wikipedia.org/wiki/Wickham%27s_striae! @8-http://en.wikipedia.org/wiki/Mucous_membrane! ^"http://en.wikipedia.org/wiki/Skin! V5)http://en.wikipedia.org/wiki/Oral_mucosa! E-http://en.wikipedia.org/wiki/Ophthalmologist! ^G6http://emedicine.medscape.com/article/229698-overview! 76http://en.wikipedia.org/wiki/Stevens-Johnson_syndrome! \ %http://en.wikipedia.org/wiki/Malaria! H*http://en.wikipedia.org/wiki/Methotrexate! >p/http://en.wikipedia.org/wiki/Immunosuppression! 4g,http://en.wikipedia.org/wiki/Corticosteroid! G .http://en.wikipedia.org/wiki/Cyclophosphamide! b/http://en.wikipedia.org/wiki/Mercury_(element)! #y'http://en.wikipedia.org/wiki/Pesticide! 5c$http://en.wikipedia.org/wiki/Silica! ;A/http://en.wikipedia.org/wiki/Complement_system! |,http://en.wikipedia.org/wiki/Renal_function! R*http://en.wikipedia.org/wiki/Inflammation! -J+http://en.wikipedia.org/wiki/Immune_system! u"?http://www.medicinenet.com/script/main/art.asp?articlekey=8067! P1http://www.healthscout.com/ency/68/429/main.html! ~\2http://en.wikipedia.org/wiki/Remission_(medicine)! f ,http://en.wikipedia.org/wiki/Nervous_system Vertebrates2u$http://en.wikipedia.org/wiki/Kidney! 9w#http://en.wikipedia.org/wiki/Liver! *http://en.wikipedia.org/wiki/Blood_vessel! @"http://en.wikipedia.org/wiki/Lung! ^"http://en.wikipedia.org/wiki/Skin! 4h#http://en.wikipedia.org/wiki/Joint! "b#http://en.wikipedia.org/wiki/Heart!  F7http://en.wikipedia.org/wiki/Connective_tissue_disease! ^*http://en.wikipedia.org/wiki/Autoimmunity! ?G/http://en.wikipedia.org/wiki/Pathergy_reaction! C%http://en.wikipedia.org/wiki/Uveitis! 3v$http://en.wikipedia.org/wiki/Iritis! V"http://en.wikipedia.org/wiki/Acne! N,.http://en.wikipedia.org/wiki/Erythema_nodosum! M ~*http://en.wikipedia.org/wiki/Folliculitis! 9o{$http://en.wikipedia.org/wiki/Lesion! ^x"http://en.wikipedia.org/wiki/Skin! \u*http://en.wikipedia.org/wiki/Epididymitis! Gr&http://en.wikipedia.org/wiki/Testicle! [ o"http://en.wikipedia.org/wiki/Anus! Yl&http://en.wikipedia.org/wiki/Hallmark! ^ i&http://en.wikipedia.org/wiki/Aphthous! f*http://en.wikipedia.org/wiki/Blood_vessel! Rc*http://en.wikipedia.org/wiki/Inflammation! %t`'http://en.wikipedia.org/wiki/Infection! -J]+http://en.wikipedia.org/wiki/Immune_system! /oZ(http://en.wikipedia.org/wiki/Vasculitis! X&W-http://en.wikipedia.org/wiki/Zinc_deficiency! :NT)http://en.wikipedia.org/wiki/Vitamin_B12! A0Q*http://en.wikipedia.org/wiki/Oral_hygiene! [5N*http://en.wikipedia.org/wiki/Saline_water! TK"http://en.wikipedia.org/wiki/Pain! KCHQhttp://www.patient.co.uk/DisplayConcepts.asp?WordId=ANTIHISTAMINES&MaxResults=50! Y@EMhttp://www.patient.co.uk/DisplayConcepts.asp?WordId=CETIRIZINE&MaxResults=50! JBRhttp://www.patient.co.uk/DisplayConcepts.asp?WordId=BENZODIAZEPINES&MaxResults=50! Y?"http://en.wikipedia.org/wiki/ELA2! m <-http://en.wikipedia.org/wiki/Upper_endoscopy! 59.http://en.wikipedia.org/wiki/Diet_(nutrition)! G6"http://en.wikipedia.org/wiki/Iron! 7S3/http://en.wikipedia.org/wiki/Microcytic_anemia! x0)http://en.wikipedia.org/wiki/Blood_tests! 4v-'http://en.wikipedia.org/wiki/Dysplasia! '{*'http://en.wikipedia.org/wiki/Endoscopy! S')http://en.wikipedia.org/wiki/Radiography! )k$'http://en.wikipedia.org/wiki/Nutrition! \!&http://en.wikipedia.org/wiki/Genetics! @*http://en.wikipedia.org/wiki/Premalignant! h!5http://en.wikipedia.org/wiki/Squamous_cell_carcinoma! Y4http://en.wikipedia.org/wiki/Iron_deficiency_anemia! *c'http://en.wikipedia.org/wiki/Glossitis! K2-http://en.wikipedia.org/wiki/Esophageal_webs! 4f'http://en.wikipedia.org/wiki/Dysphagia! g< 'http://www.mamashealth.com/oranges.asp! T[ &http://www.mamashealth.com/pregnancy/! >i7http://emedicine.medscape.com/article/1075994-overview! /i4http://en.wikipedia.org/wiki/Sodium_dodecyl_sulfate! 5a;http://www.nlm.nih.gov/medlineplus/ency/article/003808.htm  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~                            ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t  Root Entry F  @ Data  ;1TableWfWordDocument  SummaryInformation(DocumentSummaryInformation80:MsoDataStore . . YT0EZEWZBKY==2. . Item  PropertiesUCompObj yH5G3W2C3RNQ==2 . .   "#$   F'Microsoft Office Word 97-2003 Document MSWordDocWord.Document.89q Item  Properties FBJ0A04==2. . Item PropertiesERJQZN4R5N==2. . Item Properties!nOccurs="0" maxOccurs="1"/> This value indicates the number of saves or revisions. The application is responsible for updating this value after each revision. cumentation> This value indicates the number of saves or revisions. The application is responsible for updating this value after each revision. DocumentLibraryFormDocumentLibraryFormDocumentLibraryForm Oh+'0`    ( 4@HPXpalgateNormalSamar3804Microsoft Office Word@X"`@W@R:@'h7 Six chapters 2014